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Animal toxins targeting voltage-activated sodium 
(NaV1.9) channels 
Frank BOSMANS 
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Abstract 
Voltage-activated sodium (NaV) channels are crucial for initiating and transmitting action 
potentials, an ability that places them amongst the most widely targeted ion channels by drugs 
and animal venoms. An increasing number of toxins isolated from animal venom have been 
shown to interfere with the voltage-driven activation process of NaV channels, possibly by 
interacting with one or more of their voltage-sensors. This mini-review summarizes our recent 
work on identifying novel animal toxin receptor sites within NaV channel voltage-sensors and 
illustrates how chimeric approaches can be used to uncover molecules that interact with NaV1.9, 
an enigmatic NaV channel involved in nociception. 
Les toxines animales ciblant les canaux sodium (NaV1.9) activés par 
le potentiel 
Les canaux sodium dépendants du potentiel (ou canaux NaV) sont cruciaux pour initier et 
transmettre des potentiels d'action, une capacité qui les place parmi les canaux les plus ciblés par 
les médicaments et les venins animaux. Il a été démontré qu’un nombre croissant de toxines 
isolées de venins animaux interfèrent avec le processus d'activation des canaux NaV, peut-être en 
interagissant avec un ou plusieurs de leurs senseurs de potentiel. Cette mini-revue résume notre 
travail récent sur l'identification des sites de nouvelles toxines animales se fixant sur les senseurs 
de potentiel des canaux NaV et démontre comment des approches chimériques peuvent être 
utilisées pour découvrir des molécules qui influent sur NaV1.9, un canal NaV énigmatique impliqué 
dans la sensation de douleur. 
Keywords : Animal toxin, pain, sodium channel, voltage-sensor. 
 
NaV channel S3b-S4 paddle motifs 
The NaV channel (Goldin et al., 2000) pore-forming subunit consists of four connected domains (I-IV) (Catterall, 
2000), each having six transmembrane segments (S1-S6) (Figure 1a). These similar entities consist of a 
voltage-sensor (S1-S4) and a portion of the structure that forms the sodium ion selective pore in the 
membrane (S5-S6). The pore can open or close when all four voltage-sensors move in response to changes in 
membrane voltage. It is thought that each of the four voltage-sensors activates in response to changes in 
membrane voltage, however, those in domains I-III are most important for channel opening, whereas the one 
in domain IV plays a distinctive role in inactivating the channel (Cha et al., 1999; Sheets et al., 1999; Horn et 
al., 2000; Sheets et al., 2000; Chanda and Bezanilla, 2002; Bosmans et al., 2008; Campos et al., 2008). 
Despite their physiological significance, structural information on NaV channels lags when compared to the 
structurally similar voltage-activated K+ (Kv) channels, where recent data has revealed structural features 
important for channel function. More specifically, studies on Kv channel voltage-sensors have identified an S3b-
S4 helix-turn-helix motif, the voltage-sensor paddle, which moves at the protein-lipid interface and drives 
activation of the voltage-sensors which, in turn, opens the pore (Figure 1b) (Jiang et al., 2003; Alabi et al., 
2007; Long et al., 2007; Chakrapani et al., 2008; Swartz, 2008). Besides its vital role in channel gating, the 
paddle motif is also an important pharmacological target in Kv channels, as spider toxins that partition into 
membranes interact with this region to inhibit channel opening (Swartz and MacKinnon, 1997b, a; Li-Smerin 
and Swartz, 1998, 2000; Lee et al., 2003; Phillips et al., 2005; Alabi et al., 2007; Swartz, 2007). Recently, we 
have shown that distinct paddle motifs also exist in each of the four voltage-sensors of NaV channels and that 
they can be transplanted into the four-fold symmetric Kv channel to study them in isolation (Bosmans et al., 
2008; Milescu et al., 2009). Furthermore, we demonstrated that each of the four paddle motifs is capable of 
interacting with toxins from tarantulas and scorpions and that multiple paddle motifs are often targeted by a 
single toxin. For example, it was shown that the tarantula toxin ProTx-II (Middleton et al., 2002) can interact 
with the voltage-sensor in domain I, II and IV, whereas a related tarantula toxin, PaurTx3, only interacts with 
domain II (Bosmans et al., 2008). It is also interesting that the profiles of toxin-paddle interactions vary for 
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different subtypes of NaV channels. This chimeric approach was recently applied to NaV1.9, a relatively unknown 
NaV channel isoform involved in pain perception. 
 
Figure 1. Cartoon representing top views of a NaV  channel (a) and a KV 
channel (b). The central Na+ or K+ selective pore is surrounded by the four 
voltage-sensors in the four domains (delineated by dotted line). In the NaV 
channel, the paddles (color) are not identical whereas in the KV  channel, the 
paddles (grey) are identical. 
Figure 1. Figure représentant des vues de dessus d'un canal NaV (a) et un 
canal potassium (KV) (b). Le pore central sélectif pour Na+ ou K+ est entouré 
par les quatre senseurs de potentiel dans les quatre domaines (délimités par la 
ligne en pointillés). Dans le canal NaV, les palettes (couleur) ne sont pas 
identiques alors que dans le canal KV, les palettes (en gris) sont identiques. 
Animal toxin pharmacology of NaV1.9 
NaV channel expression is tissue-specific across different species. NaV1.7 is mainly expressed in sensory and 
sympathetic neurons in the peripheral nervous system. NaV1.8 and NaV1.9 are sensory neuron-specific channels 
that are normally found within small-diameter dorsal root (DRG) and trigeminal ganglia but not in the central 
nervous system neurons (Momin and Wood, 2008). Selective knockout of NaV1.7 expression in mouse 
nociceptors leads to a loss of acute mechanosensory and inflammatory pain (Nassar et al., 2004). Also, various 
human heritable pain disorders such as erythermalgia and paroxysmal extreme pain disorder map to mutations 
in SCN9A, the gene encoding NaV1.7 (Dib-Hajj et al., 2008). Studies of NaV1.8 in mice have revealed a role for 
this channel in inflammatory pain, neuropathic pain and noxious stimuli response (Joshi et al., 2006; Dong et 
al., 2007). NaV1.9 knockout mice have a largely absent inflammatory hyperalgesia in response to inflammatory 
mediators (Priest et al., 2005; Amaya et al., 2006). Although knockout mice are an extremely valuable tool to 
reveal the physiological role of NaV channels, the occurrence of genetic compensatory mechanisms might mask 
vital functional information. Therefore, the discovery of pharmacological tools that evoke a specific response 
from these channels is essential for elucidating their physiological function. To achieve this goal, heterologous 
expression and characterization of NaV1.7, NaV1.8, and NaV1.9 in oocytes or mammalian cells is of great 
importance. 
Although NaV1.9 plays a key role in nociception, fundamental questions about its function and pharmacology 
remain unanswered because previous attempts to express this channel in heterologous systems have been 
unsuccessful (Blum et al., 2002; Dib-Hajj et al., 2002). In addition, studying NaV1.9-mediated currents in 
native DRG neurons is technically challenging because only a fraction of isolated neurons produces a 
measurable amount of these currents and other NaV channels activate over a similar voltage range. We 
circumvented heterologous expression obstacles by identifying and transplanting paddle motifs from the 
putative voltage-sensors of NaV1.9 into four-fold symmetric Kv channels and investigated the function of NaV1.9 
voltage-sensors in channel gating and in forming toxin receptors (Bosmans et al., 2011). 
By taking advantage of the portable nature of paddle motifs within voltage-sensing domains (Alabi et al., 
2007; Bosmans et al., 2008; Milescu et al., 2009), we showed that these structural motifs also exist in each of 
the four NaV1.9 voltage-sensors, and that they can be transplanted into Kv channels to be studied in isolation. 
Our results revealed that each of the NaV1.9 paddle motifs can sense changes in membrane voltage and drive 
Kv channel voltage-sensor activation, similar to what was found for canonical NaV channels (Bosmans et al., 
2008). Since the pharmacological sensitivities of NaV1.9 remain unexplored, we exploited these paddle 
constructs to search for toxins that might interact with NaV1.9 channels. To this end, we screened eighteen 
toxins from tarantula, scorpion and sea anemone venom against four NaV1.9 paddle constructs and observed 
six toxins that potently inhibit one or more of the chimeras (AaHII, ProTx-I, TsVII, GrTx-SIA, HaTx, BomIV). In 
addition, we discovered that the NaV1.9 paddle motifs from all four domains can interact with toxins from 
animal venom. 
The two most interesting toxins that emerged from our screens were the scorpion toxin TsVII and the 
tarantula toxin ProTx-I, both of which interact strongly with NaV1.9 paddle motifs and potently facilitate the 
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slowly activating and inactivating NaV1.9-mediated current in rat DRG neurons (Cummins et al., 1999; 
Maruyama et al., 2004; Priest et al., 2005; Coste et al., 2007; Ostman et al., 2008). In addition to targeting 
NaV1.9, TsVII and ProTx-I have very different actions on NaV1.8, the other TTX-resistant NaV channel present in 
these sensory neurons. For example, TsVII produces a dramatic facilitation of NaV1.9-mediated currents while 
only modestly inhibiting NaV1.8, showing that the scorpion toxin can discriminate between these two TTX-
resistant NaV channels. Conversely, ProTx-I causes both a pronounced potentiation of NaV1.9-mediated currents 
and a robust inhibition of NaV1.8 (Figure 2), making this toxin a formidable tool to discriminate the currents 
generated by these two channel isoforms in DRG neurons. Taken together, our results suggest that NaV1.9 
channels possess functional voltage-sensors that interact with scorpion and tarantula toxins, features that are 
shared with canonical NaV channel isoforms. Furthermore, our screening with a wide range of toxins 
demonstrate that NaV1.9 has different pharmacological sensitivities than other NaV channel isoforms, a property 
that may be exploited for drug design. 
 
Figure 2. Effect of ProTx-I on native NaV1.9- and NaV1.8-mediated currents in rat 
DRG neurons. (a) Voltage protocol used to elicit both NaV1.9 (first depolarization 
to -55 mV) and NaV1.8-mediated currents (second depolarization to 0 mV) in a 
rat DRG neuron. (b) Evoked currents under control conditions (black) and after 
addition of 100 nM ProTx-I (red for NaV1.9, green for NaV1.8). NaV1.9-mediated 
currents are potentiated whereas NaV1.8-mediated currents are inhibited. Time 
scales for both currents are indicated in the X-axis. Experiment by Michelino 
Puopolo, Harvard Medical School (Bosmans et al., 2011). 
Figure 2. Effet de ProTx-I sur les courants natifs via NaV1.9 et NaV1.8 dans les 
neurones DRG de rat. (a) Protocole de potentiel utilisé pour activer des 
courants via NaV1.9 (première dépolarisation à -55 mV) et NaV1.8 (deuxième 
dépolarisation à 0 mV) dans un neurone de DRG. (b) Courants évoqués dans 
des conditions de contrôle (noir) et après addition de 100 nM de ProTx-I (rouge 
pour NaV1.9, vert pour NaV1.8). Les courants via NaV1.9 sont potentialisés mais 
ceux via NaV1.8 sont inhibés. Les échelles de temps pour les deux courants sont 
indiquées dans l’axe des abscisses. Expérience menée par Michelino Puopolo, 
Harvard Medical School (Bosmans et al., 2011). 
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Abstract 
Scorpion toxins have been used extensively to study the pharmacology of K+ channels, as well as 
to decipher their pore topology, and an increasing amount of molecular data is still being 
published on this subject. During the last two decades, Androctonus venoms have provided 
several structurally distinct families of peptides exhibiting different K+-channel-blocking function. 
We have largely participated to their purification, chemical, pharmacological and immunological 
characterization. In this article, we summarize our contribution to the current knowledge on these 
toxin/channel interactions. 
Vue d’ensemble des petits peptides des venins d’Androctonus 
capables de bloquer des canaux K+ activés par le potentiel 
Les toxines de scorpion ont été considérablement utilisées pour étudier la pharmacologie des 
canaux K+ ainsi que pour décrypter la topologie du pore et une quantité croissante de résultats 
moléculaires continue d’être publiée sur ce sujet. Au cours des deux dernières décades, les 
venins d’Androctonus ont fourni plusieurs familles de peptides distincts structurellement et 
capables de bloquer la fonction de différent types de canaux K+. Nous avons largement contribué 
à leur purification et à leur caractérisation chimique, pharmacologique et immunologique. Dans 
cet article, nous résumons notre contribution aux connaissances actuelles des interactions 
toxine/canal K+. 
Keywords : Potassium channels, scorpion toxins. 
 
Introduction 
K+ channel blockers’ toxins (KTx) from scorpion venoms are short peptides, which typically contain between 30-
40 amino-acid residues cross-linked by 3-4 disulphide bridges forming compact and resistant molecules. They 
block K+ channels from the extracellular side by binding to the outer vestibule of K+ channels and in most cases 
insert a Lys side chain into the channel pore (Park and Miller, 1992). They are often present at low 
concentrations in the venoms (from 0.01 to 1% by weight). Usually, they have almost no toxic effects in mice 
by subcutaneous (s.c.) injection. However, they could be very toxic when injected intracerebroventricularly 
(i.c.v.) into the brain. Based on sequence identity and cysteine pairing, they have been classified into four 
families, the  and -KTx (Tytgat et al., 1999) and today more than 120 KTx ranging from 23 up to 64 
amino acids are sequenced. Most of their structures exhibit the characteristic fold called Cystein-Stabilized-
Helix (CSH) motif, constituted by one -helix and two or three -strands, in which two disulfide bridges 
covalently link a segment of the -helix with one strand of the sheet structure, except for -KTxs which are 
formed by two parallel α-helices linked by two disulfide bridges. The -KTx family is constituted of the shortest 
peptides having diverse specific blocking activities against voltage-gated (KV) and calcium activated (KCa) 
channels. Longest peptides, with 45-68 amino acid residues reticulated by three disulfide bridges, have been 
later characterized and classified as the -KTx family. They have two structural and functional domains: an -
helix in the N-terminal with cytolytic and antimicrobial activity, as well as a tightly folded C-terminal region with 
the CSH motif and K+ channel-blocking activities (Diego-García et al., 2008). At last, the -KTx family was 
described as specific for hERG channel (Corona et al., 2002). 
This overview will summarize our main original contributions to the subject, in particular those obtained by 
the Androctonus mauretanicus venom analysis. 
The smallest toxins in Androctonus mauretanicus venom: P01 (-KTx8) and P05 
(-KTx5) 
PO5 (-KTx 5.2, 3415 Da) from Androctonus mauretanicus display high affinity (8 pM) and high specificity for 
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the so-called apamin-sensitive SKCa channel, as well as PO1 (-KTx 8.1, 3177 Da) which is much less active on 
the SKCa (300pM). They belong to the -KTx5.x's family (as Leiurotoxin1 or Scyllatoxin from the venom of the 
scorpion Leiurus quinquestriatus Hebraeus). Structure-function studies have shown that a highly positively 
charged region (in particular two Arg residues) of the -helix exposed to the solvent is involved in binding to 
the receptor, as it is for the bee venom apamin (Sabatier et al., 1993). 
The Kaliotoxin subfamily (-KTx3 subfamily) 
The KTX structure-function relationship studies were first performed using synthetic analogs such as KTX(1-37), 
KTX(1-37)-amide and shortened peptides including KTX(27-37), KTX(25-32) and KTX(1-11) (Romi et al., 1993). KTX(27-37) 
and KTX(25-32) but not KTX(1-11) competed with 125I-KTX for its receptor on rat brain synaptosomes and act as 
antagonists of KTX. This demonstrated for the first time that the C-terminal region, particularly the -sheet of 
the toxin, was involved in the interaction with the receptor and the channel blockade. KTX was further widely 
used by different international groups for probing the vestibule topology from the lymphocyte KV1.3 channel. 
Synthetic KTX analogs have been used in combination with site-directed mutagenesis of the KV1.3 channel to 
identify pairs of residues in the toxin and channel which interact specifically. It was found that the side chain of 
the Lys 27 residue enters deeply into the pore and interacts with the Asp 402 residue of each channel subunit 
(Aiyar et al., 1995). Then, the KTX binding to a chimeric K+ channel (KcsA-KV1.3) was investigated using solid-
state nuclear magnetic resonance (ssNMR) (Lange et al., 2006). Significant chemical shift changes were 
observed for the KTX residues found in interaction with the channel, reflecting conformational changes involving 
-sheet contacts between the first and third -strand. For the channel, chemical-shift changes were seen also 
for channel residues in the KTX-binding region in both the pore helix and the selectivity filter. The ssNMR data 
directly show that Asp 64 in the KcsA-KV1.3 vestibule represents an important interaction site for KTX. Large 
chemical-shift changes were seen for Gly 77, Tyr 78 and Gly 79 in the selectivity filter. Also, chemical-shift 
changes were observed for the side chains of Glu 71 and Asp 80 that form carboxyl-carboxylate pairs on the 
backside of the filter (Lange et al., 2006). 
The -KTx15 subfamily : KV4.x and hERG blockers 
The first member of the α-KTx15 subfamily characterized from Androctonus australis was Aa1 (3869 Da) 
(Pisciotta et al., 2000). At the primary sequence level, the toxin has an unusual N-terminal pyroglutamic acid. 
Aa1 totally blocked a fast IA-type K+ current from cerebellum granular cells. Shortly after, we have isolated a 
novel toxin from the venom of Androctonus mauretanicus, AmmTX3 (3827 Da), able to block a fast IA-type K+ 
current from striatal neurons in culture (Vacher et al., 2002). Then, several cDNAs encoding two Aa1 isoforms, 
AaTX1 (3867 Da) and AaTX2 (3853 Da) were identified by PCR amplification from a venom gland cDNA library 
of Androctonus australis (Legros et al., 2003) as well as in Androctonus amoreuxi (3769 Da). These toxins 
constitute the first members of the -KTx15 family (Figure 1). From a pharmacological point of view, the 
molecules shared the same target in rat brain. Autoradiograms demonstrated a heterogeneous distribution of 
125I-toxin binding sites throughout the adult rat brain. High density of receptors was found in the striatum, 
hippocampus, superior colliculus and cerebellum (Vacher et al., 2001). The nature of the K+ channels blocked 
by the toxins was assessed by performing whole cell patch recording of the K+ currents of striatal neurons and 
of cerebellum granular cells in primary culture. In all cases, the AmmTX3 inactivates the transient A-current, 
but the sustained K+ current remains fully activated. Finally, analysis by electrophysiological recording of 
transient K+ currents in mammalian cells transfected with diverse cloned K+ channels showed that only the 
rapidly activating and inactivating KV4.1-mediated current was inhibited by AmmTX3 [with a 50% blocking 
concentration (IC50) of 105 nM]. The inhibition was less effective on KV4.2 and KV4.3 channels and the toxin did 
not affect other transient currents such as KV1.4 and KV3.4 (Vacher et al., 2006). 
Further, we have reported that the -KTx15 peptides also show a significant hERG-blocking activity, like -
KTx peptides. From a structural point of view, we have proposed that two separate functional surfaces, A and 
B, coexist on the molecule, and are responsible for two different K+-current-blocking functions (Huys et al., 
2004). While -KTxs interact with channels through their β-sheets, -KTxs modulate hERG through their -
helix. A common "hot spot" with 2 basic residues (Arg18 and Lys19 in the -helix) confers hERG blockade 
activity to -KTx15 peptides (Abdel-Mottaleb et al., 2008). 
 
Figure 1. Amino acid sequences of the Androctonus toxins from the -KTx15 family. *depicted from cDNAs 
clones; Aa, Androctonus australis; Amm, Androctonus mauretanicus; Aam, Androctonus amoreuxi. Amino acids 
in red in the -helix are crucial for hERG channel blockade and those in blue in the -sheet for KV channel 
blockade. 
Figure 1. Séquences d’acide aminés des toxines d’Androctonus de la famille -KTx15. *décrypté à partir 
d’ADNcs; Aa, Androctonus australis; Amm, Androctonus mauretanicus; Aam, Androctonus amoreuxi. Les acides 
aminés en rouge dans l’hélice- sont cruciaux pour le blocage des canaux hERG et ceux en bleu dans le feuillet-
 pour le blocage des canaux KV. 
(Average mass in Da)
Aa1  ZNETNKKCQGGSCASVCRRVIGVAAGKCINGRCVCYP 3851 
AaTX1* ZIETNKKCQGGSCASVCRRVIGVAAGKCINGRCVCYP 3850 
AaTX2* ZVETNKKCQGGSCASVCRRVIGVAAGKCINGRCVCYP 3839 
AmmTX3 ZIETNKKCQGGSCASVCRKVIGVAAGKCINGRCVCYP 3823 
AamTX* ZVQTNKKCKGGSCASVCAKVIGVAAGKCINGRCVCYP 3722 
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Conclusion 
Scorpion venom remains a proven resource for novel compound discovery, especially for the pharmacologists. 
A total of 209 -KTx amino acid sequences are now referenced in the UniProtKB data bank, but only some of 
these -KTx peptides have really been shown able to block K+ currents. For the other reported peptides there is 
often no direct evidence described for their function. While some of them represent new analogs of well-known 
families displaying unique selectivity or targeting, others exhibit novel structural features or activities. The 
majority of their action has been determined on the KV1.x subfamily or on the Ca2+-activated K+ channels (on 
SKCa-sensitive to the bee venom Apamin or on BKCa). The results that we obtained during the last two decades 
provide new insight into the possible targets of some -KTxs purified from different North African Androctonus 
venoms. In particular, we have greatly contributed to the -KTx15 family definition and pharmacological 
characterization. Moreover, KTX (-KTx3-1) was finally proved to be a wonderful tool, which helped us to depict 
the molecular mechanisms of interaction between K+ channels and peptide inhibitors and to demonstrate that 
the binding of K+ channel specific scorpion toxins does not take place only on the outer vestibule of the channel 
pore but also deeper into the selectivity filter. The binding involves a combination of hydrophobic, hydrogen 
bonding and electrostatic interactions, which induced significant structural rearrangements in both molecules. It 
was then proposed that structural flexibility of the K+ channel and the toxin represents an important 
determinant for the high specificity of toxin/K+ channel interactions (Lange et al., 2006). 
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Abstract 
Sea anemone peptides have been isolated since more than 30 years, the majority being highly 
toxic for their natural preys, crustaceans, but also for mammals. These neurotoxins which may 
have also cardiotonic properties are activators of voltage-dependent Na+ channels. They 
represent a structural group of four -fold peptides. Some of their basic and hydrophobic 
aminoacids are crucial determinants for their tissue and species selectivities. More recently, 
several groups of sea anemone peptides with different structures have been characterized with 
moderate toxicities on crustacean or mammals. They allowed the characterization of several 
subtypes of voltage-dependent K+ channels involved in autoimmune diseases, and of acid-sensing 
ion channels (ASIC3) involved in pain processing. These last toxins could be promising tools for 
the design of new therapeutic molecules. 
Toxicité des toxines d’anémones de mer en relation avec leur activité 
pharmacologique sur les canaux ioniques 
De nombreuses toxines peptidiques de venins d’anémones de mer ont été isolées depuis plus de 
30 ans du fait de leur activité hautement toxique chez leurs proies naturelles, les crustacés, mais 
aussi chez les mammifères. Il s’agit de toxines neuro-excitatrices parfois cardio-stimulantes 
activant les canaux Na+ dépendants du potentiel. Elles forment un groupe structural homogène 
de toxines ayant 4 feuillets  dont la sélectivité inter-espèce et tissulaire semble dépendre de la 
présence de certains résidus d’acides aminés chargés ou hydrophobes. D’autres toxines, 
découvertes plus récemment, présentent des structures plus variables, avec des degrés de 
toxicité moindre chez les crustacés et mammifères. Ces dernières ont permis la caractérisation de 
sous-types de canaux K+ dépendants du potentiel dont certains sont impliqués dans les maladies 
auto-immunes, et de certains canaux ASIC (canaux ioniques sensibles à l’acidité extracellulaire) 
impliqués dans la douleur. Ces dernières toxines sont des outils prometteurs pour la conception 
de nouvelles molécules thérapeutiques. 
Keywords : Acid-sensing ion channels, KV channels, NaV channels, sea anemone, toxicity. 
 
Introduction1 
Animal venom components are usually called toxins, a term which evokes danger for living animals and 
humans, and are considered as bioharzardous material. But what is the definition of a toxin? Generally an 
animal toxin is defined as a natural component of the venom, able to disturb nerve, muscle or cardiac function, 
resulting in an effect which contributes to immobilize preys or to kill predators. A toxin acts at a very low 
concentration, with a highly specific activity on a cell membrane receptor. Very interestingly, evidences have 
been accumulated showing that some toxins can also be of a great utility as pharmacological tools, having low 
or no toxicity, and usable for therapeutic purposes (Koh and Kini, 2011; Miljanich, 2004; Mouhat et al., 2008). 
Since more than 40 years, animal toxins have been isolated and characterized, first, due to a public health 
concern, to understand and treat the severe poisonings they are able to induce and which can be fatal in 
humans. Diverse degrees of toxicity are described such as cardiac arrhythmias, leading to cardiac arrest, 
neurological hyperexcitability, convulsions, hypertension, paralysis, blood perturbations (coagulation, 
hemolysis). Toxins (from spiders and scorpions) are also studied in agronomy, to discover new insecticides, 
                                                 
1
Abbreviations: Acid Sensing Ion Channel (ASIC), Central Nervous System (CNS), Complete Freund’s Adjuvant (CFA), Intra-
CcerebroVentricular (i.c.v.), Intra-Cisternal (i.c.), Intra-Muscular (i.m.), Intra-Venous (i.v.), Molecular Weight (M. W.), 
Peripheral Nervous System (PNS), Sea Anemone (SA), TetrodoToXin (TTX), Voltage-gated Na+ (NaV) and K+ (KV) channels. 
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because some for instance from spider and scorpions are very selective tools that provoke insect paralysis. 
Toxins can act on diverse specific targets including ion channels, cell receptors, and less specifically on 
membrane phospholipids. However, it has been also shown that venoms contain “non-toxic” toxins, which are 
not able to induce neither visible symptoms of toxicity nor lethality, when injected to mammals, insects or 
crustaceans. These “non-toxic” toxins are therefore particularly interesting tools to study the implication of the 
targeted receptors in diverse physiological functions and can sometimes lead to therapeutic applications. 
Sea anemones belong to the phylum of Cnidaria, subdivided in three classes, Hydrozoa, Scyphozoa and 
Anthozoa. The last one includes around 6000 known species of sea anemones. The venom is present in specialized 
stinging organelles called nematocysts or cnidocysts, included in specialized cells, the cnidocytes. Nematocysts are 
distributed over the entire surface of the sea anemone body, which makes the venom difficult to extract. Usually, 
active components are extracted from the whole animal by using methanol/chloroform to obtain an aqueous 
extract which can be further separated by several steps of liquid chromatography (Beress et al., 1975b). 
The best characterized toxins in sea anemones are: (i) a group of peptides (or small proteins; M. W. from 
3,000 to 6,000 Da) acting on ion channels of excitable membranes and (ii) cytolysins (M. W. 15,000-20,000 
Da) which are proteins that have been characterized by their hemolytic activity. Most of the sea anemone 
peptides have a preference for crustaceans, their natural prey, but due to a closed evolutionary context, they 
also act on insects (Bosmans and Tytgat, 2007). To a lesser extent, and often due to their high affinity for 
specific ionic channels, they are also toxic for mammals. This review focuses on the sea anemone toxins 
effective on crustaceans and mammals, and describes their different degree of toxicity in relation with their 
specific molecular targets among different families of ion channels. 
Diversity of neurotoxic and/or cardiotoxic sea anemone peptides affecting 
voltage-dependent Na+ channels 
The most studied sea anemone (SA) toxins have been isolated more than 40 years ago based on their ability to 
induce severe neurotoxic and/or cardiotoxic effects on a variety of crustacean, insect or mammal nerve and 
muscle preparations (Beress and Beress, 1975a; Norton, 1991; Romey et al., 1976). These neurotoxins affect 
voltage-gated Na+ channels (NaV) which are supporting action potential initiation. NaV channels are the 
molecular targets for toxins that can bind at six identified receptor sites, either by blocking the channel pore, 
either by modifying the gating properties of the channel (Catterall et al., 2007). SA toxins bind to the receptor 
site 3, located on the domain IVS5-S6 of the  subunit of NaV channels which is also targeted by scorpion and 
funnel web spider toxins. They have allowed identification of subtypes of channels because they act with high 
affinities on different neuronal, muscular, or cardiac NaV. They slow-down the channel inactivation, allowing 
more Na+ entry into the cells and prolong action potential duration. Generally, the sea anemone toxins acting 
on NaV channels (SA-NaV toxins) have voltage-dependent effects because they bind with more affinity at 
polarized membrane potentials. 
The SA-NaV toxins are polypeptides with molecular weights ranging between 3,000 and 5,000 Da that are 
cross-linked by 3 (or even more) disulfide bridges. Two different types have been described with distinct 
sequences and immunological properties. Type 1 toxins are isolated from Actiniidae (Anemonia sp, Anthopleura 
sp, Bunodosoma sp, Condylactis sp, see Table 1) and types 2 are isolated from Stichodactylidae families 
[Radianthus (Heteractis) sp, Stichodactyla sp; see Table 1; Bosmans and Tytgat, 2007]. The two types are also 
distinguished by their immunoreactivity, i.e. there is no antigenic cross-reactivity between them (Norton, 1991; 
Schweitz et al., 1985). Structurally, the two types of SA-NaV toxins contain four stranded anti-parallel -sheets 
connected by two loops. One toxin, halcurin, possesses structural properties common to both type 1 and 2 toxins 
indicating that all these toxins have probably evolved from the same ancestral gene (Ishida et al., 1997). The type 
1 toxins display higher affinity for cardiac and skeletal muscle tetrodotoxin (TTX)-resistant NaV channels. In brief, 
resistance of NaV to TTX action is correlated to a high sensitivity to sea anemone toxins and vice versa. 
Species selectivity can be observed for some toxins: AsI, AsIII, RpII, and ShI are inactive on NaV channels 
of mammalian system whereas others, such as AsV, AP-A and AP-B, are both active on crustacean and also 
very active on mammalian NaV channels (Kem et al., 1989; Lazdunski et al., 1986; Schweitz et al., 1981). 
Activity of highly neurotoxic SA toxins (characterized by trembling of tail, fasciculations, salivation, difficulty 
in breathing and paralysis) is related to an effect on TTX-resistant and TTX-sensitive NaV channels (Norton et 
al., 1981; Romey et al., 1976; Schweitz et al., 1981). The most neurotoxic SA toxins active on mammals are 
found in the two structural groups: AsII, AsV, AP-B, BgII, BgIII (type 1), and RPI –V (type 2) (Table 1). The 
most potent toxins for crustaceans are ShI, AETXII, and AETXIII (Norton, 1991; Shiomi et al., 1997). 
Neurotoxicity is sometime associated with cardiotoxicity resulting in paralysis after i.v. (mice), or i.m. 
(crustacean) administration, and can lead to death (convulsions, arrhythmia and ventricular fibrillation) using 
concentration as low as 2 µg/kg (i.c. in mammals, Table 1). The well known and characterized AsI, AsII and 
AsIII isolated from Anemonia sulcata are both active on crustacean inducing neurotoxic symptoms like tetanic 
contractions and paralysis in the crab after i.m. injections (Alsen, 1983). In mammal, cardiotoxic effects 
predominate after i.v. injection of AsI or AsII, compared to neurotoxic symptoms (Alsen, 1983). AsI and AsII 
(the most active) induce a significant cardiotonic (positive inotropic) effect (Alsen et al., 1978; Renaud et al., 
1986) in different mammalian heart preparations. This effect is linked to the increased Na entry into cardiac 
cells coupled to a subsequent entry of Ca2+ through the Na/Ca exchanger. Cardiac effects are often 
characterized by a potent positive inotropic effect (case of AP-A at 0.1-1 µg/kg, i.v.) without any significant 
effect on heart or blood pressure, but at higher concentrations (>10 µg/kg, i.v.) they induce arrhythmia and 
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Table 1. Comparison of some sea anemone peptides structure, toxicities and targets. 
Tableau 1. Comparaison des structures, propriétés toxiques et cibles de peptides d’anémones de mer. 
Toxin 
(origin: Genus species) 
M. W. 
(AA) 
Structure (PDB) 
classification 
Specie / tissue 
selectivity 
Toxicity: 
DL50 (µg/kg) 
Target 
 
References 
AeK 
Actinia equina 
3807(36) 2, 6C 
SAK-I  
? ? KV1 (Minagawa et al., 1998) 
AETXI  
Anemonia erythrea 
4963(47) 46C 
Type 1 
Crust 2 (crab) 
NL (i.v./mice) 
NaV? (Shiomi et al., 1997) 
AETXII 6502(59) New struct, 10C Crust 0.5 (crab) 
NL (i.v./mice) 
? (Shiomi et al., 1997) 
AETXIII 6562(59) New Struct, 10C Crust 0.3 (crab) 
NL (iv/mice) 
? (Shiomi et al., 1997) 
AmI 
Anthopleura maculata 
2803(27) New ? 830 (crab) ? (Honma et al., 2005; 
Honma and Shiomi, 
2006) 
AmII 5128(45) 4,6C 
SAKIII 
? NL (crab) 
paralytic 
KV? (Honma et al., 2005; 
Honma and Shiomi, 
2006) 
AmIII 5134(47) 46C 
Type 1 
Crust 70 (crab) NaV? (Honma et al., 2005) 
AsI (ATXI) 
Anemonia sulcata 
4834(46) 46C (1ATX) 
Type 1 
Crust 
Cardiac, neuron 
4 (crab) 
236 (i.c./mice) 
NaV? (Alsen et al., 1978; 
Beress and Beress, 
1975a; Schweitz, 1984; 
Schweitz et al., 1981) 
AsII (ATXII) 4949(47) 46C 
Type 1 
Crust& 
mammals 
Cardiac, neuron 
4 (crab) 
2.5 (i.c./mice) 
NaV (Alsen et al., 1978; 
Beress and Beress, 
1975a; Schweitz, 1984) 
AsIII 2932(27)  Crust 
Neuron 
7 (crab) 
300 (i.c./mice) 
NaV (Beress and Beress, 
1975a; Schweitz et al., 
1981) 
AsV  46C 
Type 1 
Crust, mammals 
Cardiac, neuron 
<10 (crab) 
2 (i.c./mice) 
NaV (Schweitz et al., 1981) 
AsKC2 6772(58) 2, 1, 6C 
SAKII  
  KV1.2 (Schweitz et al., 1995) 
AsKS 3834(36) 2, 6C 
SAK-I 
  KV1.2 (Diochot et al., 1998; 
Schweitz et al., 1995; 
Yeung et al., 2005) 
BDS-I 4715(43) 4,6C (1BDS) 
SAKIII 
  KV3 (Diochot et al., 1998; 
Yeung et al., 2005) 
AP-A (AxI) 
Anthopleura 
xanthogrammica 
5132(49) 46C (1AHL) 
Type 1 
Crust, mammals 
Cardiac 
22 (crab) 
5 (i.c./mice) 
66-400 
(i.p./mice) 
NaV 
TTXr 
(Schweitz, 1984; 
Shibata et al., 1976) 
AP-B (AxII) 5268(49) 46C (1APF) 
Type 1 
Crust, mammals 
Neuron 
78 (crab) 
0.2 (i.c./mice) 
NaV (Norton, 1978; Norton 
et al., 1981) 
AXPI-I (58) 2, 1, 6C 
SAKII  
   (Minagawa et al., 1997) 
AP-C (APE2-1) 
Anthopl. elegantissima 
4877(47) 46C 
Type 1 
Crust, mammals 
Cardiac 
1 (crab) NaV 
TTXr 
(Bruhn et al., 2001; 
Norton, 1978) 
APETx1 4552(42) 4,6C (1WQK) 
SAKIII 
Cardiac  HERG (Diochot et al., 2003) 
APETx2 4558(42) 4,6C (1WXN) 
SAKIII 
Neuron  ASIC3 
NaV1.8 
(Blanchard et al., 2011; 
Diochot et al., 2004) 
BgII 
Bunodosoma granulifera 
5072(48) 46C 
Type 1 
Insects, 
mammals 
Cardiac, neuron 
0.4 (i.c./mice) NaV (Bosmans et al., 2002; 
Goudet et al., 2001; 
Loret et al., 1994) 
BgK 4275(37) 2, 6C 
SAK-I  
Crust, mammals 4.5 (i.c./mice) KV1 (Aneiros et al., 1993; 
Cotton et al., 1997) 
BcIV 
Bunodosoma caissarum 
4669(41) 4,6C 
SAKIII 
 NL >2000 (crab) 
paralytic 
? (Oliveira et al., 2006) 
CgII 
Condylactis gigantea 
 46C 
Type 1 
Crust 0,2 (crab)  (Salgado and Kem, 
1992) 
SGI 
 
5395(50) 46C 
Type 1 
Crust 14 (crab) 
NL (i.v./mice) 
 (Schweitz et al., 1981) 
GiganTxI (48) 46C 
Type 2 
? NL >1000(crab) 
paralytic 
NL>1000 
(i.c./mice) 
EGF 
activity 
(Shiomi et al., 2003) 
Halcurin 
Halcurias sp 
5080(47) 46C 
Type 1 & 2 
Crust 6 (crab) 
NL >1000(mice) 
 (Ishida et al., 1997) 
Rp-I 
Radianthus 
(Heteractis)paumotensis 
 46C 
Type 2 
Crust, mammals 
Muscle & neuron 
36 (crab) 
1.5 (i.c./mice) 
NaV (Schweitz et al., 1985) 
RpIII 5330(48) 46C 
Type 2 
Crust, mammals 
Muscle & neuron 
10 (crab) 
2 (i.c. /mice) 
NaV (Schweitz et al., 1985) 
ShI 
Stichodactyla helianthus 
5137(48) 46C (1SHI) 
Type 2 
Crust 
NL (mice) 
0.3 (crab) 
>15000 
(i.p./mice) 
NaV (Kem et al., 1989; 
Salgado and Kem, 
1992) 
ShK 4055(35) 2, 6C (1ROO) 
SAK-I  
Crust, mammals More toxic than 
BgK? 
KV1, 
KV3 
(Pennington et al., 
1995; Yan et al., 2005) 
ShPI 6110(55) 2, 1, 6C 
SAKII  
? ? ? (Antuch et al., 1993) 
SHTXI, SHTXII 
Stichodactyla haddonii 
3059(28) 2, 6C 
SAK-I  
Crust (NL) 1000 (crab) 
NL, paralytic 
KV1 (Honma et al., 2008) 
SHTXIII 7035(62) 2, 1, 6C 
SAKII  
Crust (NL) >1000 (crab) 
NL, paralytic 
KV? (Honma et al., 2008) 
SHTXIV 5229(48) 46C 
Type 2 
Crust 93 (crab) NaV? (Honma et al., 2008) 
References listed here are not exhaustive but are examples of some structural, pharmacological characterization of toxins and their toxicity studies; 
Sea anemone genus and species are indicated at the head of each group of toxin from a same SA. Abbreviations used are: Crust: crustacean, NL: 
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Non Lethal; NT: Non toxic, i.c.: intracisternal, i.m.: intramuscular; “?” indicates an unknown or proposed target; DL50 in crabs were determined after 
i.m. injections. Les références citées ici ne constituent pas une liste exhaustive mais sont quelques exemples d’étude de la caractérisation structurale 
et pharmacologique des toxines et de leur toxicité. Les genres et espèces d’anémones de mer sont indiqués en italique à la tête de chaque groupe de 
toxine issu d’une même espèce. Les abréviations utilisées sont: Crust: crustacé, NL: Non Létal; NT: Non toxique, i.c.: intracisternale, i.m.: 
intramusculaire; “?” indique une cible inconnue ou proposée; les DL50 chez le crabe sont déterminées après une injection i.m. 
ventricular fibrillation which are the cause of death in mammals (Alsen et al., 1978; Bruhn et al., 2001; Renaud 
et al., 1986; Shibata et al., 1976). The molecular mechanism implicates a major action on cardiac TTX-resistant 
NaV channels, which leads to delayed inactivation (closure) of fast Na+ currents and a prolongation of the action 
potential duration. Interestingly, AsIII, a short toxin whose structure is different from type 1 and 2 SA-NaV 
toxins, is specifically toxic on crustaceans and active on their Na+ currents (Warashina et al., 1988). AsIII is 
completely devoid of toxicity on mice and unable to displace AsII from its receptor site on neuronal NaV 
channels (Schweitz et al., 1981). 
Structure-function studies using chemical modifications or mutants revealed some crucial aminoacids 
responsible for species or tissue specificity, toxicity and binding to their receptor. In particular, a cluster of 
positively charged residues (Arg and Lys) and some hydrophobic residues are essential for the activity of type 1 
and 2 toxins (Kelso et al., 1996; Loret et al., 1994). Some examples are given below: 
 In AsII, His32, His37, Lys 35, Lys36 and Lys 46, are important for toxicity and also for binding activity 
(Barhanin et al., 1981) while Asp7 Asp9 and Gln47 are related only to toxicity. Arg14 placed in a 
flexible loop which is conserved among type 1 and 2 SA toxins is important for toxicity and binding 
(Seibert et al., 2003). 
 Hydrophobic residues like Leu18 and W33 in AP-B are important for binding affinities on NaV (Dias-
Kadambi et al., 1996b; Dias-Kadambi et al., 1996a). 
 Lys 37 residue in Ap-B is crucial for NaV interaction on site3 (Benzinger et al., 1998). 
 Examples of toxins sharing both neurotoxic and cardiotoxic properties are AsII, AsV, AP-A, AP-B, 
APE1-1, AP-C. The presence of Arg13, Pro14 and Lys49 in AP-B allows the discrimination between 
neuronal and cardiac channels (Kelso et al., 1996). 
Moreover, it is supposed that amino acids which determine the mammalian specificity could be His39 and 
Pro 41 which are found in all mammalian toxins sequenced so far, and are absent in toxins with no activity on 
mammalian channels (Lazdunski et al., 1986). 
Finally, a few number of SA toxins, presenting new structures, have been characterized along with the 
crustacean toxic SA peptides. AETXII, AETXIII, and gigantoxin I, while being highly toxic to crabs, are 
structurally distinct from the known SA type 1 or 2 toxins, and share homologies with spider neurotoxins and 
mammalian EGF factors, respectively (Shiomi et al., 2003; Shiomi et al., 1997). AETXII and AETXIII are longer 
peptides (59 residues), including 10 half cysteines. Another toxin, AmI displays low toxicity for crabs and 
presents a new structure. It is a short peptide, having no sequence homologies with any known SA-NaV toxin, 
and it could have another target among the large families of voltage-gated ionic channels (Honma et al., 2005). 
The purification of “toxic” components from sea anemone species has been largely investigated before 
1980, and only a few toxins have been described since then with new structure, pharmacology and sometimes 
relatively low toxic effects on crustaceans and mammals. 
Sea anemone peptides that block voltage-dependent K+ channels: diversity of 
structure, toxicities and targets 
Besides the nearly 50 SA-NaV toxins characterized so far, few toxins acting on voltage-dependent K+ channels 
(KV) were discovered after 1990. These KV channel blockers contribute to the toxic symptoms of envenomation, 
because they act synergistically with NaV activators, by prolonging the action potential duration maintaining the 
membrane hyperexcitability and increasing acetylcholine release at nerve endings. Some of these neurotoxins 
display paralysing activity only in crab without any lethality (AmII, BgK, SHTX I, Table 1). Neurotoxicity after 
central injections in mammals, have been described for the toxins which target KV1 channels. These neurotoxic 
effects include hyperexcitability, trembling, fasciculations, and salivation (Cotton et al., 1997). 
Potassium channels are the most diverse class of ion channels and are expressed in a large variety of 
tissues, in both excitable and non-excitable cells. They are key regulators of neuronal excitability by setting the 
resting membrane potential and controlling the shape, frequency and repolarization phase of action potentials 
(Shieh et al., 2000). The cloning of about 80 potassium channel genes has allowed a classification into three 
structural groups. The six transmembrane segments, one pore domain K+ channels, which are either voltage-
dependent (KV) or calcium-dependent (KCa) are targeted by a large number of animal toxins. Due to their high 
specificity and affinity for K+ channels, these toxins have facilitated the structure–function studies of K+ 
channels (Aiyar et al., 1995; MacKinnon, 1991). 
Sea anemones have evolved to produce structurally different peptides that target some of the KV channel 
subfamilies and use different binding mechanisms and modes of action. These toxins can be classified into three 
types, based on their structural homologies (Diochot, 2009; Honma and Shiomi, 2006; Figure 1). “Sea 
Anemone Potassium type 1” (SAK-I) are short peptides (35 to 37 amino acid residues) with 2  helices (“-
type fold”) and 3 disulfide bridges. The SAK-II group includes long peptides (58-59 amino acids) having 3 
disulfide bridges. These peptides share homologies with Kunitz-type protease inhibitor and also with 
dendrotoxin-I (DTX-I, a KV1 channel inhibitor isolated from black mamba). The third group (SAK-III) of toxins 
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belong to the -defensin fold family (“all beta structure”) which includes peptides of various origins, including 
human, snake, Platypus, some of them display antimicrobial, or, analgesic activities (Torres and Kuchel, 2004). 
The SAK-I group of toxins and their relative toxicities 
The pharmacology of SAK-I and SAK-II toxins have been first described with respect to their ability to displace, 
with subnanomolar affinities, the DTX-I binding to its specific brain membrane receptors, mainly represented by 
KV1.1, KV1.2, and KV1.6 channels, and also scorpion (charybdotoxin) binding to T lymphocytes expressing the 
KV1.3 channel (Aneiros et al., 1993; Dauplais et al., 1997; Gendeh et al., 1997; Schweitz et al., 1995; Tudor et 
al., 1996; Tytgat et al., 1995). 
 
Figure 1. Structure of sea anemone toxins in the different SAK groups. (A) Mult iple peptide sequence alignment of 
the three groups of known sea anemone toxins. Amino acid identit ies (black boxes) and homologies (grey boxes) 
are shown. (B) The sea anemone K+ channel inhibitors belong to three different structural groups. The ribbon 
structures were drawn with the RASMOL program, using coordinates from the Protein Data Bank. In the SAK-I 
group, peptides with two short -helices and one helical turn are represented by ShK (PDB code 1ROO). The SAK-II 
type includes peptides with a two-stranded -sheet and two -helices, represented here by DTX-I (PDB code 
1DEN). In the SAK-III group are peptides showing a triple-stranded antiparallel -sheet without -helix, like BDS-I 
(PDB code 1BDS). Lines correspond to disulfide bridges. BcIV, and AmII belong to the same structural SAK-III 
group but their pharmacological activity is not determined. In the same group, APETx2 is active on ASIC3 channels. 
Figure 1. Structure des toxines d’anémones de mer dans les différents groupes SAK. (A) Alignements de 
séquences peptidiques pour les trois groupes connus de toxines d’anémone de mer. Les acides aminés identiques 
(carrés noirs) et homologues (carrés gris) sont montrés. (B) Les toxines d’anémones de mer inhibitrices des canaux 
K+ appartiennent à trois groupes structuraux différents. Les structures ont été élaborées avec le programme 
RASMOL en utilisant les coordonnées PDB. Dans le groupe SAK-I, les peptides ayant deux hélices  courtes sont 
représentés par ShK (PDB code 1ROO). Le groupe SAK-II comporte des peptides ayant deux feuillets  et deux 
hélices , représenté ici par DTX-I (PDB code 1DEN). Dans le groupe SAK-III se trouvent des peptides ayant un 
triple feuillet antiparallèle sans hélice , tel que BDS-I (PDB code 1BDS). Les lignes correspondent aux ponts 
disulfures. BcIV et AmII appartiennent à la même famille structurale dans le groupe SAK-III mais leur activité 
pharmacologique n’est pas encore connue. Dans ce même groupe, APETx2 inhibe les canaux ASIC3. 
ShK BDS-IDTX-I
-
-S
-
-
-
--INKDCLLPMDVGRCRASHPRYYYNSSSKRCEKFIYGGCRGNANNFHTLEECEKVCGVR
--INKDCLLPMDVGRCRARHPRYYYNSSSRRCEKFIYGGCRGNANNFITKKECEKVCGVR
--INGDCELPKVVGRCRARFPRYYYNLSSRRCEKFIYGGCGGNANNFHTLEECEKVCGVR
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RSCIDTIPKSRCTAFQ----CKHSMKYRLSFCRKTCGTC
RTCKDLIPVSECTDIR----CRTSMKYRLNLCRKTCGSC-ACKDYLPKSECTQFR----CRTSMKYKYTNCKKTCGTC
-ACKDNFAAATCKHVKENKNCGS-QKYATN-CAKTCGKC
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BDS-I 1 -AAPCFCSGKPGRGDLWI-LRGTCPGGYGYTSNCYKWPN-ICCYPH-
BDS-II 1 -AAPCFCPGKPDRGDLWI-LRGTCPGGYGYTSNCYKWPN-ICCYPH-
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APETx2 1 -GTACSCGNS--KGIYWF-YRPSCPTDRGYTGSCRYFLG-TCCTPAD
BcIV 1 -GLPCDCHGH--TGTYWLNYYSKCPKGYGYTGRCRYLVG-SCCYK--AmII 1 ALLSCRCEGKTEYGDKWL-FHGGCN-NYGYNYKCFMKPGAVCCYPQN
A
B
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In the first of SAK-I group, the best characterized toxins are BgK, a minor component of the sea anemone 
Bunodosoma granulifera, ShK and HmK, peptides isolated from Stichodactyla helianthus and Heteractis 
magnifica, respectively, acting from picomolar to nanomolar concentration on different KV1 channels subtypes, 
with an inhibition process independent of channel opening (Aneiros et al., 1993; Cotton et al., 1997; Gendeh et 
al., 1997; Kalman et al., 1998; Pennington et al., 1995; Figure 1A). BgK was described as a potent neurotoxin 
able to induce paralysis, trembling of tail, fasciculations and death in mice (Table 1, Cotton et al., 1997). Its 
affinity for specific neuronal subtypes of KV1 channels (KV1.1, KV1.2, KV1.3 and KV1.6) is shared with ShK, which 
has even better affinity (picomolar) for the same channels (Cotton et al., 1997; Kalman et al., 1998). It can be 
supposed by extension that ShK is also able to induce severe neurotoxic symptoms and lethality as for DTX-I, 
the most neurotoxic peptide isolated from snake already known to inhibit KV1.1, KV1.2 and KV1.6 with 
nanomolar affinities (Harvey, 2001). In leukemia cells, ShK and BgK also block the intermediate-conductance 
Ca2+-activated K+ current (IKCa1), a current regulating the membrane potential and modulating the calcium 
signal in many different type of cell types (T lymphocytes, erythrocytes, coloncytes; Rauer et al., 1999). An 
extended interaction of ShK with other families of KV channels was also shown. ShK blocks with high affinity 
(IC50 = 0.3-6 nM) the KV3.2 current, which is critical for high-frequency repetitive firing in cortical GABAergic 
fast-spiking interneurons (Yan et al., 2005). 
The SAK-II group of toxins 
Only seven SA toxins are described in this group: the 3 kalicludines (AsKC1-3), ShPI isolated from 
Stichodactyla helianthus (Antuch et al., 1993), AEPI-I isolated from Actinia equina (Ishida et al., 1997), AXPI-I 
from Anthopleura xanthogrammica (Minagawa et al., 1997) and SHTXIII from Stichodactyla haddoni (Honma et 
al., 2008; Figure 1). These toxins are not toxic for crustaceans. Although extensive studies have shown that 
SAK-I peptides inhibit KV subtypes in transfected mammalian cells and neuronal preparations, only the 
kalicludines were tested for their KV blocking effects in the SAK-II group (Schweitz et al., 1995). AsKC2 inhibits 
KV1.2 channels with a lower affinity (IC50 > 1µM) than DTX-I, and it is not excluded that other KV1 channels 
could be targets for kalicludines, but this remains to be determined. 
 The other peptides ShPI, AEPI-I, AXPI-I and SHTX III have yet no pharmacology described on K+ channels 
although one of them (SHTX III) is able to displace DTX-I from its receptor on rat synaptosomal membranes 
and has been described as a non lethal peptide for crabs (Honma et al., 2008). 
The SAK-III group of toxins are not toxic 
In the SAK-III type group, the two BDS (Blood Depressing Substances) toxins are very similar 43 amino acid 
peptides, isolated from Anemonia sulcata extracts in 1985 (Figure 1). They were patented for their 
antihypertensive and antiviral activities (against Herpes simplex type I and mouse hepatitis virus) after 
intravenous injections in mammal (Beress et al., 1985; Driscoll et al., 1989a; Llewellyn and Norton, 1991). 
BDS-II, the most active, decreased the blood pressure by 50% in cats at a dose of 1 µg/kg. At this time, BDS 
toxins, which are able to induce negative inotropic effects and also to compete with AP-A binding on rat brain 
synaptosomes, were considered as antagonists of NaV channels (Llewellyn and Norton, 1991). However, BDS-I 
and BDS-II inhibition on KV channels was described 13 years later on KV3.4 (IC50 = 42 nM), KV3.1 and KV3.2 
channels (Diochot et al., 1998; Yeung et al., 2005). Both toxins induce a positive shift of the activation curve of 
KV3.1- and KV3.2-mediated currents, indicating that BDS toxins act as gating modifiers similar to a number of 
spider toxins acting on KV2 and KV4 channels. The BDS peptides would be promising tool to study the role of 
KV3 channels in pathologies, since KV3.4 channels may be of particular importance in skeletal muscle periodic 
paralysis (Abbott et al., 2001), or in Alzheimer’s disease where the KV3.4 gene seems to be overexpressed in 
cerebral cortex (Angulo et al., 2004; Lien and Jonas, 2003) and Parkinson disease (Baranauskas et al., 2003). 
In the same SAK-III group, APETx1, a 42 amino acid peptide isolated from Anthopleura elegantissima, 
shares 54% sequence homology with BDS toxins but has a different activity on K+ channels. APETx1 has 
moderate effects on KV1.4 currents at high concentrations, but it is a specific blocker of the human ether a go-
go related gene (human ERG, HERG) K+ channel (IC50 = 34 nM; Diochot et al., 2003). HERG is particularly 
expressed in mammalian heart where it contributes to the rapidly activating delayed rectifier potassium current 
(IKr) which controls the duration of the plateau phase of the action potential (Sanguinetti et al., 1995). Several 
mutations on the HERG gene are responsible for inherited disorders characterized by abnormal slow 
repolarization of action potentials associated with long QT intervals (Sanguinetti et al., 1996). APETx1 shifts the 
voltage-dependence of HERG activation towards depolarizing states (Diochot et al., 2003; Zhang et al., 2007), 
acting as a gating modifier rather than a pore blocker. APETx1, owing to its different and unique structure, has 
been reported to be selective for the neuronal and cardiac (human and rat) ERG1 channels. It does not 
compete with the scorpion toxins ErgTx1 and BeKm-1, also known to block ERG1 channels, suggesting binding 
to another region of the channel (Chagot et al., 2005a; Restano-Cassulini et al., 2006; Wanke and Restano-
Cassulini, 2007). 
 Interestingly, SAK-III peptides are not toxic or lethal after in vivo injections in crustaceans or mammals 
(crabs or mice) unlike sea anemone NaV and KV1 toxins previously described (Table 1). BDS and APETx1 were 
isolated from HPLC fractions lacking toxicity after i.m. injection in crabs (Beress, personal communication). 
Moreover, our experiments using the central i.c. or i.c.v. injections of BDS in rodents were unable to induce any 
neurotoxic effects (Diochot et al., 1998; Driscoll et al., 1989a). 
In the same group, AmII and BcIV purified from Antheopsis maculata (Honma et al., 2005) and 
Bunodosoma caissarum (Oliveira et al., 2006), respectively, have no lethal effect on crab or mice. Although 
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BcIV is supposed to be a NaV activator because it prolongs the action potential duration on crab nerve, it is less 
potent than BcIII, a type 1 NaV toxin. It could also be possible that this toxin acts on KV, which was not tested. 
 The SAK-III group includes another peptide, APETx2, which shares 64% sequence identity with APETx1 and 
blocks a Na+ permeable Acid-Sensing Ion Channel, ASIC3 (Chagot et al., 2005b; Diochot et al., 2004) and, 
although with less affinity, a TTX-resistant-NaV channel (Blanchard et al., 2011). Our recent work has shown 
the potent peripheral analgesic effect of this peptide. 
Non toxic polypeptides with therapeutic perspectives 
Use of ShK in autoimmune diseases 
The ShK toxin-channel interaction studies allowed the design of new types of toxins, such as ShK-Dap22 a 
mutant peptide where Lys22 has been replaced by a diaminopropionic acid. Binding and electrophysiological 
studies have shown that ShK-Dap22 is a highly potent and selective blocker of the KV1.3 channel with a 100-
fold decreased affinity for KV1.1, KV1.4 and KV1.6 channels (Kalman et al., 1998). A high expression level of 
KV1.3 is considered as a marker for activated effector memory T cells (TEM cells) which are involved in the 
pathogenesis of autoimmune diseases. Therefore, the selective suppression of autoreactive TEM cells with KV1.3 
blockers might constitute a novel approach for the treatment of multiple sclerosis and other autoimmune 
diseases, such as type-1 diabete mellitus or psoriasis. Both ShK and ShK-Dap22 were proven to prevent and 
treat rat autoimmune encephalomyelitis (Beeton et al., 2001; Norton et al., 2004). In addition, ShK-F6CA, a 
fluorescein-labelled analogue of ShK, has been reported to have potential applications in the diagnostic of 
autoimmune diseases (Beeton et al., 2003; Norton et al., 2004). This peptide, containing an additional 
negatively-charged moiety at the N-terminus, has a higher affinity and selectivity than ShK for KV1.3 channels, 
allowing a specific detection of activated TEM cells implicated in multiple sclerosis. 
Analgesic properties of APETx2, an inhibitor of ASIC3-containing channels 
Tissue acidosis is commonly associated with pain and is a factor found in inflammation, ischemia, fractures, 
haematomas, tumour development, or muscle incisions like for instance after surgical procedures. Tissue 
acidosis produces pain via the depolarization of the peripheral terminals of nociceptive neurons, which detect 
noxious stimuli. Ion channels gated by protons and present in nociceptors such as TRPV1 (Transient Receptor 
Potential channels Vanilloid 1) and ASICs, are mediating this depolarization. ASICs are of particular interest 
since they are particularly sensitive to extracellular protons (the native ASIC-like responses are approximately 
10-fold more sensitive to changes in H+ than the TRPV1 responses), being able to activate for very small 
acidifications. In addition, some ASICs (ASIC3) generate a sustained depolarizing current compatible to the 
detection of non-adapting pain (Deval et al., 2010; Deval et al., 2008; Lingueglia, 2007; Yagi et al., 2006). 
 ASICs belongs to the degenerin/epithelial sodium channel (Deg/ENaC) superfamily (Bianchi and Driscoll, 
2002; Kellenberger and Schild, 2002; Waldmann et al., 1996) and are related to the FMRFamide-gated Na+ 
channel FaNaC identified from the invertebrate nervous system (Lingueglia et al., 1995; Lingueglia et al., 
2006). They are expressed in both mammalian central (CNS) and peripheral (PNS) nervous system, and 
particularly in nociceptors where they are proposed to detect acidosis to inform the CNS about tissue damages. 
Six different proteins have now been identified in rodents: ASIC1a, ASIC1b, ASIC2a, ASIC2b, ASIC3 and 
ASIC4; these proteins are encoded by four genes. Functional channels, generated by the association of 3 
subunits (homo- or heterotrimers), are activated by acidic pH to mediate a sodium-selective, amiloride-
sensitive, current (Babinski et al., 2000; Bassilana et al., 1997; Hesselager et al., 2004; Jasti et al., 2007; 
Ugawa et al., 2003; Waldmann et al., 1999). The pharmacology of ASICs is restricted to non selective drugs 
which activate or inhibit the currents at high concentration ranges. To date, only two peptides isolated from 
spider and sea anemone venoms were characterized as selective and high affinity blockers of ASIC1a and 
ASIC3, respectively. The spider toxin PcTx1 proved to behave similarly to a “gating modifier toxin” by changing 
the H+ affinity of ASIC1a (Chen et al., 2005; Salinas et al., 2006). The sea anemone peptide APETx2 displays 
structural elements common to other sea anemone toxins in the SAK-III group but is a specific inhibitor for 
ASIC3. These two toxins have been of a great utility to dissect the role of ASIC isoforms in functions related to 
pain in the PNS and CNS. 
The sea anemone peptide APETx2 is a major constituent in the venom of Anthopleura elegantissima. It is a 
basic (pI = 9.59) peptide of 42 amino acids crosslinked by three disulfide bridges. APETx2 displays a high 
sequence homology (76%) with APETx1 but some sequence homologies are also found with BDS peptides 
(57%) which block KV3.4 channels, and with AP-A, AP-B, AP-C toxins (41-47%) which activate NaV channels. 
APETx2 structure was determined by two-dimensional 1H-NMR using the native toxin (Chagot et al., 2005b). It 
consists of a compact disulfide-bonded core composed of a four stranded -sheet from which a loop (15-27) 
and the N- and C-termini emerge. The mode of action of APETx2 remains to be determined. 
APETX2 blocks ASIC3 containing channels (IC50 of 63 nM on homotrimeric ASIC3 to 2 µM on heterotrimeric 
channels) in various expression systems (Diochot et al., 2004; Table 1). It has been also shown recently that 
APETx2 inhibits the TTX-resistant NaV1.8-mediated current present in DRG neurons with an IC50 of 2.6 µM 
(Blanchard et al., 2011). In DRG neurons, APETx2 (3 µM) inhibits 50% of an ASIC3-like current, mainly 
constituted by ASIC3 homomers and heteromers, which was recorded in 26.5% of the neurons. The inhibition 
of the transient peak ASIC3-mediated current is rapid and fully reversible. The effect of APETx2 on ASIC3 
containing channels in the PNS (order of potency ASIC3 > ASIC2b+3 > ASIC1b+3 > ASIC1a+3) prompted us 
to test its effects on different pain models in rodents since it does not block central ASIC1a or ASIC2a (Deval et 
al., 2008; Diochot et al., 2004). 
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APETx2 confers analgesic properties when applied peripherally to rodents. First, APETx2 can suppress bursts 
of activity induced by moderate tissue acidification (pH around 7.0) in nociceptive C-fibres in a rat nerve-skin 
preparation (Deval et al., 2008; Figure 2A). Second, APETx2 can prevent spontaneous pain behaviour (hindpaw 
flinches) in rodents when a cocktail of ASIC3 activators (moderate acidification, hypertonic solution, and 
arachidonic acid) are injected in rat hind paw (Figure 2B). 
 
Figure 2. Effect of ASIC3 inhibition by APETx2 on acid and inflammatory pain (according to Figures 1B and 3E from 
Deval et al., 2008). (A) Response of an unmyelinated C-fibre to pH 6.9 (spikes) with the corresponding time plot of 
the spike-frequency shown below. The firing of action potential is maintained at pH 6.9, and application of APETx2 
(10 µM) inhibits the response. The top trace shows the average action potential. Average spike frequency at pH 6.9 
and pH 6.9 with 10 µM APETx2 (n=9) is presented on the right. (B) Effect on pain behaviour in rat of subcutaneous 
injections of acid (pH 6.9), hyperosmolarity, and 10 µM arachidonic acid (AA) together are compared with the effect 
of pH 6.9 alone. Conditions under which 10µM APETx2 or 60nM PcTx1 were added to the injected inflammatory 
cocktail are indicated on the bargraph. The number of experiments (n) is indicated above each bar (* P<0.05, 
Kruskal-Wallis test followed by a Dunn’s post hoc test). 
Figure 2. Effet de l’inhibition de ASIC3 par APETx2 sur la douleur acide et inflammatoire (selon les Figures 1B et 3E 
de Deval et al., 2008). (A) Réponse à pH 6.9 (pics d’activité) d’une fibre de type C non myélinisée et tracé 
montrant la fréquence des signaux au cours du temps (montré en dessous). Le déclenchement du potentiel d’action 
est maintenu à pH 6.9 et l’application d’APETx2 (10 µM) inhibe la réponse. Une trace au dessus montre le potentiel 
d’action. La fréquence des signaux moyennée à pH 6.9 et pH 6.9 en présence de 10 µM d’APETx2 (n=9) est 
montrée à droite. (B) Effet de l’injection sous-cutanée d’acide (pH 6.9) d’une solution hyperosmotique, et de 10µM 
d’acide arachidonique (AA) comparées ensemble à l’effet du pH acide (6.9) seul. Les conditions selon lesquelles 
10µM d’APETx2 ou 60nM de PcTx1 ont été rajoutées au cocktail inflammatoire sont indiquées sur la barre de 
l’histogramme. Le nombre d’expériences (n) est indiqué au dessus de chaque barre (* P<0.05, test Kruskal-Wallis 
suivi d’un test Dunn’s post hoc). 
Under the same experimental conditions, the spider toxin PcTx1, which specifically blocks homomeric 
ASIC1a-mediated currents, is unable to prevent analgesia. In a model of inflammation induced by peripheral 
injections of Complete Freund’s Adjuvant (CFA) in rats, heat hyperalgesia is prevented when APETx2 is co-
injected with CFA. This analgesic effect was also obtained by using specific ASIC3 siRNA in rats, strongly 
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suggesting the implication of ASIC3 as sensors of tissue acidosis and integrators of several signals produced 
during inflammation, thus contributing to inflammatory hyperalgesia (Deval et al., 2010; Deval et al., 2008; 
Karczewski et al., 2010). Another study on acidic pain on a rat gastrocnemius muscle model shows that a pre-
treatment with APETx2 is able to prevent the development of mechanical hypersensitivity. In the same pain 
model induced by an inflammation (CFA), local administration of APETx2 has also analgesic properties 
(Karczewski et al., 2010). In a recent work, our group has shown that the expression of ASIC3 is increased in 
sensory neurons innervating the hindpaw plantar muscle in a model of rat postoperative pain induced by 
hindpaw skin and muscle incision in rats (Deval et al., 2011). In this model, spontaneous, thermal, and 
postural pain behaviours are measured 4 hours after surgery by using flinching, Hargreaves (heat 
hyperalgesia), and weight bearing tests, respectively. Interestingly, spontaneous pain and heat hyperalgesia 
behaviours are significantly reduced by a local intra-operative application of 20 µM APETx2, but it has no effect 
on postural pain (Figure 3A-C; Deval et al., 2011). However, the postural pain behaviour is attenuated in 
animals treated with APETx2, 24 hours after the surgery (Figure 3D). In conclusion, peripheral analgesic 
properties were recently demonstrated for APETx2, both in acidic, inflammatory and postoperative pain. 
Although analgesic effects of APETx2 cannot exclude the participation of NaV1.8, these effects clearly involve 
peripheral ASIC3 in skin and muscle nociceptors, as demonstrated by the use of specific ASIC3 siRNA. APETx2 
is thus a very interesting tool, with potent therapeutic implications in peripheral pain, and could serve as a 
model to design future local analgesics. 
 
Figure 3. Effect of ASIC3 inhibition by APETx2 on postoperative pain (according to Figures 3B, C, E and 4A from 
Deval et al., 2011). (A) Effect of APETx2 (20 µM) and PcTx1 (120 nM) on spontaneous pain 4 h after surgery, and 
measured as the number of flinches of the ipsilateral hindpaw over a period of 5 min (** p<0.01, Kruskal-Wallis 
test followed by a Dunn’s post hoc test). (B) Effect of local application of 20 µM APETx2 on postoperative thermal 
hyperalgesia evaluated with the Hargreaves test 4 h after surgery (*** p<0.001 compared to naïve animals, one 
way ANOVA followed by a Turkey’s post hoc test). (C and D) Effect of local application of 20 µM APETx2 on postural 
pain evaluated with the dynamic weight-bearing test 4 h (C) and 24 h (D) after surgery (* p<0.05 and *** 
p<0.001, one way ANOVA followed by a Turkey’s post hoc test). 
Figure 3. Effet de l’inhibition de ASIC3 par APETx2 sur la douleur post-opératoire (selon les Figures 3B, C, E et 4A 
de Deval et al., 2011). (A) Effet d’APETx2 (20 µM) et de PcTx1 (120 nM) sur la douleur spontanée 4 h après la 
chirurgie, mesurée par le nombre de lever de la patte arrière ipsilatérale sur une période de 5 min (** p<0.01, test 
Kruskal-Wallis suivi d’un test Dunn’s post hoc). (B) Effet de l’application locale de 20 µM d’APETx2 sur 
l’hyperalgésie thermique post-opératoire évaluée avec le test Hargreaves 4 h après la chirurgie (*** p<0.001 
comparé avec les animaux naïfs, one way ANOVA suivi d’un test Turkey’s post hoc). (C et D) Effet de l’application 
locale de 20 µM d’APETx2 sur la douleur posturale évalué avec le test de répartition du poids en dynamique 4 h (C) 
et 24 h (D) après la chirurgie (* p<0.05 et *** p<0.001, one way ANOVA suivi d’un test Turkey’s post hoc). 
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Conclusion 
Toxins from sea anemone venom do not act only on their natural marine preys, i.e. fishes and crustaceans, but 
also on mammals where a high diversity of sea anemone peptides having different structures have been 
described with different degrees of toxicity ranging from paralyzing effects to lethality, sometimes associated 
with cardiotoxic effects. High toxicity is correlated with effects of SA toxins on NaV channels, while some 
neurotoxic effects can also be attributed to the action of toxins on KV1 channels. An increasing number of 
studies reveal the presence of non-toxic or low-toxic peptides which target new channels related to important 
sensory functions. Peptides with new structures and unknown targets have also been identified. It is quite 
surprising that no activity on voltage-gated Ca2+ channels was reported yet in SA venoms, since Ca2+ channel 
blockers were largely characterized in other animal venoms like snakes, spiders, cones and scorpions, and can 
also participate to the paralyzing effects on preys. 
Recently, peptidomic and transcriptomic approaches reported the presence of more than 80 toxins in the 
venom of Bunodosoma cangicum and more than 40 new sequences in the venom of Anemonia sulcata (Kozlov 
and Grishin, 2011; Zaharenko et al., 2008). This could predict for the future years an exponential increase of 
interesting tools, isolated from sea anemones, to study ion channels as well as specific pathologies, and maybe 
to design new therapeutic agents. 
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Abstract 
Voltage-gated sodium channels are of prime importance for rapid neuronal signaling and, 
therefore, are targets of various types of peptide toxins. In order to understand the molecular 
mechanisms underlying toxin-channel interaction, detailed functional analysis of channel function 
upon heterologous expression in host cells is required. Here, we review a couple of methods that 
proved useful for the identification of interaction sites at the channel protein and for gaining 
insight into the impact of peptide toxins on channel gating. We describe the construction of 
sodium channel chimeras and specific mutants, extraction of single-channel data based on 
macroscopic currents, and methods for the unambiguous identification of current components 
associated with transiently expressed sodium channel genes. 
Des outils pour étudier la modulation des canaux sodium sensibles au 
potentiel par les toxines peptidiques 
Les canaux sodium dépendants du potentiel ont un rôle majeur dans la signalisation neuronale 
rapide et, de ce fait, sont les cibles de nombreuses espèces de toxines peptidiques. Afin de 
comprendre le mécanisme moléculaire de l’interaction toxine-canal, une étude précise du 
fonctionnement de ces canaux, à l’aide d’un système d’expression hétérologue, est nécessaire. 
Dans cette revue, nous présentons certaines méthodes particulièrement adaptées à 
l’identification du site d’interaction des toxines avec les canaux sodium et de leur impact sur le 
fonctionnement de ces canaux. Nous décrivons la construction de canaux sodium chimériques et 
de mutants spécifiques, l’extraction de données sur le canal unique à partir des courants 
macroscopiques et les méthodes d’identification, de façon non-ambiguë, des courants ioniques 
associés à l’expression transitoire des gènes de ces canaux. 
 
Keywords : Conotoxin, channel gating, patch-clamp, scorpion toxin, sodium channel. 
 
Introduction 
Voltage-gated sodium channels (NaV channels) are responsible for the rapid upstroke of an action potential and 
play a pivotal role in electrical signaling of neuronal and muscle cells. Many peptide toxins of venomous 
animals, such as scorpions, sea anemones, wasps and cone snails, have therefore evolved to specifically 
interfere with NaV channels and, hence, to affect electrical signaling of the respective target organism. 
Depending on the mode of interference, NaV channel-specific toxins inhibit (e.g. µ-conotoxins, µO-conotoxins) 
or enhance (e.g. -conotoxins, scorpion - and -toxins) Na+ currents and either block neuronal activity or 
cause hyperexcitability, respectively – in either case with deleterious consequences for the affected organism 
(for reviews see, Cestèle and Catterall, 2000; Heinemann and Leipold, 2007). 
Like other peptide toxins, NaV channel toxins have attracted considerable attention because they are very 
useful experimental tools. On one hand, they have proven very instrumental in studying the molecular 
mechanisms of NaV channel function: µ-conotoxins block the channel and therefore are used to probe the outer 
vestibule of the channel pore; other peptides such as µO-conotoxins, -conotoxins, and scorpion - and -
toxins belong to the class of voltage-sensor toxins, i.e. they interfere with the gating machinery of the channel 
and provide important information on the function of individual voltage-sensors. On the other hand, an even 
greater potential resides in the ability of some NaV toxins to distinguish different NaV channel isoforms. From 
the nine prototypic NaV channels in humans (NaV1.1-NaV1.9), most display very similar properties in terms of 
ion permeation and gating characteristics (voltage dependence and kinetics of activation and inactivation) and, 
therefore, often only can be distinguished with the aid of pharmacological intervention, such as the application 
of NaV-specific peptide toxins. 
Some peptide toxins are even promising lead structures for clinical application; for example, toxins 
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inhibiting peripheral NaV channels, such as some µ-conotoxins, are considered potential analgesics or muscle 
relaxants. In particular when addressing clinical applications, subtype specificity is an important issue because 
off-site effects, such as blockade of cardiac NaV1.5 channels, have to be avoided. Therefore, it is important to 
understand how peptide toxins affect NaV channels on a molecular level and which structural features – of the 
channel and the toxin itself – are responsible for a specific toxin-channel interaction. 
In order to reach the above-mentioned goal, several experimental requirements have to be met. Typically, 
one needs to study the toxin effects on identified channel proteins with electrophysiological methods as to 
precisely assay channel function. In most cases, it is not sufficient to study wild-type channels only, but NaV 
channel structures have to be manipulated systematically. For functional assays, corresponding constructs have 
to be expressed in host cells. Although expression in Xenopus oocytes is the most straightforward approach, 
several arguments are in favor of mammalian cells as an expression system: when studying mammalian NaV 
channels, mammalian host cells may provide a more suited environment, e.g. by providing the matching 
interaction proteins or post-translational modification mechanisms; time resolution and voltage-clamp control 
are much better in small mammalian cells than in oocytes; strong invaginations of the oocyte membrane may 
compromise the free access of toxins to all sites of the plasma membrane; finally, oocytes are large (about 1 
mm diameter) and, hence, typically much more toxin is required for functional studies – this is a serious 
limitation when working with native toxins that are only available in very small quantities.  
Here, we consider experimental approaches for studying toxin effects on NaV channels expressed in 
mammalian cells. We describe various experimental strategies for only one example, namely the investigation 
of the subtype specificity of µ-conotoxins. In this case, one may meet several technical obstacles. We will try to 
address some of them and will discuss how to overcome them. (a) For the identification of molecular entities 
determining the subtype specificity, generation of channel chimeras can be very helpful, but how to make such 
chimeras in a systematic and economic manner? (b) Toxins may not always block NaV channels completely – 
they may block partially and affect open probability; how to determine single-channel parameters from whole-
cell recordings? (c) Na+ current associated with transfected NaV channel genes may be very small, in particular 
when considering the residual components after toxin application; how do we discriminate such exogenous 
signals from currents through NaV channels endogenous to the host cells?  
Mixing and matching of sodium channel modules 
NaV channels are formed by a large -subunit and up to two small auxiliary -subunits with only one 
transmembrane segment. Most functional features of NaV channels are determined by the -subunit which is 
composed of four homologous domains (DI-DIV) comprising voltage-sensors (S1-S4) and pore/gate (S5-S6) 
modules (Figure 1a). Peptide toxins typically interact with NaV channels via the extracellular side, thus the 
primary interaction epitopes are the extracellular linkers S1/2, S3/4, and the pore loops, also referred to as 
SS1 and SS2. Such linkers show considerably less conservation than the transmembrane segments (S1-S6) 
when comparing NaV channels of various species (paralogs) or all NaV isoforms of one organism (orthologs). It 
therefore does not come as a surprise that such linkers most likely determine toxin specificity for a certain 
channel type. Depending on the class of toxins, only a few linkers may be of relevance. For example, the 
impact of scorpion -toxins is largely determined by the S3/4 linker of DIV (e.g. Rogers et al., 1996; Leipold et 
al., 2004) and by the pore loops of DI (Gur et al., 2011). Scorpion -toxins exert their effect by influencing 
S3/4 of DII (Cestèle et al., 1998), but the pore loops of DIII are also required for toxin action (Leipold et al., 
2006). In this respect, µO-conotoxins share properties with scorpion -toxins (Zorn et al., 2006; Leipold et al., 
2007) and, most likely, -conotoxins with scorpion -toxins (Leipold et al., 2005; for review, see Heinemann 
and Leipold, 2007). Thus, it appears that there are two main classes of NaV-specific voltage-sensor toxins: one 
affects the voltage-sensor in DIV but also requires the pore loops of DI, the other affects the voltage-sensor of 
DII with secondary contacts in the pore loops of DIII. The situation is different for pore-blocking toxins like µ-
conotoxins. They apparently occlude the pore from the extracellular side and, therefore, must make contact 
with the pore loops of all four domains (e.g. Dudley et al., 1995, 2000; Li et al., 2001; Choudhary et al., 2007). 
Nevertheless, depending on the structural conservation of the individual pore loops, the subtype specificity of 
µ-conotoxins may be determined by only a few pore loops or only a single residue. As the most prominent 
example, µ-GIIIA blocks rat skeletal muscle NaV1.4 channels but is about 1000 times less potent for the human 
paralog. The reason is a single S-to-L difference in the outer pore loop of DII (Cummins et al., 2002). In a 
more recent study, we could show that µ-SIIIA’s preference for rat NaV1.4 over human NaV1.7 channels is also 
located in the pore loop of DII but one residue toward the N-terminus, A-to-N (Leipold et al., 2011). 
For all these studies and for any future question addressing the localization of interaction sites and 
determinants for subtype specificity, construction and functional evaluation of channel chimeras is very useful. 
In the following, we briefly describe the experimental approach. 
Construction of domain chimeras 
Construction of several chimeric NaV channels has been reported thus far, all of them designed to address 
specific questions regarding channel function or to study the interactions of the channels with specific modifiers 
and neurotoxins. Typically, these chimeras consist of a well-characterized background channel in which 
functional modules, like voltage-sensors, pore-modules, or whole domains, were replaced with those of a NaV 
paralog or ortholog. For example, Chahine et al. (1996) swapped the large domain-connecting loops between 
NaV1.4 and NaV1.5 to identify protein parts that determine the different activation and inactivation behavior of 
both channel subtypes. Whole domains were exchanged between NaV1.4 and NaV1.5 to investigate their slow 
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inactivation behavior (O´Reilly et al., 1999) and their susceptibility to inhibition by cocaine (Wright et al., 
1999). Vijayaragavan et al. (2004) used NaV1.8/1.7 chimeras to demonstrate expressional regulation of NaV1.8 
via the C-terminal structures. A similar set of NaV1.8/1.4 chimeras was utilized by Choi et al. (2004) to 
demonstrate the importance of NaV1.8’s C-terminus for its unique inactivation behavior. Lee and Goldin (2008, 
2009) reported on N- and C-terminal chimeras of NaV1.2 and NaV1.6. There are also chimeras of mammalian 
and insect NaV channels which were preliminarily used for studying the channel specificities of neurotoxins (e.g. 
Shichor et al., 2002; Gur et al., 2011).  
For an efficient scientific exploitation of NaV channel chimeras, they are ideally generated such that 
combinations of many isoforms are easily constructed. We chose rat NaV1.4 as a reference channel because it is 
very well characterized, it expresses well in various host cells, and the handling of the coding DNA is 
straightforward. Efficient replacement of individual domains of NaV1.4 by those of orthologous or paralogous 
channel types requires unique restriction sites in the DNA sequence of the corresponding expression constructs, 
thus enabling easy release and insertion of DNA fragments by enzymatic cleavage and ligation, respectively. 
For the generation of domain chimeras, five restriction sites are needed: three in the coding sequence, one 5’ 
upstream, and another one 3’ downstream of the coding region. In order to avoid structural incompatibilities at 
the site of ligation, the cleavage sites should be in areas of strong coding-sequence conservation (Figure 1b). 
Transmembrane segments, for example, are highly conserved among NaV channels and therefore may provide 
ideal sites for the assembly of chimeras, in most cases without disturbing integrity and function of the resulting 
channels. An endogenous restriction site (endonuclease BsiWI), satisfying this criterion, is located at position 
1328 (S6 in DI) of rat SCN4A. Since no other endogenous cleavage sites were suited for the construction of 
domain chimeras, we introduced silent mutations into SCN4A that allow cleavage by NheI at position 3120 (S1 
in DIII) and ClaI at position 3863 (S6 in DIV) using a PCR-based strategy as described in Zorn et al. (2006); 
cleavage sites and their relation to the channel structure are illustrated in Figure 1. DNA fragments coding for 
individual domains from rat NaV1.2 (Zorn et al., 2006; Leipold et al., 2007) and human NaV1.5 (Leipold et al., 
2011) were PCR-amplified and the necessary restriction sites were inserted with the PCR primers. 
Subsequently, the PCR-amplified donor DNA fragments as well as the NaV1.4 background construct were 
cleaved with the corresponding restriction enzymes and individual donor domains were ligated into the 
background construct. This “mixing and matching” strategy resulted in complete sets of fully functional 
NaV1.4/1.2 and NaV1.4/1.5 domain chimeras.  
 
Figure 1. Construction of sodium channel domain chimeras. (a) Topological cartoon of a NaV  channel -subunit with four 
homologous domains DI-DIV. The color code highlights fractions used to construct domain chimeras. Also shown is a site 
used to alter tetrodotoxin (TTX) sensitivity of channels (Y401) and the inactivation motif used to render channel inactivation 
sensitive to oxidative attack (M1305). Residue numbers refer to rat NaV1.4. (b) Multiple sequence alignments of the 
indicated NaV  channel isoforms (r=rat, h=human, m=mouse) around the sites used for domain chimera construction 
showing high sequence conservation. Short DNA sequences covering the restriction sites were engineered to ease the 
mixing and matching of domains among different channel isoforms. Appropriate restriction enzymes are indicated.  
Figure 1. Construction de domaines de canaux sodium chimériques. (a) Représentation schématique d’une sous-unité 
alpha de canal sodium avec quatre domaines homologues DI-DIV. Le code couleur met en évidence les régions utilisées 
dans la construction des domaines chimériques. Les sites impliqués dans la sensibilité à la tétrodotoxine (TTX) des canaux 
(Y401) et dans celle à l’effet d’une oxydation sur l’inactivation des canaux (M1305) sont indiqués. La numérotation des 
résidus fait référence au canal NaV1.4 de rat. (b) Alignements multiples des séquences de différentes isoformes de NaV 
(r=rat, h=humain, m=souris), autour des régions impliquées dans la formation des canaux chimériques, montrant une 
grande conservation des séquences. Les courtes séquences de DNA couvrant les sites de restrictions ont été construites afin 
de faciliter l’échange de domaines entre les différentes isoformes de canaux. Les enzymes de restriction appropriés sont 
indiqués. 
NaV1.4/1.2 chimeras were used to study the channel sensitivity toward µO-conotoxin MrVIA (Conus 
marmoreus). The pore loop in DIII was identified as the molecular determinant responsible for the high 
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sensitivity of NaV1.4 toward µO-MrVIA and the poor sensitivity of NaV1.2 (Zorn et al., 2006; Leipold et al., 
2007). In addition, it could be shown that µO-MrVIA and the scorpion -toxin Tz1 interact with the same 
channel epitope, the pore loop in DIII (Leipold et al., 2006). Chimeras between NaV1.4 and NaV1.5 proved 
useful for the identification of structural components responsible for the differential sensitivity toward µ-
conotoxin SIIIA (Conus striatus). While NaV1.4 was µ-SIIIA-sensitive, we showed that the pore loop of DII is 
the major determinant for the µ-SIIIA-insensitivity of NaV1.5 (Leipold et al., 2011). 
Specific tuning of channel functions 
To study the influence of neurotoxins on NaV channels, mutations that equip the channels with novel functional 
properties can be instrumental. For example, µO-MrVIA displays striking voltage dependence, i.e. it dissociates 
from the channels upon strong depolarizations suggesting toxin interaction with the voltage-sensors. To identify 
which voltage-sensor is involved and which charge may be of particular relevance, we generated and assayed a 
set of eight NaV1.4 gating charge mutants (Leipold et al., 2007) each with one charge neutralization in either 
the first or the second position of the S4 segments. This systematic approach led to the conclusion that µO-
MrVIA “blocks” NaV channels by preventing the activation of their voltage-sensor in DII. 
When NaV channels have to be studied in host cells with large endogenous NaV channel expression, such as 
in neuronal cells needed for the functional expression of NaV1.8 (Schirmeyer et al., 2009), endogenous Na+ 
currents have to be eliminated. If they are sensitive to tetrodotoxin (TTX), like in Neuro-2A cells where 300 nM 
TTX completely blocks endogenous Na+ currents, exogenously expressed channels should be made resistant to 
TTX. Typically, this is easily achieved by mutating residue Y401 in DI (numbering of rat NaV1.4, Figure 1a) or 
the corresponding homologous residues in other channel types to serine – the side chain present in TTX-
resistant NaV1.8 and NaV1.9 channels.  
Non-stationary noise analysis of sodium currents 
Currents mediated by NaV channels are readily measured with the whole-cell patch-clamp method (Hamill et 
al., 1981). Provided the electrical pipette capacitance (about 4 pF) and cell capacitance (about 10 pF) are both 
small and well compensated, a time resolution of about 100 µs is achieved; this is not fast enough to faithfully 
infer about NaV channel activation gating transitions at high voltages, but it is sufficient for most purposes to 
yield reliable estimates of current amplitude, inactivation kinetics, and activation kinetics up to about 0 mV. 
Compilation of macroscopic current traces thus yields information on channel kinetics and voltage dependence 
of activation and inactivation. Owing to the relative rapid inactivation, true channel open probability is not 
readily estimated from macroscopic data, as this would require precise knowledge of how activation and 
inactivation are coupled. In addition, there is no direct access to the single-channel current size. 
This can be a substantial limitation when studying the effect of peptide toxins on NaV channels. Let us 
consider a µ-conotoxin applied to HEK 293 cells expressing a specific NaV isoform. The µ-conotoxin blocks the 
channel but even at high toxin concentration, a residual steady-state current is measured. This may either 
mean that the channels are only partially blocked, i.e. the single-channel current size is reduced, or a certain 
fraction of channels is blocked while another one may be resistant to block (e.g. a fraction of channels that is 
post-translationally modified to obtain a smaller sensitivity toward the toxin). In such a case, one will need to 
obtain direct estimates for the single-channel current size (i) and the maximal open probability (Po,max). After 
Sigworth (1980), such information can be extracted from non-stationary fluctuations of current amplitudes 
among successive current recordings by analyzing the ensemble current and ensemble variance according to 
Equation 1. Heinemann and Conti (1992) described this method in detail for macroscopic patch-clamp data and 
Steffan and Heinemann (1997) provided the theoretical framework for a quantitative error estimation of the 
derived parameters. Here, we address the specific problems when performing non-stationary noise analysis of 
whole-cell Na+ currents before and after application of µ-conotoxins. 
Pulse protocol and current recording 
Non-stationary noise analysis relies on successive recordings of many current traces in response to identical 
conditions and stimuli. This statement contains two major terms that need to be considered with great care. 
The meaning of “many” depends on the signal-to-noise ratio; considering wild-type NaV channels under 
physiological conditions and a peak current size of about 1 nA, one typically needs at least 100-200 current 
traces. “Identical conditions” means that for all stimulations there should be the same chance for all channels to 
open, i.e. there should be no drift in the number of channels, no other change in channel properties, and no 
drift in leak or cell capacitance. Both criteria require the rapid recording of all current traces at invariable 
intervals. It also means that the repetition interval must be large enough as to avoid cumulative channel 
inactivation. In addition, current recording has to include reference traces used for leak correction. Thus, we 
propose a stimulation protocol as outlined in Figure 2a. Rather than applying one stimulus per sweep and then 
alternating the main stimulus with the leak stimulus from time to time (Heinemann and Conti, 1992), we 
generate one stimulus template containing segments for leak correction and several segments for Na+ current 
recording covering a range of depolarizations. In the example shown where the holding potential is -120 mV, 
there are steps to -140 mV and -100 mV used for generating leak currents, and depolarizing steps to -20, -10, 
+10, and +20 mV; all steps must have equal lengths. The time between test depolarizations is chosen to allow 
complete recovery from fast inactivation: here, 40 ms. Such a protocol can be repeated at a rate of 1 Hz 
without running into cumulative slow inactivation, i.e. the recording of 200 sweeps will take 200 s. The 
sampling rate should be chosen as high as possible; typical values are 20 µs with an 8-pole low-pass Bessel 
filter set to 5 kHz. 
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Prior to automatic analysis, one should make sure that there are no obvious artifacts in the recordings, and 
that the leak, capacitance and NaV-mediated currents are roughly stable. Elimination of “bad” recordings can 
also be automated according to objective criteria as described in Heinemann and Conti (1992). As the result of 
raw data analysis, there will be the mean leak traces, the mean leak-corrected Na+ current traces (Figure 2b) 
and, based on the differences of successive recordings (Figure 2a), the mean ensemble variances of the Na+ 
currents (Figure 2b). 
 
Figure 2. Non-stationary noise analysis of Na+ currents recorded in the whole-cell configuration from transfected HEK 293 
cells. (a) Pulse protocol used to activate NaV  channels (top). Current traces resulting from the blue stimulation segments are 
used for correcting leak and capacitive currents. Superposition of 6 raw data traces (center) and 5 differences of successive 
traces (bottom). (b) Leak-corrected mean current (bottom) and mean ensemble variance (top) for NaV1.4 channels, before 
(black) and after (red) application of 100 µM µ-SIIIA. Mean data are based on 200 individual current sweeps each. (c) Mean 
ensemble variance as a function of mean current for four different voltages (gray) with superimposed global fits according to 
Equation 1 on a logarithmic scale under control conditions (top) and after application of µ-SIIIA (bottom). (d) Resulting 
parameters as a function of test-voltage: maximal open probability (Po,max, top) and single-channel current (i, bottom) for 
control conditions (n=6, open symbols) and after µ-SIIIA application (n=4, filled symbols). Po,max values are connected by 
straight lines; i values are superimposed with linear fits. Error bars indicate standard error of the mean (S.E.M.) values. 
Figure 2. Analyse de bruit non stationnaire des courants Na+ enregistrés dans la configuration « cellule entière » au niveau de 
cellules HEK 293 transfectées. (a) Protocole d’impulsions utilisé pour activer des canaux NaV (en haut). Traces de courant 
résultant de la série bleue de stimulations et utilisés pour corriger les courants de fuite et capacitifs. Superposition de 6 traces 
de données brutes (au centre) et de 5 différences de traces successives (en bas). (b) Courant moyen corrigé du courant de 
fuite (en bas) et moyenne de l’ensemble des variances (en haut) pour les canaux NaV1.4, avant (en noir) et après (en rouge) 
l’application de 100 µM de μ-SIIIA. Dans chaque cas, les données moyennes sont basées sur 200 balayages de courant 
individuel. (c) Moyenne de l’ensemble des variances en fonction du courant moyen pour quatre potentiel différents (en gris) 
avec superposition des ajustements globaux selon l'Equation 1 sur une échelle logarithmique, dans des conditions contrôles (en 
haut) et après l’application de μ-SIIIA (en bas). (d) Paramètres résultants en fonction de la stimulation test: probabilité 
maximale d’ouverture (Po,max, en haut) et courants via un seul canal (i, en bas) pour les conditions contrôles (n=6, symboles 
blancs) et après l'application de μ-SIIIA (n=4, symboles noirs). Les valeurs de Po,max sont reliées par des lignes droites; celles 
de i sont ajustées linéairement. Les barres d'erreur indiquent les valeurs de l’erreur standard de la moyenne (E.S.M.). 
Noise analysis and global data fitting 
The next step in non-stationary noise analysis is to plot the mean ensemble variance (2) as a function of the 
mean current (I). Given the limited time resolution of whole-cell patch-clamp, one should only use those data 
corresponding to inactivating currents, i.e. from the peak current to the end. These data are then fitted with 
Equation 1 to yield the background variance (2b), the single-channel current (i) and the total number of channels 
(N). The maximal open probability (Po,max) is subsequently obtained from Imax = Po,max * i * N. This procedure only 
works well if the data contain information about a wide range of Po values; ideally, Po should go from zero to 
greater than 0.5, i.e. the parabola defined by Equation 1 should exceed its maximum. For NaV channels with their 
rapid inactivation, however, Po typically is much smaller than 0.5. Therefore, current recordings at -20 mV or 
below might be useful for estimating the single-channel current size (i), but such data do not constrain the fit as 
to allow faithful estimation of N. Therefore, as proposed earlier for the analysis of Shaker K+ channel-mediated 
current recordings (Starkus et al., 2003), N needs to be constrained by additional data. Rather than fitting 2-I 
relationships for individual test potential, we apply here a global fit to the data of all test potentials simultaneously 
using individual single-channel currents [i(V)] but only one total number of channels N (Figure 2c). 
 2   b2  i I  I
2
N
 Equation 1 
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A corresponding experiment is illustrated in Figure 2. NaV1.4 channels were expressed in HEK 293 cells, and 
single-channel parameters were determined before and after application of 100 µM of µ-SIIIA. For detailed 
experimental protocols, refer to Leipold et al. (2011). Even this saturating toxin concentration does not block 
the macroscopic current completely (see Figure 2b, red traces). We thus analyzed control currents and current 
after toxin application for 200 successive data traces each, and compiled leak-corrected mean current and 
ensemble variance using PulseTools software (HEKA Elektronik, Lambrecht/Pfalz, Germany). Such data were 
exported to IgorPro (WaveMetrics, Lake Oswego, OR, USA) and the falling phases of the current traces were 
plotted in a parametric manner, i.e. 2 versus I (Figure 2c). In IgorPro, a global fit according to Equation 1 was 
applied to all data of one condition, leaving as free parameters 4 background variances (2b, for 4 voltages), 4 
single-channel currents and only one total number of channels (N). The results, based on 4-6 such 
experiments, are summarized in Figure 2d: while the maximal open probabilities only showed some voltage 
dependence in the range explored, they did not significantly differ between control and toxin conditions. Single-
channel current, however, was reduced substantially by µ-SIIIA. The conductance derived from a linear fit to 
the i(V) data was reduced from 23.3±1.2 to 5.2±0.3 pS, thus clearly showing that µ-SIIIA does not occlude the 
NaV channel pore completely but leaves some “leak” current of about 20% of the original value. In addition, it 
was noticed that the total number of channels dropped to about 55%, indicating that some channels were 
either completely blocked or disappeared because of other reasons.  
Non-invasive and rapid removal of fast channel inactivation 
As shown above, non-stationary noise analysis can be applied to analyze current components that persist upon 
toxin application. Such a component, however, could also be of alternative origin. Although electrically non-
excitable, HEK 293 cells also exhibit some endogenous Na+ currents. Depending on cell culture conditions and 
transfection, about 100 pA of peak Na+ currents can be recorded. Such endogenous currents appear to be 
particularly apparent when cells are transfected with plasmids (e.g. empty vectors). Judged from the voltage 
dependence of steady-state inactivation, these endogenous currents share some similarity with cardiac NaV1.5-
mediated currents; in addition, the currents are not completely blocked with 300 nM TTX (not shown). PCR 
analysis of cDNA from HEK 293 cells suggests some expression of NaV1.7, NaV1.5 and NaV1.6 channels. Thus, 
HEK 293 cells are a very suited expression system for NaV channels because most cells do not exhibit 
endogenous Na+ currents, although some residual endogenous current components cannot be excluded. 
Therefore, in particular in experiments where the exogenous channel gene expresses poorly or when only a 
small fraction of residual current has to be analyzed (Figure 3), one may need independent proof for the 
identity of the respective current component. We have already seen that it can be useful to alter the TTX 
sensitivity of the channel under investigation in order to discriminate it clearly from endogenous components. 
However, in some experiments, this method may be insufficient because (a) the endogenous current may 
contain TTX-sensitive and –insensitive components (such as in dorsal root ganglion neurons, for example), or 
(b) TTX may interfere with the toxin under investigation. This is particularly relevant when studying µ-
conotoxins that target receptor site-1 of NaV channels much like TTX and saxitoxin. Therefore, specific 
modulation of channel inactivation may be an alternative option. 
Most NaV channel isoforms share strong similarity regarding their kinetics of inactivation. Deliberate removal 
of inactivation would therefore be an ideal tool to identify exogenously expressed channels. In addition, 
removal of fast inactivation will “simplify” the complex gating scheme of NaV channels and may, therefore, help 
to understand the molecular mechanisms underlying the specific interaction of some peptide toxins with the 
channel’s voltage-sensors. It therefore appears quite straightforward to generate NaV channel mutants in which 
fast channel inactivation is eliminated. Based on the knowledge of the functional relevance of the IFM 
inactivation motif in the intracellular linker connecting domains III and IV (Figure 1a; West et al., 1992), one 
could alter this motif to IQM or QQQ in order to remove inactivation. However, such mutations apparently have 
a strong effect on cell function. While inactivation-deficient NaV channels express reasonably well in Xenopus 
oocytes (e.g. Schlief et al., 1996), current amplitudes obtained in mammalian cells are typically very small 
(Grant et al., 2000). Although not studied in detail, it appears that non-inactivating NaV channels contribute to 
cell depolarization and, hence, reduce the likelihood of survival. Besides such technical considerations, 
expression of inactivation-deficient NaV variants bears the disadvantage of lacking control conditions, i.e. 
channels with intact inactivation.  
Therefore, it would be ideal to use a NaV channel mutant with functional properties virtually 
indistinguishable from wild-type channels and whose inactivation can be eliminated during the course of an 
experiment in a largely non-invasive manner without changing pipette or bath solution. An approach followed 
here relies on the chemical modification of the IFM inactivation motif. While the methionine alone is already a 
target for oxidative modification that ultimately leads to loss of inactivation (Kassmann et al., 2008), we 
previously showed that placement of a cysteine residue inside this motif (ICM) makes channel inactivation very 
sensitive to oxidative modification (Haenold et al., 2008). Here, we introduce channel mutant “IFC” as also very 
sensitive but displaying almost complete inactivation under control conditions. Such mutant, when expressed in 
mammalian cells and assayed in the whole-cell recording configuration, has to be challenged chemically to 
remove inactivation. This is readily obtained, e.g. by the extracellular application of 100 µM of the membrane 
permeant cysteine-specific modifier DTNP [2,2'-Dithiobis(5-nitropyridin)]. Such an external application, 
however, may interfere with simultaneous external application of toxins under study. We therefore propose an 
alternative method. 
Rather than using acute application of a chemical that modifies the cysteine in the “IFC” motif to remove 
inactivation, we make use of the light-sensitive dye Lucifer Yellow. When irradiated with blue light, it 
decomposes and releases radicals that rapidly react with thiol groups and even remove inactivation of wild-type 
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NaV channels when exposed for a long time (Higure et al., 2003; Kassmann et al., 2008). In the experiment 
shown in Figure 3, it is illustrated how Lucifer Yellow, loaded into the cell via the patch-pipette, is used to 
rapidly remove inactivation of “IFC” channels during application of µ-conotoxin SmIIIA (from Conus 
stercusmuscarum) to identify the nature of the small current component remaining after toxin application.  
Lucifer Yellow, at a concentration of 250 µM, is supplemented to the pipette solution. A few minutes after 
establishing a whole-cell configuration, the cell is loaded with the dye. These operations and the acquisition of 
control current data are performed with dim transmission microscope light. Breakdown of Lucifer Yellow is 
elicited by application of blue light from a 50-W HBO mercury lamp, directed to the cell via a 10x objective and 
passed through a GFP epifluorescence filter set (492/SP, 495/BS). As can be seen in Figure 3b, illumination of 
the cell removed inactivation of NaV1.4-IFC channels almost completely without any apparent channel 
deterioration. Inactivation removal occurred with a time constant of about 10 s (Figure 3c), i.e. a total light 
exposure of one minute was sufficient to reach saturation. When the same procedure was applied to wild-type 
NaV1.4 channels, loss of inactivation within one minute was less than 5% (Kassmann et al., 2008). 
 
Figure 3. Removal of fast NaV  channel inactivation with light-exposed Lucifer Yellow. (a) Experimental design showing a 
HEK 293 cell under whole-cell patch-clamp control; the cell is loaded with Lucifer Yellow via the patch-pipette. Toxin is 
locally applied via a small pipette and Lucifer Yellow is excited by blue light via the objective. (b) Sample NaV1.4-IFC-
mediated current traces at -20 mV, before (black) and 40 s after (blue) light was turned on. (c) Time course of inactivation 
removal in response to light stimulation. The superimposed curve is a single-exponential fit with a t ime constant of 9.7±0.6 
s. (d) NaV1.4-IFC-mediated current traces before (black) and after (red) application of 1 µM µ-SmIIIA (left); the toxin 
reduces the peak current to a few percents. Magnified current trace after µ-SmIIIA application (right) before (red) and after 
(blue) the light was turned on; the residual current clearly loses inactivation, indicating that is was no endogenous current 
but truly results from NaV1.4-IFC. (e) Time course of peak inward current (top) and fraction of non-inactivating current 
(bottom) with the indicated stimulation with toxin and light. Continuous curves are single-exponential data fits with time 
constants of 19.9±0.8 s for channel block by µ-SmIIIA (red) and 9.5±2.5 s for light-induced removal of inactivation of the 
toxin-resistant current component (blue). 
Figure 3. Suppression de l'inactivation rapide du canal NaV avec le Jaune Lucifer exposé à la lumière. (a) Conception 
expérimentale montrant une cellule HEK 293 enregistrée en patch-clamp dans la configuration « cellule entière »; la cellule 
est chargée de Jaune Lucifer via la pipette de patch. La toxine est appliquée localement, via une petite pipette, et le Jaune 
Lucifer est excité par une lumière bleue à travers l'objectif. (b) Echantillon de traces de courant médié par les canaux 
NaV1.4-IFC à -20 mV, avant (noir) et 40 s après (bleu) que la lumière ait été ouverte. (c) Evolution dans le temps de la 
suppression de l’inactivation, en réponse à une stimulation lumineuse. La courbe superposée est un ajustement selon une 
seule exponentielle avec une constante de temps de 9,7±0,6 s. (d) Traces de courant médié par les canaux NaV1.4-IFC 
avant (noir) et après (rouge) l'application de 1 µM de μ-SmIIIA (gauche); la toxine réduit le pic de courant quelques 
pourcents. Trace amplifiée de courant après l’application de μ-SmIIIA (droite) avant (rouge) et après (bleu) que la lumière 
ait été ouverte; le courant résiduel perd clairement son inactivation, ce qui indique que ce n’était pas un courant endogène 
mais un courant réellement médié par les canaux NaV1.4-IFC. (e) Evolution dans le temps du pic de courant entrant (haut) 
et de la fraction de courant qui ne s’inactive pas (bas) avec la stimulation par la toxine et la lumière, comme indiqué. Les 
courbes continues sont des ajustements mono-exponentiels des données avec des constantes de temps de 19,9±0,8 s pour 
le blocage du canal par la μ-SmIIIA (rouge) et 9,5±2,5 s pour la suppression de l’inactivation, produite par la lumière, de la 
composante de courant résistante à la toxine (bleu). 
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In Figure 3d-e, currents through NaV1.4-IFC channels were measured under control conditions (black) and 
during application of 1 µM µ-SmIIIA, which blocks the peak current by about 95% within about 100 s. To reveal 
the nature of the remaining small current (shown in red in Figure 3d), Lucifer Yellow breakdown was initiated 
with a 60-s episode of blue light illumination. About 30 s after light was turned on, inactivation of the residual 
current was completely removed (Figure 3d, blue trace), clearly showing that the channels responsible for the 
remaining current component are the exogenously expressed NaV1.4-IFC channels and not channels 
endogenous to HEK 293 cells. 
Conclusion 
We conclude that channel chimeras, when constructed in a systematic manner, (a) have a high chance of 
yielding functional channels, (b) transplant functional channel modules, (c) are useful tools for finding out 
where/how toxins bind to the channel protein and what causes the subtype specificity of some toxins. 
Furthermore, we conclude that non-stationary noise analysis, applied to voltage-gated ion channels, is tricky 
because of the limited time resolution. However, when simultaneously applied for several voltages and using 
global fit procedures, it provides a rapid and easy access to single-channel parameters otherwise not attainable. 
Finally, light-induced removal of rapid inactivation is a useful tool for the identification of “foreign” current 
components in HEK 293 cells. In addition, deliberate removal of fast inactivation provides access to kinetic 
studies otherwise hard to perform because non-inactivating sodium channels typically do not result in sizable 
currents in mammalian cells. 
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Abstract 
Numerous toxins bind central and peripheral nervous system receptors, including ion channels. 
Among them, ciguatoxins are non-peptidic compounds produced by tropical dinoflagellates 
(Gambierdiscus genus). They are responsible for a human intoxication, named ciguatera fish 
poisoning, mediated through seafood and fish. These toxins were initially described as voltage-
gated sodium channel activators. Hence, they are responsible for various perturbations of the 
biophysical properties of these channels, such as inhibition of part of their inactivation and shift of 
their activation towards more negative potentials. In addition, ciguatoxins target and block 
voltage-dependent potassium channels in excitable membranes. These modifications of sodium 
and potassium voltage-gated channel properties result in a variety of neurocellular perturbations, 
such as massive Na+ entry, increase in intracellular Ca2+, enhancement of neuronal excitability, 
sustained increase in spontaneous and transient increase in evoked neurotransmitter release 
from the motor nerve terminals, and uncoordinated muscular fibres contraction. However, the 
interaction between ciguatoxins and ion channels does not account for all the symptoms 
associated with ciguatera fish poisoning. Recent data strongly suggest that these toxins can also 
target, at low concentrations, other membrane receptors. Such interactions could be explained by 
the non-peptidic nature of these toxins and their low molecular weight. 
Une vue d’ensemble de la modulation des canaux ioniques et des 
altérations neurocellulaires produites par les ciguatoxines 
De nombreuses toxines interagissent avec des récepteurs des systèmes nerveux central et 
périphérique, dont les canaux ioniques. Parmi elles, les ciguatoxines sont des toxines non-
peptidiques, issues de dinoflagellés (genre Gambierdiscus) des zones tropicales et responsables 
d’une intoxication humaine, nommée ciguatéra, par la contamination de poissons et de fruits de 
mer. Ces toxines ont été initialement décrites comme des activateurs des canaux sodium 
sensibles au potentiel de membrane. A ce titre, elles sont responsables de modifications 
importantes des propriétés biophysiques de ces canaux, telles que l’inhibition partielle de leur 
inactivation et le déplacement de leur activation vers des potentiels de membrane plus négatifs. 
De plus, les ciguatoxines ciblent et bloquent les canaux potassium dépendants du potentiel dans 
les membranes excitables. Ces altérations fonctionnelles des canaux sodium et potassium, 
sensibles au potentiel, se traduisent par un ensemble de perturbations neurocellulaires, telles que 
l’entrée massive d’ions Na+, l’augmentation du Ca2+ intracellulaire, l’augmentation de l’excitabilité 
neuronale, l’accroissement maintenu de la libération spontanée et celui transitoire de la libération 
évoquée de neurotransmetteur au niveau des terminaisons nerveuses motrices, ainsi que la 
contraction incoordonnée des fibres musculaires. Cependant, l’interaction des ciguatoxines avec 
les canaux ioniques ne suffit pas à rendre compte de la totalité des symptômes associés à la 
ciguatéra. Des travaux récents suggèrent fortement que ces toxines se lient également, à faibles 
concentrations, à d’autres récepteurs membranaires. De telles liaisons pourraient s’expliquer par 
la nature non-peptidique des toxines et leur faible poids moléculaire. 
Keywords : Brevenal, ciguatoxins, dinoflagellate, neurological symptoms, neuronal excitability, 
neurotransmitter release, voltage-gated ion channels. 
 
Introduction 
Ciguatoxins (CTXs) are responsible for ciguatera fish poisoning, a human syndrome acquired through the 
marine food chain. Poisoning appears after the consumption of tropical and subtropical fish which contain at 
least one form of CTXs (Achaibar et al., 2007; Isbister and Kiernan, 2005). CTXs are cyclic polyether 
compounds produced by different dinoflagellates of the genus Gambierdiscus (G. toxicus, G. Pacificus, G. 
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australes, G. polynesiensis, and G. Belizeanus; Chinain et al., 2010; Roeder et al., 2010) which colonizes the 
coral reef and gets eaten by herbivorous fish (for a review, see Molgó et al., 2010). The disease’s symptoms 
include gastro-intestinal, cardiac, dermatological, neurological and muscle disorders (Friedman et al., 2008). 
Variations in symptoms depend on the geographical area of the intoxication, as well as on the nature and 
concentration of toxins, and on individual susceptibility (Achaibar et al., 2007). Ciguatera is considered as a 
major public health issue since up to 50,000 cases can be recorded in a single year. It concerns mainly the 
endemic areas, but ciguatera appeared recently under temperate latitudes, in Spanish and Portuguese Islands, 
as well as in the Mediterranean, probably through the development of the fishing industry and the modifications 
of the climate (Otero et al., 2010; Alfonso et al.; 2010). No cure is available yet, and symptomatic treatment is 
administered to people exhibiting ciguatoxic symptoms. It consists in intravenous perfusion of D-mannitol to 
counter-balance neurological symptoms, in analgesics against muscle pain troubles, in antihistaminics for 
dermatological allergies and, in acute cases, in monitoring vital parameters (Achaibar et al., 2007). The 
ecological role of CTXs remains unknown, but recent data on Karenia brevis, a dinoflagellate which produces 
CTX-structurally related toxins, named brevetoxins (PbTxs), strongly suggest that salinity modification of 
marine medium enhances PbTx production from K. brevis. Hypo-osmotic stress induces the dinoflagellate to 
produce PbTxs and then, to resist to these important osmotic changes (Errera and Campbell, 2011). 
Increased neuronal excitability 
CTXs bind to the  subunit of voltage-sensitive sodium channels (VSSCs) at their receptor site 5 and trigger the 
opening of the pore at the resting membrane potential (Bidart et al., 1984; Lombet et al., 1987; Benoit et al., 
1996). The toxins are responsible for alteration of the biophysical properties of the channels: CTXs inhibit, in 
part, their inactivation process (Figure 1A) and shift the voltage-dependence of their activation to more 
negative membrane potentials (Benoit et al., 1986, 1996). These modifications were observed on both sensory 
and motor nerve fibres and led to the appearance of spontaneous and repetitive action potentials (Benoit et al., 
1996; Strachan et al., 1999; Mattei et al., 1999). CTXs, like PbTxs, target the receptor site 5 of VSSCs and 
exhibit an affinity for, at least, NaV1.2 (brain), NaV1.4 (skeletal muscle), NaV1.5 (heart), NaV1.6 (motor neuron) 
and NaV1.8 (sensory neurons) in heterologous or native systems (Caldwell et al., 2000; Yamaoka et al., 2004, 
2009; Lombet et al., 1987; Mattei et al., 2010). Although CTXs have been shown to activate VSSCs by altering 
their inactivation mechanism, other data strongly suggest that they are also able to down-regulate VSSC 
activation. Inhibition of Na+ currents was described using different CTXs, in a concentration-dependent manner 
(Yamaoka et al., 2004; Schlumberger et al., 2010). This led authors to speculate about a multimodal effect of 
CTXs on VSSCs, with both stimulatory and inhibitory aspects, which could be due to the chemical nature of 
these toxins: (i) their lipophilic properties enable CTXs to insert within the membrane and (ii) their relatively 
high molecular size (Yamaoka et al., 2004). 
Other membrane receptors are thought to be targeted by CTXs and may contribute to the increased 
neuronal excitability. The fact that CTXs could act on voltage-sensitive K+ channels was first proposed when it 
was observed that CTXs produce an increase in the duration of action potentials recorded from single frog 
myelinated axons and DRG neurons (Mattei et al., 1999; Birinyi-Strachan et al., 2005). Then, in various cellular 
preparations – frog myelinated nerve fibre (Figure 1B), rat myotubes and DRG neurons – CTXs were shown to 
decrease K+ currents (Hidalgo et al., 2002; Birinyi-Strachan et al., 2005; Schlumberger et al., 2010). Thus, 
CTXs increase the neuronal excitability of both sensory and motor nerve fibres through a dual action on Na+ 
and K+ channels at nanomolar concentrations. 
 
Figure 1. Effects of ciguatoxins on ionic currents recorded from frog single myelinated axons, during 
40 ms depolarizations to 0–50 mV from a holding potential of -120 mV. (A) Representative traces of 
sodium current before (control) and after addition of 10 nM Pacific ciguatoxin-1B (P-CTX-1B). (B) 
Representative traces of potassium current before (control) and after addition of 24 nM Pacific 
ciguatoxin-4B (PCTX-4B). Dashed lines indicate the zero current level. 
Figure 1. Effets des ciguatoxines sur les courants ioniques enregistrés sur des axons myélinisés isolés 
de grenouille, au cours de dépolarisations de 40 ms à 0–50 mV à partir d’un potentiel de maintien de -
120 mV. (A) Traces représentatives de courant sodium avant (contrôle) et après l’addition de 10 nM de 
ciguatoxine-1B du Pacifique (P-CTX-1B). (B) Traces représentatives de courant potassium avant 
(contrôle) et après l’addition de 24 nM de ciguatoxine-4B du Pacifique (PCTX-4B). Les lignes en traits 
discontinus indiquent le niveau zéro de courant. 
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Morphological disturbances 
The up-regulation of VSSCs by CTXs promotes an increase in intracellular Na+ concentration (Na+i), which may 
saturate all the cellular pumps and exchangers that are activated to reduce Na+i (Mattei et al., 2008). The 
intracellular osmotic disorders induced by this Na+ entry are compensated by an influx of water which causes 
an increase in cellular volume. To assess the morphological modifications of neuronal preparations induced by 
CTXs, the styryl FM1-43, classically used as an endo-exocytosis dye, was used. In myelinated nerve fibres and 
nerve terminals, CTXs, like PbTxs, elicit an about 2-fold volume increase (Benoit et al., 1996; Mattei et al., 
1999, 2010). Evidence of an osmotic disorder was brought by the observation that addition of hyperosmotic D-
mannitol reverses CTX-induced cellular swelling. Furthermore, in cells where CTXs did not trigger spontaneous 
and repetitive action potentials, the raise of Na+i is not sufficient to induce a volume increase (Bidart et al., 
1984; Benoit et al., 1998). 
Intracellular Ca2+ perturbations 
The activation of VSSCs by CTXs has been shown to increase intracellular concentration of Ca2+ (Ca2+i). This is 
due to a direct mobilisation of these ions from intracellular Ca2+ stores and to an indirect activation of the 
Na+/Ca2+ exchanger in the reversed mode, allowing Ca2+ influx against Na+ efflux (Molgó et al., 1993; Hidalgo 
et al., 2002; Mattei et al., 2008). Voltage-sensitive Ca2+ channels are also probably opened by the depolarizing 
effect of CTXs, allowing Ca2+ to enter into cells. This tetrodotoxin (TTX)-sensitive Ca2+ mobilization is thought to 
be mediated by IP3 receptors because it prevented a subsequent action of bradykinin (Molgó et al., 1993). 
Direct evidence for the increase in IP3 mass levels following Na+-entry has been obtained with PbTX-3 (Liberona 
et al.,2008). Then, Ca2+i increase is supposed to initiate exocytosis of neurotransmitter-containing vesicles. 
Neurotransmitter release and hormonal secretion enhancement 
The CTX-induced up-regulation of VSSCs and inhibition of K+ channels are followed by a variety of 
consequences on neurotransmission and neurosecretion. When bathed with CTXs, the neuromuscular junction 
exhibit a post-synaptic depolarization and trains of repetitive action potentials (Molgó et al., 1990; Mattei et al., 
2010). CTXs first increase, then reduce and eventually block Ca2+-dependent nerve-evoked transmitter release. 
However, they also enhance Ca2+-independent spontaneous quantal acetylcholine release from neuromuscular 
junctions. This is followed by the depletion of acetylcholine-containing synaptic vesicles and, consecutively, by a 
complete blockade of neurotransmitter release. Electron microscopy revealed that CTXs inhibited the recycling 
of synaptic vesicles (Molgó et al., 1991). Therefore, CTXs increase synaptic transmission through both 
spontaneous and repetitive synchronous release of neurotransmitter. Subsequent membrane depolarisation and 
impairment of action potential generation contribute to the neurotransmission decrease (Molgó et al. 1990). In 
bovine chromaffin cells, CTXs exhibit a potent secretory effect. In fact, the activation of VSSCs and the 
subsequent Ca2+i increase trigger exocytosis of catecholamine-containing vesicles. This CTX-induced secretion 
relies on both extra- and intracellular Ca2+, and was abolished by previous intoxication of chromaffin cells with 
the botulinum neurotoxin A (Mattei et al., 2008). 
Inhibition of ciguatoxin actions 
TTX, a potent Na+ channel inhibitor, was used to prevent almost all the CTX-induced effects on excitable cells 
(Molgó et al., 1991; Benoit et al., 1996; Mattei et al., 2008). In addition, because of the osmotic perturbations 
they generate – i.e. Na+ influx and subsequent cellular volume increase – a hyperosmolar solution of D-
mannitol either reverses or prevents the neurocellular actions of CTXs. Hence, D-mannitol inhibits bursts of 
CTX-induced spontaneous action potentials in myelinated nerve fibres and thus decreases the cellular swelling 
of nodes of Ranvier and nerve terminals (Benoit et al., 1996; Mattei et al., 2010). For years, intravenous D-
mannitol was considered as a beneficial treatment in human ciguatera intoxications (Palafox et al., 1988), but 
more recent epidemiological data show that patients improved without treatment (Isbister and Kiernan, 2005). 
Finally, brevenal, a natural molecule isolated from the dinoflagellate K. brevis, was shown to inhibit the 
stimulatory effect of CTXs, in a range of physiological concentrations (Mattei et al., 2008; Nguyen-Huu et al., 
2010). Brevenal was initially shown to displace PbTx binding to receptor site 5 of VSSCs (Bourdelais et al., 
2004). Its blocking effect towards CTX-induced neurosecretion through an allosteric effect on VSSCs could be 
useful in a future treatment of ciguatera. 
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Abstract 
Pinnatoxins belong to an emerging class of phycotoxins of the cyclic imine group. Detailed studies 
of their biological effects have been impeded for a long time due to unavailability of both the 
complex natural product and its natural source. Recent studies point out that the dinoflagellate 
Vulcanodinium rugosum Nézan et Chomérat, gen. nov., sp. nov., first discovered in France, is 
responsible for the production of pinnatoxins E, F and G in New Zealand, Australia, Japan and 
France. With synthetic pinnatoxin A, a detailed study has been performed, providing conclusive 
evidence for its mode of action as a potent inhibitor of nicotinic acetylcholine receptors (nAChRs), 
more selective for the human neuronal 7 subtype than for  or muscle subtypes. Such 
studies resulted in the revision of the mode of action of pinnatoxin A from calcium channel 
activation (originally proposed) to the inhibition of nAChRs with a notable selectivity for the 
neuronal human 7 subtype. Electrophysiological and competition binding studies confirmed the 
hypothesis that the spiroimine component of pinnatoxins is an important structural factor for 
blocking nAChRs. 
Pinnatoxins : une famille émergente de phycotoxines marines ciblant 
les récepteurs nicotiniques de l'acétylcholine avec une haute affinité 
Les pinnatoxines appartiennent à une classe émergente de phycotoxines du groupe des imines 
cycliques. Les études détaillées de leurs effets biologiques ont été entravées, pendant une longue 
période, par l'indisponibilité à la fois du produit complexe naturel et de sa source naturelle. Des 
études récentes soulignent que le dinoflagellé Vulcanodinium rugosum gen. nov., sp. nov. Nezan 
et Chomérat, d'abord découvert en France, est responsable de la production de pinnatoxines E, F 
et G en Nouvelle-Zélande, Australie, Japon et France. Avec la pinnatoxine A synthétique, une 
étude détaillée a été effectuée, fournissant une preuve concluante de son mode d'action comme 
inhibiteur puissant des récepteurs nicotiniques de l'acétylcholine (nAChR), plus sélectif pour le 
sous-type neuronal humain 7 que pour les sous-types musculaires  ou . De telles 
études ont abouti à la révision du mode d'action de la pinnatoxine A, de l'activation des canaux 
calciques (proposée initialement) à l'inhibition des nAChR avec une sélectivité remarquable pour 
le sous-type neuronal humain 7. Des études d’électrophysiologie et de fixation compétitive ont 
confirmé l'hypothèse selon laquelle la composante spiro-imine des pinnatoxines est un facteur 
structural important pour le blocage des nAChR. 
Keywords : Pinnatoxins, Vulcanodinium rugosum dinoflagellate, toxicity, voltage-clamp 
electrophysiology, Xenopus laevis. 
 
Introduction 
Marine environments are massively complex and contain diverse assemblage of life forms which occur in 
environments with extreme variations in pressure, salinity and temperature. As a result, marine 
microorganisms have developed unique metabolic and physiological capabilities to survive in such extreme 
habitats that led them to produce different kind of metabolites. Human poisoning by toxins of marine origin is a 
substantial worldwide hazard that may occur by the ingestion of contaminated finfish or shellfish, and through 
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water or aerosol exposure. Shellfish constitute a worldwide rich food resource that may be contaminated by 
toxins produced by harmful dinoflagellates upon which filter-feeding bivalve mollusks (such as clams, mussels, 
oysters or scallops) feed. Shellfish can concentrate these phycotoxins in their edible tissues and act as vectors 
for transferring these toxic chemical compounds to fish, crabs, birds and humans. The increased frequency and 
wide distribution of toxic algal blooms has become an environmental and economic problem that menaces 
wildlife and human health. 
Pinnatoxins an emerging class of phycotoxins 
Pinnatoxins (Figure 1) are toxins that were originally identified in shellfish of the genera Pinna and Pteria in 
Japan, after food poisoning incidents in China (Zheng et al., 1990) linked to consumption of Pinna spp (Pinna 
attenuate). However, it is still uncertain whether these toxins were the cause of these events. Pinnatoxin A was 
the first pinnatoxin to be chemically characterized. It was isolated from the bivalve Pinna muricata from the 
sub-tropical Okinawa region in Japan (Uemura et al., 1995). This was followed by the further chemical 
description of pinnatoxins B-D from the same bivalve material (Chou et al., 1996a,b; Takada et al., 2001). 
More recently, three novel analogues of pinnatoxin A, the pinnatoxins E, F and G, were isolated and structurally 
characterized from the digestive glands of two bivalves: Pacific oysters (Crassostrea gigas) and the razorfish 
(Pinna bicolor; McNabb et al., 2008; Selwood et al., 2010). Pinnatoxins F and G were proposed as the 
progenitors of all the known pinnatoxins and pteriatoxins, via metabolic and hydrolytic transformations in 
shellfish (Selwood et al., 2010). Pinnatoxins are a family of toxins belonging to a heterogeneous group of 
macrocyclic compounds called cyclic imines (for reviews see Molgó et al., 2007; Cembella and Krock, 2008; 
Guéret and Brimble, 2010). The distinguishing feature of these compounds is the presence of a cyclic imine 
moiety which has also been found in other marine toxins like gymnodimines (Seki et al., 1995), spirolides (Hu 
et al., 2001), pteriatoxins (Takada et al., 2001), prorocentrolides (Chou et al., 1996a,b), and spiro-
prorocentrimines (Lu et al., 2001). 
 
Figure 1. Chemical structure of all pinnatoxins known to date, and pteriatoxin structure shown for comparison. 
Figure 1. Structure chimique des pinnatoxines connues à ce jour et celle des ptériatoxines montrée pour 
comparaison. 
A new species of dinoflagellate responsible for pinnatoxin production and 
contamination 
Dinoflagellate cysts were isolated from surface sediments in mangrove habitats in both New Zealand and South 
Australia, where shellfish were reported positive for pinnatoxins. Analysis of these sediment samples resulted in 
the discovery of a peridinoid dinoflagellate producing pinnatoxins E and F in New Zealand, and pinnatoxins E, F 
and G in South Australia (Rhodes et al., 2010a,b, 2011a). Recent studies on surface sediment samples 
obtained from Ishigakijima (Okinawa, Japan) have also reported the presence of a thecate dinoflagellate 
(Peridiniales, Dinophyceae) which appeared under the light and scanning electron microscope morphologically 
identical to those isolated from New Zealand and Australian waters. The Japanese cultured cells produced only 
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pinnatoxin G, as determined by liquid chromatography-mass spectrometry, and further confirmed by collision 
induced dissociation experiments (Smith et al., 2011). 
Morphological and phylogenetic similarities were observed between the Japanese dinoflagellate and a 
recently described new peridinoid dinoflagellate named Vulcanodinium rugosum (Nézan and Chomérat, 2011). 
This new armoured marine dinoflagellate, obtained in water samples of Mediterranean lagoons in the coast of 
France, V. rugosum Nézan et Chomérat, gen. nov., sp. nov., exhibits a morphology that looks like either 
peridinioid or gonyaulacoid species (see Figure 2). A phylogenetic study, based on the large subunit (LSU) rDNA 
sequence data, confirmed that this taxon is new and belongs to the order Peridiniales. However, its affiliation to 
a particular family or to a known genus was not possible. Therefore, a new generic name, Vulcanodinium, was 
proposed (Nézan and Chomérat, 2011). Interestingly, the dinoflagellate V. rugosum has recently been reported 
not only to be morphologically identical to the previously reported dinoflagellates from New Zealand, Australia 
and Japan, but also to have large similarities in the LSU rDNA (96–97%) and internal transcribed spacer (ITS) 
sequences (84-88%) compared to the French material (Rhodes et al., 2011b). These results indicate that this 
dinoflagellate is responsible for the production of pinnatoxins E, F and G in New Zealand, Australia and Japan 
and also in France (Philipp Hess, Ifremer, personal communication). 
Shellfish contamination (mussels and clams) by pinnatoxins and the link to the dinoflagellate V. rugosum 
have been first reported in France in 2011 (Hess, 2011), but retro-analysis of contaminated shellfish samples 
indicates high levels of pinnatoxin G since 2006. However, due to the lack of certified standards for pinnatoxins, 
these toxins have not been reported in Europe until recently. A survey of Norwegian blue mussels for the 
presence of pinnatoxins by LC-MS/MS analysis of extracts, obtained as part of Norway's routine monitoring 
program for regulated micro-algal toxins, revealed that pinnatoxin G was widespread and present in 69% of the 
shellfish samples analyzed (Rundberget et al., 2011). These results suggest that pinnatoxins may be much 
widespread than previously suspected, and indicate that they could be responsible for sporadic incidents of 
rapid-onset symptoms during mouse bioassays of shellfish in Europe and elsewhere. However, their 
toxicological significance remains at present unclear. 
 
Figure 2. Contrast phase (A) and scanning electron micrographs (B and C) of the dinoflagellate Vulcanodinium rugosum 
Note in (A), the cell nucleus (n). (B) Ventral view of the dinoflagellate. Note the small indentation in the c6 plate (white 
arrow). (C) Smaller form of the dinoflagellate revealing the arrangement of its thecal surface. Adapted with permission from 
Nézan and Chomérat (2011; Figures 4, 7 and 25). 
Figure 2. Observations en contraste de phase (A) et en microscopie électronique à balayage (B et C) du dinoflagellé 
Vulcanodinium rugosum. Notez en (A) le noyau (n) de la cellule. (B) Vue ventrale du dinoflagellé. Notez la petite 
indentation sur le bord antérieur de la plaque c6 (flèche blanche). (C) Petite forme du dinoflagellé montrant l’arrangement 
de sa surface thécale. Reproduit avec permission de Nézan et Chomérat (2011; Figures 4, 7 et 25). 
Pinnatoxins exhibit fast-acting toxicity in rodents 
Pinatoxins exhibit fast-acting toxicity in rodent bioassays. The symptoms following intraperitoneal (i.p.) 
injection of a lethal dose of pinnatoxin A to mice give a toxicological profile characterized by transient mouse 
hyperactivity followed by a decrease in respiratory rate with prominent abdominal breathing, leading to death 
due to respiratory paralysis. Such a toxicological profile is also seen with most cyclic imine toxins that are 
highly toxic to mice by i.p injection, causing death in as little as 5 min (Munday, 2008). Crude extracts of mass 
dinoflagellate cultures containing pinnatoxins G, E, F and A, or pinnatoxin G only, when tested for toxicity in 
mice by i.p. injection, gavage and voluntary consumption, revealed toxicity ratios of 1.0:1.8:4.5 for the former 
and 1.0:2.9:7.8 for the latter, respectively (Rhodes et al., 2011a). This is similar to the ratios obtained for New 
Zealand dinoflagellate isolates (Rhodes et al., 2010b), but differs from other cyclic imines for which oral toxicity 
was reported to be 10-1000-fold less by i.p. administration (Munday, 2008). If this is confirmed with pure 
pinnatoxins, a re-appraisal of the current process would be necessary for establishing the “toxic equivalency 
factor” values (EFSA, 2009), in which i.p. toxicities are used to estimate the relative oral toxicities of marine 
micro-algal toxins in sea food. 
Pinnatoxin A targets nicotinic acetylcholine receptors with high affinity 
It has been initially suggested that the mode of action of pinnatoxins involved calcium channel activation 
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(Zheng et al., 1990; Uemura et al., 1995). However, the symptoms following an i.p. injection of a lethal dose of 
pinnatoxin A to mice gave a toxicological profile that suggested affecting nicotinic acetylcholine receptors 
(nAChRs) at the skeletal neuromuscular junction and in the central nervous system. Furthermore, there is 
growing evidence that other structurally related cyclic imine toxins (gymnodimine A and 13-desmethyl spirolide 
C) affect both muscle and neuronal nAChR subtypes (Kharrat et al., 2008; Bourne et al., 2010). 
Thanks to a robust multi-step and scalable synthetic access to pinnatoxin A, that delivered large quantities 
of the toxin, it was possible to perform a detailed study of its mode of action (Stivala and Zakarian, 2008; 
Aráoz et al., 2011a). As shown in a representative recording (Figure 3A), in oocytes expressing the human 7 
nAChR, the perfusion of 350 μM acetylcholine (ACh; corresponding to the EC50 determined experimentally) 
elicited peak currents of 1 to 3 µA amplitude at a holding membrane potential of –60 mV. 
 
Figure 3. Effect of pinnatoxin A on  nAChR subtype expressed in Xenopus oocytes. (A) ACh-evoked current recorded 
at a holding potential of -60 mV on the same oocyte, before (black tracing) and after (red tracing) addition of 250 pM 
pinnatoxin A. (B) Concentration-dependent inhibition of ACh-evoked currents by pinnatoxin A for human 7 nAChR 
subtype. Adapted with permission from Aráoz et al. (2011a) [Copyright (2011) American Chemical Society]. 
Figure 3. Effet de la pinnatoxine A sur le sous-type  de nAChR exprimé dans des ovocytes de xénope. (A) Courant 
évoqué par l’ACh et enregistré à un potentiel de maintien de -60 mV sur un même ovocyte, avant (noir) et après 
(rouge) l’addition de 250 pM de pinnatoxin A. (B) Inhibition dépendante de la concentration de pinnatoxine A des 
courants évoqués par l’ACh pour le sous-type humain 7 de nAChR. Reproduit avec permission d’Aráoz et al. (2011a) 
[Copyright (2011) American Chemical Society]. 
The ACh-evoked currents started to desensitize within about 300 ms, but pinnatoxin A did not appear to 
affect the rate of receptor desensitization. However, ACh-evoked currents were markedly reduced in amplitude 
by pico- to nanomolar pinnatoxin A concentrations, as shown in the concentration-inhibition curve (Figure 3B). 
Pinnatoxin A (0.1-50 nM), when applied on its own, did not evoke any inward current, indicating that it has no 
agonist effect on the 7 nAChR subtype. Pinnatoxin A also blocked the human  nAChR subtype expressed in 
Xenopus oocytes, but higher concentrations were needed to block the ACh-evoked currents, indicating that the 
toxin was less potent for this neuronal receptor subtype compared to the subtype. In oocytes in which the 
Torpedo muscle nAChR subtype has been incorporated into their membranes, pinnatoxin A also blocked 
the ACh-evoked nicotinic currents, in a concentration-dependent manner, with an IC50 of 5.53 nM (4.5-6.8 nM, 
95% confidence intervals). The electrophysiological and competition binding studies demonstrated the ability of 
pinnatoxin A to interact efficiently with various nAChR subtypes. The selectivity profile and affinity values 
determined by the two approaches were similar: human 7 (0.1-0.3 nM) > muscle-type Torpedo (3-5 
nM) > human  = 2 (10-30 nM), demonstrating the ability of this toxin to recognize muscle as well as 
neuronal subtypes (Aráoz et al., 2011a). 
To determine whether the spiroimine fragment in pinnatoxin A was required for blocking nAChR subtypes, 
experiments were performed with a pinnatoxin A analog containing an acyclic form of the imine ring (pinnatoxin 
AK). Both electrophysiological and competition binding assays showed the inactivity of pinnatoxin AK with 
different nAChR subtypes, highlighting the crucial role of the cyclic imine for the biological activity of pinnatoxin 
A. This inactivity can be explained by the existence of conformers strongly stabilized by an intramolecular ionic 
interaction between the ammonium and carboxylate groups of pinnatoxin AK in solution (for further details see 
Aráoz et al., 2011b). 
Conclusion 
A considerable advance has been obtained during the last two decades in pinnatoxin research, following the 
first report on pinnatoxin toxicity. This family of phycotoxins has been not only well characterized from the 
chemical point of view, but also the dinoflagellate V. rugosum Nézan et Chomérat, gen. nov., sp. nov., has 
been identified as responsible for the production of pinnatoxin E, F and G in New Zealand, Australia, Japan and 
France. Electrophysiological and competition binding studies confirmed the hypothesis that the spiroimine 
component of pinnatoxins is an important structural factor for blocking nAChRs. Finally, the success in the total 
synthesis of pinnatoxin A and pinnatoxin G (Aráoz et al., 2011a), and the knowledge of their revisited mode of 
action, pave the way for both the production of certified standards to be used for mass spectrometry 
determination of toxins in marine matrices and the development of tests to detect these toxins in contaminated 
shellfish. 
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Abstract 
The interaction between a macrocyclic spiroimine phycotoxin, pinnatoxin A, with three different 
subtypes of nicotinic acetylcholine receptors (nAChRs) has been explored using molecular 
modeling techniques. A two-step protocol has been used for flexible docking of the macrocyclic 
toxin at the nAChR subunit interface. The protein-ligand interactions identified are in good 
agreement with the selectivity profile determined experimentally. A particular conformation has 
been evidenced for the acyclic amino-ketone form of the pinnatoxin A, which explains the lack of 
biological activity observed for this derivative and emphasizes the importance of the spiroimine 
pharmacophore within this phycotoxin family. 
Etude de l’interaction de la pinnatoxin A avec les récepteurs 
nicotiniques de l’acétylcholine par modélisation moléculaire 
L’interaction d’une phycotoxine macrocyclique de type spiroimine, pinnatoxine A, avec trois sous-
types de récepteurs nicotiniques de l’acétylcholine (nAChRs) a été étudiée par différentes 
techniques de modélisation moléculaire. Une procédure en deux étapes a été utilisée pour le 
« docking » flexible de ces toxines macrocycliques à l’interface de deux sous-unités de nAChR. Les 
interactions protéine-ligand ainsi identifiées sont en accord avec le profil de sélectivité déterminé 
expérimentalement. Une conformation particulière a été mise en évidence pour la forme acyclique 
amino-cétone de la pinnatoxine A, qui explique le manque d’activité biologique observé pour ce 
dérivé et souligne l’importance du pharmacophore spiroimine dans cette famille de phycotoxines. 
Keywords : Conformational analysis, homology modeling, molecular docking, nicotinic 
acetylcholine receptors, pinnatoxin A, spiroimine toxins. 
 
Introduction 
Macrocyclic spiroimine phycotoxins represent a newly emerging group of marine toxins with worldwide 
distribution, associated with marine algal blooms and shellfish toxicity (Molgó et al., 2007). This family comprises 
five different classes of toxins: gymnodimines, spirolides, pinnatoxins, pteriatoxins, and spiro-prorocentrimines. 
Among them, pinnatoxins (1, Figure 1) are of special interest since, unlike the other phycotoxins, they have been 
shown to retain their toxicity following oral administration at a level similar to that observed for intraperitoneal 
injection (Rhodes et al., 2010; Selwood et al., 2010). Additionally, limited information about pinnatoxin A is 
available due to the low and unreliable availability from natural sources, undermined by the fact that their 
producing organism has not been identified until recently (Rhodes et al., 2010). A robust and scalable synthetic 
access to pinnatoxin A described very recently provided the required quantities for the validation of a new 
mechanism of action, as a potent inhibitor of nicotinic acetylcholine receptors, with a selectivity for the human 
neuronal 7 subtype (Stivala and Zakarian, 2008; Aráoz et al., 2011). 
In this work, we present a detailed discussion of the structural determinants of the interaction between 
pinnatoxin A (1) and its acyclic amino-ketone form (2) and three subtypes of nicotinic acetylcholine receptors 
(nAChRs). These interactions were identified using molecular modeling techniques and are in very good 
agreement with the selectivity profile previously determined experimentally (Aráoz et al., 2011). 
Materials and methods 
Three-dimensional coordinates of the ligands were generated using Corina software v3.44 
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(http://www.molecular-networks.com/). All conformational search calculations were carried out using 
MacroModel v9.7 (http://www.schrodinger.com/) with the default values, with the exception of a conformer 
energy window of 42 kJ/mol within the Mixed MCMM/Low-Mode search protocol. 
 
Figure 1. Chemical structures of pinnatoxin A (1) and its acyclic amino-ketone form (2). 
Figure 1. Structures chimiques de la pinnatoxine A (1) et de sa forme acyclique amino-cétone (2). 
Three-dimensional structures for the three nAChRs subtypes were built by homology modelling with 
Modeller v9.7 (Eswar et al., 2008), using the crystal structure (PDB code 2WZY) of AChBP in complex with 13-
desmethyl spirolide C (Bourne et al., 2010) as template. 
Gold software v4.1 (Verdonk et al., 2003) was used for molecular docking calculations, the binding site 
being defined as a sphere with a 15 Å radius centered at half-distance between backbone oxygen atoms of 
residues W147 and C190 and the GoldScore scoring function was used, all other parameters having default 
values. Whenever it was possible, side chain flexibility was introduced in key positions of the binding site in 
order to optimize the establishment of protein-ligand interactions. AutoDock 4.0 (Morris et al., 1998) was also 
used for testing an approach described in the literature dealing with the flexibility of macrocyclic systems (Forli 
and Botta, 2007). Images were generated with Chimera (Pettersen et al., 2004). 
Results and Discussion 
Three-dimensional structures of various nAChR subtypes have been previously described in the literature, built 
by homology modeling with a soluble analogue of nAChRs, the Acetylcholine Binding Protein (AChBP): human 
7 (Schapira et al., 2002; Henchman et al., 2003; Espinoza-Fonseca, 2004; Law et al., 2005; Taly et al., 2005; 
Iorga et al., 2006), chick 7 (Le Novere et al., 2002), rat 7 (Dutertre and Lewis, 2004), human 42 
(Schapira et al., 2002; Iorga et al., 2006; Pedretti et al., 2008; Henderson et al., 2010), rat 42 (Le Novere et 
al., 2002), human 44 (Pedretti et al., 2008), human 34 (Iorga et al., 2006; Gonzalez-Cestari et al., 2009), 
human 32 (Schapira et al., 2002), rat 32 (Everhart et al., 2003; Dutertre and Lewis, 2004), rat 34 
(Costa et al., 2003), rat 32 (Everhart et al., 2003), human 121 (Sine et al., 2002), mouse 121 (Molles 
et al., 2002; Willcockson et al., 2002), Torpedo 121 (Le Novere et al., 2002; Samson et al., 2002; Sullivan 
et al., 2002). In this work, homology models of human 7, 42 and Torpedo marmorata 121 nAChR 
pentamers were built using the standard protocol implemented in Modeller (Eswar et al., 2008). Among the 
available AChBP crystal structures, the recently published (Bourne et al., 2010) complex with 13-desmethyl 
spirolide C (PDB code 2WZY) was chosen as template, given the structural similarity between this ligand and 
pinnatoxin A. The sequence alignment described previously (Bourne et al., 2010) was used for building 
homology models. However, the models of the 121 subtype contained the loop F positioned in the main 
binding site, which obviously was not compatible with the subsequent docking of pinnatoxin A at the same site. 
For this subtype, a new generation of protein conformers was generated using the Modeller’s module capable of 
building models in the presence of a bound ligand, in this case 13-desmethyl spirolide C (PDB code 2WZY). 
Additionally, a particular attention was directed to the conformation of the loop F of the  subunit, which 
contains a relatively big insertion compared to the AChBP template, and which is probably very flexible. This 
loop remained unresolved in the Unwin’s electron microscopy structure of Torpedo nAChR (Unwin, 2005). The 
conformation of this loop was thus optimized using the Modeller’s “loop refine” module and the “very slow” 
refinement method. For each homology modeling calculation, 100 conformers were generated, and the one 
with the best DOPE (Discrete Optimized Protein Energy) score was retained. 
Direct docking (Verdonk et al., 2003) of the pinnatoxin A structure generated with Corina on these 
homology models, at the subunit interface, were unsuccessful, mainly because the most stable conformation of 
pinnatoxin A in vacuum was not able to fit into the receptor binding site. It was clear that we would need to use 
a docking protocol capable of introducing flexibility for the macrocyclic system of pinnatoxin A. 
Presently, to the best of our knowledge, no docking software is able to deal directly with the problem of 
ligand flexibility in macrocyclic structures. A workaround has been recently proposed (Forli and Botta, 2007) 
using AutoDock (Morris et al., 1998), but unfortunately in our hands this protocol was ineffective, resulting in 
conformations that are too distorted to be useful. We propose here a new, two-step procedure which involves 
the initial generation of an ensemble of conformers probing macrocycle flexibility followed by docking of this 
ensemble to identify the most suitable macrocycle conformation for a given target. Flexibility of ligand 
fragments other than the macrocycle is properly handled by the standard docking protocol implemented in 
Gold. This procedure is general, and can be successfully applied to any macrocyclic ligand. 
An ensemble containing 47 pinnatoxin A conformers was obtained by conformational search, using dihedral 
restraints extracted from the common pattern of ligand X-ray structures for gymnodimine A and 13-desmethyl 
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spirolide C (Bourne et al., 2010). This ensemble was subsequently docked using Gold (Verdonk et al., 2003) at 
the subunit interface of the three homology models generated previously. Overall, the docking protocol used in 
this work introduces flexibility at the level of both ligand (including macrocycle) and binding site protein side 
chains, in order to generate realistic protein-ligand complexes. 
A detailed analysis of interactions between pinnatoxin A and various subtypes of nAChRs is presented in 
Figure 2 and Table 1. The ligand is positioned in a similar manner in all three complexes, with differences in 
binding affinity arising mainly from the residue variability in key positions of the binding site. Pinnatoxin A 
establishes an important number of hydrogen bonds (seven) with 7 nAChR, which are well distributed in the 
binding site and involve most of the ligand’s functional groups. Conversely, only five hydrogen bonds are 
observed in the 42 complex, covering approximately 50% of the binding site at a close distance. The 121 
complex shows intermediate behavior, with the five hydrogen bonds more equally distributed in the binding 
site. The latter complex also benefits from important hydrophobic contacts with the complementary  subunit; 
these interactions are substantially reduced in the 42 complex. Most of the residues present in the binding 
site are conserved among the three nAChRs subtypes considered (residues 93, 143, 147, 149, 188, 190, 191 
and 195 from the principal side and residues 55, 79, and 118 from the complementary side, highlighted in 
Table 1). At the same time, in a few positions with amino acid variability the neighboring residues are able to 
compensate for the missing interaction (e.g. in 121, the carboxylate group of pinnatoxin A is not able to 
establish an ionic interaction with V186 as it does with the equivalent residue R186 in the 7 and 42 nAChR 
subtypes; instead, it interacts with K143). However, in some cases, differences in amino acid sequence are 
responsible for changes in the protein-ligand interaction pattern. One example is Q116 from the 7 subtype, 
which interacts with an oxygen atom from the bis-spiroketal core, while the equivalent residues F116 from 42 
and T116 from the 121 subtype are unable to establish similar interactions. Similarly, Q57 from the 7 
subtype and D57 from the 121 subtype form hydrogen bonds with a hydroxy group at the C28 position of 
pinnatoxin A near the solvent-exposed site, whereas the side chain of the equivalent T57 residue from the 42 
subtype is too short to form analogous interactions. Overall, the protein-ligand interactions identified in these 
three complexes are in very good agreement with the experimental biological data, with pinnatoxin A showing 
significantly stronger interactions with the 7 nAChR subtype compared to the 42 subtype, while the 121 
subtype displayed intermediate interactions, showing significant hydrophobic contribution from the 
complementary side. 
Table 1. Protein-ligand interactions within a 4 Å distance between atoms in pinnatoxin A and various subtypes of nAChRs. 
Residues that are conserved in the alignment of subunits 7, 4, 1 and 7, 2,  are represented in bold, and those 
establishing hydrogen bonds with the ligand are colored in blue. Residue numbering is the same as previously described 
(Bourne et al., 2010). Reprinted with permission from Aráoz et al., Total synthesis of pinnatoxin A and G and revision of the 
mode of action of pinnatoxin A. Journal of the American Chemical Society 133: 10499-10511 [Copyright (2011) American 
Chemical Society]. 
Tableau 1. Interactions protéine-ligand dans un rayon de 4 Å par rapport au ligand, entre la pinnatoxine A et différents 
sous-types de récepteurs nicotiniques de l’acétylcholine. Les résidus conservés dans l’alignement de séquences des sous-
unités 7, 4, 1 et 7, 2,  sont représentés en gras, et ceux qui forment des liaisons hydrogène avec le ligand sont 
colorés en bleu. La numérotation des résidus est la même que celle décrite précédemment (Bourne et al., 2010). Reproduit 
avec permission de l'article Aráoz et al., Total synthesis of pinnatoxin A and G and revision of the mode of action of 
pinnatoxin A. Journal of the American Chemical Society 133: 10499-10511. [Copyright (2011) American Chemical Society]. 
Ligand fragment 7/7 interface 4/2 interface 1/ interface 
(+)-subunit (–)-subunit  subunit  subunit  subunit  subunit 
carboxylate R186, Y188 – R186 – K143 W55, 
I161(+9)* 
cyclohexene ring Y93, R186, 
Y188 
W55 Y93, W147, 
R186 
W55 Y93, K143, 
W147 
W55, 
I161(+9)* 
7-membered 
imine ring 
Y93, W147, 
S148, G150, 
Y188, Y195 
– Y93, S146, 
W147, 
Y149, D150, 
R186, Y195 
– Y93, I148, 
W147, T148, 
Y149, Y188, 
Y195 
– 
solvent-buried 
branch 
W147 W55, Q116, 
L118 
W147 W55, L118 Y93, W147, 
T148 
W55, Y103, 
L108, L118 
bis-spiroacetal 
core 
W147, S148, 
Y188, C190, 
C191, Y195 
R79, L108, 
Q116 
D150, Y188, 
C190, C191, 
E193, Y195 
– W147, T148, 
K153, Y188, 
C190, C191, 
D193, Y195 
L108, R110 
Solvent-exposed 
branch 
– W55, Q57, 
Q116, L118 
– S36, W55, 
T57, L118 
Y188 W55, D57, 
L118 
* This isoleucine res idue belongs to the main insertion on the  subunit’s loop F, 9 residues after D161. 
* Ce résidu isoleucine appartient à l’insertion principale sur la boucle F de la sous-unité , 9 résidus après D161. 
A similar protocol (conformational search producing an ensemble containing 280 conformers followed by 
docking) was applied to the acyclic amino-ketone form of pinnatoxin A (2, Figure 1). Docking analysis showed 
that this compound binds non-specifically at the subunit interface, the main interaction observed being between 
Study of pinnatoxin A – nAChRs interaction using molecular modelling 
 
52
the ammonium group of 2 and the side chain of D197. To determine whether the spiroimine fragment in 
pinnatoxin A is required for its potent blockage of nAChR subtypes, experiments were performed with 
compound 2 and both electrophysiological and binding assays showed its inactivity with different nAChRs, 
highlighting the crucial role of the cyclic imine for the biological activity of pinnatoxin A (Aráoz et al., 2011). 
This inactivity can be explained by the existence of conformers strongly stabilized by an intramolecular ionic 
interaction between the ammonium and carboxylate groups of 2 in solution (Figure 3). These conformers, 
which are unable to bind directly to the nAChR subunit interface, would require an energetically unfavorable 
disruption of the intramolecular ion pair to produce an “open” form of the ligand, which could potentially 
interact with the binding site. 
 
Figure 2. Representative protein-ligand interactions in pinnatoxin A-nAChR complexes obtained by molecular 
modeling: (a) human 7 (green, 7-7 interface), (b) human 42 (magenta, 4-2 interface), and (c) Torpedo 
11 (cyan, 1- interface). Only amino acids interacting through hydrogen bonds with the ligand (and the residues 
from equivalent positions in the sequence alignment) are shown (see Table 1 for further information). Pinnatoxin A is 
colored in (a) yellow, (b) light blue, and (c) violet. For each complex, two different views, rotated by 90°, are 
presented. Non-polar hydrogen atoms of the ligand are not shown for clarity. Adapted with permission from Aráoz et 
al., Total synthesis of pinnatoxin A and G and revision of the mode of action of pinnatoxin A. Journal of the American 
Chemical Society 133: 10499-10511 [Copyright (2011) American Chemical Society]. 
Figure 2. Interactions représentatives protéine-ligand dans les complexes pinnatoxine A-récepteurs nicotiniques de 
l’acétylcholine, générés par modélisation moléculaire: (a) sous-type humain 7 (vert, interface 7-7), (b) sous-type 
humain 42 (magenta, interface 4-2), et (c) sous-type Torpedo 11 (cyan, interface 1-). Seuls les acides 
aminés qui forment des liaisons hydrogène avec le ligand (et les résidus dans les positions équivalentes de l’alignement 
de séquences) sont représentés (voir le Tableau 1 pour plus d’informations). La pinnatoxine A est colorée en (a) jaune, 
(b) bleu clair, et (c) violet. Pour chaque complexe, deux vues différentes, avec une rotation de 90°, sont présentées. 
Les atomes d’hydrogène non-polaires du ligand sont cachés pour plus de clarté. Reproduit avec permission de l'article 
Aráoz et al., Total synthesis of pinnatoxin A and G and revision of the mode of action of pinnatoxin A. Journal of the 
American Chemical Society 133: 10499-10511. [Copyright (2011) American Chemical Society]. 
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Figure 3. Three-dimensionnal structure of the pinnatoxin A acyclic amino-ketone form (2) 
showing strong ionic interaction between the ammonium and carboxylate groups. Adapted with 
permission from from Aráoz et al., Total synthesis of pinnatoxin A and G and revision of the 
mode of action of pinnatoxin A. Journal of the American Chemical Society 133: 10499-10511 
[Copyright (2011) American Chemical Society]. 
Figure 3. Structure tridimensionnelle de la forme acyclique amino-cétone de la pinnatoxine A 
(2) montrant une forte interaction ionique entre les groupes ammonium et carboxylate. 
Reproduit avec permission de l'article Aráoz et al., Total synthesis of pinnatoxin A and G and 
revision of the mode of action of pinnatoxin A. Journal of the American Chemical Society 133: 
10499-10511. [Copyright (2011) American Chemical Society]. 
These observations reinforce the functional role of the cyclic imine and the importance of its structural 
integrity for the interaction with nAChRs. The cyclic imine moiety represents the key feature in this family of 
phycotoxins and its role in binding of pinnatoxin A to nAChRs, according to the modeling, is dual. First, in 
conjunction with the C28 hydroxy group of the bridged EF-ketal, it anchors the ligand to the binding site 
through hydrogen bonds in a conformation ideally poised to optimize the interactions with neighboring residues. 
Moreover, the hydrogen bond established by this group with the backbone carbonyl of W147 is observed not 
only in all three docking complexes obtained in this work, but also in the two crystal structures of the 
complexes between AChBP and gymnodimine A or 13-desmethyl spirolide C (Bourne et al., 2010). Second, 
binding of the closed imino ring A in pinnatoxin A (1) appears to be more favorable, both sterically and 
energetically, than that of the corresponding open amino ketone form (2). 
The presence of a protonated imine nitrogen might represent a common functional feature in the cyclic 
imine phycotoxins interacting with nicotinic receptors, as has been shown for pinnatoxin A (Aráoz et al., 2011), 
gymnodimine A, and 13-desmethyl spirolide C (Kharrat et al., 2008; Bourne et al., 2010) and that has yet to 
be demonstrated for pteriatoxins and prorocentrolides. 
Conclusion 
In this work, molecular modeling studies provided further detailed insight into the structural determinants of 
the interaction between a macrocyclic spiroimine phycotoxin, pinnatoxin A, with three different subtypes of 
nAChRs. A two-step protocol has been established for flexible docking of the macrocyclic toxin at the nAChR 
subunit interface. The protein-ligand interactions identified are in good agreement with the selectivity profile 
determined experimentally. A particular conformation has been evidenced for the acyclic amino-ketone form of 
the pinnatoxin A, which explains low, if any, biological activity observed for this derivative and emphasizes the 
importance of the spiroimine pharmacophore within this phycotoxin family. 
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Abstract 
The VacA toxin from Helicobacter pylori is composed by a N-terminal 33-kDa and a C-terminal 
55-kDa fragment (named p33 and p55, respectively), thus structurally resembling an A-B toxin. 
Through its p55 fragment, VacA binds to lipid rafts of host cells and, upon hexamerization, inserts 
its p33 domain into the lipid bilayer of plasma membrane forming an anion-selective channel, 
being thus currently classified as a pore-forming toxin. VacA is then internalized by the GEEC 
(GPI-enriched Early Endosomal Compartment) endocytic pathway (specialized in the endocytosis 
of glycosylphosphatidylinositol-anchored proteins). Exploiting the peculiar actin-comet-tail-
dependent motility of a subpopulation of early endosomes, VacA partly reaches mitochondria 
(where its pore-forming activity is transferred into the inner mitochondrial membrane and 
triggers cell death), while the most part reaches a late endosomal compartment whose osmotic 
swelling leads to cytoplasmic vacuolation. Considering its structure-function relationship, VacA 
might be a new type of A-B toxin in which the enzymatic activity of A subunit has been replaced 
by a pore-forming one. 
Trafic intracellulaire et mécanisme d’action de la toxine VacA 
d’Helicobacter pylori dans les cellules épithéliales 
La toxine VacA d’Helicobacter pylori est composée d'un fragment N-terminal de 33 kDa et d’un 
fragment C-terminal de 55 kDa (appelés p33 et p55, respectivement). Elle ressemble donc, 
structuralement, à une toxine A-B. Par son fragment p55, VacA se lie aux radeaux lipides («lipid 
rafts») des cellules hôtes et, après hexamérisation, insère son domaine p33 dans la bicouche 
lipidique en induisant la formation d’un canal sélectif aux anions, étant ainsi actuellement classée 
comme une toxine formant des pores. Elle est alors internalisée par la voie endocytaire 
dépendante des compartiments endosomaux précoces enrichis en GPI (GEEC) et spécialisée dans 
l'endocytose des protéines ancrées au glycosylphosphatidylinositol. Grâce à l’actine qui est 
responsable de la motilité d’une sous-population des endosomes précoces, une partie de VacA 
rejoint les mitochondries (où son activité de formation des pores est transférée dans la 
membrane mitochondriale interne et déclenche la mort cellulaire), tandis que la plupart de VacA 
atteint un compartiment endosomal tardif dont le gonflement osmotique entraîne une 
vacuolisation cytoplasmique. Compte tenu de sa relation structure-fonction, VacA pourrait être un 
nouveau type de toxine A-B dans laquelle l'activité enzymatique de la sous-unité A serait 
remplacée par une activité porogène. 
Keywords : A-B Toxins, Helicobacter pylori, intracellular trafficking, VacA/CagA relationship, 
VacA toxin. 
 
Introduction 
VacA toxin, one of the most important virulence factors of Helicobacter pylori, is a protein which apparently exerts 
pleiotropic effects on mammalian cells and tissues. In 2005, Nature Rev Microbiol published a landmark paper by 
Cover and Blanke in which VacA was thus proposed as a paradigm for toxin multifunctionality (Cover and Blanke, 
2005). However, an increasing body of evidence now suggests that VacA may rather be the prototype of a new 
class of monofunctional A-B toxins. The present paper is devoted to discuss the characteristics of VacA as a new 
type of A-B toxin depicting its journey and action mechanism in epithelial cells where H. pylori is however 
modulating VacA-induced toxicity by means of another virulence factor such as CagA. 
The pleiotropic effects of VacA 
Since the discovery that H. pylori (at that time named Campylobacter pylori) releases in its broth culture 
supernatant a toxin (later identified as VacA) causing a unique cytoplasmic vacuolation in cultured cells (Leunk 
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et al., 1988), a flurry of quite different cellular activities has been attributed to VacA which is to date 
consequently qualified in the literature as a multifunctional toxin (Cover and Blanke, 2005; Isomoto et al., 
2010). However, a careful analysis of VacA cellular effects described so far shows that only three toxin activities 
have been repetitively confirmed by independent laboratories suggesting that they are true biological effects. 
These activities are (i) osmotic swelling of late endocytic compartments (by indirect overactivation of their V-
ATPase) which leads to cell vacuolation (Szabò et al., 1999), (ii) induction of apoptosis by triggering the so-
called intrinsic pathway (i.e. mitochondria-dependent; Galmiche et al., 2000), and (iii) inhibition of the 
proliferation of T lymphocytes by blockage of the nuclear transcription factor NFAT activation (Gebert et al., 
2003). Worth noting, all these three activities rely totally on one single property of VacA, namely its pore-
forming activity (Szabò et al., 1999; Boncristiano et al., 2003; Cover et al., 2003). Nevertheless, many other 
disparate VacA activities on different cell types have been described, but all these effects are still waiting for 
independent confirmation and the possibility arises that at least some of them, if confirmed, might simply be 
epiphenomena of a single primary toxin action. In particular, VacA has been reported to cause (for a review see 
Ricci et al., 2000; Cover and Blanke, 2005; Isomoto et al., 2010): (1) increase in the permeability of the 
epithelial paracellular route, (2) selective inhibition of Ii-dependent antigen presentation, (3) increased 
transport of urea across epithelia, (4) binding of the toxin to a putative intermediate filament-interacting 
protein and disorganization of the cytoskeletal architecture of gastric epithelial cells, (5) activation of Ca2+-
dependent Cl- channels which may result in enterotoxic effect and diarrhea, (6) interaction with RACK1 protein, 
(7) increase in bicarbonate and pepsinogen secretion by gastric mucosa and, by contrast, decrease in 
bicarbonate secretion by duodenal mucosa, (8) increased extracellular secretion of acidic hydrolases, (9) 
induction of cytosolic calcium oscillations and activation of mast cells, (10) blockade of phagosome maturation 
and impairment of the degradative power of late endosomes and lysosomes, (11) interaction with extracellular 
matrix adhesive proteins (such as fibronectin) altering cell adhesion and spreading, (12) activation of the p38 
MAPK/ATF-2 cell signalling pathway, and (13) through activation of the PI3K/Akt signalling pathway, inhibition 
of glycogen synthase kinase (GSK)-3, with subsequent translocation of beta-catenin to the nucleus. 
Thus, is VacA really a paradigm for toxin multifunctionality as previously suggested (Cover and Blanke, 
2005; Isomoto et al., 2010), taking that all the fully-documented activities of VacA closely depends on its pore-
forming action? Or, alternatively, might VacA be better considered as a monofunctional toxin? In this respect, 
we are now focusing on the interactions of VacA with epithelial cells. 
VacA structure/function relationship 
According to their action strategy on target cells, bacterial protein toxins are commonly classified into three 
classes (Boquet and Gill, 1991; Montecucco et al., 1994): (a) interfering with transmembrane signalling 
cascade, (b) affecting plasma membrane permeability (i.e. the so-called pore-forming toxins), and (c) acting 
inside the cell. As the prototype of the aforementioned first-class toxins, we can consider the heat-stable toxin 
STa from enterotoxigenic Escherichia coli. Indeed, STa acts on the surface of target cells binding to an 
endogenous ligand surface receptor so as to trigger an intracellular signaling cascade ultimately resulting in an 
increased Cl- intestinal secretion and watery diarrhea (Schiavo and van der Goot, 2001; Taxt et al., 2010). As 
prototypes of the second class, we can consider streptolysin O from Streptococcus pyogenes and alpha toxin 
from Staphylococcus aureus (Schiavo and van der Goot, 2001), that form holes into cell membranes. Finally, 
the A-B toxins (whose the most well-known are diphtheria toxin and Shiga toxin) represent the third-class 
toxins (Schiavo and van der Goot, 2001). The action strategy of an A-B toxin is to induce the highest cell 
damage with the lowest dose of toxin by exploiting its enzymatic activity on a key cytosolic regulatory protein. 
However, to reach its cytosolic target, an A-B toxin is obliged to cross cell membranes (the plasma membrane 
and/or the limiting membrane of cytoplasmic organelles). To this purpose, A-B toxins are organized into two 
different subunits (named A and B, respectively). The A subunit is the toxic part of the toxin and is linked to the 
B one in turn committed to bind the target cells and to allow the A subunit to translocate into the cytosol where 
exerting its enzymatic activity. 
In its mature form (Figure 1A), VacA is a 88-kDa protein which encompasses an N-terminal and a C-
terminal subunits (named p33 and p55, respectively) linked by a protease-sensitive loop (Cover and Blanke, 
2005; Isomoto et al., 2010). The p33 subunit has been shown to form anion-selective channels in membranes 
(i.e. it exhibits a pore-forming activity) of host cells while the p55 one allows toxin binding to target cells 
(Cover and Blanke, 2005; Isomoto et al., 2010). Apparently, VacA is thus presenting all the characteristics of a 
typical A-B toxin in which, however, the pore-forming activity of A subunit (p33) would replace the classical 
enzymatic one. However, a pore-forming activity seems to be much less potent than an enzymatic one to affect 
cell homeostasis because holes in membranes may be efficiently repaired by the cell (Bischofberger et al., 
2009). Nevertheless, among the different cell membranes, the most fragile one seems to be the inner 
mitochondrial membrane (IMM) whose alteration rapidly lead to cell death (Galmiche and Boquet, 2006). The 
VacA p33 subunit has been shown to target mitochondria, to localize in the IMM, to drop cellular ATP, and to 
cause cell death (Kimura et al., 1999; Galmiche et al., 2000; Domanska et al., 2010). Taken together, these 
findings thus suggest that VacA might represent the prototype of a new class of bacterial A-B toxins that 
associates a specific mitochondrial pore-forming subunit (p33) to a cell binding component (p55). However, 
how does this A-B toxin reach its target with a maximum of efficiency? 
VacA intracellular trafficking 
To deliver its enzymatic subunit into the cytosol, a canonical A-B toxin may usually follow two different 
approaches. 
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Figure 1. (A) Structure of the VacA toxin. The large vertical arrow shows the possible nicking, by proteolysis, of the mature 88-
kDa toxin into two separated A and B subunits of 33 kDa (p33) and 55 kDa (p55), respectively. (B) Action mechanism of VacA 
and the interfering effects of CagA. The toxin is secreted by the bacterium but remains attached to the bacterial surface and is 
slowly released in the extracellular medium. VacA binds to its cell surface receptor, oligomerizes and is inserted into the plasma 
membrane at the level of lipid rafts forming a pore endowed with anionic transport properties. The toxin is endocytosed and 
reaches early endosomal compartments (EE) which can move due to the formation of actin comet tails. These VacA-containing 
endosomes, which may activate the proapoptotic molecules BAX/BAK by the presence of the toxin, then fuse their membrane with 
those of mitochondria, favored by the presence of the mitochondrial-addressing sequence at the N-terminus of p33 (this sequence 
being also involved in the transport of the toxin to the inner mitochondrial membrane (IMM)) but possibly also facilitated by 
activated proapoptotic molecules. In the IMM the toxin pore disrupts the electrical proton gradient required for the integrity of 
mitochondrial activity and opens IMM pockets releasing cytochrome c (Cyt c) in the mitochondrial intermembrane space. This is 
followed by release of Cyt c in the cytosol through outer mitochondrial membrane (OMM)-inserted proapoptotic BAX/BAK channels 
leading to caspase 9 and 3 activation and apoptosis. Remarkably, few toxin pores inserted in the IMM can be enough for triggering 
such an effect. The mobile early endosomes can also fuse with late endosomes (LE) where most part of VacA is delivered. 
Overactivation of the endosomal proton pump (i.e. V-ATPase) through intraluminal transport of anions (i.e. Cl-) results in 
accumulation of weak bases (such as ammonia) by protonation that gives rise to the osmotic swelling finally leading to the typical 
VacA-dependent cell vacuolation. CagA is injected into the host gastric epithelial cell by a type IV secretion system. This protein can 
block the intracellular trafficking of VacA by interfering with the formation of actin comet tails at the surface of VacA-containing 
endosomes, inhibiting their motility and thereby their fusion with either mitochondria (blocking VacA-induced apoptosis) or LE 
(blocking VacA-induced vacuolation). In addition, CagA may also directly block VacA-induced apoptosis at the level of mitochondria 
(for instance, by raising the level of anti-apoptotic factors such as Bcl2). 
Figure 1. (A) Structure de la toxine VacA. La large fleche verticale montre une possible coupure, par protéolyse, de la toxine 
mature (88 kDa) en deux sous-unités séparées de 33 kDa (p33) et 55 kDa (p55), respectivement. (B) Mécanisme d'action de 
VacA et ses interactions avec CagA. La toxine est secrétée par la bactérie, mais elle reste attachée à la surface bactérienne et 
elle est relarguée lentement dans le milieu extérieur. VacA se lis à son récepteur à la surface cellulaire, s'oligomérise et s'insère 
dans la membrane plasmatique au niveau des radeaux lipidiques en formant un pore ayant des propriétés de transport anionique. 
La toxine est endocytosée et gagne les endosomes précoces (EE) qui peuvent migrer grâce à la formation de queues de comète 
d'actine. Les endosomes contenant VacA, qui peuvent activer les molécules pro-apoptotiques BAX/BAK en présence de la toxine, 
fusionnent leur membrane avec celle des mitochondries, grâce à la séquence d'adressage aux mitochondries dans la séquence N-
terminale de p33 (cette séquence étant aussi impliquée dans le transport de la toxine à la membrane interne des mitochondries 
(IMM)), mais aussi peut-être grâce aux molécules pro-apoptotiques activées. Dans la IMM le pore formée par la toxine supprime le 
gradient électrique de protons qui est nécessaire pour l'intégrité de l'activité mitochondriale, et il ouvre les poches de IMM et induit 
la fuite de cytochrome c (Cyt c) dans l'espace intermembranaire mitochondrial. Ceci est suivi par le relargage de Cyt c dans le 
cytosol à travers les canaux des molécules pro-apoptotiques insérés dans la membrane externe mitochondirale (OMM) et conduit à 
l'activation des caspases 3 et 9 et à l'apoptose. Il faut noter que quelques pores de toxine insérés dans l'IMM sont suffisants pour 
déclencher cet effet. Les endosomes précoces mobiles peuvent aussi fusionner avec les endosomes tardifs (LE) où la plupart de 
VacA est relâchée. La suractivaition de la pompe à proton endosomale (i.e. V-ATPase) dans le transport d'anions (i.e. Cl-) vers la 
lumière de l'endosome aboutit à l'accumulation de bases faibles (telles que l’ammoniaque) par protonation qui élève la pression 
osmotique entraînant une augmentation de volume cellulaire et une vacuolisation typique de VacA. CagA est injectée dans la cellule 
épithéliale gastrique par un système de sécrétion de type IV. Cette protéine peut bloquer le trafic intracellulaire de VacA en 
interférant avec la formation des queues de comète d'actine à la surface des endosomes contenant VacA, et en inhibant leur 
mobilité et ainsi leur fusion avec soit les mitochondries (bloquant l'apoptose induite par VacA) ou les LE (bloquant la vacuolisation 
induite par VacA). De plus, CagA peut directement bloquer l'apoptose induite par VacA au niveau des mitochondries (par exemple 
en élevant le niveau des facteurs anti-apoptotiques tels que Bcl2). 
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In the first one (it is the case, for instance, of diphtheria toxin), upon endocytosis of the toxin-receptor 
complex, the entire toxin reaches early endosomes where, because of the acidic pH of this compartment, 
undergoes a conformational change of a translocating domain located in the B subunit. This leads the fusion of 
the B subunit of the toxin with the endosomal membrane followed by transport of the enzymatic A subunit into 
the cytosol where it targets its prey protein. Toxins exploiting such an intracellular trafficking pathway are 
defined as “short-trip toxins” (Pei et al., 2001). 
In the second approach (it is the case, for instance, of Shiga toxin), the toxin undergoes a longer journey 
inside the cell before the A subunit may enter the cytosol. These “long-trip toxins” (Pei et al., 2001) have to 
progressively pass through early endosomes, the Golgi apparatus and the endoplasmic reticulum (ER). The 
enzymatic subunit of the toxin then reaches the cytosol by exploiting the ER-associated degradation (ERAD) 
machinery through which misfolded proteins are normally retrotranslocated from ER into the cytosol for 
proteasomal degradation (Johannes and Römer, 2010). 
VacA would follow an alternative pathway (Figure 1B). There is no cytosolic release of the pore-forming 
subunit because it would be poorly effective. The toxin pore is directly formed in the lipid bilayers of cell plasma 
membrane upon hexamerization of VacA monomers after binding to the receptor (Cover and Blanke, 2005; 
Isomoto et al., 2010). After clathrin-independent internalization through the GEEC endocytic pathway 
(specialized in the endocytosis of glycosylphosphatidylinositol-anchored proteins), the toxin is then transported 
to early endosomes which acquire a high motility because of the formation of actin comet tails at their surface 
(Gauthier et al., 2007). This motility allows such endosomes to reach mitochondria (Oldani et al., 2009) and, as 
recently shown, by endosomes-mitochondria juxtaposition exchange the transfer of a small amount of VacA to 
mitochondria together with the activation of the proapoptotic BAX and BAK molecules (Calore et al., 2010). It 
has been furthermore suggested that the presence of activated BAX and BAK at the surface of VacA-containing 
endosomes might be involved in the docking of these endosomes to mitochondria (Calore et al., 2010). 
Translocation of the p33 subunit or of the entire toxin to the IMM is achieved through its N-terminal stretch of 
32 hydrophobic amino acids that, acting as a novel mitochondrial-addressing sequence, exploits the 
mitochondrial import machinery by which exogenous proteins enter this organelle (i.e. the TOM complex) 
(Domanska et al., 2010). By this way, VacA can disrupt the transmembrane electrical potential of the IMM 
resulting in cell death. The swelling of late endosomal compartments (i.e. cell vacuolation) would simply be a 
side-effect of the toxin which is mostly routed to these compartments (Ricci et al., 1997). This is a quite 
common behaviour for an A-B toxin in which the A subunit is so powerful that also a very small amount 
reaching its intracellular target is sufficient to fully intoxicate the cell. 
VacA/CagA relationship 
Apparently, the role of VacA in H. pylori pathogenic action is confined to the early phase of bacterial infection 
(Salama et al., 2001). Secreted through a type V (i.e. autotransporter-dependent) secretion system (Schmitt 
and Haas, 1994), the toxin is progressively released from the bacterial surface upon detachment by limited 
proteolysis from its autotransporter moiety (Nguyen et al., 2001). H. pylori has developed the capacity to live 
in the human stomach which is characterized by an extremely low luminal pH. A pivotal bacterial mechanism to 
maintain a neutral pH within the bacteria is the utilization of urea by means of a powerful urease system (Sachs 
et al., 2006). Moreover, parietal cells (i.e. the producer of the hydrochloric acid responsible for the low gastric 
pH) are highly sensitive to VacA (Kobayashi et al., 1996; Wang et al., 2008). We have shown that VacA targets 
and impairs mitochondria (Galmiche et al., 2000). Mitochondria are highly abundant in parietal cells which 
necessitate a large amount of ATP to secrete hydrochloric acid via the gastric proton pump (Helander and 
Keeling, 1993). Taking into account the activity of VacA on mitochondria, the toxin is thus ideally suited to shut 
down the gastric acid production by parietal cells, in particular during the early step of H. pylori gastric 
colonization, when the bacteria (which are neutralophiles able of acid-acclimation, and not acidophiles (Sachs et 
al., 2005 and 2006)) are exposed to the high acidity characterizing the gastric lumen. Once H. pylori is 
attached to the gastric surface epithelium, it is now partially protected from acidic pH by the mucus-bicarbonate 
layer rich in urea overlying the gastric epithelium and thus the activity of VacA is no longer required. In 
addition, after bacterial adherence to the gastric epithelial cells, VacA activity might be deleterious for the 
persistence of colonization since it would lead to epithelial cell death. 
We and others have recently shown that by injecting CagA through a type IV secretion system H. pylori 
protects the colonized gastric epithelial cells against VacA injuring action (Figure 1B) (Oldani et al., 2009; 
Akada et al., 2010). This might explain the virtually constant association of VacA with CagA in highly 
pathogenic H. pylori (i.e. the so-called type I strains) even though the respective genes are far apart on the H. 
pylori chromosome and their expression levels are not mutually related (Peek and Blaser, 2002). Worth noting, 
acquisition of VacA and CagA genes by H. pylori has been achieved probably together and positive selection has 
shaped the structure of both VacA and CagA separately from the core genome of the bacterium (Gangwer et 
al., 2010). This selection could arise by a form of pseudolinkage of functionally interacting genes in order to 
balance bacterial damaging action on the host and thus facilitating a persistent gastric colonization (Gangwer et 
al., 2010). This further supports the idea that CagA may control the cytotoxic action of VacA. 
Conclusions 
The journey and action mechanism of VacA (as a new type of A-B toxin) in gastric epithelial cells can thus be 
summarized in a scheme (panel B of Figure 1) which is simple, maybe incomplete, but nevertheless helpful for 
designing new experiments to completely decipher the action strategy of this important bacterial toxin. As 
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stated by the famous French poet and essayist Paul Valéry “what is simple might be not exact, but what is 
complicated is useless”. 
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Abstract 
About 60% of newly synthesized mitochondrial proteins carry a presequence which acts as a 
targeting signal. Presequences are positively charged amino-terminal extensions which are 
cleaved upon import into the organelle. Several computer programs are available for the 
identification of presequences on the basis of the amino acid sequence. However, the import of all 
other mitochondrial proteins, about 40%, is independent of a classical presequence. In many 
cases, the alternative targeting signals are unknown. Correspondingly, it is often difficult to 
identify a mitochondrial targeting signal in a toxin of obvious mitochondrial localization. Recent 
work on the Helicobacter pylori VacA toxin revealed a peculiar mitochondrial targeting signal that 
had never been observed in any endogenous mitochondrial protein. 
Signaux d'adressage mitochondriaux connus et inconnus 
Près de 60% des protéines mitochondriales synthétisées dans le cytoplasme présentent une 
préséquence qui sert de signal d'adressage. Les préséquences sont des extensions amino-
terminales chargées positivement qui sont clivées lors de l'import vers les organites. Il existe de 
nombreux programmes informatiques permettant d'identifier des préséquences sur la base de 
leur séquence en acides aminés. Néanmoins, l'import de toutes les autres protéines 
mitochondriales, environ 40%, est indépendant de toute préséquence classique. Souvent, les 
signaux d'adressage alternatifs sont inconnus. C'est pour cette raison qu'il est généralement 
difficile d'identifier le signal d'adressage mitochondrial d'une toxine de localisation mitochondriale 
évidente. Des travaux récents sur la toxine VacA de Helicobacter pylori ont révélés un signal 
d'adressage mitochondrial étonnant qui n'a été observé dans aucune protéine mitochondriale 
endogène. 
Keywords : -barrel proteins, mitochondria, prediction programs, presequence, protein 
targeting. 
 
Introduction 
An increasing number of toxins and effector proteins is recognized to target mitochondria (Boya et al., 2004; 
Kozjak-Pavlovic et al., 2008; Arnoult and Castanier, 2010; Lamkanfi and Dixit, 2010). In all these cases, the 
question arises if the interaction is specific. An answer is facilitated if a specific mitochondrial targeting signal 
can be identified in the primary structure of the protein. Several prediction programs are available to detect 
such targeting signals. Unfortunately, these programs often fail to detect distinct targeting sequences, even if 
experiments have provided compelling evidence of a mitochondrial location. 
In fact, mitochondrial import of authentic cellular proteins is mediated by several different mechanisms and 
thus dependent on different targeting sequences. The algorithms that are provided in the internet are restricted 
to the identification of the most abundant type of mitochondrial targeting sequences, the positively charged N-
terminal presequence. It is therefore important to consider alternative systems of specific mitochondrial 
targeting if the intracellular distribution of a protein is investigated. 
N-terminal presequences 
Human mitochondria contain about 1500 different proteins, but the mitochondrial genome encodes only 13 
polypeptides. All other proteins are encoded in the nucleus, synthesized in the cytosol, and eventually imported 
into the mitochondria. About 60% of these proteins are targeted to the mitochondria by positively charged 
presequences (Schmidt et al., 2010). These are N-terminal extensions of 10-80 amino acid residues with a 
tendency to form -helical structures. Under these conditions, the positively charged residues are often 
concentrated at one side of the helix, with uncharged residues located at the opposing side. Presequences are 
usually completely devoid of negative charges. Highly conserved motifs of distinct amino acid residues are not 
contained in these sequences (Allison and Schatz, 1986). However, in some proteins, a single amino acid 
exchange can be sufficient to inactivate the presequence (Messmer et al., 2011). An example of a presequence 
contained in a bacterial protein is shown in Figure 1. 
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Figure 1. N-terminal presequence of Map, the mitochondria associated protein 
secreted by EPEC strains. The protein is injected into host cells by a type III 
secretion system. Inside mitochondria, the protein accumulates in the matrix 
(Papatheodorou et al., 2006). 
Figure 1. Préséquence N-terminale de Map (mitochondria associated protein) 
sécrétée par les souches EPEC. La protéine est injectée dans la cellule hôte par 
le système de sécrétion de type III. Dans les mitochondries, la protéine 
s’accumule dans la matrice (Papatheodorou et al., 2006). 
To identify mitochondrial presequences, several excellent prediction programs were developed (Habib et al., 
2007; Neupert and Herrmann, 2007): 
TargetP http://www.cbs.dtu.dk/services/TargetP/ 
PSORT II http://psort.ims.u-tokyo.ac.jp/ 
MITOPRED http://bioinformatics.albany.edu/~mitopred/ 
MitoProt II http://ihg.gsf.de/ihg/mitoprot.html 
Predotar http://urgi.versailles.inra.fr/predotar/predotar.html 
The programs easily detect typical mitochondrial presequences with high probability. Remarkably, most of 
these proteins are imported into the matrix (i.e. the inner compartment of the mitochondria). Presequence-
mediated import is probably the only possibility for a protein to enter the matrix compartment. In this pathway, 
presequences have at least seven different functions: 
1. Presequences can increase the solubility of newly synthesized proteins in the cytosol, prior to interactions 
with the mitochondria (Zara et al., 2003). 
2. mRNAs encoding mitochondrial proteins have a tendency to accumulate at the surface of mitochondria. 
Recent data show that ribosomes, together with mRNAs, are recruited to the mitochondrial surface if they 
synthesize proteins containing N-terminal presequences (Garcia et al., 2010). 
3. Presequences mediate binding to import receptors (Tom20 and Tom22) that are exposed at the 
mitochondrial outer surface (Neupert and Herrmann, 2007; Chacinska et al., 2009; Endo et al., 2011). 
4. They mediate an insertion of the preprotein into the general import pore (formed by Tom40, the central 
component of the outer membrane TOM complex). 
5. They interact with receptor structures provided by proteins of the inner membrane (components of the 
TIM23 complex). 
6. Due to their positively charged residues, presequences are pulled into the matrix, driven by the electric 
potential difference across the mitochondrial inner membrane (the matrix is negatively charged). 
7. Inside the matrix, mitochondrial heat shock proteins (mtHsp70) bind to the presequences and mediate 
the import of the entire protein. 
Following translocation across the inner membrane, presequences are no longer required and they are 
usually quickly cleaved at defined sites (Vögtle et al., 2009) and degraded (Falkevall et al., 2006). Because of 
their involvement in the membrane potential-dependent step, presequences are essential in the translocation of 
proteins across the inner membrane. Some proteins contain structures that prevent a complete translocation of 
the entire protein. The biogenesis of these proteins is similarly dependent on their presequence, but they 
accumulate in the inner membrane or in the intermembrane space (Reif et al., 2005). 
Presequences are often thought to represent the general targeting signal of mitochondrial proteins. 
However, targeting is only one of several different functions of these sequences. In the case of the rat 
mitochondrial citrate carrier (CIC), the presequence is even dispensable for targeting. In this protein, the 
presequence is only required to improve the solubility of the newly synthesized protein (Zara et al., 2003). 
Similarly, in the citrate carrier of the eel, the positive charges of the presequence can be exchanged against 
negative charges without loss of activity (Zara et al., 2007). Moreover, the biogenesis of about 40% of all 
mitochondrial proteins is completely independent of a presequence (Schmidt et al., 2010). 
Alternative mitochondrial targeting signals 
As presequence-dependent import is characteristic of matrix-targeting, alternative targeting is characteristic of 
proteins that have their functional location in other mitochondrial compartments. In particular, proteins of the 
mitochondrial outer membrane and of the intermembrane space are lacking presequences (Neupert and 
Herrmann, 2007, Chacinska et al., 2009): 
Tail-anchored proteins. Members of the Bcl-2 family are known to target the outer membrane. Their 
essential targeting signal is provided by their hydrophobic C-terminus (Motz et al., 2003; Rapaport, 2003; Ott 
et al., 2007). The hydrophobic segment is flanked by positive charges and responsible both for targeting and 
for membrane insertion. Bcl-2 and similar proteins are tail-anchored membrane proteins. 
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N-terminally anchored proteins. Other outer membrane proteins, such as the major import receptors 
Tom20 and Tom70, are N-terminally anchored. Similar as with tail-anchored proteins, their targeting is 
dependent on a hydrophobic transmembrane segment (Figure 2; Waizenegger et al., 2003; Rapaport, 2003). 
 
Figure 2. N-terminal amino acid sequence of human Tom20 
(Hanson et al., 1996). 
Figure 2. Séquence en acides aminés de l'extrémité N-
terminale de la protéine humaine Tom 20 (Hanson et al., 
1996). 
-barrel proteins. The -barrel proteins of the mitochondrial outer membrane are of particular interest 
because both in their structure and in their biogenesis they closely resemble the -barrel proteins of their 
bacterial relatives (Dolezal et al., 2006; Neupert and Herrmann, 2007; Chacinska et al., 2009). Examples of 
endogenous -barrel proteins of the mitochondria are Tom40 (the central component of the TOM complex), and 
porin (an abundant pore-forming protein, often named VDAC). Unfortunately, the structural elements have not 
yet been identified that determine if a -barrel protein is imported into mitochondria. In the yeast 
Saccharomyces cerevisiae, any bacterial -barrel protein seems to be imported into the mitochondria if 
expressed in the cytosol of intact cells (Walther et al., 2009). However, recently published data show that 
human mitochondria import only a very limited subset of -barrel proteins (Kozjak-Pavlovic et al., 2011). 
Remarkably, -barrel proteins do not contain a single defined segment in their amino acid sequence that could 
act as a mitochondrial targeting signal (Müller et al., 2002). The requirements of mitochondrial targeting in 
human cells were investigated in detail in a study on the pore-forming -barrel protein PorB of Neisseria 
gonorrhoeae. The results indicated that the mitochondrial protein import machinery does not recognize a 
specific sequence of the primary structure, but a long part of the protein that has retained the capability to 
form a distinct tertiary structure (Müller et al., 2002). This conclusion was recently confirmed by a study on the 
expression of the protein YadA from Yersinia enterocolitica in yeast (Müller et al., 2011). Unfortunately, no 
algorithm is available to predict mitochondrial targeting of a -barrel protein. 
Intermembrane space proteins. The mitochondrial intermembrane space contains some proteins that are 
synthesized with a presequence, but most intermembrane space proteins are imported by other mechanisms. 
Similar as with the outer membrane proteins, it is currently impossible to predict if a protein may belong to this 
compartment. No intermembrane space targeting signal has been identified. Interestingly, several 
intermembrane space proteins are imported by a "folded trap mechanism" (Neupert and Herrmann, 2007). The 
proteins insert into the general import pore (formed by the outer membrane TOM complex) by an unknown 
mechanism, get transiently exposed to the intermembrane space, and are trapped in this compartment by 
special means. The polypeptide of cytochrome c interacts with the cytochrome c heme lyase, binds a heme 
group, and by adopting its native structure, it is trapped inside the mitochondrion (Diekert et al., 2001; 
Neupert and Herrmann, 2007; Giegé et al., 2008). A subset of intermembrane space proteins is trapped by 
redox reactions. These proteins contain two cysteine residues forming a twin Cx9C motif. The proteins 
catalysing the redox reactions show obvious similarities to proteins in the periplasmic space of bacteria 
(Chacinska et al., 2009). 
Inner membrane metabolite carrier proteins. The mitochondrial inner membrane does not contain any 
pore-forming proteins because it has to keep the mitochondrial membrane potential . All exchange of 
metabolites across this membrane depends on carrier proteins. They are the most abundant proteins of the 
inner membrane. Import of newly synthesized carrier proteins is dependent on the membrane potential (which 
is required for protein insertion into the membrane), but the membrane potential-dependent step is 
independent of any presequence. For a long time, the targeting signals of these proteins have been enigmatic. 
However, it was shown that the membrane-spanning segments of the carrier proteins, with some assistance by 
flanking residues, mediate binding to the mitochondria and subsequent translocation across the mitochondrial 
outer membrane (Curran et al., 2002; Chacinsca et al., 2009). The carrier proteins constitute a family of about 
40 related proteins. The amino acid sequences do not reveal any consensus targeting signal. A mitochondrial 
location is only indicated by the overall similarity of the proteins. Due to this similarity, it was possible to 
identify the gene of a metabolite carrier (VMC1) in the genome of the mimivirus (a large DNA virus replicating 
in Acanthamoeba polyphaga; Monné et al., 2007). 
Known and unknown mitochondrial targeting signals in toxins and effector 
proteins 
While at least 60% of all endogenous mitochondrial proteins are imported with the help of a presequence 
(Schmidt et al., 2010), the abundance of presequences in the proteins of mitochondrial location encoded by 
pathogenic bacteria and viruses seems to be even lower. Up to now, only a few examples are known (Kozjak-
Pavlovic et al., 2008). Well established is the function of the N-terminal presequence of the mitochondria 
associated protein (Map) of enteropathogenic Escherichia coli strains (EPEC; Papatheodorou et al., 2006). The 
same bacteria secrete the protein EspF which is similarly targeted by a classical presequence (Papatheodorou et 
al., 2006). 
   +                    -++++     
MVGRNSAIAAGVCGALFIGYCIYFDRKRRS... 
1........10........20........30.. 
Mitochondrial targeting  
 
64
 Most toxins and effector proteins are devoid of an obvious mitochondrial targeting signal and their 
mitochondrial location has to be investigated experimentally: (i) Fusion proteins containing a GFP moiety can 
be expressed in the cytosol and tested for their distribution in the cell. (ii) The authentic proteins can be 
expressed in the cytosol, and their distribution can subsequently be monitored by cell fractionation, including 
the isolation of purified mitochondria. (iii) The proteins can be synthesized in commercially available 
reticulocyte lysate in the presence of 35S-labelled methionine and tested for import into isolated mitochondria. 
(iv) If import into isolated yeast mitochondria is possible, mitochondria can be isolated from mutant strains 
lacking defined components of the mitochondrial import machinery. It is then possible to investigate details of 
the mitochondrial import pathway (Papatheodorou et al., 2007).  
 In a project on the VacA toxin of Helicobacter pylori, we observed that the N-terminal domain of the toxin 
accumulated in mitochondria if expressed in the cytosol of HeLa cells (Galmiche et al., 2000). Unfortunately, 
the primary structure of the toxin did not reveal any similarity to a mitochondrial protein or to a mitochondrial 
targeting sequence. In a series of experiments we found that the 32 N-terminal residues of VacA were 
necessary and sufficient for mitochondrial targeting (Domanska et al., 2010). The VacA N-terminus is devoid of 
any charged residue (Figure 3). A targeting signal of this type has never been observed in any endogenous 
mitochondrial protein: N-terminally anchored proteins (such as Tom20 and Tom70) contain shorter hydrophobic 
segments, they always contain some positively charged residues, and they are targeted to the mitochondrial 
outer membrane. The VacA N-terminus differs in its structure, and it directs the toxin to the mitochondrial inner 
membrane (Domanska et al., 2010). Initially it was difficult to reconcile these observations with the fact, that 
VacA enters host cells by endocytosis and accumulates in endosomes (Boquet et al., 2003; Cover and Blanke, 
2005). Interestingly, there seems to be a mechanism to transfer VacA from the endosomes to mitochondria, 
depending on direct contact of both membranes (Gauthier et al., 2007; Calore et al., 2010). The VacA N-
terminus is essential in the transfer of the toxin from the endosomes to the mitochondria (Calore et al., 2010). 
It is tempting to speculate that the 32 residues of the VacA toxin act as a mitochondrial targeting signal, 
specifically to mediate this transfer between the two different membrane systems (Galmiche and Rassow, 
2010). 
 
Figure 3. N-terminal amino acid sequence of the Helicobacter 
pylori VacA toxin (Domanska et al., 2010). 
Figure 3. Séquence en acides aminés de l'extrémité N-terminale de 
la toxine VacA d'Helicobacter pylori (Domanska et al., 2010). 
 Moreover, it is remarkable that the specificity for the transfer of VacA to mitochondria is merely encoded in 
the length of an unpolar and hydrophobic sequence. In this respect, the situation resembles the targeting 
system of Kesv, a potassium channel encoded by EsV-1 (a virus isolated from the brown algae Ectocarpus 
siliculosus). Kesv is a small polypeptide of only 124 amino acid residues. The specificity for import into 
mitochondria is defined by the length of the second of its two membrane-spanning domains (Balss et al., 
2008). 
Conclusion 
Mitochondria are an attractive target for pathogens because mitochondria play a central role in the regulation of 
cell death and survival (Boya et al., 2004; Kozjak-Pavlovic et al., 2008; Rudel et al., 2010; Lamkanfi and Dixit, 
2010). Mitochondria can be involved not only in apoptosis, but also in necrotic cell death (Carneiro et al., 
2009). The proteins that have so far been identified to target mitochondria are extraordinarily heterogenous, 
and it is difficult to discern common principles of targeting or function. To further elucidate the interactions 
between virulence factors and mitochondria, it will be necessary to investigate the different systems that 
determine the specificity of mitochondrial targeting. In these systems, N-terminal presequences appear to be of 
only minor relevance. To confirm interactions of proteins with mitochondria, it can be misleading to rely on 
prediction programs, because these programs are usually designed to detect presequences as the only type of 
targeting signals. Considering alternative systems of targeting may be helpful to identify additional toxins and 
effector proteins that interact with mitochondria. 
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Abstract 
Epsilon toxin (ETX) is produced by strains of Clostridium perfringens classified as type B or D. 
ETX belongs to the heptameric -pore-forming toxins including aerolysin and C. septicum alpha 
toxin, which are characterized by the formation of a pore through the plasma membrane of 
eukaryotic cells consisting in a -barrel of 14 amphipatic -strands. In contrast to aerolysin and 
C. septicum alpha toxin, ETX is a much more potent toxin, which is responsible for enterotoxemia 
in animals, mainly in sheep. ETX induces perivascular edema in various tissues and accumulates 
particularly in the kidneys and in the brain, where it causes edema and necrotic lesions. ETX is 
able to pass through the blood brain barrier and to stimulate the release of glutamate, which 
accounts for the nervous excitation symptoms observed in animal enterotoxemia. At the cellular 
level, ETX causes a rapid swelling followed by a cell death involving necrosis. The precise mode of 
action of ETX remains to be determined. Therefore, ETX is a powerful toxin. However, it also 
represents a unique tool to vehicle drugs into the central nervous system or to target 
glutamatergic neurons. 
Toxine epsilon de Clostridium perfringens : une toxine fascinante 
La toxine epsilon (ETX) est produite par les souches de Clostridium perfringens classées en type B 
ou D. ETX appartient à la famille des toxines qui forment des pores heptamériques comprenant 
l'aérolysine et la toxine alpha de C. septicum. Ces toxines se caractérisent par la formation de 
pores à travers la membrane plasmique des cellules eucaryotes qui consistent en une structure 
en tonneau comprenant 14 feuillets  amphipatiques. Contrairement à l'aérolysine et à la toxine 
alpha de C. septicum, ETX est une toxine beaucoup plus puissante. Elle est responsable 
d'entérotoxémie chez les animaux, principalement les ovins. ETX induit des oedèmes 
périvasculaires dans divers tissus et s'accumule particulièrement dans les reins et le cerveau où 
elle provoque une libération de glutamate à l'origine des signes nerveux d'excitation observés au 
cours de l'entérotoxémie. Au niveau cellulaire, ETX induit des effets rapides de gonflement suivis 
d'une mort par nécrose. Le mode précis d'action d’ETX reste à déterminer. ETX est une puissante 
toxine qui représente un outil unique pour véhiculer des composés thérapeutique au système 
nerveux central et cibler les neurones glutamatergiques. 
Keywords : Aerolysin, cell necrosis, Clostridium perfringens, C. septicum alpha toxin, epsilon 
toxin, pore-forming toxin. 
 
Introduction 
Clostridium perfringens is a Gram positive, rod-shaped, anaerobic and sporulating bacterium which produces 
the largest number of toxins compared to other bacteria. It is a proteolytic and glucidolytic Clostridium which 
grows rapidly in complex medium. According to the main lethal toxins (alpha, beta, epsilon, and iota toxins), C. 
perfringens is divided into 5 toxinotypes (A to E). Epsilon toxin (ETX) is synthesized by toxinotypes B and D. 
However, the high diversity of toxin combinations, which can be produced by C. perfringens strains, makes 
more complex the classification in 5 toxinotypes (Petit et al., 1999). 
Based on the toxins produced, C. perfringens is responsible for diverse pathologies in man and animals, 
resulting from a gastro-intestinal or wound contamination and including food poisoning, enteritis, necrotic 
enteritis, enterotoxemia, gangrene, and puerperal septicemia. Toxinotype B is the causative agent of lamb 
dysenteria which is only found in some countries like the UK, whereas toxinotype D is responsible for a fatal, 
economically important disease of sheep worldwide, called enterotoxemia. ETX contributes with beta toxin to 
the pathogenesis of toxinotype B, and it is the causative virulence factor of all symptoms and lesions due to 
toxinotype D. ETX is one of the most potent toxins known. Its lethal activity ranges just below the botulinm 
neurotoxins. Indeed, the lethal dose by intraperitoneal injection in mice is 1.2 ng/kg for botulinum neurotoxin A 
and 70 ng/kg for ETX (Gill, 1987; Minami et al., 1997). For this reason, ETX is considered as a potential 
biological weapon classified as biological agent of the category B, although very few ETX-mediated natural 
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disease has been reported in humans (Mantis, 2005). ETX belongs to the family of aerolysin pore-forming 
toxins. However, its precise mode of action accounting for its high potency remains to be defined (Knapp et al., 
2010b). 
ETX structure 
At the amino acid sequence level, ETX shows some homology with the Bacillus sphaericus mosquitocidal toxins 
Mtx2 and Mtx3, with 26 and 23% sequence identity, respectively (Hunter et al., 1992). Mtx2 and Mtx3 are 
toxins specific of mosquito larvae, which are activated by proteolytic cleavage and which probably act by pore 
formation (Phannachet et al., 2011). In addition, a hypothetical protein encoded by a gene located in the 
vicinity of the C2 toxin genes on a large plasmid in C. botulinum type D shows a sequence similarity with that 
of ETX (Sakaguchi et al., 2009). 
ETX retains an elongated form and contains three domains, which are mainly composed of -sheets (Cole et 
al., 2004). Despite poor sequence identity (14%), the ETX overall structure is significantly related to that of the 
pore forming toxin aerolysin produced by Aeromonas species (Gurcel et al., 2006; Parker et al., 1994), and to 
the model of alpha-toxin from Clostridium septicum, an agent of gangrene (Melton et al., 2004). However, ETX 
is a much more potent toxin with a 100 times more lethal activity in mouse, than aerolysin and C. septicum 
alpha-toxin (Gurcel et al., 2006; Minami et al., 1997; Tweten, 2001). The main difference between toxins is 
that the aerolysin domain I, which is involved in initial toxin interaction with cells, is missing in ETX. Domain 1 
of ETX consists in a large -helix followed by a loop and three short -helices and is similar to domain 2 of 
aerolysin which interacts with the glucosyl phosphatidylinositol (GPI) anchors of proteins. This domain of ETX 
could have a similar function of binding to receptor. A cluster of aromatic residues (Tyr49, Tyr43, Tyr42, 
Tyr209, and Phe212) in ETX domain 1 could be involved in receptor binding (Cole et al., 2004). Domain 2 is a 
-sandwich structurally related to domain 3 of aerolysin. This domain contains a two-stranded sheet with an 
amphipatic sequence predicted to be the channel-forming domain (see below). In contrast to the cholesterol-
dependent cytolysins, only one amphipathic –hairpin from each monomer is involved in the pore structure of 
ETX and other heptameric -pore-forming toxins (β-PFTs) like aerolysin. Domain 3 is also a -sandwich 
analogous to domain 4 of aerolysin and contains the cleavage site for toxin activation. Domain 3, after 
removing of the C-terminus, is likely involved in monomer-monomer interaction required for oligomerization 
(Cole et al., 2004; Knapp et al., 2010b). 
The pore-forming domain has been identified in domain 2. The segment His151-Ala181 contains alternate 
hydrophobic-hydrophilic residues, which are characteristic of membrane-spanning -hairpins, and forms two 
amphipatic -strands on ETX structure. Site-directed mutagenesis confirmed that this segment is involved in 
ETX channel activity in lipid bilayers (Knapp et al., 2009). Interestingly, the ETX pore-forming domain shows 
higher sequence similarity to those of the binding components (Ib, C2-II, CDTb, CSTb) of clostridial binary 
toxins [iota toxin, C2 toxin, C. difficile transferase (CDT), C. spiroforme toxin (CST), respectively], and to a 
lesser extent to B. anthracis protective antigen (PA, the binding component of anthrax toxins), than with that of 
aerolysin. However, the ETX segment Lys162 to Glu169, which is exposed to the transmembrane side of the 
channel and forms the loop linking the two β-strands forming the transmembrane β-hairpin, is unrelated at the 
amino acid sequence level to those of other β-PFTs. The ETX loop is flanked by two charged residues, Lys-162 
and Glu-169, and contains a proline in the central part, similarly to the sequence of the corresponding aerolysin 
loop. Binding components share a similar structure organization with that of β-pore-forming toxins and notably 
contain an amphipathic flexible loop that forms a β-hairpin, playing a central role in pore formation (Geny and 
Popoff, 2006; Schleberger et al., 2006). This suggests that binding components and β-PFTs have evolved from 
a common ancestor. However, β-PFTs have acquired a specific function consisting in the translocation of the 
corresponding enzymatic components of binary toxins through the membrane of endosomes at acidic pH. In 
contrast, β-PFTs such as ETX and aerolysin can form pores in plasma membrane at neutral pH, which are 
responsible for cytotoxicity. 
Essential amino acids for the lethal activity have been identified by biochemistry and mutagenesis. A 
previous work with chemical modifications shows that His residues are required for the active site, and Trp and 
Tyr residues are necessary for the binding to target cells (Sakurai, 1995). The molecule contains a unique Trp 
and two His. Amino acid substitutions showed that His106 is important for the biological activity, whereas 
His149 and Trp190 probably are involved to maintain the structure of ETX but are not essential for the activity 
(Oyston et al., 1998). 
Molecular and cellular mechanism of action 
Specific activity of ETX is also observed in cultured cells. Only very few cell lines including renal cell lines from 
various species such as Madin-Darby canine kidney (MDCK), mouse kidney cortical collecting duct (mpkCCDcl4), 
and to a lesser extent the human leiomyoblastoma (G-402) cells are sensitive to ETX (Payne et al., 1994; 
Shortt et al., 2000). Surprisingly, kidney cell lines from ETX-susceptible animal species like lamb and cattle, are 
ETX resistant suggesting that the ETX receptor in primary cells is lost in cultured cell lines (Payne et al., 1994 
and unpublished data). 
A marked swelling is observed in the first phase of intoxication, followed by mitochondria disappearance, 
blebbing and membrane disruption. The cytotoxicity can be monitored by using an indicator of lysosomal 
integrity (neutral red) or mitochondrial integrity [3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide 
MTT] (Borrmann et al., 2001; Heine et al., 2008; Lindsay et al., 1995; Payne et al., 1994; Petit et al., 1997; 
Shortt et al., 2000). 
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ETX binds to MDCK cell surface, preferentially to the apical site, and recognizes a specific membrane 
receptor which is not present in insensitive cells. Binding of the toxin to its receptor leads to the formation of 
large membrane complexes which are very stable when the incubation is performed at 37°C. In contrast, the 
complexes formed at 4°C are dissociated by sodium dodecyl sulfate (SDS) and heating. This suggests a 
maturation process like a prepore and then a functional pore formation. Endocytosis and internalization of the 
toxin into the cell were not observed, and the toxin remains associated to the cell membrane throughout the 
intoxication process (Petit et al., 1997). The ETX large membrane complex in MDCK cells and synaptosomes 
correspond to the heptamerization of toxin molecules within the membrane and pore formation (Miyata et al., 
2001; Miyata et al., 2002; Petit et al., 1997). ETX prototoxin is able to bind to sensitive cells but does not 
oligomerize, in contrast to activated ETX. Thus, the 23 C-terminal residues of the prototoxin control the toxin 
activity by preventing the heptamerization. These amino acids are removed in the active toxin molecule (Miyata 
et al., 2001). 
ETX binding to susceptible cells or synaptosomes and subsequent complex formation are prevented by 
protease treatment but not or weakly by phospholipase C, glycosidases or neuraminidase, indicating a protein 
nature of ETX receptor (Dorca-Arevalo et al., 2008; Nagahama and Sakurai, 1992; Payne et al., 1997; Petit et 
al., 1997). ETX receptor could be related to a 34 or 46 kDa protein or glycoprotein in MDCK cells (Payne et al., 
1997; Petit et al., 1997) and to a 26 kDa sialyglycoprotein in rat brain (Nagahama and Sakurai, 1992). 
Hepatitis A virus cellular receptor 1 (HAVCR1) has been identified to facilitate ETX cytotoxicity in MDCK cells 
and the human kidney cell line ACHN. ETX binds to HAVCR1 in vitro (Ivie et al., 2011). However, it is not yet 
clear whether HAVCR1 is a functional ETX receptor. Moreover, although ETX does not directly interact with a 
lipid, the lipid environment of ETX receptor is critical for the binding of ETX to cell surface, since detergent 
treatment prevents ETX binding to the cell surface (Payne et al., 1997; Petit et al., 1997). It is noteworthy that 
ETX can interact with artificial lipid bilayers and form functional channels, without the requirement of a specific 
receptor in contrast to cell membrane, albeit less efficiently compared to MDCK cells. Lipid bilayers have 
smooth surfaces without any surface structure including the surface-exposed carbohydrates and proteins of 
biological membranes, which means that the toxins can interact with the hydrocarbon core of the lipid bilayer 
and can insert without the help of receptors, whereas receptors are required to promote such an interaction in 
cell membrane (Petit et al., 2001). 
In synaptosomes and MDCK cells, the ETX receptor has been localized in lipid raft microdomains, which are 
enriched in certain lipids such as cholesterol and sphingolipids as well as in certain proteins like GPI-anchored 
proteins, suggesting that such a protein could be an ETX receptor (Chassin et al., 2007; Miyata et al., 2002). 
However, in contrast to aerolysin and C. septicum alpha-toxin, ETX does not interact with a GPI-anchored 
protein as receptor, since phosphatidylinositol-specific phospholipase C did not impair binding or ETX complex 
formation (Chassin et al., 2007). Localization of ETX receptor in lipid microdomains is further supported by the 
fact that ETX prototoxin and active form bind preferentially to detergent-resistant membrane fractions (DRM) 
and only activated ETX forms heptamers in DRM (Miyata et al., 2002). In addition, membrane cholesterol 
removal with methyl-beta-cyclodextrin (MCD) impairs ETX binding and pore formation (Chassin et al., 2007; 
Lonchamp et al., 2011; Miyata et al., 2002). The composition of lipid rafts in sphingomyelin and gangliosides, 
as well as membrane fluidity, influence ETX binding to sensitive cells, heptamerization, and cytotoxicity 
(Nagahama et al., 2006; Shimamoto et al., 2005). Thus, inhibitors of sphingolipid or glycosphingolipid 
synthesis increase cell susceptibility to ETX, whereas inhibitors of sphingomyelin synthesis or addition of 
monosialotetrahexosylganglioside (GM1) dramatically decreases ETX binding and subsequent heptamerization 
(Shimamoto et al., 2005). Moreover, phosphatidylcholine (PC) molecules, which increase membrane fluidity, 
facilitate ETX binding and assembly (Nagahama et al., 2006). ETX bound to its receptor shows a confined 
mobility on cell membrane probably permitting interaction between ETX monomers and subsequent 
oligomerization (Masson et al., 2009). Local lipid composition and membrane fluidity likely control ETX bound to 
receptor in cell membrane. In addition, lipids such as diacylglycerol and phosphatidyl ethanolamine, which 
induce a negative membrane curvature, increase ETX pore formation in liposome, whereas lipids having an 
opposite effect like lyso-PC, impair ETX activity (Nagahama et al., 2006). This is consistent with the model of a 
ETX prepore formation and subsequent insertion into the membrane to form a functional channel. The structure 
of ETX pore has been defined as a cone shape (Nestorovich et al., 2011), and thus its insertion in lipid bilayer 
might be favored by a specific lipid membrane organization. Therefore, although ETX does not directly bind to a 
lipid receptor, the lipid composition and physical properties of membrane influence ETX access to the receptor, 
ETX monomer assembly and insertion of ETX pore in membrane. 
The cytotoxicity is associated to a rapid loss of intracellular K+, and an increase in Cl- and Na+, whereas an 
increase in Ca++ occurs later. In addition, the loss of viability also correlates with the entry of propidium iodide, 
indicating that ETX forms large pores in cell membrane. Pore formation is evident in artificial lipid bilayer. ETX 
induces water-filled channels permeable to hydrophilic solutes up to a molecular mass of 1 kDa, which 
represent general diffusion pores slightly selective for anions (Petit et al., 2001). In polarized MDCK cells, ETX 
induces a rapid and dramatic increase in permeability. Pore formation in the cell membrane is likely responsible 
for the permeability change of cell monolayers. Actin cytoskeleton and organization of tight and adherens 
junctions are not altered, and the paracellular permeability to macromolecules is not significantly increased 
upon ETX treatment (Chassin et al., 2007; Petit et al., 2003). ETX causes a rapid cell death by necrosis, 
characterized by a marked reduction in nucleus size without DNA fragmentation. Toxin-dependent cell signaling 
leading to cell necrosis is not yet fully understood and includes ATP depletion, AMP-activated protein kinase 
stimulation, mitochondrial membrane permeabilization, and mitochondrial-nuclear translocation of apoptosis-
inducing factor, which is a potent caspase-independent cell death factor (Chassin et al., 2007). The early and 
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rapid loss of intracellular K+ induced by ETX, and also by C. septicum alpha toxin, seems to be the early event 
leading to cell necrosis (Knapp et al., 2010a). It is intriguing that ETX, which has a pore-forming activity related 
to that of aerolysin and C. septicum alpha toxin, is much more active. Does ETX induce a specific intracellular 
signal responsible for a rapid cell death? MCD, which prevents ETX pore formation in lipid rafts, does not 
inhibit the sudden decrease in cellular ATP and cell necrosis (Chassin et al., 2007). A subset of ETX channels 
unaffected by MCD might be sufficient to trigger an intracellular signal leading to cell necrosis, excluding the 
requirement of a large diffusion pore to induce the intracellular toxic program. Therefore, ETX is a very potent 
toxin which alters the permeability of cell monolayers such as epithelium and endothelium, causing edema and 
cell death. However, its precise mode of action remains unclear. 
Conclusion 
ETX belongs to the heptameric β-PFTs family including aerolysin and C. septicum alpha toxin which are 
characterized by the formation of a pore consisting in a β-barrel resulting from the arrangement of 14 
amphipatic β-strands (Knapp et al., 2010b). Although these toxins share a similar mechanism of pore 
formation, ETX is much more potent than aerolysin and C. septicum alpha toxin. A main difference is that 
aerolysin and C. septicum alpha toxin recognizes GPI-anchored proteins as receptors, whereas ETX receptor, 
although localized in lipid rafts, is distinct from GPI-anchored proteins and is distributed in a limited number of 
cell types. The specific ETX receptor possibly accounts for the high potency of ETX, which also might be 
dependent of a specific intracellular signaling induced by the toxin. Another particularity of ETX, compared to 
the other β-PFTs, is its ability to cross the blood brain barrier, likely mediated by the interaction with its specific 
receptor. ETX can be considered as a neurotoxin since it targets specific neurons which are glutamatergic 
neurons. In contrast to the other bacterial neurotoxins which inhibit the release of neurotransmitter, ETX has 
an opposite effect by stimulating the release of glutamate and also acts on other non-neuronal cells. This opens 
the door to design ETX molecules as delivery system to address compounds into the central nervous system. 
Thereby, ETX has been used to facilitate the transport of the drug, bleomycin, through the blood brain barrier 
for the treatment of experimental malignant brain tumor in mice (Hirschberg et al., 2009). Whether ETX is a 
powerful toxin, which requires a medical vigilance for the prevention of animals, this toxin also represents a 
unique tool to vehicle drugs in the central nervous system and/or to target glutamatergic neurons. 
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Abstract 
Binary toxins of the AB7-type are of special interest for scientific investigations as they are among 
the most potent and specialized bacterial protein toxins. Initiated with the purpose to find cure 
against anthrax toxin intoxication, nowadays the focus shifted to the investigation of the 
sophisticated transport mechanism of these molecular syringes. In the intoxication process, the 
B-subunits multimerize to form a pore that binds with high affinity to host cell receptors and the 
A-subunits. Followed by endocytosis of the complex into cells the translocation of the enzymatic 
component into the cytosol occurs upon acidification of the endosomes. Recent publications 
elucidate that the forces involved in transport include binding affinity, proton gradient and voltage 
across the endosomal membrane. The data presented here focus on different binding partners of 
Bacillus anthracis protective antigen (PA), which range from ions and small molecule inhibitors to 
effector proteins related or unrelated to the AB7-type of toxins. Thereby, possible ways to block 
intoxication by anthrax toxin or to use anthrax PA as specific transportation system are 
discussed. 
Les différents partenaires de liaison à l’antigène protecteur (PA) de 
Bacillus anthracis partagent des structures semblables 
Les toxines binaires de type AB7 sont d'un grand intérêt scientifique du fait qu'elles sont parmi les 
plus puissantes et les plus spécialisées des toxines bactériennes. Initialement l'objectif était de 
trouver un traitement contre l'intoxication à la toxine du charbon, actuellement les recherches se 
sont portées sur l’étude du mécanisme de transport très sophistiqué de ces seringues 
moléculaires. Au cours du processus d'intoxication, les sous-unités B se multimérisent pour 
former un pore qui se lie avec une haute affinité à des récepteurs cellulaires et aux sous-unités A. 
Après endocytose du complexe dans la cellule, la translocation du composant enzymatique dans 
le cytosol intervient à la suite de l'acidification des endosomes. Des publications récentes ont mis 
en évidence que les forces impliquées dans le transport incluent l'affinité de liaison, le gradient de 
proton et la différence de potentiel à travers la membrane endosomale. Les données présentées 
ici concernent les différents partenaires de liaison à l'antigène protecteur (PA) de la toxine du 
charbon, qui comprennent des ions et des petites molécules inhibitrices jusqu'à des protéines 
effectrices reliées ou non aux toxines de type AB7. Ainsi, les voies possibles pour bloquer 
l'intoxication par la toxine du charbon ou pour utiliser l'antigène protecteur PA comme système 
de transport spécifique sont discutées. 
Keywords : Bacillus anthracis, cationic binding, protective antigen, voltage-dependence. 
 
Introduction 
Anthrax toxin represents one of the main virulence factors of Bacillus anthracis. The plasmid-encoded tripartite 
toxin comprises a receptor-binding moiety termed protective antigen (PA) and two intracellular active enzymes, 
edema factor (EF) and lethal factor (LF) (Friedlander, 1986; Mock and Fouet, 2001; Collier and Young, 2003). 
EF is a calcium and calmodulin-dependent adenylate-cyclase (89 kDa) that causes a dramatic increase of 
intracellular cAMP level, upsetting water homeostasis and destroying the balance of intracellular signaling 
pathways (Dixon et al., 1999; Mock and Fouet, 2001; Lacy and Collier, 2002). LF is a highly specific zinc 
metalloprotease (90 kDa) that removes specifically the N-terminal tail of mitogen-activated protein kinase 
kinases (MAPKKs) (Collier and Young, 2003; Turk, 2007; Rolando et al., 2010). This cleavage leads to 
subsequent cell death by apoptosis. 
Protective antigen (PA) is a cysteine-free 83 kDa protein that binds to two possible receptors, a ubiquitously 
expressed integral membrane receptor (ATR) and also to the LDL receptor-related protein LRP6, which can both 
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be involved in anthrax toxin internalization (Scobie and Young, 2005; Wei et al., 2006). PA83 present in the 
serum or bound to receptors is processed by furin to a 63 kDa protein PA63 (Ezzell and Abshire, 1992; Petosa et 
al., 1997). PA63 spontaneously oligomerizes in the serum and/or on the cell surface into a heptamer or octamer 
(Petosa et al., 1997; Feld et al., 2010) and binds EF and/or LF with very high affinity (Escuyer and Collier, 
1991; Elliott et al., 2000; Cunningham et al., 2002). The assembled toxic complexes are then endocytosed and 
directed to endosomes. There, low pH results in the translocation of EF and LF across the endosomal 
membrane. Combined with acidification is channel formation by PA63, which could represent the mechanism for 
the translocation scheme of the toxins (Finkelstein, 1994; Miller et al., 1999; Zhang et al., 2004; Abrami et al., 
2005). 
Recombinant, nicked anthrax protein PA63 from B. anthracis was obtained from List Biological Laboratories 
Inc., Campbell, CA. One mg of lyophilized protein was dissolved in 1 ml 5 mM HEPES, 50 mM NaCl, pH 7.5 
complemented with 1.25% trehalose. Aliquots were stored at -20°C. 
Black lipid bilayer membranes were formed as described previously (Benz et al., 1978). The instrumentation 
consisted of a Teflon chamber with two aqueous compartments connected by a small circular hole. The hole had 
a surface area of about 0.4 mm2. Membranes were formed by painting onto the hole a 1% solution of 
diphytanoyl phosphatidylcholine (Avanti Polar Lipids, Alabaster, AL) in n-decane. The aqueous salt solutions 
(Merck, Darmstadt, Germany) were buffered with 10 mM MES-KOH, pH 6. Control experiments revealed that 
the pH was stable during the time course of the experiments. PA63 was reconstituted into the lipid bilayer 
membranes by adding concentrated stock solutions to the aqueous phase to the cis-side of a membrane in the 
black state. Channel reconstitution reached its maximum between 60 to 120 minutes after addition of PA to the 
cis-side. 
Membrane conductance was measured after application of a fixed membrane potential from a battery-
operated voltage source with a pair of silver/silver chloride electrodes with salt bridges inserted into the 
aqueous solutions on both sides of the membrane. The membrane current was measured with a home-made 
current-to-voltage converter using a Burr Brown operational amplifier with feedback resistors between 0.1 and 
10 GΩ. The potentials applied to the membranes throughout the study always refer to those applied to the cis-
side, the side of addition of PA. Similarly, positive currents were caused by positive potentials at the cis-side 
and negative ones by negative potentials at the same side. The temperature was kept at 20°C throughout. 
Titration experiments were performed with membranes containing only a few or many PA63-channels. The 
amplified signal was recorded with a strip chart recorder to measure the absolute magnitude of the membrane 
current and to calculate the stability constant K for substrate binding to PA. The conductance data of the 
titration experiments were analyzed using a formalism derived earlier for the carbohydrate-induced block of the 
maltoporin and CymA-channels (Benz et al., 1987; Orlik et al., 2002; Orlik et al., 2003) and the block of the 
PA63-channels with LF and EF (Neumeyer et al., 2006a; Neumeyer et al., 2006b). The conductance, G(c), at a 
given concentration c of substrates relative to the initial conductance, Gmax (in the absence of substrates), was 
analyzed using the following equation: 
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        Equation 1 
where K is the stability constant for the binding of substrates to the PA63-channel. The half saturation constant, 
Ks, of its binding is given by the inverse stability constant 1/K. 
Results : Known binding substrates of protective antigen 
There are different substrates which are characterized to bind to protective antigen. These are proteins, related 
or not related to the AB7-type toxins, and small molecule inhibitors. 
Native effector proteins of protective antigen 
Full length EF and LF 
Anthrax toxin consists of the binding and translocation component protective antigen (PA) and the two 
enzymatic components edema factor (EF) and lethal factor (LF). They both bind to the same motif located in 
domain 1 of the PA63-prepore (Lacy and Collier, 2002; Pimental et al., 2004). As two monomers of the 
heptameric prepore are required to bind one enzymatic component (Cunningham et al., 2002) the heptameric 
form of the PA-channel is able to bind up to three molecules at the same time (Mogridge et al., 2002), whereas 
the PA octamer provides up to four binding sites (Feld et al., 2010). Both EF and LF attach with their N-terminal 
end to PA. Arora and Leppla (1993) could show that the N-terminal domain is sufficient to bind to PA and also 
to translocate fusion proteins. Recently, Feld and colleagues demonstrated that LF initially binds with its N-
terminal domain to an amphipatic cleft on the surface of the PA63-prepore, the so called α-cleft (Feld et al., 
2010). 
In lipid bilayer membranes titration experiments revealed that binding only occurred when EF and LF were 
added to the same side as PA63 (the cis-side of the membrane), substrate given to the trans-side did not show 
any effect indicating that the PA-pore only possesses one binding site within the mushroom body (Neumeyer et 
al., 2006a; Neumeyer et al., 2006b). The conductance decreased in a dose-dependent manner. The affinity to 
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the PA-pore is in the low nanomolar range and it could be shown that the block of PA is a single hit process. As 
the binding is ionic strength-dependent the Ks values increase by a factor of about 500 from 50 mM to 1000 
mM KCl electrolyte concentration. 
EFN and LFN 
EF’s and LF’s N-terminal fragments called EFN and LFN as well as fusion proteins are able to bind to PA-
channels, e.g. LFN-DTA (LF fused to diphtheria toxin), and are translocated through the pore into the cytosol of 
target cells (Blanke et al., 1996). Therefore, the truncated components EFN and LFN were supposed to have 
similar binding properties as full length EF and LF. However, the affinity of the truncated proteins is tenfold 
weaker compared to full length EF and LF indicating that further interactions of the C-terminal region of EF and 
LF are involved in the binding process (Leuber et al., 2008). 
His-tagged proteins 
Several studies elucidated that an N-terminal His6-tag attached to EF or LF increases the binding affinity to the 
PA-channel (Blanke et al., 1996; Neumeyer et al., 2006a; Neumeyer et al., 2006b). As the binding is due to 
interactions between negative charges of the PA-pore and positive charges of the enzymatic components, 
additional positive charges of the His6-tag enhance the binding of the truncated EFN and LFN to the PA-channel 
as well by a factor of about 10 (Leuber et al., 2008). 
Cross-reactivity of anthrax- and C2-toxin 
Binding of close related proteins 
Another prominent member of the AB7-toxin family is the C2-toxin of Clostridium botulinum. It performs a very 
similar mode of intoxication and the channel forming components C2II and PA exhibit about 35% amino acid 
homology. To test if these two toxins are also functionally interchangeable, cross-reaction experiments were 
performed by combining the channel forming component of one toxin with the respective enzymatic component 
of the other toxin (Kronhardt et al., 2011). In lipid bilayer experiments binding could be observed for each 
combination, however, anthrax EF and LF had higher binding affinities to the C2II-channel than C2I to the PA-
channel. In vitro experiments revealed that PA is not only able to bind but also to translocate the enzymatic 
component C2I of C2-toxin resulting in intoxication and cell death. The combination of C2II and EF or LF, 
respectively, merely led to toxic effects when exposed to HUVEC cells (Kronhardt et al., 2011). Due to this high 
flexibility PA is an extremely interesting protein for a general transport system across membranes. 
Binding of unrelated proteins is enabled by His6-tag 
It was shown before that polycationic peptides fused to diphtheria toxin (DTA) enhances the uptake of this 
protein via PA-pores (Blanke et al., 1996). This work focused on different, charged tags, which exhibited either 
no change in affinity for Glu6-tag and random sequence (compared to untagged DTA) or increased binding for 
His6-, Arg6- and Lys-tags of different length. With the knowledge of the binding properties of his-tagged native 
effectors, the DTA experiments and cross-reactivity of C2I, the next step was to check for His6-C2I. The affinity 
to PA in vivo and in vitro was strongly increased as expected (Beitzinger et al., 2011). Following this set of 
experiments a protein fragment of Lambda phage protein (gPJ) not related to any toxins was tested. Whereas 
gpJ was not able to bind to PA, its affinity towards the PA-channel was in the range of EF and LF when it was 
coupled to a His6-tag (Beitzinger et al., 2011). Finally, the authors could show similar results for EDIN of 
Staphylococcus aureus, which ADP-ribosylates and inactivates Rho-GTP binding proteins. His6-EDIN binds to the 
PA-channel in titration experiments and is transported through the PA-channel in intoxication assays. 
Additionally, it has been found that the process is highly voltage-dependent. This means that PA-pores may be 
used as molecular syringes, which deliver His6-tagged target proteins into cells possessing the known receptors 
for PA (Lang et al., 2010). 
Small molecule inhibitors 
Chloroquine and other 4-aminoquinolones block protective antigen 
Anthrax toxin is one of the most potent bacterial toxins and could be used as a biological weapon or for 
terroristic activities by spreading spores of multi resistant B. anthracis bacteria (Keim et al., 2001; Inglesby et 
al., 2002; Jernigan et al., 2002). This threat could be handled by introducing small molecules which are able to 
block PA-pores and efficiently prohibit translocation of the effectors, therefore buying time to deal with the 
bacterial infection. First results were found for chloroquine and other 4-aminoquinolones formerly used as 
antibiotics (Lewis et al., 1973; Vedy, 1975). These substrates depicted high affinity binding in titration 
experiments to PA (Orlik et al., 2005). Additionally, it is well known that chloroquine acquires positive charges 
under acidic condition and accumulates in endosomes (Neumeyer et al., 2008). Both effects would enhance the 
blockage of PA in vivo. Concerning the side effects of chloroquine and related substances on humans, there is 
the urge for blocker-molecules with homologous structure, which do not exhibit cell toxicity. 
Cyclodextrin-complexes form a plug for the PA-pore 
Cyclodextrins have been found to bind to CymA-porin of Klebsiella oyxtoca (Pajatsch et al., 1999; Orlik et al., 
2003). The ring-shaped complex of seven glucose units in β-cyclodextrin happens to be in a perfect size for the 
blockage of binary toxin channels and is itself not toxic at all. Additionally, β-cyclodextrin and PA share a sevenfold 
symmetry, which offers one side chain of β-cyclodextrin for each PA63 monomer. Therefore, β-cyclodextrin has 
been tested as a basis drug for PA blockage (Nestorovich et al., 2010). Recently, experiments with β-cyclodextrin 
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and C2II – a very homologous AB7-toxin-channel as described before – were performed in a trial of modern, 
literature based drug design. In this study, changes in the outward facing part of the rings functional groups led to 
enhanced binding stabilities. Interestingly, the introduction of a positive charge and some aromatic residues were 
found to be responsible for this effect (Nestorovich et al., 2011). The possible seven charges in the β-cyclodextrin 
structure seem to match with the PA binding pocket. Even though the authors could show blockage of intoxication 
in cell-based assays, the seven permanent charges could avoid specificity or passage through membranes in vivo, 
which reasons in the necessity of further pharmacological studies. 
Results : Binding of divalent and trivalent cations to protective antigen 
The PA-channel is known to be highly cation selective (Blaustein et al., 1989) and additional positive charges of 
His6-tags increase the binding properties of several proteins (Blanke et al., 1996; Neumeyer et al., 2006a; 
Neumeyer et al., 2006b; Leuber et al., 2008; Beitzinger et al., 2011). Therefore, we addressed the question if 
also divalent and trivalent cations are able to bind and to block the PA63-channel. 
The binding of CuSO4, ZnCl2, NiCl2 and LaCl3 to the PA63-channel was investigated by performing titration 
experiments similar to those described for binding of EF and LF (Boquet and Lemichez, 2003; Neumeyer et al., 
2006a; Neumeyer et al., 2006b). After reconstitution of the PA-channels added to the cis-side of a lipid bilayer 
membrane, the rate of insertions became very small. Then, concentrated solutions of divalent or trivalent 
cations were added to the cis- or the trans-side of the membrane, respectively, while stirring to allow 
equilibration. The membrane conductance decreased in a dose-dependent manner meaning that the cations 
bound to the PA-channel and thereby reduced the conductance. Analysis of the titration experiments by 
Lineweaver-Burke plots according to equation (1) indicated that the interaction between the cations and the 
PA-channel represents a single hit binding process. The results shown in Table 1 reveal that there are 
considerable differences concerning the stability constants of the respective cations to the PA-pore. Highest 
binding affinity was observed for Cu2+, followed by La3+, which was in the micromolar range, whereas the 
binding affinity of Ni2+ and Zn2+ were in the millimolar range. The binding constants of the divalent and trivalent 
cations to the PA-channel decreased in the series KCu > KLa > KZn > KNi from about 10,000 M-1 to about 100 M-1 
in 150 mM KCl (see Table 1). 
Table 1. Stability constants K and half saturation constants Ks for the binding of divalent 
and trivalent cations to the PA63 channel. 
Tableau 1. Constantes de stabilité K et de demi-saturation Ks pour la liaison de cations 
bivalents et trivalents au canal PA63 
      PA63 with   K [M-1] Ks [mM] 
Cu2+ cis +10mV 9237 0.11 
  cis -10mV 7244 0.14 
  trans +10mV 5254 0.19 
Ni2+ cis +10mV 122 8.2 
  cis -10mV 47 21.3 
  trans +10mV 65 15.4 
Zn2+ cis +10mV 1246 0.8 
  cis -10mV 307 3.3 
  trans +10mV 244 4.1 
La3+ cis +10mV 1383 0.7 
  cis -10mV 654 1.5 
Stability constants K of Cu2+, Ni2+, Zn2+ and La3+ to PA63-channels reconstituted in lipid 
bilayer membranes formed from diphytanoyl phosphatidylcholine/n-decane. The aqueous 
phase contained 150 mM KCl, 10 mM MES-KOH pH 6.0; T=20°C. The voltage was applied 
as indicated. The data represent the means of at least three individual experiments. Ks is 
the half saturation constant, calculated as 1/K. 
Constantes de stabilité K du Cu2+, du Ni2+, du Zn2+ et du La3+ aux canaux PA63 reconstitués 
dans des bicouches lipidiques formées à partir de diphytanoyl phosphatidylcholine/n-
décane. La phase aqueuse contient 150 mM de KCl, 10 mM de MES-KOH pH 6,0; T=20°C. 
La différence de potentiel a été appliquée comme indiqué dans le tableau. Les données 
correspondent aux moyennes d’au moins trois expériences indépendantes. Ks est la 
constante de demi-saturation et est égale à 1/K. 
Binding to the PA-channel is generally supposed to rely on ion-ion interaction. Therefore, we performed 
titration experiments for binding of Cu2+ in various electrolyte concentrations to check if this was also true for 
the binding of the divalent cations. The stability constants K for Cu2+ binding to the PA-channel decreased with 
increasing electrolyte concentration from about 80,000 M-1 at 50 mM KCl to about 1,500 M-1 at 1 M KCl (see 
Table 2). That means that the stability constant of copper ion binding to the PA-channel is strongly ionic-
strength dependent. 
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Interestingly, the binding of the cations was barely influenced by the side of addition. Irrespectively of the 
side of addition, the stability constants were nearly stable. Additionally, the binding affinities of the cations to 
the PA-channel were not changed when negative voltage in the physiological range was applied. This indicates 
that the cations were able to equilibrate rapidly across the PA-channel irrespective of the applied voltage. 
Table 2. Ionic-strength dependence of the binding of Cu2+ to the PA63-channel. 
Tableau 2. La liaison du Cu2+ au canal PA63 est dépendante de la force ionique. 
      PA63 with   K [M-1] Ks [mM] 
Cu2+ 50 mM 87935 0.01 
  150 mM 9237 0.11 
  300 mM 3638 0.27 
  1 M 1626 0.62 
Stability constants K of Cu2+ to PA63-channels reconstituted in lipid bilayer membranes 
formed from diphytanoyl phosphatidylcholine/n-decane. The aqueous phase contained four 
different KCl-concentrations, 10 mM MES-KOH pH 6.0; T=20°C. The data represent means 
of at least three titration experiments. Ks is the half saturation constant, calculated as 1/K. 
Note that the ionic strength had a considerable influence on the stability constant of binding 
of copper ions to the PA63-channel. 
Constantes de stabilité K du Cu2+ aux canaux PA63 reconstitués dans des bicouches 
lipidiques formées à partir de diphytanoyl phosphatidylcholine/n-décane. La phase aqueuse 
contient quatre concentrations différentes de KCl, en présence de 10 mM de MES-KOH pH 
6,0; T=20°C. Les données correspondent aux moyennes d’au moins trois expériences de 
titration. Ks est la constante de demi-saturation et est égale à 1/K. Il est à noter que la 
force ionique a une influence considérable sur la liaison des ions cuivre aux canaux PA63 
comme indiqué par les valeurs des constantes de stabilité K. 
The results of the titration experiments suggested that the PA-channel either contains two different binding 
sites for divalent and trivalent cations, one at the cis- and one at the trans-side of the channel, or just one 
binding site which is accessible from both sides of the channel. This could be the case, as the small cations are 
able to cross the channel rapidly and equilibrate in the aqueous solution. Titration experiments with copper ions 
on both sides of the membrane led to subsequent decrease of PA-induced conductance. Then, 5 mM EDTA was 
added to the trans-side of the membrane. No effect on the conductance could be observed. However, addition 
of EDTA to the cis-side of the membrane resulted in increasing conductance. The copper induced blockage of 
the PA-channels could be fully restored meaning that the PA-pore only contains one binding site for copper ions 
which is localized at the cis-side of the channel. 
Conclusion 
Binding substrates of protective antigen share common motives 
Positive charges play a crucial role in binding to PA63-channels 
It is well known that PA-pores are strongly cation selective up to a factor of 20 pc/pa (Blaustein et al., 1989). 
Additionally, recent studies found proof, that negatively charged amino acids in the vestibule of PA-channels 
play a crucial role in the binding of EF and LF (Orlik et al., 2005; Leuber et al., 2008). These findings already 
indicate the importance of ion-ion interaction for binding and translocation events to PA. The data presented 
here underline this assumption by depicting the existence of positive charges in high affinity substrates ranging 
from simple ions, over small inhibitor molecules and molecule complexes as well as peptides, to related 
proteins and finally protein effectors only containing chargeable tags. 
First time evidence that different cationic electrolytes serve as a binding partner to PA-channels is presented 
in this work. This is of special interest, as the ions themselves seem to be too small to block the channel 
conductance. The sevenfold symmetry of the pore provides seven possible negative charges for each acidic 
amino acid facing the lumen of PA63. On top of that, the constriction site of PA, the so-called Φ-clamp is 
surrounded by these rings of negative charges. Therefore, a plug consisting of more and more cations may 
form around this site explaining the results. Additional support for this theory is provided by the studies with 
sevenfold charged β-cyclodextrin and the length dependent binding of positive charged tags (Blanke et al., 
1996; Nestorovich et al., 2010). Binding of cations could be possible from both sides of PA-channels out of two 
reasons. First, ions might be small enough to pass the Φ-clamp and bind from the opposite side. Second, 
multiple rings of acidic amino acids exist in the lumen of the channel on both sides of the Φ-clamp forming 
more than one binding site. It has been shown that this is not the case as only one binding site could be 
identified for all the substrates. 
Aromatic residues enhance affinities towards PA-pores 
Another important function is represented by aromatic ring-systems. Especially when the affinity of blocker-
substrates is discussed, it becomes obvious that the existence of aromatic residues strengthens the binding to 
toxin channels (Nestorovich et al., 2011). This could found on the existence of the Φ-clamp, too. As the on-rate 
derived by current noise analysis is in the range of diffusion for molecules like chloroquine, the off-rate 
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contributes to a larger extend to the stability constant (Orlik et al., 2005). That reasons that molecules which 
are directed directly to the constriction site and settle there should form the most stable block. Considering the 
Φ-clamps composition out of seven phenylalanine residues, it is easy to understand, that aromatic side-chains 
serve this purpose best (Orlik et al., 2005). Taken the pharmacological use of those substrates into 
consideration, the aromatic residues could provide a further purpose in enabling these molecules to cross 
membranes and reach the endosome, where they are charged due to acidic pH. This trapping-effect known 
from chloroquine and other 4-aminoquinolones further increases blockage of PA-channels. 
Binding of charged substrates is voltage-dependent 
Recently a change in voltage-dependency of the PA-channel after His6-EDIN titration has been found (Beitzinger 
et al., 2011). The stability constants for binding are influenced when positive voltages are applied. It seems to 
be the case, that the force of the electric field pulls the tagged N-terminus of the protein deeper into the pore, 
thereby increasing the stability constant for binding of these His6-tagged polypeptides. This finding partially 
serves as an explanation for the translocation of foreign substrates in vivo, which possess positively charged 
tags, as the acidic endosome exhibits this field direction. Further studies are necessary to fully elucidate this 
voltage-dependent binding and translocation process of all charged substrates to the PA-pore mentioned here. 
Outview 
Considering the data provided and summed up here, it is obvious, that binding and translocation concerning PA 
is of special interest. Not only for understanding one of the most potent bacterial toxins in more detail, but in 
order to cure anthrax intoxication in the context of biological terrorism and the potential usage of PA as a 
versatile molecular syringe for various purposes, further work has to be done in this vital field of studies. 
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Abstract 
Staphylococcal leucotoxins operate by two distinct proteins of approximately 31 kDa and 35 kDa. 
The components associate with the targeted membranes before stabilising oligomers that are 
able to activate cell, i.e. human polymorphonuclear cells, Ca2+ metabolism, and thereafter pores 
become functional lyze cells by huge loss of water and mainly monovalent cations. We found that 
some peptides may block up pores and induce loss of the lytic leucotoxin activity. Such peptides 
were useful to analyze the calcium entry in hPMNs. In such a context, some calcium channels 
activated by leucotoxins HlgC-HlgB and Panton-Valentine leucocidin were identified using some 
inhibitors, thus leading to absolute inhibition of their biological activity. We then evidence the 
involvement of calcium store release via IP3 receptors, and some linked calcium channels at the 
membrane. Other ways exist to completely inhibit these leucotoxins and these inhibitors might 
gain application when they efficiently target the largest number of leucotoxins. This is the case of 
new humanized antibodies and other organic compounds derivatives from calixarenes. Both these 
molecules interact with and neutralize leucotoxins, thus antagonizing their binding to 
membranes. These products have shown efficacy in blocking the inflammatory role of leucotoxins 
in vivo. 
Différentes approches pour l’inhibition partielle ou totale des 
leucotoxines de staphylocoques 
Les leucotoxines staphylococciques opèrent via deux protéines distinctes d’environ 31 et 35 kDa 
Ces composés s’associent à la surface de la membrane avant de se stabiliser en oligomères 
responsables d’une activation du métabolisme calcique des cellules cibles, i.e. les polynucléaires 
humains. Ensuite, des pores deviendront fonctionnels et lyseront les cellules après la perte d’eau 
et de cations monovalents. Des peptides synthétiques sont capables d’obturer le pore et induisent 
une perte de l’activité lytique. Ces peptides sont utilisés pour identifier des canaux calciques 
activés par les leucotoxines. Ainsi, certaines voies et canaux calciques comme la voie de l’IP3 et 
certains canaux associés ont été identifiés après l’action de la gamma-hémolysine HlgC-HlgB et 
de la leucocidine de Panton et Valentine grâce à différents inhibiteurs, bloquant alors toute 
l’activité biologique. Il existe cependant d’autres approches séduisantes pour bloquer l’activité 
biologique de l’éventail le plus large possible de leucotoxines. C’est le cas d’anticorps humanisés, 
mais aussi de composés organiques dérivés des calixarènes. Ces composés interagissent et 
neutralisent la capacité des leucotoxines à se fixer sur les membranes. Leurs propriétés anti-
inflammatoires sélectives ont pu être vérifiées in vivo. 
Keywords : Binding inhibition, calcium channels, pathogenicity, staphylococcal leucotoxins, 
therapeutics. 
 
Introduction 
Staphylococcal leucotoxins now gather a cohort of bi-component pore-forming toxins (PFTs) active against 
human leucocytes that are secreted by Staphylococcus aureus (SA), Staphylococcus intermedius and 
Staphylococcus pseudointermedius (Prévost, 2005; Ventura et al., 2010; Riegel et al., 2011). The alpha-toxin 
from SA is an example of a related one-component pore-forming toxin (Song et al., 1996). The bipartite 
character is supported by the interaction of two distinct proteins distinguished as class S and class F proteins of 
31-32 and 34-35 kDa, respectively. These secreted PFTs may be constant or not according to the leucotoxin 
and, thus, may have more or less clinical significance. After a decade of controversies, it appears that one of 
them, the Panton-Valentine leucotoxin (PVL) is a gravity factor for a number of necrotizing infections including 
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pneumonia, osteomyelitis, ... and is a determinant factor for furuncles (Prévost, 2005; Baba Moussa et al., 
2011). Finally, the complementary features of these leucotoxins, and their role in the acuteness in infections is 
mostly admitted. Because these proteins have to assemble to target membranes and form a pore, the bipartite 
model has longer been studied to determine its specificity, possibility to combine proteins (Prévost, 2005), 
difference in the ion selectivity of pores (Comai et al., 2002), sandwich position of the two proteins inside the 
pore (Viero et al., 2006), mode of the deployment of the central domain that form the -hairpins, the basic 
elements of the trans-membrane -barrel forming the pore (Viero et al., 2008). Several reports suggested a 
stoichiometry of the pore reaching an octamer (Miles et al., 2002; Joubert et al., 2006), and the publication of 
the three-dimensional structure of HlgA-HlgB, i.e. gamma-hemolysin has recently confirmed the previous data 
(Yamashita et al., 2011). 
After the formation of an octameric prepore constituted of 4 alternating class S and class F proteins, the 
central domains of each monomer will participate to the building of a transmembrane -barrel. While most of 
leucotoxins are not equivalent for their cell spectra, polymorphonuclear cells (PMNs) remain common target 
cells. The other common features meet the biological activities that are mainly composed of a cell activation 
consisting in the calcium entry into cytoplasm of target cells, and secondarily to the formation of pores leading 
to the equilibrium of monovalent cations and to the osmotic exchange involving water that leads to cell necrosis 
(Genestier et al., 2005). As leucotoxins probably are involved in human pathology, the various possibilities to 
inhibit leucotoxins may have interest and possible applications. Thus, in this short review we will meet some 
possibilities to block biological activities of these toxins, or to selectively block the calcium activation or the 
pore function following the formation of oligomers. Moreover, even classified as pore-forming toxins, we do not 
have evaluation of the effects of leucotoxins at low concentrations on cell signaling. Whereas the pore 
formation can be detected within few minutes following applications of toxins, Ca2+ entry rises faster and with 
large amplitude into cells. 
Blocking the whole activity of staphylococcal leucotoxins 
These approaches might be dedicated to possible future therapeutics in case of acute SA infections and risk of 
non response to treatment even if dedicated antimicrobials were administered. Indeed, by blocking the largest 
number of pore-forming leucotoxins that SA may produce, this might result in a lesser inflammatory response 
and tissues necrosis, thus giving an advantage to antimicrobial therapy. We got the opportunity to test 
innovative antibodies against staphylococcal leucotoxins, and tentatively try to understand and develop some 
chemicals that specifically interact with staphylococcal leucotoxins. The main interest of these two approaches 
is, while constituting promising inhibitors, they might offer tools to target all or almost all leucotoxins and 
project the ability to totally suppress a family of toxins produced by a pathogenic micro-organism. 
Blocking the biological activity by humanized antibodies 
Humanized Heavy Chain only Antibodies (HCAb) were generated against the S. aureus Panton-Valentine 
leucotoxin (PVL) from immunized transgenic mice to neutralize toxin activity (Figure 1A). Genes encoding 
antibodies were in fact cloned from llama heavy chains from immunoglobulins into a phage display system and 
mutated to be humanized, selected after panning reactive antibodies, and further stably transfected into 
Human Embryogenic Kidney cells (HEK)(Laventie et al., 2011). One anti-LukS-PV HCAb, three anti-LukF-PV 
HCAbs with nanomolar affinities and one engineered tetravalent (Figure 1B) and bi-specific HCAb were tested in 
vitro (Figure 1C) and in vivo (Figure 1D). They all prevent toxin binding and pore formation. After their 
incubation with a non immune serum, these antibodies remained almost fully active. 
HCAbs against LukS-PV do not recognize LukF-PV. Conversely, HCAbs against LukF-PV do not detect LukS-
PV (Figure 1C). This excludes the possibility that the antibodies recognize common epitopes present in both 
recombinant proteins. The bi-specific HCAb obviously detects both LukS-PV and LukF-PV. Further analysis 
showed that other bi-component leucotoxins (HlgA-HlgB, HlgC-HlgB, LukE-LukD) are not inhibited except anti-
LukS-PV HCAb which also inhibited the gamma-hemolysin couple HlgC-HlgB (Figure 1C). Anti-LukS-PV HCAb 
also binds to gamma hemolysin C (HlgC) and inhibits HlgC-HlgB pore formation. The IC50 of the anti-LukS-PV 
3A11 and the bi-specific antibody were 1.14 nM and 0.31 nM (Laventie et al., 2011), respectively for the PVL 
(LukS-PV 0.1 nM / LukF-PV 5 nM) and 0.10 and 0.12 nM respectively against HlgC-HlgB (HlgC 0.1 nM / HlgB 
0.5 nM) as measured by BiacoreTM. The IC50 of anti-LukF-PV 4, 82, 125 and the bi-specific antibody 3A11-4 
were 0.93, 0.91, 0.65 and 1.44 nM, respectively for PVL (LukS-PV 1 nM / LukF-PV 1 nM). Complete PVL 
inhibition was reached >3 nM of anti-LukS-PV, and 0.3 nM for gamma-hemolysin. This inhibition remains stable 
in time (maximum tested: 2 h). Complete PVL inhibition was reached with ~8 nM of anti-LukF-PV. If a higher 
amount of anti-LukS-PV 3A11 or anti-LukF-PV 4 (7 nM) is added 5 or 15 min after toxin application onto 
hPMNs, it stabilizes but does not reduce the ethidium entry slope. Thus, the antibodies block neo-pore 
formation, but for already formed pores we are not sure that the residual signal correspond to ethidium already 
stored into cells or reflect a somewhat equilibrium between cells loosing ethidium due to necrosis and a reduced 
entry of the molecule into permeated cells (see Laventie et al., 2011). Strictly parallel observations were made 
for calcium entry. Finally, the observed neutralization was operating onto the binding of the targeted 
component in almost a 1:1 ratio. 
Experiments in vivo in a toxin-induced rabbit endophthalmitis model showed these HCAbs inhibit 
inflammatory reactions and tissue destruction caused by leucotoxins. HCAbs are also biologically active in vivo 
by neutralizing the PVL effect in rabbit eye vitreous. While the inflammatory condition of eyes injected with PVL 
rapidly aggravate within 48hrs, the inhibition achieved with antibodies is stable in time (48 to > 96h) without 
apparent default in vision or behavior (Figure 1D). The same molar amount of tetravalent antibody dimer is 
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more effective than the HCAb dimers. Thus, the tetravalent complex offers advantage, because more effective 
at lower dose and, since it consists of a single chain, easier to produce. Our results suggest the possibility of 
antibody application in combination with intravitreal antimicrobial management strategy for post cataract 
surgery endophthalmitis and possibly other infections. 
 
Figure 1. Blocking effect of recombinant humanized HCAbs onto staphylococcal leucotoxins. (A) Schematic structure of 
Heavy Chains only Antibodies and the constructed Tetravalent antibody directed against both LukS-PV and LukF-PV. (B) 
Affinity constants obtained by Surface Plasmon Resonance of the antibodies for targeted PVL components; the given 
values are means of three independant experiments. (C) Neutralization of the pore-forming activity onto human PMNs 
of the four tested HCAbs against various staphylococcal leucotoxins; errors barrs were obtained from 3 distinct 
experiments. (D) An inflammatory score of both the posterior and anterior chambers of rabbit eyes injected by PVL 
and/or HCAbs evidenced their power to neutralize the toxin effects; significant differences were established from three 
sets of data by the Mann-Whitney test. 
Figure 1. Les HCAbs humanisés recombinants anti-leucotoxines ont un effet neutralisant. (A) Structure schématique 
des HCAbs et de l’anticorps tétravalent reconstruit, dirigés contre LukS-PV et LukF-PV. (B) Constantes d’affinité 
déterminées en Résonance Plasmonique de Surface des anticorps pour les composés de la leucocidine de Panton et 
Valentine; les valeurs sont des valeurs moyennes issues de 3 expériences indépendantes. (C) Neutralisation de la 
formation des pores de 4 leucotoxines staphylococciques par les HCAbs; les barres d’erreurs sont issues de 3 
expériences indépendantes réalisées sur des polynucléaires humains provenant de donneurs différents. (D) Scores 
inflammatoires combinés des chambres postérieure et antérieure d’yeux de lapin injectés par la PVL en présence ou non 
d’HCAbs ; les différences statistiques sont obtenues sur la base de trois séries d’analyses par le test de Mann-Whitney. 
Blocking the biological activity by small chemicals : calixarenes 
Based on the rapid screening of molecules that would present a hydrodynamic diameter compatible with the entry 
of the pore of leucotoxins, we finally retain three cyclic compounds that differ by their complexity. They are para-
sulfonato-calix[4 or 6 or 8]arenes (SCn; Figure 2A). These molecules were able to inhibit the full activity of most 
staphylococcal leucotoxins at a concentration of 30 µM when toxins were applied at nM concentrations onto 
synthetic membranes or liposomes or erythrocytes or human PMNs (Potrich G, personal communication). These 
calixarenes were not significantly hemolytic to human erythrocytes compared to the concentration cited. Also, 
they were not able to modify both the width and the granularity of human PMNs. Thus, no displacement and no 
necrosis were observed for these compounds applied onto PMNs in concentrations corresponding to a therapeutic 
index of 5 to 10. While the entry of calcium promptly promoted by leucotoxins was inhibited as well as that of the 
delayed entry of ethidium into the cells, we questioned whether these molecules may interfere with the binding of 
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toxins onto targeted cells. In fact, these molecules did not interact with membranes by themselves, since the 
calixarenes first applied, then washed by centrifugation from cells have no effect onto the further application of 
leucotoxins onto PMNs. By using fluorescent class S proteins and calixarenes and flow cytometry, we observed 
that the presence of calixarenes strongly inhibit this binding onto live cells compared with a competition with non 
fluorescent class proteins. This binding appeared sensitive to the presence of calixarenes, but SC4 has almost no 
influence while the two other molecules are effective. The binding of class F proteins was only affected with 
concentrations of SC6 or SC8 20-50-fold larger than those sufficient to inhibit class S proteins (Figure 2C). 
Moreover, SC6 and SC8 were able to interact with the class S protein bound to membranes that renders non 
effective a further application of the class F protein to operate an oligomer (Figure 2D). The application of 
calixarenes on already formed pores into PMNs led us to observe that neither calcium nor ethidium continued to 
accumulate into cells evoking that pores were arrested. In order to evidence a possible and direct interaction 
between class S protein and calixarenes, we used Electrospray mass spectrometry and Surface Plasmon 
Resonance (SPR; Anderluh G, personal communication). Electrospray mass spectrometry (ESI-MS/MS) allows to 
evidence that leucotoxins, placed in 50 mM ammonium acetate, pH 4.8 acquired, in the presence of SCn, bound 
SC8>SC6>>SC4 with some differences according to the class S proteins that were tested at a 1/1 ratio that may 
be displaced with an excess of SCn (Figure 2B). 
 
 
      
Figure 2. Some para-sulfonato calixarenes interact directly with class S leucotoxin proteins and inhibit their binding to 
membranes and biological activity. (A) Schematic plane structure of SC4, SC6 and SC8. (B) Acquisition of mass of 
LukS-PV after its incubation with SC8 as measured by using Electrospray Ionisation Mass Spectrometry corresponds to 
the interaction at a ratio 1:1. (C) Values of inhibitory concentrations 50% and 90% for the pore-forming activity onto 
human PMNs by flow cytometry and the binding of PVL and LukS-PV, respectively for six calixarenes; the given IC50, 
IC90 (µM) values are direct means of three independant sets of data, standard errors never exceed 8%. (D) When the 
SC8 was applied after that of fluorescent LukS-PV onto human PMNs, there was a decrease of the bound LukS-PV 
indicating the displacement of the protein. 
Figure 2. Certains para-sulfonato calixarènes interagissent directement avec les leucotoxines et inhibent leur fixation 
sur les membranes et leurs fonctions biologiques. (A) Représentation schématique plane des SC4, SC6, et SC8. (B) La 
co-incubation de LukS-PV avec le SC8 implique une acquisition de masse, mesurée par spectrométrie de masse 
electrospray correspondant à celle de SC8. (C) Valeurs moyennes obtenues en cytométrie en flux de trois expériences 
indépendantes à partir des PMNs de donneurs différents de concentrations inhibitrices 50% et 90% (µM) pour la 
fonction de perméation des membranes révélée par l’entrée d’éthidium et pour la fixation aux membranes de LukS-PV 
fluorescent. (D) L’application de SC8 ultérieure à l’incubation de LukS-PV fluorescent sur les PMNs humains révèle en 
cytométrie en flux une chute de la fluorescence associée aux cellules. 
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Once again, class F proteins did not significantly interact with calixarenes. SPR confirmed these data, and 
the resonance signal was disturbed when calixarenes or leucotoxins class S proteins were immobilised. 
Moreover, when liposomes were deposited onto SPR-chips, the binding of HlgA was decreased when we submit 
a flow of class S protein mixed with SCn. Finally, SC6 or SC8 demonstrated their efficacy in vivo by the proof 
that SC6 or SC8 are able to control the inflammation induced by the intra-vitreal injection of leucotoxins into 
the rabbit eye. 
The development of new calixarenes (SC4-1, -2, -3) is now starting with the emergence of new SC4 
derivatives that finally, are still non toxic, but can inhibit leucotoxins in a comparable manner and intensity as 
did SC6 and SC8 (Figure 2C). Such molecules may have interest due to their relatively low molecular weight 
and their relative solubility. 
Blocking the pore of staphylococcal leucotoxins 
In the screening cited above, a cyclic peptide had some influence onto the pore formation induced by HlgA-HlgB 
into liposomes and rabbit red blood cells. As such a peptide may have the interest to harbour a hydrodynamic 
diameter compatible with the upper side of the leucotoxin pore, it was evaluated onto human PMNs further 
incubated with HlgC-HlgB or with the PVL. In both cases, while the entry of ethidium was strongly reduced, the 
calcium entry remained comparable as for the toxin alone, despite low toxin concentrations (Figure 3A, B). 
Cells are naturally tight to ethidium, the two constitutive leucotoxin components are required to induce the 
entries of both calcium, then ethidium, thus this cyclic peptide can be considered as a tool for the further 
investigation of cell signaling mediated by leucotoxins. 
 
Figure 3. A cyclic peptide, cP4, is able to selectively block the pore-forming activity of staphylococcal leucotoxins in 
human PMNs. (A) When added at 10 µM, the cP4 peptide dramatically reduced the entry of ethidium induced by HlgC-
HlgB in human PMNs; only a weak activity was recorded after 20 min of toxin application, whereas it is prominent in the 
control at the same time. (B) Inversely, the entry of Ca2+ remained at the same level as for the control. (C) The same 
influence of the peptide was observed on the PVL (LukS-PV 0.05 nM – LukF-PV 0.5 nM). 
Figure 3. Un peptide cyclique, cP4, bloque sélectivement l’activité de formation de pores des leucotoxines de 
staphylocoques sur les PMNs humains. (A) Lorsque le peptide est ajouté à 10 µM, il provoque un important retard de 
l’entrée d’éthidium dans les PMNs humains traités par HlgC-HlgB, dont le temps de latence est d’environ 20 min contre 
5 min pour le contrôle. (B) Inversement, l’entrée de Ca2+ dans les mêmes cellules traitées par la même toxine n’est pas 
affectée. (C) Une influence similaire du peptide a été observée pour la leucocidine de Panton et Valentine. 
Blocking the calcium activation of staphylococcal leucotoxins 
The use of the cyclic peptide described above allows the observation of Ca2+ signaling without the disastrous 
damage of pores that disturb evolution of cell signaling pathways. The origin of the rise of the intracellular Ca2+ 
induced by the leucotoxins is investigated by using flow cytometry and Ca2+ probes Fura-2 or Fluo-3, in order to 
identify the signaling pathways activated by these leucotoxins in human PMNs. Calcium channels were 
challenged with inhibitors to identify those channels activated in the presence of leucotoxins (Bird et al., 2008). 
The 2-Aminoethoxydiphenyl borate (2-APB) is an inhibitor of IP3-induced Ca2+ release and a blocker of store-
operated Ca2+ entry (SOCE). When used in absence of extracellular Ca2+ (Figure 4), the 2-APB strongly inhibited 
the intracellular Ca2+ rise induced by HlgC-HlgB but not by the PVL. These results suggest that in the case of 
HlgC-HlgB, the IP3-induced Ca2+ release is implicated in the Ca2+ signaling pathway. The use of Ryanodine, an 
inhibitor of the ryanodine receptor, has no effect on intracellular Ca2+ rise, thus allowing to conclude that the 
ryanodine receptors are not involved. In presence of extracellular Ca2+ (see Figure 4), the 2-APB also inhibited 
the intracellular Ca2+ rise induced by HlgC-HlgB but again not that of the PVL. In presence of extracellular Ca2+, 
the 2-APB effect must be due to the inhibition of store-operated Ca2+ entry (SOCE) as well. 
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To prove the involvement of the SOCE in the leucotoxins induced Ca2+ signaling pathway in human PMNs, 
we used specific antibodies targeting the reticular Ca2+ sensor stromal interacting molecule (Stim), a 
component of the SOCE complex, and confocal microscopy (Staali et al., 1998; Collins et al., 2011; Roos et al., 
2005; Vamai et al., 2009). The goat polyclonal N-19 antibody and the mouse monoclonal A-8 antibody were 
used to check the subcellular location of Stim-1 compared to the location of HlgC-HlgB and PVL tagged with 
Alexa-488 on HlgB and LukF-PV, respectively. Figure 4 shows that the toxin localizes in an internal 
compartment which is also labeled by the anti Stim-1 antibodies. 
In addition to these data, the use of other inhibitors such as N-(p-amylcinnamoyl)anthranilic acid (ACA), a 
direct blocker of several Transient Receptor Potential channels (TRP), suggest the involvement of TRPs in the 
intracellular Ca2+ rise induced by HlgC-HlgB. 
 
Figure 4. Effect of 2-APB on the increase in [Ca2+]i due to HlgC- HlgB and PVL. In the absence of extracellular Ca2+, 2-APB 
strongly inhibited the increase in [Ca2+]i in the presence of (A) HlgC-HlgB, but not (B) PVL. Similarly, in the presence of 
extracellular Ca2+, 2-APB inhibited the increase in [Ca2+]i after treatment of cells with (C) HlgC-HlgB, but not (D) PVL. 
These results indicate that IP3R, SOCs, and thus IP3 pathway of hPMNs, are involved in calcium signaling of HlgC-HlgB. (E) 
Confocal microscopy of PMNs labelled with leucotoxin HlgC-HlgB-Alexa-488 (green) and the anti Stim-1 A-8 antibody (red). 
Photographs correspond to pixels labeled with both markers; (a) HlgC/HlgB, (b) A-8, and (c) merge. The nucleus is labeled 
with Hoesht 33258 (blue). Bars size = 1.02 µm. 
Figure 4. Effet du 2-APB sur l’influx de Ca2+ induit par HlgC-HlgB dans les PMNs humains. En l’absence de Ca2+ 
extracellulaire, le 2-APB inhibe très fortement l’augmentation de Ca2+ intra-cellulaire dans les cellules traitées par (A) HlgC-
HlgB, (B) mais n’a pas d’influence si les PMNs sont traités par la PVL. De manière similaire, en présence de Ca2+ extra-
cellulaire, le 2-APB inhibe l’influx de Ca2+ après le traitement des cellules par (C) HlgC-HlgB, mais pas (D) la PVL. Ces 
résultats indiquent que les récepteurs IP3, les SOCs, et donc la voie IP3, est mise en jeu dans les PMNs humains par la 
leucotoxine HlgC-HlgB, mais pas par la PVL. (E) Microscopie confocale des PMNs humains marqués par la leucotoxine HlgC-
HlgB-Alexa-488 (vert), et par l’anticorps A-8 anti-Stim-1 (rouge). Les photographies correspondent aux pixels colorés par 
les deux marqueurs : (a) HlgC-HlgB*, (b) A-8µ, (c) la superposition des deux colorations. Les noyaux sont colorés au 
Hoechst 32528 (bleu). Les barres représentent une échelle de 1,02 µm. 
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In conclusion, our results suggest that following the binding of the leucotoxins to their membrane specific 
ligand at the plasma membrane, they can be internalized with Stim-1 into intracellular compartments triggering 
the intracellular Ca2+ increase as a result of calcium channels activation. Additional experiments should be done 
to decipher the internal distribution of the leucotoxins into cell compartments and the chronology and role of 
Ca2+ signals. One hypothesis would be that the internalised leucotoxin, by its presence in endosomes carrying 
Stim1, starts a process which includes the Ca2+ release from the endosome and that may be followed by the 
formation of the Stim1/ORAI1 complex. More work is needed to identify the signalling pathways and cell 
responses generated by leucotoxins. 
Conclusion 
We now have acquired different means to block both functions of staphylococcal leucotoxins or to selectively 
block pore-formation or Ca2+ activation in human PMNs, or into sensitive neurons (see Jover et al., 2011). Both 
HCAbs and calixarenes approaches are exciting because they may give opportunity to block most or all bipartite 
leucotoxins and may be few other related toxins. They are now about to be evaluated in infectious models 
where they might provide some beneficial effects in the context of acute infections due to particular virulent 
strains where antimicrobial treatment only is not sufficient to eradicate infection or not satisfying enough to 
avoid irreversible tissue damage. The possibility to block pores really allows a more significant study of signal 
pathways involved by the action of low concentrations of leucotoxins or particular ones. At evidence this 
suggests the translocation of these toxin and their cell trafficking into endoplasm. This feature is now 
completed by a dissection of Ca2+ channels and pathways involved in the rise of divalent cation, and strongly 
the role of the complex Stim-1 / Orai1, which a novel concept of the action of these leucotoxins. Finally, it 
appeared that some of the Ca2+ inhibitors have no similar efficacies according to the leucotoxin analyzed, and 
again they appear more complex than speculated. Such studies applied on different target cells will evoke the 
complex proteomics operated according to tissues and may emphasize new knowledge in the understanding of 
some infections and associated inflammation. 
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Abstract 
The cholesterol-dependent cytolysins (CDCs) are a large family of pore forming toxins that 
contribute to the pathogenesis of many Gram-positive pathogenic bacteria. The study of the pore 
forming mechanism of these toxins has revealed that they undergo a series of remarkable 
structural transitions during their transition from soluble monomers to a membrane-embedded 
oligomeric pore complex. These studies have led to the discovery that the family of eukaryotic 
and prokaryotic membrane attack complex/perforin (MACPF) proteins may use a CDC-like 
mechanism to form pores and may be ancient ancestors of the CDCs. Finally, understanding the 
molecular mechanism of the CDCs has allowed the rational design of potential vaccine derivatives 
of the CDCs that maintain the antigenic structure of their soluble form. 
Les cytolysines dépendantes du cholestérol : du mécanisme 
moléculaire au développement de vaccins 
Les cytolysines dépendantes du cholestérol (CDC) constituent une grande famille de toxines 
formant des pores qui contribuent à la pathogenèse de nombreuses bactéries pathogènes à 
Gram-positif. L'étude du mécanisme de formation de pores de ces toxines a révélé qu'elles 
subissent une série de transitions structurelles remarquables pendant leur transition de 
monomères solubles en complexes oligomériques formant des pores insérés dans la membrane. 
Ces études ont mené à la découverte que la famille de protéines, procaryotes et eucaryotes, qui 
forment des complexes attaquant ou perforant les membranes (membrane attack 
complex/perforin; MACPF) peuvent utiliser un mécanisme similaire à celui des CDC pour former 
des pores et pourraient être les ancêtres des CDC. Enfin, la compréhension du mécanisme 
moléculaire des CDC a permis une conception rationnelle de vaccins potentiels dérivés des CDC 
qui maintiennent la structure antigénique de leur forme soluble. 
Keywords : Cholesterol-dependent cytolysins, intermedilysin, membrane attack 
complex/perforin, perfringolysin O, pneumolysin, pore-forming toxin. 
 
Introduction 
The CDCs constitute a large class of cytolytic pore-forming proteins that contribute to the pathogenesis of many 
Gram-positive bacteria. The CDCs are secreted as soluble monomers, which then bind to cholesterol-rich 
membranes and assemble a large β-barrel pore (Hotze and Tweten, 2011). The CDCs have been shown to 
function as primary or ancillary pathogenesis factors in those bacterial pathogens where the role of the CDC has 
been studied. Whether they also serve other roles remains unclear. Many CDC producing bacteria are 
infrequent opportunistic pathogens and spend most of their life as commensals. Hence, it is possible that CDCs 
may also contribute to the maintenance of the commensal state of many bacterial species in ways that remain 
unclear. 
Although the CDCs are termed β-hemolytic toxins, it is unlikely that CDC-mediated hemolysis is a primary 
feature of CDCs during pathogenesis. In fact, the use of CDCs as general cytolytic agents has not been 
rigorously shown to be a primary function of any CDC. It is not necessary to form a pore comprised of 30-40 
monomers with a diameter 20-30 nM, as is formed by the CDCs (Czajkowsky et al., 2004), to lyse a cell. A 
much smaller pore would function as an efficient lytic agent at a significantly lower energy cost to the cell. 
Presumably, the large pore formed by the CDC is used in more sophisticated ways by bacteria than as a brute 
force cytolytic agent, although how bacterial pathogens employ the large pore to cause a myriad of cellular 
effects remains less well understood. 
The CDCs, formerly known by various names including the thiol-activated cytolysins, oxygen labile toxins or 
cholesterol binding toxins, exhibit several hallmark characteristics that include a complete dependence on 
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cholesterol for their cytolytic activity, the formation of extraordinarily large pore complexes and the presence of 
an 11 residue signature peptide motif termed the undecapeptide or tryptophan-rich motif. Many bacterial pore-
forming toxins assemble β-barrel pores (Olson and Gouaux, 2005; Olson et al., 1999; Song et al., 1996): the 
mechanism by which the CDCs assemble their β-barrel pore, however, exhibits many novel features not 
previously observed in other β-barrel pore forming toxins. Herein the focus will be on the current state of 
understanding of the structure and pore forming mechanism of the CDCs. 
Membrane recognition by the CDCs 
For nearly 60 years the CDC cytolytic mechanism was known to be sensitive to the presence of membrane 
cholesterol (Howard et al., 1953): membranes that lack cholesterol are not sensitive to pore formation by the 
CDCs. The ability to inhibit the lytic activity of the CDCs with added cholesterol has been one measure of 
whether a pore forming protein may be a CDC. Many studies have been performed on the interaction of the 
CDCs with cholesterol. It has been assumed that cholesterol inhibited the CDCs by occupying a receptor 
binding site that specifically bound membrane cholesterol. However, as described below, the nature of the 
cholesterol binding motif has been elusive and only recently has its structure been identified. 
The structural requirements of the sterol for CDC recognition and binding are fairly rigid. Prigent and Alouf 
(1976) initially performed a series of analyses that elucidated these requirements, which showed that the CDCs 
primarily bind to cholesterol and closely related sterols that maintain an intact 3-β-hydroxy headgroup. It is 
clear that the 3-β-hydroxyl is a key determinant for binding as any perturbation of this structure, even a 
change in its stereochemistry, abrogates binding. The surrounding lipid structure also has a significant 
influence on the ability of CDCs to recognize and bind to cholesterol: studies have shown that lipids that pack 
tightly with cholesterol or that have large headgroups can decrease the ability of the CDCs to recognize and 
bind cholesterol (Flanagan et al., 2009; Nelson et al., 2008), presumably by steric occlusion of the small 3-β-
hydroxy headgroup of cholesterol.  
Until recently it was generally accepted that the conserved undecapeptide signature motif (Figure 1) of the 
CDCs was the cholesterol-recognition/binding motif (CRM). Mutations or chemical modification of the 
undecapeptide residues often affected binding affinity, but never completely abrogated binding (Nakamura et 
al., 1995; Ohno-Iwashita et al., 1988). More recently, Soltani et al. (2007) showed that membrane insertion of 
the three domain 4 loops (L1-L3, Figure 1) was cholesterol dependent, but membrane insertion of the 
undecapeptide was not, which suggested that the CRM was located in one or more of these three loops. 
Farrand et al. (2010) recently identified the CRM in loop L1 (Figure 1) and showed that it is comprised of a 
threonine-leucine pair. The structure of the CRM was surprisingly simple, but then the structure of the 
cholesterol headgroup exposed at the surface of the bilayer is also comparatively limited since it is comprised of 
the 3-β-hydroxy. The Thr-Leu pair is conserved in all known CDCs suggesting that its structure cannot be 
changed, even by substitution of conservative mutations. Farrand et al. (2010) confirmed this by showing that 
the most conservative mutations of these residues resulted in dramatic loss of binding activity on cells. 
A small, but growing family of CDCs use human CD59 as their receptor rather than cholesterol: these CDCs 
include Streptococcus intermedius intermedilysin (ILY; Giddings et al., 2004), Gardnerella vaginalis vaginolysin 
(VLY; Gelber et al., 2008) and Streptococcus mitis lectinolysin (LLY; Wickham et al., 2011). The pore-forming 
activity of these CDCs, however, remains cholesterol dependent. LaChapelle et al. and Farrand et al. solved the 
basis for the cholesterol-dependence of these toxins (Farrand et al., 2010; LaChapelle et al., 2009). LaChapelle 
et al. showed that ILY disengaged from CD59 upon prepore to pore conversion. Farrand et al. subsequently 
demonstrated that if the CRM was knocked out in ILY it dissociated from the membrane upon prepore to pore 
conversion. Hence, to maintain contact with the membrane during prepore to pore conversion the CRM of the 
CD59 binding CDCs must initiate the cholesterol dependent membrane insertion of loops L1-L3, which firmly 
anchors the prepore complex to the membrane. 
Formation of the CDC prepore structure 
Upon membrane binding the CDC monomers interact with each other to form the prepore complex. The 
assembly of the large CDC pore complex is a complex process that is only partially understood. The oligomeric 
complex of perfringolysin O (PFO) is assembled from 34-37 monomers (Czajkowsky et al., 2004). It was 
demonstrated by Shepard et al. (2000) that PFO formed a prepore complex prior to the insertion of the β-barrel 
pore and subsequently Hotze et al. (2001) showed that PFO could be engineered with a disulfide to trap it in 
the prepore state and upon its reduction the β-barrel pore rapidly inserted into the membrane. These studies 
also showed that the oligomerization of the membrane bound monomers of PFO into the prepore complex was 
the rate-limiting step in the assembly of the pore complex. It is currently unknown if the β-barrel pore forms 
prior to its insertion into the membrane, but it seems likely since the formation of interstrand hydrogen bonds 
would greatly reduce the energy cost of their insertion by satisfying the hydrogen bond potential of the polar 
atoms of the β-hairpin backbone. 
The soluble monomers of PFO do not oligomerize in solution, even at the high concentrations required for 
crystallization. At high concentrations head-to-tail dimers are formed, but it is not clear if these are present at 
the concentrations expressed by bacteria during infections. One reason that soluble monomers cannot 
oligomerize is the edge-on interaction of β-strand 5 (β5) with β4 (Figure 1), which blocks the intermolecular 
interaction of β1 of one monomer with β4 of another monomers. In membrane bound monomers β5 must break 
its edge-on interaction with β4 and swing out of the way to allow the formation backbone hydrogen bonds 
between β4 and β1 of another monomer. The disruption of this interaction appears to be initiated by the 
 
Toxines et Transferts ioniques – Toxins and Ion transfers 
 
91
 
Figure 1. Crystal structures of perfringolysin O and intermedilysin monomers. Shown are some of the 
features of the soluble monomer structures of perfringolysin O (PFO, left panel; Rossjohn et al., 1997) and 
intermedilysin (ILY, right panel; Polekhina et al., 2005). The locations are shown of the -helices (yellow) that 
ultimately form the transmembrane hairpins (TMHs) that comprise the membrane spanning β-barrel pore. Also 
shown are the following structures: β5, which swings away from β4 to allow edge-on interactions between β4 of 
one monomer with β1 of another monomer, the location of the glycine pair (blue space-filled atoms) between β4 
and β5 that are conserved in all CDCs and are also conserved in the MACPF proteins, loops 1-3 (L1-L3) that insert 
into the bilayer to anchor the monomers perpendicular to the membrane surface (magenta), the Thr-Leu pair 
(green) that comprise the cholesterol recognition/binding motif (CRM) and the location of the conserved 
undecapeptide motif (orange). On the right the same structures are shown in the CD59 binding CDC, ILY. In 
addition, the residues that comprise the CD59 binding motif and the undecapeptide, are different from that of PFO. 
Figure 1. Structures cristallines des monomères de perfringolysine O et d'intermedilysine. La figure 
montre quelques-unes des caractéristiques structurales du monomère soluble de la perfringolysine O (PFO, 
panneau de gauche; Rossjohn et al., 1997) et d'intermédilysine (ILY, panneau de droite; Polekhina et al., 2005). 
Les localisations des hélices alpha (jaune), qui forment finalement les épingles transmembranaires (TMH) 
constituant la structure du pore en cylindre-béta s'insérant dans la membrane, sont indiquées. Les structures 
suivantes sont aussi montrées: β5, qui oscille loin de β4 pour permettre l'interaction bord à bord entre β4 d'un 
monomère et β1 d'un autre monomère, l'emplacement de la paire de glycine (atomes bleus) entre β4 et β5 qui sont 
conservées dans tous les CDC et qui sont également conservées dans les protéines MACPF, les boucles 1-3 (L1-L3) 
qui s'insèrent dans la bicouche pour ancrer les monomères perpendiculairement à la surface de la membrane 
(magenta), la paire Thr-Leu (vert) qui compose le motif de reconnaissance du cholestérol (CRM), et l'emplacement 
du motif conservé de 11 résidus (undécapeptide; orange). Sur la droite sont présentées les mêmes structures de la 
CDC liant CD59, l’ILY. De plus, les résidus qui constituent le motif de liaison à CD59 et l'undécapeptide, sont 
différents de ceux de PFO. 
interaction of the monomers with the membrane (Ramachandran et al., 2004). The formation of a -stacking 
interaction of two aromatic residues in β1 (Tyr-181) and β4 (Phe-318) is also necessary to the formation of the 
pore complex. Loss of either aromatic resulted in a cytolytically inactive oligomeric complex. We have proposed 
that the stacking of these two residues maintains the correct intermolecular pairing of transmembrane hairpins 
(TMHs; Ramachandran et al., 2004), but this may not be the entire story. These two residues are conserved in 
most CDCs but they are not conserved in all CDCs, which suggests that their function(s) has been accomplished 
in a different way in these CDCs. 
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Conversion of the prepore to the pore complex 
A key structural transition in the formation of the β-barrel pore is the disruption of the domain 2-3 interface 
where the α-helical bundle that ultimately forms TMH1 (Figure 1) is buried. This interface is not complementary 
suggesting it has evolved to be easily disrupted (Rossjohn et al., 1997). Using a variety of fluorescence 
spectroscopic methods Shepard et al. (1998) and Shatursky et al. (1999) demonstrated that the two sets of -
helical bundles in domain 3 were converted into membrane spanning amphipathic β-hairpins (TMH1 and TMH2, 
Figure 1). As indicated above, it is likely that TMH1 and TMH2 assemble into a partially or wholly formed pre-β-
barrel prior to membrane insertion. In membrane bound monomers domain 3 is positioned about 40 Å above 
the membrane, thus when TMH1 and TMH2 are extended into hairpins this would allow them to form a pre-β-
barrel above the bilayer. This scenario, however, also engendered a problem: Shepard et al. (1998) and 
Shatursky et al. (1999) clearly showed the TMHs extended across the membrane, yet the fact that domain 3 
was suspended 40 Å above the membrane showed that the extended TMHs were only long enough to reach the 
membrane surface but not cross it. This conundrum was resolved by Czajkowsky et al. (2004) who showed by 
atomic force microscopy that the prepore complex underwent a 40 Å vertical collapse that brought domains 1 
and 3 sufficiently close to the membrane to allow the TMHs to span the bilayer. This was subsequently 
confirmed by Ramachandran et al. (2005) using fluorescence resonance energy transfer (FRET) based distance 
measurements. Hence, these studies suggest that the CDCs assemble the β-barrel pore above the bilayer, 
thereby satisfying the hydrogen bond potential of the TMH peptide backbone and decreasing the energetic cost 
of their membrane insertion, and then undergoing a vertical collapse that plunges the β-barrel pore into the 
membrane. 
The membrane attack complex/perforin family of proteins 
The molecular structure of the CDCs exhibits many distinct features: the most notable of these is the structure 
of domain 3, which forms the transmembrane β-barrel (Figure 1). The domain 3 protein fold was not found in 
another family of proteins until the solution of several membrane attack complex/perforin (MACPF) family 
proteins. The crystal structures of the soluble monomers of several MACPF family proteins (Figure 2) revealed a 
protein fold that exhibited a remarkable similarity to the domain 3 of the CDCs. Based on this structural 
similarity it has been suggested that the MACPF family proteins form a β-barrel pore that originates from the 
unfolding of the α-helical bundles found in the domain 3-like protein fold of the MACPF proteins. Whether this is 
true remains to be proven, but seems likely given the fact that the CDC domain 3 fold exhibits several unique 
features that are designed to form its β-barrel pore and these features appear to be maintained in the MACPF 
proteins. 
 
Figure 2. Structure of MACPF monomers. Shown are the crystal structures of three MACPF family proteins: 
mouse perforin (Law et al., 2010), a complement C9-like protein from Photorhabdus luminescens (Rosado et al., 
2007) and human complement C8 (Hadders et al., 2007; Slade et al., 2008), compared to that of PFO (Rossjohn 
et al., 1997). Shown are the structures in the MACPF proteins that exhibit a similar structural fold to domain 3 of 
PFO which forms the TMHs (magenta), the domain 3 core β-sheet (yellow) and the short loop (red) comprised of β5 
and a short -helix. 
Figure 2. Structure des monomères MACPF. La figure montre les structures cristallines de trois protéines de la 
famille MACPF: la perforine de souris (Law et al., 2010), une protéine de Photorhabdus luminescens similaire au 
complément C9 (Rosado et al., 2007) et le complément humain C8 (Hadders et al., 2007; Slade et al., 2008), 
comparées à celle de la PFO (Rossjohn et al., 1997). La figure montre les structures des protéines MACPF qui 
présentent un repliement structural similaire à celui du domaine 3 de la PFO qui forme les TMHs (magenta), le 
domaine 3 du cœur du feuillet β (jaune) et la boucle courte (rouge) composée de β5 et d’une courte hélice . 
PFO C9-like
(Photorhabdus luminescens)
C8Mouse Perforin
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Designing a better Streptococcus pneumoniae vaccine 
S. pneumoniae is a major cause of pneumonia worldwide and in developing countries children are especially 
vulnerable to this infection. Current S. pneumoniae vaccines are based on the polysaccharide capsule, of which 
there are over 90 different variations. Current vaccines of capsule cover 23 serotypes and conjugate vaccines 
for children under 2 years cover 13 serotypes. These vaccines are complex and costly to produce, and it has 
been shown that serotype shifts can occur (Gladstone et al., 2011; Park et al., 2008). Furthermore, the 
genome of S. pneumoniae exhibits a remarkable plasticity (Croucher et al., 2011), suggesting it is capable of 
significant adaptation to vaccine and antibiotic pressure. A protein-only vaccine has not been developed for S. 
pneumoniae, but would be advantageous if one could be developed that was comprised of conserved proteins 
that covered most or all serotypes. Surprisingly a conserved pathogenesis factor, the S. pneumoniae CDC 
pneumolysin (PLY), has never been incorporated into vaccine formulations. This has been in part due to 
residual toxicity of genetically inactivated variants of PLY. 
The problem of residual toxicity can now be overcome by a variety of methods now that we have a much 
better understanding of the mechanism of the CDCs and how they can be inactivated. We have developed 
several different approaches to inactivating CDCs (Hotze et al., 2002; Hotze et al., 2001; Ramachandran et al., 
2004). Decreasing toxicity of PLY, however, is only the first part of generating a better vaccine version of this 
toxin: how it is accomplished and the nature of the resulting toxoid may also be important. As is evident from 
the above discussion once the CDC binds to the cell surface via cholesterol a series of conformational changes 
are initiated and the monomers oligomerize. These processes change the epitope structure of the CDC 
monomer and occlude epitopes at interacting protein surfaces. Based on our studies all potential PLY vaccine 
candidates reported to date still retain the capacity to bind the cell in a cholesterol-dependent fashion and 
undergo some oligomerization. The best version of a CDC vaccine would theoretically prevent binding thereby 
preventing these structural changes, which would preserve the structure and solubility of the monomer. This 
would preserve all of the epitopes that would be potentially neutralizing, which would include regions of the 
CDC involved in binding, oligomerization and insertion of the β-barrel pore. Until recently this type of mutant 
was not possible since the true identity of the cholesterol-binding motif was not known. Only with the discovery 
of the cholesterol recognition/binding motif (Farrand et al., 2010) could we generate this mutant. By altering 
the cholesterol cholesterol-binding motif of PLY to prevent binding, we were able to generate a non-binding 
mutant that was >20,000-fold less toxic than native PLY and that preserved the solubility and structure of the 
monomer. Studies with this mutant have demonstrated that this mutant performs well in animal challenge 
studies and is significantly more protective than native PLY. 
Conclusions 
The study of the CDC pore forming mechanism has revealed a pore forming mechanism that established many 
new paradigms and has provided a deep understanding into the molecular transitions that occur as the CDCs 
make the transition from a soluble monomer to the large membrane embedded pore complex. Furthermore, 
our understanding of the pore forming mechanism of the CDCs has enable us to rationally design better CDC-
based vaccines and has allowed others to propose a pore forming mechanism for the large family of MACPF 
proteins that play key roles in immune defense and in the pathogenesis of eukaryotic organisms such as 
Toxoplasma and malaria. It is likely that the continued studies of the large family of CDCs will reveal new 
paradigms and will broaden our understanding of their roles in bacterial pathogenesis. 
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Abstract 
A previous study conducted in our laboratory revealed that cultured cells having internalized 
heat-stable enterotoxin b (STb) displayed apoptotic-like morphology. We therefore investigated if 
STb induces apoptosis in the IEC-18 cell line (rat ileum epithelial cells) by verifying the activation 
of caspases-9, -3 and -8 as well as DNA fragmentation of cells treated with purified toxin. We 
observed activation of caspases-9 and -3 as well as DNA laddering, indicating that STb induces 
apoptosis in IEC-18 cells. 
L’entérotoxine STb produite par Escherichia coli induit l’apoptose des 
cellules intestinales épithéliales de rat 
Une étude antérieure menée dans notre laboratoire a révélé que des cellules en culture ayant 
internalisé l’entérotoxine STb démontraient une morphologie rappelant celle de l’apoptose. Nous 
avons évalué l’apopotose des cellules IEC-18 (cellules épithéliales de l'iléon de rat) traitées avec la 
toxine STb purifiée, en vérifiant l’activation des caspases-9, -3 et -8 et la fragmentation de l’ADN. 
L’observation de l’activation des caspases-9 et -3 et de la fragmentation de l’ADN indique que 
STb induit l’apoptose des cellules IEC-18. 
Keywords : Apoptosis, caspase, DNA fragmentation, Escherichia coli, STb enterotoxin. 
 
Introduction 
Heat-stable enterotoxin b (STb) is one of the toxins produced by enterotoxigenic Escherichia coli (ETEC) strains 
shown to be responsible for the induction of diarrhea and is most commonly associated with post-weaning 
diarrhea in piglets (Dubreuil, 2008). STb toxin is capable of forming non-specific pores in pig jejunal brush 
border membrane vesicles (Gonçalves et al., 2007) and of inducing histological damages of the intestine 
characterized by shortening and atrophy of the villi and thus reduction of the mucosal surface (Rose et al., 
1987). These damages have been associated with diminished absorptive ability of the villi and secretion of 
electrolytes and water during diarrhea. 
A previous study conducted in our laboratory demonstrated that cells having internalized STb displayed 
mitochondrial potential changes and an apoptotic-like morphology (Gonçalves et al., 2009). Indeed, the ability 
of pore-forming toxins to induce apoptosis is well documented (Braun et al., 2007; Saka et al., 2008; Tran et 
al., 2011). Apoptosis is a form of programmed cell death characterized by membrane blebbing, chromatin 
condensation, and DNA fragmentation. Apoptosis can be induced through either an extrinsic or intrinsic 
pathway. 
Extrinsic apoptosis is activated following the interaction of a ligand and a membrane-bound receptor 
belonging to the Tumor Necrosis Factor Receptor (TNFR) family. This results in the formation of DISC (Death 
Inducing Signalling Complex) and the activation of caspase-8. Intrinsic apoptosis is the result of intracellular 
stress causing a change in mitochondrial membrane potential leading to the formation of the apoptosome and 
the activation of caspase-9. Both caspases-8 and -9 activate caspase-3 which targets downstream substrates 
leading to DNA fragmentation and eventual cell death. 
As STb has been shown to cause apoptotic-like morphology in cultured cells and as rats are used as an 
animal model for the study of STb, we investigated the ability of STb to induce apoptosis in rat intestinal 
epithelial cells in culture. 
Material and methods 
In order to determine if STb induces apoptosis in intestinal epithelial cells of rats, we treated the IEC-18 cell 
line (rat ileum epithelial cells) with various quantities (nanomole) of purified STb toxin for a period of 24 hours. 
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Harvested cells were then assessed for caspases activation and DNA fragmentation. The implication of 
caspases-9, -3 and -8 was verified using fluorescent substrates specific for each of these caspases. 
Fluorescence emitted from the cleaved substrates was measured with a fluorescence microplate reader at 500 
nm. Extracted DNA of toxin-treated IEC-18 cells was migrated on a 1.8% agarose gel and then visualized under 
a UV lamp at 260 nm. Staurosporine was used at 2 µM (final concentration) as a positive control for apoptosis. 
Results 
Activation of caspases-9 and -3 (Figure 1) was observed in IEC-18 cells treated with 0.05 and 0.5 nmol of STb, 
similarly to cells treated with staurosporine, our positive control for apoptosis. As caspases-9 and -8 are 
initiator caspases of the intrinsic and extrinsic pathways, respectively, the evaluation of their activation allowed 
us to determine the precise pathway targeted by STb. Activation of caspase-3 was also assessed to ensure the 
implication of the caspase cascade in STb-mediated apoptosis. The activation of caspase-9 in our study 
indicates that the intrinsic pathway is targeted by STb. Treatment of cells with the same amount of toxin 
yielded similar activation levels of either caspase-9 or -3 but not of caspase-8 (Figure 1), a caspase activated 
when the extrinsic pathway is involved. The induction of apoptosis by STb through the intrinsic pathway is in 
accordance with other pore-forming toxins (Génestier et al., 2005; Manente et al., 2008). 
 
Figure 1. Activation of caspases-9, -3 and -8 in IEC-18 cells treated with 0.05 and 0.05 nmol of STb toxin. Negative 
control consisted of untreated cells whereas our positive control consisted of cells treated with staurosporine (STS). 
Mean ± standard error of the mean of 2 experiments. 
Figure 1. L’activation des caspases-9, -3 et -8 dans les cellules IEC-18 traitées avec 0,05 et 0,5 nmol de toxine STb. 
Les cellules non-traitées représentent le témoin négatif tandis que les cellules traitées avec la staurosporine (STS) 
représentent le témoin positif. Moyenne ± erreur standard de la moyenne de 2 expériences. 
Extracted DNA from IEC-18 cells treated with 0.25 and 0.5 nmol of STb revealed a similar laddering 
pattern as observed with extracted DNA of cells treated with staurosporine (Figure 2). DNA fragmentation is 
the result of cleavage by endonucleases of internucleosomal DNA into 180 bp – 200 bp multiples. The 
fragments of extracted DNA of cells treated with STb are 1000 bp or smaller. Each ladder step is 
approximately a multiple of 200 bp, indicating the DNA cleavage at internucleosomal sites. 
 
Figure 2. Extracted DNA of IEC-18 cells treated with STb toxin migrated on an agarose gel. M: molecular markers in 
base pairs; 1: Untreated cells (negative control); 2 and 3: Cells treated with 0.25 and 0.5 nmol of STb, respectively; 4: 
Cells treated with staurosporine (positive control for apoptosis). 
Figure 2. ADN extrait des cellules IEC-18 traitées avec la toxine STb et migré sur gel d’agarose. M: Marqueurs 
moléculaires en paires de bases; 1: Cellules non-traitées (contrôle négatif); 2 et 3: Cellules traitées avec 0,25 et 0,5 
nmol de STb, respectivement; 4: Cellules traitées avec la staurosporine (contrôle positif pour l’apoptose). 
Conclusion 
We showed for the first time that STb enterotoxin induces apoptosis in rat intestinal epithelial cells. The 
activation of caspase-9 and -3, but not of caspase-8, in our study is an indication of STb-mediated intrinsic 
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apoptosis in IEC-18 cells. This pathway involves a change in mitochondrial membrane potential as it was 
observed in a previous study conducted in our laboratory but using the NIH-3T3 cell line. DNA fragmentation 
confirms that apoptosis is occurring in rat intestinal epithelial cells following treatment with STb. Apoptosis of 
villus epithelial cells can explain, at least in part, the accumulation of fluid observed in pig ligated loops. The 
death of these cells could be related to a loss of absorptive capacity of the intestine intoxicated by STb toxin. 
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Abstract 
Tetanus and botulinum neurotoxins enter nerve terminals via endocytosis inside acidic vesicles. 
Using a novel cellular assay, we have found that (1) these neurotoxins have to be bound to the 
membrane via at least two anchorage sites for a productive low-pH induced membrane 
translocation of the active chain to occur, (2) this only happens if the single inter-chain disulfide 
bond is intact, and (3) the pH dependence of membrane translocation is similar for the various 
toxins. 
Sur le mode d'entrée des neurotoxines clostridiales dans le cytosol 
des terminaisons nerveuses 
Les neurotoxines tétanique et botuliques entrent dans les terminaisons nerveuses par endocytose 
dans des vésicules acides. En utilisant un nouveau test cellulaire, nous avons démontré que (1) 
ces neurotoxines doivent être liées à la membrane par au moins deux sites d’ancrage pour une 
translocation membranaire efficace du domaine enzymatique à pH acide, (2) ceci n’intervient que 
si le pont disulfure reliant les deux chaînes est intact, et (3) la translocation membranaire est 
dépendante du pH de manière similaire pour ces toxines. 
Keywords : Botulism, membrane translocation, molecular model, tetanus. 
 
Tetanus neurotoxin (TeNT) and botulinum neurotoxins (seven different serotypes: BoNT/A, /B, /C, /D, /E, /F 
and /G) cause a prolonged blockade of neuroexocytosis by entering into nerve terminals and cleavage of the 
SNARE (soluble N-ethylmaleimide-sensitive factor-attachment protein-receptor) proteins which form the core of 
the nanomachine which mediates neurotransmitter release. They are dichain (H, heavy chain and L, light chain) 
toxins with a single interchain disulfide bond (Rossetto et al., 2006; Binz and Rummel, 2009; Montal, 2010). 
Their cellular mechanism of intoxication consists of four steps: (1) binding, (2) endocytosis inside acidic 
vesicles, (3) membrane translocation of the metalloprotease L chain, (4) cleavage of either VAMP, or SNAP-25 
or syntaxin (Montecucco and Schiavo, 1995). The third step is the least understood because it takes place 
inside the lumen of a vesicle which is acidified by the v-ATPase proton pump, specifically inhibited by 
bafilomycin A1 which is a strong inhibitor of TeNT and of BoNTs (Simpson et al., 1994; Williamson and Neale, 
1994). It is established that, at low pH, the H chain inserts into the membrane and chaperones the partially 
unfolded L chain on the cytosol side where the SS bond is reduced and displays its metalloprotease activity: 
TeNT, BoNT/B, /D, /F and /G cleave VAMP/synaptobrevin; BoNT/A, /C and /E cleave SNAP-25; and BoNT/C also 
cleaves syntaxin (Rossetto et al., 2006; Montal, 2010). How low pH converts a highly water soluble molecule 
into a transmembrane protein conducting channel is not understood. 
To tackle this problem at the cellular level, we decided to "export" the site of membrane translocation by 
making it to occur at the plasma membrane of nerve terminals. We used two types of neurons in culture: 
cerebellar granular neurons (CGN) because they are a pure culture of primary neurons and NGF-differentiated 
PC12 cells because they are a cell line. These neurons resist to exposure to short incubation at media of pH as 
low as 4.5 without any loose of viability or detachment from the substrate. The normal pathway of entry via 
acidic vesicles was blocked by the presence of bafilomycin A1. The presence of the metalloprotease chain in the 
cytosol was deduced by their metalloprotease activity measured by blotting with specific antibodies the three 
SNARE proteins and determining the ratio of the cleaved SNARE and of the uncleaved one, an internal 
"ratiometric" method which compensates for any heterogeneity among samples. Using this method,  we found 
that neither BoNT/A nor BoNT/B were induced by the external low pH to enter neurons and cleave their 
respective substrates. We reasoned that this was due to the fact that they would bind to the cells only via the 
polysialoganglioside binding site (Binz and Rummel, 2009) and that this single anchorage would leave to the 
molecule a too high degree of freedom of movement with respect to the membrane with the result that the 
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toxin molecule would have the possibility of interacting with the membrane surface in many unproductive ways. 
As one special feature of these neurotoxins is that of having two binding sites in their C-terminal binding 
domain (Montecucco, 1986; Binz and Rummel, 2009), we reasoned that it was possible that two anchorage 
points would be needed in order for a productive entry into the membrane to occur. Beginning with TeNT 
(Rummel et al., 2003), BoNT/C and /D were also shown to have two polysialoganglioside binding sites in their 
binding domain. Accordingly to these reports and to our hypothesis, TeNT, BoNT/C and /D should enter into the 
two types of neurons used here in a low pH dependent way and cleave their respective substrates. Indeed, 
Figure 1 shows that this is the case and, even more remarkably, the three toxins did with the same pH 
dependence (Pirazzini et al., 2011). 
 
Figure 1. pH dependence of the cleavage of intracellular SNARE proteins by 
tetanus and botulinum neurotoxins in cerebellar granular neurons in culture 
after 5 min incubation in extracellular media of the indicated pH value and 
further incubation at neutral pH in the presence of bafilomycin A1. The 
percentage of intact SNARE proteins is reported as a function of the pH of the 
extracellular medium for TeNT (green triangles, target protein: 
VAMP/synaptobrevin), for BoNT/C (blue rounds refer to syntaxin, dark green 
squares to SNAP-25) and BoNT/D (red triangles refer to the target protein 
VAMP/synaptobrevin). No pH jump refers to neurons intoxicated via the normal 
route of endocytosis in the absence of bafilomycin A1  
Figure 1. Coupure des protéines SNARE intracellulaires des neurones en grain 
du cervelet en culture par les neurotoxines tétanique et botuliques en fonction 
du pH, après 5 min d’incubation en présence de milieux extracellulaires dont la 
valeur du pH est indiquée, puis d’une incubation supplémentaire à pH neutre en 
présence de bafilomycine A1. Le pourcentage de protéines SNARE intactes est 
indiqué pour chaque valeur de pH du milieu extracellulaire en présence de TeNT 
(triangles verts, protéine cible: VAMP/synaptobrévine), de BoNT/C (ronds bleus 
pour la syntaxine, carrés verts foncés pour SNAP-25) et BoNT/D (triangles 
rouges, protéine cible: VAMP/synaptobrévine). L’absence de saut de pH signifie 
que les neurones ont été intoxiqués par la voie normale d’endocytose en 
l’absence de bafilomycine A1. 
If this "two feet on the ground" explanation is correct, then the exposure of the synaptotagmin binding 
domain of BoNT/B on the surface of neurons should make the cell sensitive to BoNT/B. Indeed, this was found 
to be the case (Pirazzini et al., 2011), providing further support to the proposal that, in order to undergo a 
productive entry into the membrane at low pH, these neurotoxins have to be bound to the membrane via two 
binding sites. The nature of the receptors apparently makes no difference, as we found that two 
polysialogangliosides or one polysialoganglioside plus a protein receptor support entry with the same pH 
dependence profile for the four neurotoxins tested here. These findings are at variance with those of Sun et al. 
(2011) who reported that one single polysialoganglioside binding site was sufficient to mediate the low pH 
induced translocation of BoNT/B into hippocampal neurons exposed in culture at low pH. However, there is only 
an apparent contradiction among the two studies, as these authors exposed their neurons to high potassium 
media and it is well known that membrane depolarization does induce fusion of synaptic vesicle with exposure 
on the lumen of the vesicle on the cell surface, including the BoNT/B binding domain of synaptotagmin. 
Therefore, they worked under conditions very similar to those that we used for BoNT/B in our study, and their 
findings provide further and independent support to our proposal of the "two feet on the ground" for the low 
pH-mediated entry of TeNT and BoNTs into the membrane. 
As it is known that the reduction of the single interchain disulfide bridge of TeNT and BoNT/A (Schiavo et 
al., 1990; de Paiva et al., 1993) abolishes neurotoxicity, we tested here if reduction affects the low pH-induced 
entry of TeNT, BoNT/C and BoNT/D and have found that these three toxins after reduction lose their capability 
of entering into neurons. This result indicates that an intact SS interchain bridge is necessary at same stage of 
the process of low pH-nduced membrane insertion and translocation (Pirazzini et al., 2011). 
The close similarity of the pH interval of membrane translocation for the four neurotoxins suggests that 
similar and conserved residues are protonated. Such residues have been identified by sequence comparison 
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and then their pKa values were estimated via the program PROPKA3.0 which considers the positions of the 
residue in the crystallographic structure; our analysis was based on the structure of BoNT/B because of its 
higher resolution (PDB: 2NP0) (Chai et al., 2006). All the carboxylate residues with pKa values close to the pH 
interval of Figure 1 are on the same surface of the BoNT/B molecule that includes the interchain SS bond and 
the segment predicted by Eswaramoorthy et al. (2004) to have a high tendency to insert into membrane. 
On this basis, we propose that this face of the BoNT/B and TeNT molecules becomes positively charged 
upon acidification and that it rotates on the two membrane receptors to lie flat on the negatively charged 
surface of the membrane. The first two segments that are proposed to insert into the lipid bilayer are the one 
mentioned above and the highly hydrophobic SS bond. This is followed by a concerted conformational change 
of both the L and H chains with creation of a chaperone-channel by the H chain, which conducts the partially 
unfolded L chain across the membrane. Our previous experimental evidences indicate that both the L and H 
chain expose part of their surface to lipids (Montecucco et al., 1985; Montecucco, 1986). Once the L chain is 
translocated, a H channel is open across the membrane and transports ions with a conductance determined in 
previous studies (Hoch et al., 1985; Donovan and Middlebrook 1986; Gambale and Montal, 1985; Koriazova 
and Montal, 2003; Fischer and Montal, 2007; Montal, 2010). In this view, the TeNT and BoNT channel 
characterized so far and reviewed recently (Montal, 2010) is a consequence of the membrane translocation of 
the L chain and not a pre-requisite for its translocation, as discussed more in depth previously (Montecucco and 
Schiavo, 1995). 
Conclusion 
The cellular assay of the membrane translocation of tetanus and botulinum neurotoxins will be very useful in 
studying the molecular aspects of this mysterious process also because it has generated a molecular model that 
is already under experimental test via generation and assay of the various activities of selected BoNT mutants. 
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Abstract 
Peptide neurotoxins isolated from animal venoms are widely employed in neuroscience research 
because of their ability to activate or inhibit specific ionic currents. However, because neurotoxins 
are soluble and dispersed into the media, their action cannot be restricted to a single cell population 
within a cell network. Here, we review a recombinant strategy based on genetically encoded 
membrane tethered toxins (t-toxins) for long-term inhibition of ion channels and receptors. Due to 
their membrane attachment, the activity of recombinant t-toxins is restricted to genetically targeted 
cells, without affecting identical channels on neighboring cells that do not express the t-toxin. This 
review describes the development and application of the t-toxin technology to the functional 
dissection of brain circuits and its potential translation to cell-based therapies and drug discovery 
Des toxines peptidiques ancrées à la membrane pour l’étude des 
circuits neuronaux, thérapie cellulaire et découverte de médicament 
Les neurotoxines peptidiques issues de venins d’animaux sont largement employées en 
neuroscience du fait de leur capacité à activer ou inhiber spécifiquement des courants ioniques. 
Cependant, les neurotoxines sont solubles et diluées dans le milieu et leur action ne peut être 
restreinte à une population cellulaire unique dans la cellule. Dans cette revue, nous présentons 
une stratégie recombinante basée sur l’expression de toxines ancrées à la membrane (t-toxines) 
afin d’inhiber de façon prolongée des récepteurs et canaux ioniques. Du fait de leur insertion dans 
la membrane, l’activité des t-toxines est restreinte aux cellules génétiquement ciblées, sans 
affecter les canaux ioniques identiques des cellules voisines n’exprimant pas ces t-toxines. Cette 
revue décrit le développement et les applications de cette technologie dans l’étude fonctionnelle 
des circuits neuronaux et dans son application potentielle en thérapie cellulaire ou dans la 
découverte de médicament. 
Keywords : Ion channel, tethered toxin, mouse genetic strategies, neurotransmission. 
 
Introduction 
Historically, toxin-based methods for manipulating neuronal circuits have included microinjection of 
tetrodotoxin or other neurotoxic agents into target areas, and the local administration of anesthetics or other 
pharmacologic agents. Many of these manipulations, however, are not reversible and frequently disrupt more 
than one neuronal circuit. Powerful genetic approaches have provided new opportunities for manipulations of 
specific cell populations within neuronal circuits. For instance the identification of gene promoters [i.e. Bacterial 
Artificial Chromosomes (BACs)] that allow cell-type specific manipulations of functionally related neuronal 
populations (Gong et al., 2002) can be used to trace neuronal connections, achieve cell-specific conditional 
mutagenesis or drive functional changes within circuits by in vivo microinjections with viral vectors (Hatten and 
Heintz, 2005; Luo et al., 2008; Tolu et al., 2010). 
As research on venom toxins discovers new specific inhibitors and modulators of ion channels and receptors, 
the pharmacopeia of specific naturally occurring venom peptides continues to increase. Thus, single venom 
peptide toxins with characteristic cysteine backbones and selective affinities for voltage-gated sodium (NaV), 
calcium (CaV), and potassium (KV) ion channels, and ligand-gated receptors, such as nicotinic acetylcholine 
receptors (nAChRs), N-methyl-D-aspartate (NMDA) and G-protein coupled receptors (GPCRs) have been 
identified (for reviews see Terlau and Olivera, 2004; Twede et al., 2009). Their high specificity makes them 
ideal tools for deciphering the contribution of ionic currents to neurophysiology, but their activity cannot be 
restricted to a single cell-population in brain slices or in a living organism and usually requires constant 
administration (Figure 1A). To bypass these limitations, we developed genetically encoded tethered toxins (t-
toxins) that are bound to the cell surface by membrane tethers and act only on ion channels and receptors of 
the cell-population that expresses the t-toxin and not on identical receptors present in neighboring cells that do 
not express the t-toxin (Ibañez-Tallon et al., 2004; Figure 1B). 
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In this review, we describe the combined use of genetically encoded membrane t-toxins with cell-specific 
genetic targeting strategies in mice as a novel approach to neurocircuitry that extends our ability to modify 
singular ionic currents in specific neurons in vivo. 
Origin and design of membrane tethered toxins 
The engineering of tethered toxins derived from the discovery of endogenous, cell-membrane bound prototoxins 
of the lynx1 family (Miwa et al., 1999). Lynx1 belongs to the Ly-6/neurotoxin gene family and is an evolutionary 
precursor to snake venom toxins with structural homologies to the nicotinic acetylcholine receptor (nAChR) 
antagonists α- and κ-bungarotoxin. lynx1 is attached to the cell surface by a glycosylphosphatidylinositol (GPI) 
anchor and shows a complex disulfide fold (the tree finger fold), a characteristic feature of most peptide toxins 
(Miwa et al., 1999). Functional analyses indicated that lynx1, and the closely related molecule lynx2, are not 
ligand or neurotransmitters, but directly assemble with nAChRs at the cell-membrane and modulate their functions 
in the presence of acetylcholine or nicotine (Miwa et al., 1999; Ibanez-Tallon et al., 2002; Miwa et al., 2006; 
Tekinay et al., 2009). The first recombinant membrane-bound toxins were designed by replacing lynx1 with the 
sequences encoding for bungarotoxins and α-conotoxins downstream of the secretory signal sequence, followed by 
a short linker and the GPI anchor signal sequence (Ibanez-Tallon et al., 2004). This design directs the toxin 
peptide to the secretory pathway, where the signal sequence is cleaved and the GPI targeting sequence is 
substituted by a covalent bond to GPI, thereby anchoring the peptide to the extracellular side of the plasma 
membrane of the cell in which it is expressed (Figure 1B). 
 
Figure 1. Illustration of ion channel inhibition by soluble peptide toxins or genetic expression of recombinant 
tethered-toxins. (A) Soluble peptide toxins cause instantaneous block of target ion channels, but their use in vivo is 
limited by the accessibility of the brain structure to be targeted, the necessity of constant re-administration and the lack of 
cellular selectivity within a circuit or cell network. (B) Genetically encoded toxins tethered to the membrane via a 
glycosylphosphatidylinositol (GPI) anchor or a transmembrane (TM) domain allow cell-autonomous block of ion channels 
and the integration of domains (i.e. Flag or other epitopes, EGFP or other markers) to monitor their long-term expression in 
targeted cells. From Auer and Ibañez-Tallon (2010). 
Figure 1. Illustration de l’inhibition des canaux ioniques par des peptides solubles ou par des toxines ancrées à 
la membrane et exprimées de façon recombinante. (A) Les toxines solubles provoquent un blocage immédiat du canal 
ionique ciblé mais leur utilisation in vivo est limitée par l’accessibilité des structures cérébrales à cibler, par la nécessité de 
les administrer en continu et par le manque de sélectivité cellulaire dans un réseau neuronal. (B) Les toxines 
recombinantes insérées dans la membrane grâce à une ancre de glycosylphosphatidulinositol (GPI) ou un domaine 
transmembranaire (TM) permettent un blocage des canaux ioniques indépendant de la cellule et l’insertion de marqueurs 
(Flag, épitropes, EGFP ou autres) afin de suivre leur expression prolongée dans la cellule ciblée. D’après Auer et Ibañez-
Tallon (2010). 
The t-toxin design has been further optimized by introducing other membrane tethers, i.e. the 
transmembrane domain of the PDGF receptor (Auer et al., 2010) as well as fluorescent markers (EGFP, 
mCherry and EBFP2) and immunotags (i.e. Flag-tag; Figure 1B). These modifications have greatly increased 
the ability to monitor the expression levels and subcellular localization of the recombinant molecules, which are 
important prerequisites for their use in neurocircuitry. So far, approximately 40 different t-toxins constructs 
have been cloned in our group, and their activity has been characterized on voltage- and ligand-gated ion 
channels (Ibanez-Tallon et al., 2004; Holford et al., 2009; Auer et al., 2010; Sturzebecher et al., 2010). 
Expression and functional assays of these recombinant tethered effectors have revealed that several elements 
are critical to achieve robust expression on the cell-surface and steric availability for functional binding of the t-
toxin to the receptor or channel of interest. The affinity of the bioactive peptide for its cognate ion channel or 
receptor has to be taken into account. Other relevant features when designing t-toxin constructs is the choice 
of anchor and the length of the linker sequence bridging the toxin peptide to the GPI anchor or TM domain 
(Figure 1B). For more details on the design of t-toxins, please see Holford et al. (2009) and Auer and Ibanez-
Tallon (2010). 
Toxines et Transferts ioniques – Toxins and Ion transfers 
 
105
Genetic approaches for t-toxin delivery to neuronal circuits 
The fact that peptide toxins maintain their functionality when expressed exogenously in mammalian neurons 
opened up the possibility to implement an important number of genetic strategies for studies of neurocircuitry 
in vivo using genetically encoded recombinant t-toxins. Thus, studies in vivo have been possible using different 
genetic approaches to drive their cell-autonomous action. These include transgenesis in zebrafish (Ibanez-
Tallon et al., 2004), Drosophila (Wu et al., 2008) and mouse (Sturzebecher et al., 2010), as well as 
recombinant viral systems (Auer et al., 2010; Hruska et al., 2007). In particular, the possibility to encode t-
toxins in viral vectors has further allowed the stable genetic delivery of t-toxins to a variety of mammalian 
cells, including neurons in vitro and in vivo. Furthermore, the use of viral vectors has provided the possibility to 
implement inducible and Cre recombinase-dependent approaches for regulated and cell-specific expression of t-
toxins in mice that we will discuss later (Auer et al., 2010). Here, we discuss some examples of the use of t-
toxins with these genetic approaches to target specific neuronal populations in the mouse nervous system. 
Selective manipulation of sodium voltage-gated currents in Drosophila and in 
mice with t-toxins 
Given that initiation and propagation of electrical signals in excitable tissues depend on voltage-gated sodium 
channels (VGSC, NaV), it is not surprising that many venom peptides target VGSC. Venom peptide toxins bind 
to different receptor sites on the channel protein. Few of them physically block the pore and prevent sodium 
conductance, while a great majority of toxins change channel gating by voltage-sensor trapping through 
binding to extracellular receptor sites (Caterall et al., 2007). For example, μO-conotoxins partially block ionic 
influx by binding close to the pore of sodium channel types expressed in the heart (NaV1.5), muscle (NaV1.4) 
and peripheral nociceptive neurons (NaV1.8; Leipold et al., 2007), while δ-atracotoxins and β-scorpion toxins 
inhibit inactivation of activated channels inducing tetanus-like bursts of action potentials followed by plateau 
potentials resulting in neuronal transmission block and paralysis of the prey. 
Circuit analyses have been done using tethered sodium toxins with these two opposed types of activities. For 
instance, δ-atracotoxin Hv1a has been used in its tethered form to alter the rhythmicity of circadian neurons in 
Drosophila with the GAL4-UAS transgenic system (Wu et al., 2008), while our study employed the t-MrVIA μO-
conotoxin and mouse BAC transgenesis to target nociceptive neurons and interfere with pain perception (Auer et 
al., 2010; Sturzebecher et al., 2010). In both cases, the tethered toxin specifically inhibited sodium voltage-gated 
currents within the genetically targeted neuronal population. Functional analyses of mouse nociceptive neurons 
expressing t-MrVIA revealed that the t-toxin acts at the membrane, as it can be released by enzymatic cleavage of 
the GPI anchor (Sturzebecher et al., 2010). Importantly, the studies in transgenic mice indicated that t-MrVIA 
produced preferential inactivation of NaV1.8 channels without compensation by NaV1.7, as it occurs in NaV1.8 
knockout mice (Sturzebecher et al., 2010). This is interesting since this channel is a target for the treatment of 
pain, and its relatively depolarized activation-voltage dependence may allow it to continue to function when 
nociceptive neurons are depolarized in the cold (Figure 2; Baker and Wen, 2010). 
 
 
 
Figure 2. (A) Schematic representation of the nociceptive 
cascade; sensory neurons are indicated in red. (B, C) 
Electrophysiological recordings of dorsal root ganglia neurons 
from wt ant t-MrVIA transgenic mice demonstrate specific bloc 
of sodium currents in nociceptors but not in neighboring 
mechano-receptors. (D) NaV1.8t-MrVIA mice showed negligible 
responses to noxious cold. Responses to noxious cold pain were 
measured by placing the mice on a 00C cooled plate, and 
scored as the number of paw licking and jumping. (E) 
Representative trace of a cutaneous C fiber of NaV1.8t-MrVIA 
mouse showing start of firing at temperatures below 10°C. 
Figure 2. (A) Représentation schématique du processus 
de nociception; les neurones sensoriels sont indiqués en 
rouge. (B, C) Enregistrements électrophysiologiques des 
neurones de la corne dorsale ganglionaire de souris sauvages 
et transgéniques exprimant la t-MrVIA démontrant le blocage 
spécifique des courants sodiques nocicepteurs mais pas celui 
des mécano-récepteurs voisins. (D) Les souris NaV1.8t-MrVIA 
montrent une réponse minime au froid. Les réponses à une 
douleur due au froid sont mesurées en plaçant la souris sur une 
plaque maintenue à 0°C et en comptant le nombre de léchage 
de pattes et de saut. (E) Tracé représentatif d’une fibre C 
cutanée de souris NaV1.8t-MrVIA montrant le début de 
décharge à des températures inférieures à 10°C. 
Thus, these studies using t-toxins, taken together with previous studies on cold-sensitive neurons (Carr et al., 
2002; Zimmermann et al., 2007), indicate that NaV1.8 is the likely channel to encode for cold perception. As 
research on venom peptide toxins and synthetic peptide ligands progresses, it would be interesting to identify and 
test other antagonists and inactivation blockers of VGSC channels expressed in central neurons for neurocircuitry 
studies. 
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Silencing neurotransmission with calcium channel specific t-toxins 
At presynaptic nerve terminals, the two voltage-gated calcium channels CaV2.1 and CaV2.2 play an essential 
and joint role in the electrochemical signal conversion by coupling the arriving presynaptic action potential to 
neurotransmitter release. The first step in this complex process is the opening of the voltage-gated CaV2.1 and 
CaV2.2 channels due to a rapid membrane depolarization that is caused by an arriving action potential. The 
resulting Ca2+ influx into the presynapse then enables the multimeric vesicle fusion machinery to fuse 
neurotransmitter (NT) filled vesicles with the synaptic membrane, thereby releasing NT to the synaptic cleft 
(Chua et al., 2010; Caterall and Few, 2008). As the NT release is proportional to the third or fourth power of 
Ca2+ influx, a 2-fold change in presynaptic Ca2+ influx results in an 8 to 16-fold change in NT exocytosis (Zucker 
and Regehr, 2002). Thus, regulation of presynaptic calcium channels is an efficient way to control synaptic 
transmission. Besides deciphering distinct neuronal connections and their physiological functions, controlling 
the activity of these channels enables detailed studies of contributions of individual channels to neuronal 
circuits. With these aims in view, our group generated recombinant t-toxins that are able to block CaV2.1 and 
CaV2.2 channels by integration of the ω-agatoxins AgaIIIA and AgaIVA, as well as ω-conotoxins MVIIA and 
MVIIC. We found that these t-toxins were well expressed in cultured mammalian cells, primary cultures of 
hippocampal neurons and in neurons of mice injected with lentivirus encoding t-toxins (Figure 3). The capability 
to block one or both channels was then confirmed by electrophysiological recordings of HEK293-Cav2.2 cells 
and rat hippocampal neurons in vitro (Auer et al., 2010). Overall, we found that AgaIVA and MVIIA provided 
the best blocking capabilities, and in fact that these two t-toxins were as effective as the soluble toxins in fully 
inhibiting their respective target channels in a cell (Auer et al., 2010). 
 
Figure 3. Expression of t-toxins in neurons. (a–d) Schematics of the membrane-tethered toxin variants: no toxin–
PE negative control containing the PDGF receptor transmembrane (TM) domain and EGFP (a), MVIIA-PE (b), AgaIVA-
VG containing extracellular Venus and a GPI anchor (c) and AgaIVA-VG and MVIIA-PC containing PDGF-R–TM domain 
and mCherry (d).(e–p) Fluorescence images of cells expressing constructs in a–d (e, h, k, n) Flag-epitope 
immunofluorescence images (f, i, l, o) and merged images in transduced rat hippocampal cultures (g, j, m, p). Green, 
EGFP and Venus; red, mCherry; blue, DAPI. Scale bars, 20 m. From Auer et al. (2010). 
Figure 3. Expressions de t-toxines dans les neurones. (a-d) Schémas des variants de toxines ancrées à la 
membrane. Contrôle négatif avec le domaine TM du récepteur PGDF et l’EGFP mais sans toxine (a), MVIIA-PE (b), AgaIVA-
VG contenant un domaine extracellulaire Venus et une ancre GPI (c) et AgaIVA-VG et MVIIA-PC contenant le domaine TM 
du récepteur PGDF et la mCherry (d). (e–p) Images de fluorescence des cellules exprimant les différentes constructions 
a-d (e, h, k, n), immunofluorescence de l’épitope Flag (f, i, l, o) et images cumulées dans des cultures d’hippocampes de 
rat (g, j, m, p). Vert, EGFP et Venus; rouge, mCherry; bleu, DAPI. Barres d’échelle, 20 m. D’après Auer et al. (2010). 
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We performed the first in vivo proof-of-function of CaV t-toxins in the nigro-striatal pathway of mice because 
of its unique behavioral phenotype after unilateral inhibition. The nigro-striatal pathway is part of the basal 
ganglia, which are associated with a variety of functions, including motor control and learning. They consist of 
two primary input structures [subthalamic nucleus (STN) and striatum], two primary output structures 
[substantia nigra pars reticulate (SNpr) and globus pallidus internal segment (GPi)], and two intrinsic nuclei 
[globus pallidus pars externa (GPe) and substantia nigra pars compacta (SNpc)] (Mink, 1996; Groenewegen, 
2003). The SNpc consists of dopaminergic neurons, receives input from the striatum and sends most of its 
output back to the striatum via the medium forebrain bundle (mfb; Figure 4; Mink, 1996; Groenewegen, 2003). 
Basal ganglia disorders, like Parkinson’s disease, which is caused by the death of dopaminergic (DA) neurons in 
SNpc, are typically characterized by an inability to correctly initiate and terminate voluntary movements, an 
inability to suppress involuntary movements, and an abnormal muscle tone (Takakusaki et al., 2004). In the 
past, the neurotoxin 6-hydroxydopamine (6-OHDA) has been used extensively for the induction of unilateral 
lesion of DA neurons in the substantia nigra to induce circling behavior in rats. These studies played an 
essential role in the dissection of the nigro-striatal pathway and its role in motor coordination (Ungerstedt and 
Arbuthnott, 1970; Schwarting and Huston, 1996). In response to the resulting striatal DA depletion, a receptor-
mediated supersensitivity, caused by increasing affinity and number of striatal D2-receptors in denervated 
postsynaptic neurons, develops (Schwarting and Huston, 1996). This supersensitivity on the side of the 
lesioned hemisphere usually causes the reversal of the rotational direction if DA agonists like apomorphine are 
administered (Figure 4; Ungerstedt and Arbuthnott, 1970; Schwarting and Huston, 1996). 
 
Figure 4. Representation of the nigro-striatal pathway and induced rotational behavior in mice 
stereotactically injected with t-toxins MVIIA-PE and AgaIVA-VG. Sagittal view of the basic nigro-striatal 
pathway. Dopaminergic neurons of the substantia nigra pars compacta (SNpc) project to the striatum via the medial 
forebrain bundle (mfb), and release dopamine to medium spiny neurons (MSN). This input is relayed via several circuits 
to the neocortex, finally regulating important physical condit ions, including motor coordination. Lesion or inhibition of 
dopaminergic neurons from only one hemisphere leads to an imbalance in dopaminergic signaling. Higher activity on 
the intact side usually results in an ipsilateral rotational phenotype of the animal. If apomorphine, a dopamine receptor 
agonist, is administered, the imbalance is changed to the inhibited/lesioned side, due to increased receptor affinity and 
number of receptors, as a physiological reaction to the missing innervation. This results in a change of the rotational 
behavior to contralateral circling. From Auer et al. (2010). 
Figure 4. Représentation de la voie nigrostriatale et du comportement de rotation induit chez la souris 
injectée avec les t-toxines MVIIA-PE and AgaIVA-VG. Vue sagitale de la voie nigrostriatale. Les neurones 
dopaminergiques de la pars compacta de la substance noire (SNpc) projettent vers le striatum via le faisceau médian 
du cerveau antérieur (mfb) et relarguent la dopamine dans les neurones épineux moyens (MSN). Cette stimulation est 
relayée au travers de nombreux circuits du néocortex contrôlant d’importantes fonctions physiologiques comme la 
coordination motrice. La lésion ou l’inhibition des neurones dopaminergiques d’un seul hémisphère conduit à un 
déséquilibre de la signalisation dopaminergique. D’une activité renforcée du côté intact résulte un phénotype de 
rotation ipsilatérale de l’animal. Si l’apomorphine, un agoniste des récepteurs dopaminergiques, est administrée, le 
déséquilibre est transféré du côté inhibé ou lésé, du fait de l’affinité augmentée du récepteur et du nombre de 
récepteurs, réaction physiologique à l’innervation manquante. Cela résulte en un changement du comportement de 
rotation vers une rotation controlatérale. D’après Auer et al. (2010). 
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Mice stereotactically injected in SNpc with lentiviruses encoding for both t-toxins (MVIIA-PE and AgaIVA-VG) 
displayed a robust rotational phenotype and reversal upon apomorphine administration. These findings strongly 
suggest an imbalance in the motor coordination of t-toxin injected mice, resulting from the inhibition of the 
dopaminergic nigro-striatal pathway by the action of both t-toxins (Auer et al., 2010). 
 This first proof of function of the validity of using virally encoded t-toxins in vivo in the mouse demonstrates 
the general applicability of the t-toxin strategy as a straightforward method that can be used to block CaV2.1 
and CaV2.2 calcium currents, resulting in cell-specific and cell-autonomous silencing of neurotransmission. 
These data also suggest that both t-toxins could be broadly applied for long-term inhibition of CaV2.1 and 
CaV2.2 channels individually or simultaneously, to allow the characterization of the channel contribution to 
physiological functions and circuit analyses in a wide variety of species. 
Extension of the tethered toxin strategy to peptide ligands and further 
applications of t-toxins and t-peptides beyond neurocircuitry 
The t-peptide strategy has been successfully extended to other bioactive peptides, such as ligand peptides for 
constitutive activation of GPCRs (Choi et al., 2009; Fortin et al., 2009), illustrating the general applicability of 
this approach for cell-surface modulation of receptors (Figure 5). Ion channels and receptors are involved in 
every physiological action from breathing to heart beating. Understanding the mechanics and functional activity 
of these macromolecular complexes is a grand challenge in science. The tethered-peptide method is one tool 
that has the potential to tackle certain aspects of this challenge, particularly in the area of cell-specific 
modulators. Genetically encoded cell-surface modulators can be adapted to a wide range of applications due to 
their small size, amenability to point mutagenesis, and relative ease to be combined with fluorescent markers. 
Inhibition or constitutive activation of ion channels and receptors can be attained in a cell-type specific manner 
depending on the selectivity of the neuroactive peptide or hormone. 
Cell-based therapies 
The tethered-peptide strategy represents a potential new avenue for the development of genetic therapies for 
chronic diseases caused by malfunction of ion channels and peptide ligand receptors. For instance, cases of 
severe chronic pain in humans, resistant to analgesics and opioids, are currently being treated with ω-conotoxin 
MVIIA (commercialized as Prialt; Zamponi et al., 2009; Miljanich, 2004). However, the use of this toxin 
requires the implantation of intrathecal microinfusion pumps, which allow constant administration of the soluble 
drug to minimize the substantial side effects due to block of CaV2.2 channels present in the CNS. Genetic 
targeting of t-MVIIA to nociceptive neurons in transgenic mice has shown that these mice are protected from 
inflammatory and neuropathic pain (Auer et al., 2010). Therefore the t-toxin could be a viable alternative 
therapy to avoid uncontrolled diffusion of the injected toxin and the necessity for repetitive treatments once 
safe viral methods for genetic intervention in humans will be implemented. Other disorders which have been 
traced to mutations in genes encoding ion channels or regulatory proteins, such as channelopathies (George, 
2005), could also benefit from the use of specific toxins if these could be selectively targeted to the affected 
neuronal population. For instance t-toxins producing partial or total block of particular ion channel subtypes 
could be used in disorders caused by missense mutations that result in channel hyperactivity. Examples of 
hyperactive disorders include familial hemiplegic migraine type 1 (FHM-1) caused by gain-of-function mutations 
in P/Q-type (CaV2.1) calcium channels (Ophoff et al., 1996), or different types of epilepsy such as autosomal 
dominant nocturnal frontal lobe epilepsy (ADNFLE) associated to mutations in nAChRs (Klaassen et al., 2006). 
It could be interesting to use t-toxins to dissect the circuitry of the disease in these or other mouse mutant 
models of ion channel mutations. Conversely, activation of receptors with t-peptide ligands could be beneficial 
to control GPCRs in a cell-selective manner (Figure 5). For instance, isoforms of glucagon-like and calcitonin-
gene-related peptides are presently being used to regulate insulin release and bone remodeling in diabetes and 
osteoporosis. Similarly, feeding regulation neuropeptides such as orexin or ghrelin could be targeted to circuits 
involved in appetite control, or tethered opioid peptides could be directed to nociceptive neurons. 
 With an ever-growing interest in identifying the potential of naturally occurring venom peptide toxins 
(Twede et al., 2009), as well as novel ligands for orphan GPCRs encrypted in the human proteome (Jiang and 
Zhou, 2006), an increasing number of peptide based therapies could be possible. Furthermore, parallel 
development on the safety of viral methods for genetic intervention will increase the number of diseases to 
which the t-peptide strategy is applicable. 
Drug discovery 
Ion channels and GPCRs are some of the biggest molecular drug targets yet presently remain underexploited in 
drug discovery efforts. Peptide toxins, which are highly effective modulators of ion channels and GPCRs, offer 
an intriguing opportunity for increasing the drug development pipeline. Specific areas in which peptide toxins 
have demonstrated their potential include chronic pain (Miljanich, 2004) and myasthenic autoimmune response 
(Drachman, 1981). A major drawback to the universal usage of peptide toxins in the development of 
therapeutics has been the scarcity of obtaining the venom product. To circumvent this, most toxins are 
synthesized chemically, but this too has significant problems, one being obtaining the correct disulfide scaffold 
with in vitro folding. To combat these synthesis hurdles several structural strategies and characterization 
methods have been developed (Walewska et al., 2009). However, even when the toxin is successfully 
synthesized, soluble toxins cannot be directed to single cell populations, are expensive, and have a limited time 
of application that makes their use in vivo problematic. The t-peptide strategy surmounts these limitations with 
the ability to recombinantly synthesize the toxins or peptide ligands in the cell itself, and co-express it with the 
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Figure 5. Applications of the tethered-peptide strategy. Endogenous peptide ligands, natural toxins, and synthetic, 
modified versions of ligands or toxins can be integrated into recombinant membrane-attached fusion constructs and applied 
in vitro in transfected or transduced cells in cell-culture, or in vivo in transgenic or virus-transduced animals. The t-peptide 
retains the specificity of the toxin/peptide ligand allowing controlled manipulation of distinct subtypes of ion channels and 
receptors in a given neuronal circuit without affecting other channels/receptors in the cell. From Holford et al. (2009). 
Figure 5. Applications de la stratégie des toxines ancrées à la membrane. Les ligands peptidiques endogènes et les 
toxines naturelles, synthétiques ou modifiées peuvent être intégrés dans les expressions recombinantes de peptides ancrés, 
fusionnés et utilisés in vitro dans des cellules transfectées ou transduites ou in vivo dans des animaux transgéniques ou 
génétiquement modifiés par des virus. Les t-peptides conservent la spécificité des toxines ou ligands peptidiques 
permettant la manipulation contrôlée de différents canaux ioniques et récepteurs dans un circuit neuronal particulier, sans 
affecter d’autres canaux et récepteurs de la cellule. D’après Holford et al. (2009). 
molecular target (receptor or channel) to be screened. Such a cell-surface peptide tethering strategy can 
readily introduce point mutations to interconvert tethered agonists into antagonists. Several recent reports use 
the t-peptide technology to characterize point mutants of peptide hormones against class B1 GPCRs (Ibañez-
Tallon et al., 2004; Fortin et al., 2009). In a similar manner, the t-peptide technology could be applied to 
screen gene libraries of t-peptides against specific membrane proteins by co-expression in the same cell. T-
peptides with activating or blocking capabilities could be monitored with functional assays, i.e. calcium influx. 
This type of screen could be beneficial to block channels that are hyperactive in certain diseases, for which no 
natural toxins have yet been identified. These features make the t-peptide genetic approach a promising 
strategy for drug discovery and development of targeted therapeutics. 
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Abstract 
C2 toxin from Clostridium botulinum is a binary toxin which consists of two non-linked proteins, 
which are the transport component C2II and the enzyme component C2I. Activated C2II (C2IIa) 
mediates the transport of C2I into the cytosol of eukaryotic target cells, where C2I mono-ADP-
ribosylates actin. This results in depolymerization of actin filaments, cell-rounding and delayed 
cell death. During cellular uptake, C2IIa is a ring-shaped heptamer with two different functions. 
First, C2IIa binds to its cell receptor and assembles with C2I what triggers receptor-mediated 
endocytosis of the C2IIa/C2I complex. Later, in acidified endosomes, C2IIa changes its 
conformation due to the low pH and inserts into the endosomal membrane, thereby forming a 
translocation pore for C2I. Subsequently, C2I translocates as an unfolded protein through the 
C2IIa pore across endosomal membranes into the cytosol. We discovered recently that C2I 
translocation is facilitated by host cell chaperones, such as heat shock protein Hsp90 and 
cyclophilin A, a peptidyl-prolyl cis/trans isomerase. The pharmacological inhibition of these 
factors prevents translocation of C2I into the cytosol and thus protects cells from intoxication 
with C2 toxin. 
Nouveaux aspects sur la translocation à travers les membranes de la 
toxine C2 de Clostridium botulinum formant des pores 
La toxine C2 de Clostridium botulinum est une toxine binaire consistant en deux protéines non 
reliées entre elles qui sont, d'une part, le composant de transport C2II et, d’autre part, le 
composant enzymatique C2I. Le composant de transport activé (C2Iia) est responsable du 
transport de C2I dans le cytosol des cellules eucaryotes cibles où il mono-ADPribosyle l'actine. 
Ceci conduit à la dépolymérisation des filaments d'actine, à l'arrondissement puis à la mort des 
cellules. Au cours de l'entrée dans la cellule, C2IIa forme un heptamère en anneau ayant deux 
fonctions différentes. Premièrement, C2IIa se lie à son récepteur cellulaire et s'assemble avec 
C2I, ce qui déclenche l'endocytose du complexe C2IIa/C2I. Ensuite, dans les endosomes acidifiés, 
C2IIa change de conformation à cause du bas pH et s'insère dans la membrane de l'endosome 
formant ainsi un pore de translocation pour C2I. Ainsi, C2I est transporté sous une forme dépliée 
à travers le pore constitué par C2IIa dans la membrane de l'endosome. Récemment, nous avons 
montré que la translocation de C2I est facilitée par des protéines chaperonnes de la cellule hôte, 
telles que la protéine du choc thermique (Hsp90) et la cyclophiline A qui est une peptide-prolyl-
cis/trans isomérase. L'inhibition pharmacologique de ces facteurs empêche la translocation de C2I 
dans le cytosol et protège ainsi les cellules des effets toxiques de la toxine C2. 
Keywords : C2 toxin, chaperone proteins, Clostridium botulinum, endocytose, pore-formation. 
 
Introduction 
Bacterial AB-type exotoxins act as enzymes in eukaryotic cells and exploit vesicular traffic pathways of their 
host cells to deliver their enzyme moieties (A-subunits) into the cytosol (Sandvig and Olsnes, 1984; 
Montecucco et al., 1994; Olsnes et al., 2000; van der Goot and Gruenberg, 2006). This implies, however, that 
following internalization of the toxin, the A-subunits must translocate across an intracellular membrane to 
escape from endosomal vesicles into the cytosol. Several toxins translocate from acidified endosomal vesicles 
and it was found that the translocation domains of such toxins form pores into endosomal membranes which 
mediate the pH-dependent translocation of the A-subunits (Sandvig and Olsnes, 1980; Sandvig and Olsnes, 
1981; Olsnes et al., 1988). 
Binary toxins are a special variation of AB-type toxins because their A- and B-subunits are located on two 
different proteins (for review see Barth et al., 2004). The single A- and B-components are not toxic when 
applied to cells or animals but exhibit their cytotoxic effects when applied in combination. The A- and B-
components assemble on the surface of target cells to form a biologically functional toxin complex which is then 
internalized via receptor-mediated endocytosis. In acidic endosomal vesicles, the B-components form pores and 
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the A-components translocate through these pores into the cytosol where they modify their substrate 
molecules. Besides the two toxins from Bacillus anthracis, lethal toxin and edema toxin, the clostridial actin-
ADP-ribosylating toxins are binary toxins. The latter comprises Clostridium botulinum C2 toxin, on the one 
hand, and the iota like-toxins C. perfringens iota toxin, C. difficile toxin (CDT) and C. spiroforme toxin, on the 
other hand (for review see Barth et al., 2004). Their A-components are mono-ADP-ribosyltransferases that 
covalently transfer ADP-ribose from NAD+ onto arginine-177 of G-actin what induces depolymerization of actin 
filaments and results in the complete destruction of the actin cytoskeleton of eukaryotic target cells (Aktories et 
al., 1986). Finally, intoxicated cells undergo delayed caspase-dependent apoptosis (Heine et al., 2008). 
C. botulinum type C and D strains produce the binary C2 toxin (Ohishi et al., 1980), a potent enterotoxin 
that consists of C2I (enzyme component, ~49 kDa) and C2II (binding/translocation component, ~ 80 or 100 
kDa depending on the strain). C2I selectively mono-ADP-ribosylates G-actin at arginine-177 (Aktories et al., 
1986). The uptake of C2 toxin into cells starts with binding of activated C2IIa to the receptor on target cells 
and the subsequent formation of the C2IIa/C2I complex on the cell surface. C2II requires proteolytic activation 
(“nicking”) to form ring-shaped heptamers (Barth et al., 2000) with an inner diameter of about 2-3 nm 
(Schleberger et al., 2006). Importantly, only the activated C2IIa heptamers can bind to the receptor and 
assemble with C2I (Barth et al., 2000; Stiles et al., 2002). 
Membrane translocation of C2 toxin requires host cell chaperones 
Following receptor-mediated endocytosis, C2I translocates from early acidified endosomes into the cytosol. 
Acidification of the endosomal lumen triggers a conformational change of C2IIa heptamers, which then expose 
hydrophobic residues on their surface and insert into the endosomal membranes and form pores. We found that 
pore formation by C2IIa is an absolutely essential prerequisite for the translocation of C2I from the endosomal 
lumen into the cytosol (Blöcker et al., 2003). 
The narrow inner lumen of C2IIa pores implies that C2I must (at least partially) unfold to translocate 
through the pore. We used a dihydrofolate reductase (DHFR)-C2I fusion protein to demonstrate that C2I indeed 
unfolds during membrane translocation (Haug et al., 2003b). How does C2I become refolded after membrane 
translocation? In 2003, we have found that the chaperone Hsp90 is crucial for translocation and/or refolding of 
C2I in mammalian cells (Haug et al., 2003a). The specific pharmacological inhibition of Hsp90 activity by 
radicicol (Rad) or geldanamycin (GA) blocked the uptake of C2I into the cytosol and consequently, cells were 
protected from the cytoxic effects of C2 toxin. When we investigated the underlying mechanism in more detail, 
we found that the Hsp90 inhibitors prevented translocation of C2I (Haug et al., 2003a), demonstrating that 
Hsp90 is involved in the membrane translocation of C2 toxin. Later, we obtained comparable results for the 
related binary Iota toxin from Clostridium perfringens (Haug et al., 2004). 
More recently, we could show that membrane translocation of C2I also depends on the activity of the 
protein-folding helper enzyme cyclophilin A (CyP-A), a peptiyl/prolyl cis/trans isomerase (PPIase; Kaiser et al., 
2009). Cyclosporin A (CsA), a specific pharmacological inhibitor of cyclophilins, prevented intoxication of 
mammalian cells including HeLa, Vero and CaCo-2 cell lines, with C2 toxin and inhibited the uptake of C2I into 
the cytosol (Figure 1). As the Hsp90 inhibitors, CsA had no effect on the early steps of toxin uptake or on the 
enzyme activity of C2I, but clearly inhibited membrane translocation of C2I from early acidified endosomes into 
 
 
 
 
 
 
Figure 1. Current model of membrane translocation of the binary C. botulinum C2 toxin. Translocation of C2I 
requires the C2IIa pore in the endosomal membrane, as well as the activity of the chaperone Hsp90 and the prolyl 
isomerase cylophilin A (CyP-A; left panel). The specific pharmacological inhibitors cyclosporin A (CsA) and radicicol or 
geldanamycin inhibit translocation of C2I across endosomal membranes into the cytosol and protect cells from intoxication 
with C2 toxin (right panels; Kaiser et al., 2009). Con: control. 
Figure 1. Modèle actuel de la translocation membranaire de la toxine binaire C2 de C. botulinum. La translocation 
de C2I nécessite le pore C2IIa dans la membrane endosomale, ainsi que l'activité de la chaperonne Hsp90 et de la prolyl-
isomérase cyclophiline A (CyP-A; panneau de gauche). Les inhibiteurs pharmacologiques spécifiques, cyclosporine A (CsA) 
et radicicol ou geldanamycine, inhibent la translocation de C2I à travers les membranes endosomales dans le cytosol et 
protègent les cellules contre l'intoxication par la toxine C2 (panneaux de droite; Kaiser et al., 2009). Con: contrôle. 
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the cytosol in vitro as well as in intact cultured cells. We used isolated early endosomes to study membrane 
translocation of C2I in vitro. C2 toxin-loaded early endosomes were incubated with fresh cytosol to trigger the 
release of C2I from these endosomes. The succesfull translocation of C2I into the cytosol was shown by C2I-
catalyzed ADP-ribosylation of actin. When cytosol was pre-treated with CsA to inhibit cyclophilin prior to 
addition to C2 toxin-loaded endosomes, C2I did not translocate. By using a specific inhibitory antibody, we 
could demonstrate that CyP-A is the crucial cyclophilin which facilitates membrane translocation of C2 toxin. 
Translocation of C2I was also prevented when the cytosol was pre-incubated with antibody against CyP-A, 
indicating that CyP-A is necessary for membrane translocation of C2I (Kaiser et al., 2009). 
Conclusion 
Although the combined application of inhibitors suggested that cyclophilin and Hsp90 work synergistic during 
C2I translocation, the precise mechanism how these host cell factors facilitate membrane translocation of C2 
toxin is not known so far and subject to our present research activities. 
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Abstract 
Venoms from scorpions, spiders, sea anemones and cone snails comprise complex mixtures of 
peptides and mini-proteins, many of which have evolved to selectively target ion channels for 
prey capture and/or defence. Sodium channels including Nav1.7 and 1.8 play key roles in pain 
pathways and selective inhibitors offer potential for the treatment of difficult to manage painful 
conditions. To accelerate ligand discovery at this target, we have developed a high throughput 
assay for Nav1.7 and next generation transcriptomics to identify novel sequences. To guide the 
rational development of inhibitors, we have constructed a molecular model of sodium channels to 
generate docking simulations that can help identify interacting residues and opportunities for 
improving selectivity and/or potency. 
Les toxines ciblant les canaux ioniques pour la découverte et le 
développement de médicaments 
Les venins de scorpions, d’araignées, d’anémones de mer et de cônes comprennent des mélanges 
complexes de peptides et de mini-protéines, dont beaucoup ont évolué pour cibler sélectivement 
les canaux ioniques pour la capture des proies et/ou la défense. Les canaux sodium, dont Nav1.7 
et 1.8, jouent des rôles clés dans les voies de la douleur et les inhibiteurs sélectifs offrent un 
potentiel pour le traitement du mal à gérer les conditions douloureuses. Pour accélérer la 
découverte de ligands à cette cible, nous avons développé un test à haut débit pour Nav1.7 et des 
transcriptomes de la prochaine génération pour identifier de nouvelles séquences. Afin de guider 
le développement rationnel d'inhibiteurs, nous avons construit un modèle moléculaire des canaux 
sodium pour générer des simulations d'amarrage qui peuvent aider à identifier les résidus 
impliqués dans les interactions et les possibilités d'améliorer la sélectivité et/ou l’efficacité. 
Keywords : Conotoxin, pain, sodium channel, venom peptide. 
 
Introduction 
Venom peptides provide a rich source of peptides with highly diverse sequences and structures evolved for prey 
capture and/or defence (Lewis and Garcia, 2003; Fry et al., 2009). Not surprisingly given their pivotal roles in 
essential physiological processes, many venom peptides have been found to target ion channels, including a 
number with clinical potential that target voltage-gated calcium and potassium channels, ligand-gated NMDA 
glutamate and nicotinic acetylcholine receptors (nAChR), and the sodium-dependent norepinephrine transporter 
(Table 1). Toxins have proved especially useful in dissecting the physiological roles of different Nav channels, as 
well as helping to identify up to seven distinct, ligand-accessible binding sites on these large membrane 
proteins. Tetrodotoxin (TTX), the first sodium channel toxin identified, acts at site 1 in the P-loop region of the 
ion conducting pore of TTX-sensitive Nav1.1-1.4, 1.6 and 1.7 at low nM concentrations, and at TTX-resistant 
Nav1.5, 1.8 and 1.9 at μM concentrations. In contrast, alkaloid toxins from frogs and plants (batrachotoxin, 
veratridine) act at site 2, polyether toxins from dinoflagellates (brevetoxins and ciguatoxins) act at site 5, 
pyrethroids from plants act at site 7, while venom peptides act at or near sites 1, 3/6 and 4. 
Venom peptides acting at Nav subtypes include scorpion toxins acting at sites 3 and 4, spider toxins acting 
at or near sites 1 and 4 on mammalian targets or site 3 on insect targets, and cone snail toxins acting at or 
near sites 1, 4 and 3/6. Cone snail toxins acting at Nav subtypes include the globular µ-conotoxins which 
possess an exposed arginine/lysine in loop 2 required for high affinity at Nav1.2/1.4. The therapeutic potential 
of µ-conotoxins is presently limited, since they preferentially target Nav1.4 and 1.2, and have only weak or no 
detectable affinity at the validated therapeutic targets Nav1.7 or 1.8. However, models built from the recently 
described crystal structure of a bacterial voltage-gated sodium channel have opened up opportunities to 
rationally develop inhibitors of more therapeutically relevant subtypes. In this review, opportunities for the 
accelerated discovery of venom peptides targeting sodium channels are examined that have the potential to 
generate leads to new ion channel therapies to treat difficult to manage painful conditions. 
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Table 1. Potential ion channel and related therapeutics from venoms. 
Tableau 1. Canaux ioniques et thérapeutiques de venins potentiels. 
 
Venom peptide modulators of sodium channels 
The µ-conotoxins are amongst the first venom peptides identified to inhibit Na+ channels. These highly 
positively charged 16–25 amino acid (a.a.) peptides possess a globular structure stabilised by a network of 
three disulfide bonds. Nuclear magnetic resonance (NMR) solution structures of SIIIA, TIIIA, PIIIA, GIIIA, 
GIIIB, KIIIA and SmIIIA reveal all have a similar fold except SIIIA, which has a much shorter loop 1 and an 
helical motif between residues 11–16 (Schroeder et al., 2008) not seen in the larger µ-conotoxins like TIIIA 
(Lewis et al., 2007). All μ-conotoxins possess either an exposed arginine or lysine in loop 2 that is important for 
high affinity at Nav1.2 and 1.4, although this role is less critical for SIIIA and KIIIA, where the pharmacophore 
has shifted into the helical region of the peptide (Schroeder et al., 2008). The therapeutic potential of µ-
conotoxins is presently limited, since they preferentially target Nav1.4 and 1.2 and have weak or no detectable 
affinity at the validated therapeutic targets Nav1.7 or 1.8. A docking model depicting how µ-conotoxin TIIIA 
might plug the selectivity filter of the muscle Na+ channel (Nav1.4) is shown in Figure 3B. This model highlights 
the critical role of Arg13 for the high affinity interaction with Nav1.4. As our understanding of the overall 
architecture of the outer vestibule of the Na+ channel develops, conotoxins able to block specific Na+ channel 
subtypes may start to be rationally designed. 
Cone snail venoms also contain two classes of hydrophobic Na+ channel toxins, the μO-conotoxins MrVIA 
and MrVIB isolated from Conus marmoreus and the more diverse δ-conotoxins isolated from a range of mollusc 
and fish hunting cone snails. The µO-conotoxins are 31 a.a. peptides that preferentially block (~ 15-fold 
selective) Nav1.8 and 1.4 over other Nav subtypes by interfering with the domain II voltage sensor of the Na+ 
channel (Leipold et al., 2007). Unfortunately, structure-activity relationships for μO-conotoxins at different Nav 
subtypes have been hampered by difficulties folding and purifying these hydrophobic peptides efficiently. The 
27–31 residue δ-conotoxins have structures reminiscent of the µO-conotoxins; however, these activating 
peptides work by inhibiting Na+ channel inactivation like the  scorpion toxins (Barbier et al., 2004). The δ-
conotoxins include TxVIA a selective activator of mollusc Na+ channels, and EVIA which selectively activates 
mammalian neuronal Na+ channels. 
Finally, two conotoxins belonging to the ι-conotoxin class have been identified as Nav activators that are 
without effects on Nav inactivation. ι-RXIA is a large, 46 residue peptide from the I superfamily that forms an 
ICK motif, while LtIIIA is a small, 17 residue peptide belonging to the M superfamily of conotoxins. 
Potential for peptide inhibitors of sodium channels to treat pain 
Voltage-gated sodium (Nav1-9) channels are 4-domain membrane proteins essential for electrical signalling in 
cells. Naturally occurring mutations to Nav can lead to epilepsy, migraine and several pain-free and painful 
conditions. Knockout studies in mice have shown that Nav1.7, 1.8 and 1.9 play key roles in pain pathways and 
suggest that inhibition of these subtypes might reduce pain without introducing significance adverse effects 
commonly associated with non-specific inhibitors like local anaesthetics, which are often efficacious only at or 
near toxic levels. Thus more selective venom peptides that target Nav subtypes selectively expressed in 
nociceptive nerves (Nav1. 7 and 1.8), or are upregulated in pain states (Nav1.3) could significantly advance the 
treatment of chronic pain. 
The recent finding that loss of function mutations at Nav1.7 ablates human pain genetically validates Nav1.7 
as a new therapeutic target (Cox et al., 2006). Presently spiders appear to be the best source of Nav1.7 
inhibitors. These appear to inhibit channel opening by binding to extracellular surface residues involved in 
channel gating (Schmalhofer et al., 2008; Xiao et al., 2010). Small neuronally active μ-conotoxins like μ-SIIIA 
and μ-SIIIB define a new pharmacophore for interactions at Nav1.2 and Nav1.4 (Lewis et al., 2007; Schroeder 
et al., 2008). Interestingly, SIIIB and the recently reported KIIIA (Zhang et al., 2007) also have weak to 
moderate potency at Nav1.7, opening the way to the development of μ-conotoxins with improved Nav1.7 
selectivity that can reverse chronic pain behaviours without dose-limiting side-effects. Confirming Nav1.8 
knockout studies, our discovery that μO-conotoxin inhibitors of Nav1.8 sodium channel (Daly et al., 2004) 
Name AAs S-S 
bonds 
Source  Ion channel 
target 
Site of 
injection 
Indication Stage 
Prialt® 
(-MvIIA) 25 3 Conus magus CaV2.2 Intrathecal Chronic pain Approved 2004
Xen2174 
(-MrIA) 13 2 
Conus 
marmoreus 
Norepinephrine 
transporter Intrathecal 
Severe 
pain Phase 2b 
CNSB004 
(-CVID) 27 3 Conus catus CaV2.2 Subcutaneous 
Neuropathic 
pain Phase 2a 
ShK-192 35 3 Stichodactyla helianthus 
KV1.3 
channel Parenteral 
Autoimmune 
disease Phase 1 
CGX-1051 
(-PVIIA) 27 3 
Conus 
purpurascins 
Shaker-type 
KV channel 
Parenteral 
(i.v. injection) 
Myocardial 
infarction Phase 1 
ACV-1 
(-Vc1.1) 16 2 Conus victoriae GABAB and nAChR 
Parenteral 
(s.c. injection) Neuropathic pain Phase 2a 
CGX-1007 
(Conantokin-G) 17 0 
Conus 
geographus NMDA receptor Intrathecal Epilepsy Phase 1 
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reverse inflammatory and neuropathic pain states without motor deficits (Ekberg et al., 2006) opens the way to 
the development of novel peptide inhibitors at this pivotal pain target. 
Accelerated assays for sodium channel inhibitor 
Traditional approaches to identify novel, subtype-selective modulators of Nav suffer from drawbacks. While 
electrophysiological techniques can provide high quality data that offer mechanistic insights into the state-
dependence of inhibition, despite the development of novel fully automated patch-clamp technology this 
approach can currently achieve medium throughput at best and requires highly skilled personnel. In contrast, 
fluorescence-based assays measuring changes in membrane potential or intracellular sodium concentration 
have the potential for assaying a large number of compounds but often require specialized excitation and 
emission filters and are prone to artefacts and sensitivity problems. Similarly, radioligand binding assays are 
particularly prone to high false negative rates due to the large number of putative allosteric sites on Nav and in 
addition cannot provide functional information. Finally, an inherent problem with these approaches are 
difficulties encountered with cloning and heterologous expression of the large Nav channel complexes, which 
further restrict the development of functional assays with sufficient capacity. 
To overcome these problems, we have developed a novel high throughput assay based on fluorescent 
calcium signaling mediated through TTX-sensitive Nav1.2 and Nav1.7 endogenously expressed in the human 
neuroblastoma cell line SH-SY5Y. Activation of these endogenously expressed Nav isoforms by the alkaloid 
veratridine results in influx of Na+ ions and subsequent membrane depolarization. This membrane 
depolarization in turn generates a Ca2+ influx through endogenously expressed voltage-gated L- and N-type 
calcium channels that can be detected by fluorescent Ca2+ dyes such as Fluo-4 in high throughput format. Block 
of Nav1.2 by the conotoxin TIIIA or stimulation in the presence of the scorpion toxin OD1 produces a Nav1.7-
specific assay, and conversely block of Nav1.7 by low concentrations of ProTxII isolates Nav responses mediated 
by Nav1.2. The ability to detect changes in Na+ channel activity using Ca2+ dyes such as Fluo-4 takes advantage 
of the extremely high sensitivity inherent to fluorescent Ca2+ imaging. In addition, this assay can detect both 
pore blockers and gating modifier toxins as Na+ channels are expressed at physiological membrane potential in 
a native context, and provides a cheap, readily available alternative for the high-throughput identification of 
novel Na+ channel inhibitors. A pipeline from venom to sequence is exemplified in Figure 1, showing result for 
the detection, isolation and sequencing of MrVIA from Conus marmoreus. 
 
Figure 1. Application of a FLIPR-based high throughput assay for Nav1.7 for the discovery of 
Na+channel inhibitors. Illustrated is the identification and sequence obtained for MrVIB 
identified in the crude venom of Conus marmoreus. 
Figure 1. Application d'une analyse à haut débit pour Nav1.7, basée sur la méthode FLIPR, 
pour la découverte d'inhibiteurs de canaux Na+. L'identification et la séquence obtenue pour 
MrVIB identifié dans le venin brut de Conus marmoreus sont illustrées ici. 
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Transcriptomic/proteomic discovery 
Thanks to large scale genomic projects, such as the Human Genome Project, technologies for high throughput 
DNA sequencing are now widely available for genome and transcriptome analysis of non-model organisms. 
Indeed, these “next-generation sequencing” technologies, as opposed to the traditional Sanger sequencing, 
have delivered on the promise of sequencing DNA and RNA at unprecedented speed and reduced cost, thereby 
enabling impressive scientific achievements and novel biological applications (Morozova et al., 2009). Different 
platforms are available, each having their own pros and cons, and the choice made by the user will depend on 
the final application. For example, the 454-pyrosequencing technology from Roche provides the longest reads 
(300–350 bp on average), a clear advantage for the accurate assembly of contigs in the absence of a reference 
genome. Particularly relevant to venom-based discovery projects, transcriptome analysis of venom gland mRNA 
has the potential to reveal all toxin sequences in one single experiment (Hu et al., 2011). This strategy will 
undoubtedly accelerate the discovery of novel isoforms and families of toxins, assuming that appropriate 
bioinformatic support is provided. Unfortunately, in the case of cone snails, the high prevalence of post-
translational modifications preclude direct discovery process from transcriptomic data alone, and proteomic 
data integration are required to determine the correct form of the mature compound (Figure 2). 
 
Figure 2. Integration of transcriptomic and proteomic data. Here, we illustrate the need of combined transcriptomic and 
mass spectrometry (MS) data for the correct identification of mature venom peptides. In the venom gland transcriptome of 
Conus marmoreus, we have found the precursors of Na+ channel toxins, O-MrVIB and -MrIIIE. In the case of MrVIB, the 
mature peptide detected by MS is identical to the predicted mature peptide. However, in the case of MrIIIE, MS detected 
peptide revealed the post-translational cleavage of the C-terminal glycine residue, creating an amidated mature peptide. 
Post-translational modifications (PTMs) can have dramatic effects on stability and biological activity of peptides, hence the 
need to clearly identify them. 
Figure 2. Intégration de données transcriptomiques et protéomiques. Dans cette figure, nous illustrons la nécessité de 
combiner les données de transcritpomiques et de protéomiques pour l’identification correcte des toxines matures. Dans le 
transcriptome de Conus marmoreus, nous avons identifié les précurseurs des toxines agissant sur les canaux sodium, O-
MrVIB et MrIIIE. Dans le cas de MrVIB, le peptide détecté par spectrométrie de masse (SM) se révèle identique à la 
séquence prédite à partir du précurseur. Cependant, dans le cas de MrIIIE, la SM révèle le clivage du résidu glycine en 
position N-terminale, laissant un peptide mature amide. Les modifications post-traductionnelles peuvent avoir des effets 
importants sur la stabilité et l’activité biologique des peptides, d’où la nécessité de les identifier clairement. 
 Mass spectrometry (MS) has become a method of choice to study the complexity of venoms. Soft ionisation 
technologies (ESI and MALDI) are almost exclusively utilized to unravel the composition of these proteinaceous 
mixtures (Davis et al., 2009; Escoubas et al., 2008). While venoms can be studied as a whole sample (mass 
fingerprinting or profiling), a pre-fractionation step will usually provide a better resolution, diminution of the ion 
suppression effect and higher coverage. Recent improvements in sensitivity (dynamic range) and accuracy of 
mass spectrometers are allowing high throughput analysis from minute sample. For instance, using a combined 
Orbitrap-ETD with a targeted chemical derivatization strategy, de novo sequencing of 31 peptide toxins could 
be obtained from just 7% of the crude venom of a single Conus textile (Ueberheide et al., 2009). Combining 
the sequence database deduced from transcriptomics with the masses extracted from crude venom MS analysis 
is emerging as a remarkably powerful approach. A major issue is the correct assignment of each detected mass 
to a sequence. Here, MS/MS will be essential to confirm the cleavage sites and the presence/nature of post-
translational modifications (PTMs). 
Rational development of peptidic sodium channel inhibitors 
Voltage-gated ion channels (VGICs) share a common structural arrangement with four homologous subunits 
that form a central ion conducting pore. As is the case for most transmembrane proteins, structure 
determination is technically challenging, especially for mammalian VGICs which are multi-domain proteins 
comprised of over 2,000 amino acids. This structural complexity has hampered the rational drug design for 
channel-associated diseases. In the absence of a detailed 3D molecular view of VGICs, a wealth of information 
on functional domains of VGICs was only obtainable from structure-activity relationships (SARs) of small 
molecule or peptide inhibitors, including μ-conotoxins GIIIB (Li et al., 2000) and TIIIA (Lewis et al., 2007). 
A breakthrough in revealing the ion selectivity and ion conduction pathway of VGICs at the molecular level 
came with the determination of high resolution crystal structures of mammalian Kv (Long et al., 2005) and 
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more recently bacterial NavAb (Payandeh et al., 2011). Given that VGICs share a conserved structural 
architecture, homology modeling, in combination with docking simulation, provides an alternative approach to 
study the molecular basis of ligand-Nav interactions. Our preliminary data, derived from docking simulation of 
μ-conotoxin TIIIA to an homology model of human Nav1.4 generated using crystal structure of NavAb 
(Payandeh et al., 2011), have shown that the inhibition of μ-conotoxin TIIIA likely occurs via an extensive 
network of ionic interaction at the extracellular mouth of the ion conducting pathway (Figure 3). This docking 
pose is supported by SAR studies of μ-conotoxin GIIIB at Nav1.4 (Li et al., 2000) and our previous mutational 
studies on TIIIA (Lewis et al., 2007). This demonstrates that by combining homology modeling and related 
computational studies, such as docking or molecular dynamic simulation, useful insights into SARs in VGICs can 
be obtained that might help in the rational design of subtype selective inhibitors. 
 
Figure 3. Docking simulation of μ-conotoxin TIIIA (orange with grey transparent molecular surface) to homology model of 
human Nav1.4 (slate). The predicted unstructured extracellular loops between transmembrane helix 5 and extracellular P1 
in subunits 1 and 3 were removed for clarity. (A) The docking simulation reveals that μ-conotoxin TIIIA binds at the 
extracellular entry of Nav1.4, suggesting that it is a pore blocker. (B) Docking reveals a large contact area (represented in 
white transparent molecular surface) between μ-conotoxin TIIIA and Nav1.4, in agreement with its high binding affinity 
(~ 0.1 nM; Lewis et al., 2007). (C) A detailed analysis of this docking complex shows that R14 on μ-conotoxin TIIIA forms 
an extensive ionic interaction network (black dash lines) with two glutamate and one aspartate residues on Nav1.4. This 
ionic network is also observed in the studies of μ-conotoxin GIIIB and skeletal muscle (μ1) Na+ channel (Li et al., 2000) and 
supports our previous mutational studies showing that R14A-TIIIA reduces μ-conotoxin TIIIA potency at Nav1.4 by ~100 
fold (Lewis et al., 2007). 
Figure 3. Simulation d'amarrage de la μ-conotoxine TIIIA (en orange avec la surface moléculaire transparente en gris) au 
modèle homologue du canal Nav1.4 humain (en ardoise). Les boucles extracellulaires non structurées prédites entre l’hélice 
transmembranaire 5 et le P1 extracellulaire dans les sous-unités 1 et 3 ont été retirées pour plus de clarté. (A) La 
simulation d'amarrage révèle que la μ-conotoxine TIIIA se lie à l'entrée extracellulaire de Nav1.4, ce qui suggère que c’est 
un bloqueur du pore. (B) L’amarrage révèle une grande surface de contact (représentée par la surface moléculaire 
transparente blanche) entre la μ-conotoxine TIIIA et Nav1.4, en accord avec son affinité de liaison élevée (~ 0,1 nM; Lewis 
et al., 2007). (C) Une analyse détaillée de ce complexe d'amarrage montre que R14 sur la μ-conotoxine TIIIA forme un 
vaste réseau d'interactions ioniques (tirets noirs) avec deux résidus glutamate et un résidu aspartate sur Nav1.4. Ce réseau 
ionique est également observé dans les études de la μ-conotoxine GIIIB et le canal Na+ du muscle squelettique (μ1; Li et 
al., 2000) et soutient nos études mutationnelles précédentes montrant que R14A-TIIIA réduit par ~ 100 fois l’efficacité de 
la μ-conotoxine TIIIA vis-à-vis du canal Nav1.4 (Lewis et al., 2007). 
Conclusions 
A combination of accelerated bioassay and transcriptomic/proteomic approaches has the potential to greatly 
accelerate new conotoxin discovery. Through the development of several new Na+ assays, we are now well-placed 
to focus these new tools to the discovery of new sodium channel inhibitors with potential to selectively inhibit pain 
pathways. Using the recently determined crystal structure for a bacterial sodium channel, we are able to start to 
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rationally design modifications to new and existing Na+ sodium channel inhibitors with potential to generate more 
selective inhibitors that could be lead to a new generation of peptide therapeutics to treat pain. 
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Abstract 
At a time when pharmaceutical companies are having trouble finding new low molecular weight 
drugs and when biologics are becoming more common, animal venoms constitute a valid but still 
underexploited source of novel drug candidates. Animal venoms are large combinatorial libraries of 
biologically active peptides that encompass a wide variety of structures and pharmacological 
activities. As such, they represent a resource of up to 40,000,000 novel molecules that can be 
developed as drug leads and diagnostics tools. Here, we describe how, in the Dendroaspis 
angusticeps venoms, we succeed to discover and characterize novel toxins active on adrenoceptors. 
Les récepteurs couplés aux protéines G, une famille inexploitée de 
cibles des toxines animales : exploration du venin du mamba vert 
pour de nouveaux ligands adrénergiques 
Alors que l’industrie pharmaceutique à de plus en plus de difficultés à trouver de nouveaux 
médicaments de faibles poids moléculaires et que les « biologics » sont de plus en vogues, les 
venins d’animaux constituent une source valide, mais toujours sous-exploitée, de nouveaux 
candidats thérapeutiques. Les venins d’animaux constituent une vaste librairie combinatoire de 
peptides, biologiquement actifs, recouvrant une large diversité de structures et d’activités 
pharmacologiques. Ainsi, ils représentent une ressource de plus de 40 millions de nouvelles 
molécules pouvant être développées comme candidats thérapeutiques et comme outils de 
diagnostic. Ici, nous décrivons comment, à partir du venin de Dendroaspis angusticeps, nous avons 
réussi à découvrir et à caractériser de nouvelles toxines actives sur les récepteurs adrénergiques. 
Keywords : Animal toxins, benign prostate hypertrophy, drug development, G-protein coupled 
receptor, hypotension, in vivo experiments, screening. 
 
Introduction 
Pharmacological activities of animal toxins stems mostly from their effects on ion channels which play an 
important role in controlling the mobility of the prey of the venomous animal. Intriguingly, only a few tens of 
the 3,000 known toxins are active against G protein-coupled receptors (GPCRs). GPCRs are membrane proteins 
constituted by seven transmembrane segments that transduce external stimuli into the cell and control almost 
all physiological processes in humans (Jacoby et al., 2006). GPCRs constitute the largest family of membrane 
proteins (between 1,500 and 2,000 encoded by the human genome) and are the targets of over 25% of the 
1,065 approved drugs for which molecular targets could be identified (Jacoby et al., 2006). Belong the 356 
GPCRs activated by endogenous agonists (Vassilatis et al., 2003), only about 60 GPCR subtypes are currently 
targeted by marketed drugs, with another 220 remaining unexploited, mostly due to a lack of specific ligands. 
We looked for identifying novel animal toxins active against GPCRs, the most frequently exploited class of 
treatment targets, with the aim to develop novel research tools and drug candidates. Screening of green 
mamba (Dendroaspis angusticeps) venom against adrenoceptors identified two novel venom peptides. ρ-Da1a 
showed a sub-nanomolar affinity for the α1a-adrenoceptors (AR) while ρ-Da1b displayed nanomolar affinities 
for the three α2-ARs. These two venom peptides have sequences similar to those of muscarinic toxins and 
belong to the three-finger-fold protein family. α1a-AR is the primary target for the treatment of prostate 
hypertrophy, and α2-ARs are the prototype of GPCRs not currently used as treatment targets due to a lack of 
specific ligands. 
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Screening of green mamba venom on adrenoceptors 
To identify novel animal toxins active on GPCRs, we screened the green mamba (Dendroaspis angusticeps) 
venom on the nine AR subtypes and discovered two original venom peptides. Their amino-acid sequences were 
determined by Edman degradation and mass fragmentation techniques, and they both belong to the three 
finger fold peptide family, with high sequence similarities with the muscarinic toxins. All the following results 
have been obtained with their synthetic homologues. 
Binding experiments showed that ρ-Da1a is specific to the α1aAR subtype with an affinity of 0.36 nM 
(Figure 1) while ρ-Da1b displayed affinities between 14 and 73 nM for the three α2-ARs subtypes (Figures 2; 
Maiga et al., 2011; Quinton et al., 2010; Rouget et al., 2010). None of these peptide displayed activity to more 
than 30 other GPCRs, including the muscarinic receptors. 
  
Figure 1. Pharmacological profile of ρ-Da1a on various 
adrenoceptor subtypes. 
Inhibition of 3H-prazosin on α1aAR with HEAT (○, 125iodo-2-
[Beta-(4-hydroxyphenyl)-ethyl-aminomethyl] tetralone), and ρ-
Da1a (●). Inhibition of 3H-prazosin, 3H-rauwolscine and 3H-
CGP-12177 on hα1B- (□), and α1dAR (◊), on α2aAR (Δ), α2bAR 
( x) and α2cAR (▼), on β1AR (+) and β2AR (►), respectively. 
Figure 1. Profil pharmacologique de la ρ-Da1a sur différents 
sous-types de récepteurs adrénergiques. 
Figure 2. Pharmacological profile of ρ-Da1b on various 
adrenoceptor subtypes. 
Inhibition of 3H-rauwolscine on α2aAR with rauwolscine 
(▲) and ρ-Da1b (○), and α2bAR (■) or α2cAR (●) with ρ-
Da1b. Inhibition of 3H-prazosin by ρ-Da1b on α1aAR (□). 
Figure 2. Profil pharmacologique de la ρ-Da1b sur 
différents sous-types de récepteurs adrénergiques. 
Binding experiments were performed on membranes from eukaryotic cells expressing the different human receptors as 
previously described (Rouget et al., 2010). Les expériences de fixation on été réalisées sur des membranes de cellules 
eucaryotes exprimant les différents récepteurs humains, comme décrit précédemment (Rouget et al., 2010). 
Cell-based functional tests showed that both toxins displayed atypical pharmacological properties. Classical 
competitive antagonists, such as yohimbine, induce a parallel right-shift of agonist activation curves, which can 
be converted in a linear Schild plot representation with slope close to unit. ρ-Da1a antagonizes α1aAR in an 
insurmountable way by reducing agonist efficacy and preventing any Schild plot representation (Figure 3). ρ-
Da1b antagonizes by a non-competitive manner α2aARs, since it induces a right shift of the activation curves, 
but with a Schild plot showing a slope significantly lower than unit (0.67) while the yohimbine one was closed 
to unit (0.97; Figure 4). The pA2 values calculated were 5.93 for yohimbine and 5.32 for ρ-Da1b. 
Both toxins display high selectivity for their respective targets and antagonize their receptor target in an 
atypical ways, at a time where clinicians are looking for modulators instead of pure competitors. α1aAR is the 
primary target for the treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasia 
while α2ARs are implicated in uterine smooth muscle contraction, intestinal motility and orthosteric 
hypotension. Both toxins are under development as therapeutic candidates. The following presentation will 
focus on the interaction between ρ-Da1a and α1aAR. 
ρ-Da1a as a drug candidate against lower urinary tract symptoms 
Belonging to the lower urinary tract symptoms, benign prostatic hyperplasia is a very common disease affecting 
90% of the 90 years old men. In order to reduce symptoms, like urinary obstruction, the first line of treatment 
consists on the blockage of the prostatic α1aAR to reduce prostatic tone. Tamsulosin, a classical competitive 
antagonist of α1aAR, represents 40% of the medical prescriptions against benign prostatic hyperplasia and will 
serve as a reference drug. 
The insurmountable antagonist activity of ρ-Da1a described on α1aAR heterologously expressed in 
eukaryotic cells was also found on isolated prostate muscle from rabbit (Figure 5) as well as from human 
(Figure 7). On its own, tamsulosin on rabbit prostate muscle induce the classical parallel right-shift of 
phenylephrine activation curves (Figure 6). ρ-Da1a, unlike tamsulosin, is able to totally abolish muscular tone 
whatever the concentration of agonist used. 
Compounds, M
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Figure 3. Functional characterization of ρ-Da1a on Chinese 
hamster ovary (CHO) cells expressing α1aAR. 
Concentration-response curves for epinephrine activation in 
the presence of increasing concentrations of ρ-Da1a. 
Figure 3. Caractérisation fonctionnelle de la ρ-Da1a sur 
α1aAR exprimé dans des cellules CHO. 
 
Figure 4. Functional characterization of ρ-Da1b and 
yohimbine on COS [CV-1 (simian) in Origin, and carrying 
the SV40 genetic material] cells co-expressing α2aAR and 
the chimeric G-protein GqTop. 
Schild plot representation of concentration-response curves 
for epinephrine in the presence of antagonists. 
Figure 4. Caractérisation fonctionnelle de la ρ-Da1a et de 
la yohimbine sur α2aAR co-exprimé avec la protéine G 
chimérique GqTop dans des cellules COS 
Experiments were performed on a Flex Station II, following the cells calcium release induced by receptors’ activation. Les 
experiences ont été réalisées sur la station de travail “Flex Station II”, après la liberation de calcium induite par l’activation 
des récepteurs. 
 
   
Figure 5. ρ-Da1a (AdTx1) on rabbit 
isolated prostate muscle. 
Figure 5. ρ-Da1a (AdTx1) sur le muscle 
prostatique isolé de lapin. 
Figure 6. Tamsulosine on rabbit 
prostate muscle. 
Figure 6. Tamsulosine sur le muscle 
prostatique isolé de lapin. 
Figure 7. ρ-Da1a (AdTx1) on human 
isolated prostate muscle. 
Figure 7. ρ-Da1a (AdTx1) sur le 
muscle prostatique isolé humain. 
Cumulative concentration-response curves for α1aAR agonists were obtained in prostatic strips after 30 min incubation with 
solvent or antagonist. Contractile responses to agonists are presented as mean of the maximal tension. Les courbes 
“concentration-réponse” pour les agonistes de α1aAR ont été obtenues sur des tranches prostatiques après 30 min 
d’incubation avec le solvant ou l’agoniste. Les réponses contractiles aux agonistes sont les moyennes de la tension maximale. 
 
  
Figure 8. Effects of ρ-Da1a (AdTx1) and tamsulosin on intra 
urethral pressure. 
Figure 8. Effets de la ρ-Da1a (AdTx1) et de la tamsulosine sur la 
pression intra urétrale. 
Figure 9. Effects of ρ-Da1a (AdTx1) and tamsulosin on 
arterial pressure. 
Figure 9. Effets de la ρ-Da1a (AdTx1) et de la 
tamsulosine sur la pression artérielle. 
Vehicle, ρ-Da1a and tamsulosin were injected intravenously (i.v.) 30 min before injections of increased concentrations of 
phenylephrine in anesthetized male rats. Le vecteur, la ρ-Da1a et la tamsulosine ont été injectés (i.v.) 30 min avant les 
injections de concentrations croissantes de phényléphrine dans des rats mâles anesthésiés. 
C.
6 45
Yohimbine
-Da1b
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We finally evaluated the in vivo ρ-Da1a efficacy to reduce urethral sphincter tone on anesthetized male rats. 
The urethral effect was used as a model for prostatic tone. In parallel, in order to quantify the major side 
effects of tamsulosin, i.e. the hypotension due to the blockage of the α1bAR subtype, arterial pressure was also 
monitored during experiments. Figure 8 shows that, thanks to its insurmountable antagonist property, 0.3 mg 
of ρ-Da1a (corresponding to 40 nmoles, blue curve in Figure 8) displayed the same relaxant effect than 0.01 
mg of tamsulosin (corresponding to 20 nmoles, black curve in Figure 8), despite the fact that tamsulosin has a 
ten fold higher affinity (0.035 nM) than ρ-Da1a (0.36 nM) on α1aAR. In addition, while 20 nmoles of tamsulosin 
induced a large fall in arterial pressure (violet curve in Figure 9), the corresponding amount of ρ-Da1a induced 
only a small decrease (green curve in Figure 9). The fact that ρ-Da1a induces much less side effects is directly 
connected to its better selectivity than tamsulosin, as the ρ-Da1a affinity for the α1bAR is 53 nM (i.e. 150 fold 
higher α1aAR selectivity vs α1bAR), while tamsulosin has an affinity of 0.7 nM (i.e. 20 fold higher α1aAR 
selectivity vs α1bAR). 
As a conclusion, antagonistic potency of ρ-Da1a on α1aAR (pKB = 8.2) is very close to tamsulosin potency 
(pKB = 8.9) whereas, in vivo, ρ-Da1a demonstrated the same efficacy as tamsulosin to reduce prostatic tone 
but with much less hypotension. In addition, ρ-Da1a have shown no per os activity, as expected based on its 
peptidic nature. 
Molecular interaction between ρ-Da1a and α1aAR 
ρ-Da1a is the first peptide ligand specific to α1aAR and nothing is known about its interaction with its receptor. 
The mode of action of MT7, a three-finger-fold toxin sharing 55% sequence identity with ρ-Da1a, has been 
studied in details. MT7 significantly affects the dissociation kinetics of 3H-N methyl scopolamine and 3H-
acetylcholine (Mourier et al., 2003; Olianas et al., 2000) and leaves a small residual binding on equilibrium 
binding experiments (Fruchart-Gaillard et al., 2006). As a negative allosteric modulator, MT7 reduces 
carbamylcholine efficacy and potency on M1 muscarinic receptors expressed in CHO cells (Olianas et al., 2000) 
and, in agreement with an allosteric mode of action, MT7 binding site is located on external loops 2 and 3 of the 
M1 muscarinic receptor (Kukkonen et al., 2004). 
  
Figure 11. 3H-prazosin dissociation kinetics rate on α1aAR 
induced by prazosin (1 μM, black) or ρ-Da1a (1 μM, blue) or 
both (red). 
Figure 11. Cinétique de dissociation de la 3H -prazosine sur 
α1aAR induite par la prazosine (1 µM, noir) ou la ρ-Da1a 
(1µM, bleue) ou les deux (rouge). 
Figure 12. 125I-ρ-Da1a (125I-AdTx1) dissociation kinetics 
rate on α1aAR induced by 1 μM ρ-Da1a alone (open circles) 
or in addition with 1 μM prazosin (close circles). 
Figure 12. Cinétique de dissociation de la 125I-ρ-Da1a (125I-
AdTx1) induite par 1 μM de ρ-Da1a seule (cercles blancs) ou 
en association avec 1 µM de prazosine (cercles noirs).  
Binding tests were realized on human α1aAR express in yeast (Quinton et al., 2010). Les tests de fixation ont été réalisés 
sur des α1aAR humains, exprimés dans la levure (Quinton et al., 2010). 
ρ-Da1a share similarities with MT7, as it leaves also a residual binding (Figure 1) and reduces agonist 
efficacy (Figure 3). We thus wanted to characterize ρ-Da1a mode of action, by binding and mutagenesis 
studies. Most of the negative allosteric modulators change their radiotracer dissociation kinetics rates, as 
already shown with MT7. We looked on the influence of ρ-Da1a and prazosin on their own dissociation kinetics 
rates. ρ-Da1a had no influence on 3H-prazosin kinetics rate (Figure 11), and prazosin had no influence of 125I-ρ-
Da1a kinetics rate (Figure 12). These results are in favor of a competitive mode of action between ρ-Da1a and 
prazosin on the α1aAR. 
We aimed to confirm the competitive behavior of ρ-Da1a on α1aARs at the molecular level. Two regions of 
biogenic amine receptors, the external loop 2 and the orthosteric pocket, were previously identified as crucial 
for the binding of various ligands. Preliminary results seem to confirm that ρ-Da1a is a competitive ligand since 
it interacts with residues localized into the orthosteric pocket of the receptor. Complementary work should now 
be done to confirm this point and to understand how a large peptide like ρ-Da1a, which can be represented as 
a 35 Å isosceles triangle of around 10 Å thickness, is able to interact with residues located insight the buried 
orthosteric pocket of the receptor. 
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Conclusion 
This work presents part of large screening tests done on collection of GPCRs and illustrate that this family of 
receptors is a valid target for venom toxins. Reticulated toxins, by their pharmacological and biochemical 
properties, deserve to be extensively developed as drug candidates, on a time where peptide drugs are 
positively considered by the pharmaceutical industry. 
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Abstract 
Snake venoms contain more than 100 different proteins and peptides and are an important 
source of biomolecules that selectively target several membrane receptors, such as cell adhesion 
molecules (integrins, cadherins …). International research and development in this area, based 
on multidisciplinary approaches including molecular screening, proteomics, genomics and 
pharmacological tests in vitro, ex vivo and in vivo assays, allowed the identification and 
characterization of highly specific molecules. Since recently, several peptides and 
peptidomimetics are used as medicament, such as cilengitide based on RGD motif, which targets 
specifically glioblastoma and actually is in clinical trial III. For over twenty years, the Laboratory 
of Venoms and Toxins from Pasteur Institute of Tunis has characterized from Macrovipera 
lebetina and Cerastes cerastes venoms, several peptidic molecules with pharmacological potency. 
These molecules belong to different families (phospholipases, disintegrins, C-type lectins and 
metalloproteinases). We have demonstrated that these proteins present anti-tumor, anti-
angiogenic and/or pro-apoptotic activities. Our results show that C-type lectin and phospholipases 
A2 interact with and v integrins whereas lebestatin, a small disintegrin, targets  
integrin, a collagen receptor. 
Les peptides anti-tumoraux issus de venins de serpents 
Les venins de serpents contiennent un mélange de protéines et de peptides différents qui 
représentent une importante source de biomolécules ciblant sélectivement les récepteurs 
membranaires tels que les molécules d'adhésion cellulaire (intégrines, cadhérines …). La 
recherche internationale et de développement dans ce domaine, basée sur une approche 
pluridisciplinaire incluant le dépistage moléculaire, protéomique et des tests pharmacologiques in 
vitro, ex vivo et in vivo, a permis l'identification et la caractérisation de molécules très 
spécifiques. Récemment, plusieurs peptides et peptidomimétiques sont utilisés comme 
médicaments, tels que le cilengitide, un pentapeptide basé sur le motif RGD,  qui cible 
spécifiquement le glioblastome. Ce peptide est actuellement en phase III d’essais cliniques. 
Depuis plus de vingt ans, le Laboratoire des Venins et Toxines de l'Institut Pasteur de Tunis a 
caractérisé, à partir des venins de Macrovipera lebetina et de Cerastes cerastes, plusieurs 
molécules peptidiques ayant un potentiel pharmacologique. Ces molécules appartiennent à 
différentes familles (phospholipases, désintégrines, lectines de type C et métalloprotéases). Nous 
avons démontré que ces protéines présentent des activités anti-tumorales, anti-angiogéniques 
et/ou pro-apoptotiques. L’étude des mécanismes d’action de ces molécules a montré que les 
lectines de type C et les phospholipases A2 interagissent avec les intégrines v et alors que 
la lébestatine, une disintégrine courte, cible l’intégrine , un récepteur du collagène. 
Keywords : Cancer cells, integrin, snake venom. 
 
Introduction 
Snake bite is still a serious threat in both developed and under-developed countries. The worldwide mortality 
caused by snake envenomation is estimated at 50,000 deaths annually (Deshimaru et al., 1996). 
Snake venom contains complex mixtures of pharmacologically active molecules, including organic and 
mineral components, small peptides and proteins (Markland, 1998; Fry, 1999). Venoms of Viperidae and 
Crotalidae snakes (vipers and rattlesnakes) contain a number of different proteins that interfere with the 
coagulation cascade, the normal hemostatic system and tissue repair. Consequently, the envenomation by 
these snakes generally results in persistent bleeding. These proteins can be grouped into a few major proteins 
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families including enzymes (serine proteinase, Zn2+-dependent metalloproteinases and group II phospholipase 
A2 isoenzymes) and proteins with no enzymatic activity (C-type lectin-like proteins and disintegrins) (Menez, 
2002; Juarez et al., 2004). The biological effects of venoms are complex because different components have 
distinct actions and may, in addition, act in concert with other molecules. The synergetic action of venom 
proteins may enhance their activities or contribute to the spreading toxins. 
Cerastes cerastes and Macrovipera lebetina represent the most important poisonous snakes in Tunisia. In 
the Laboratory of Venoms and Toxins at the Pasteur Institute of Tunis, these venoms have been subjected to 
ample research of new molecules with physiological effect. Thus, we have purified and characterized proteins 
belonging to the family of C-type lectin (lebecetin and lebectin), phospholipase A2 (MVL-PLA2, CC-PLA2-1 and 
CC-PLA2-2), short disintegrins (lebestatin) and disintegrin-like peptides (leberagin-C). All these molecules 
target specific integrins and present anti-tumor and anti-angiogenic activities. 
C-type lectin proteins 
C-type lectin proteins (CLPs) are a family of snake venom proteins that are structurally homologous to the 
carbohydrate recognition domain of animal C-type lectins. CLPs are 30 kDa proteins consisting of the 
association of two subunits. In spite of their highly conserved primary structure (40-70% similarity), CLPs are 
characterized by very distinct biological activities (Marcinkiewicz et al., 2000; Wang et al., 2001 and references 
therein). For example, several CLPs inhibit von Willebrand factor (vWF) binding to the GPIb/IX complex, thus 
impeding platelet agglutination, whereas alboaggregins activate the GPIb complex, causing platelet 
agglutination. Other CLPs exhibit anticoagulant activities by binding to vWF or to the coagulation factors IX 
and/or X, while convulxin induces platelet aggregation by activating the collagen receptor GPVI (for a review 
see Andrews and Berndt, 2000). Besides the action on platelet aggregation, it has been reported that snake 
venom CLPs can affect integrin function. EMS16, a CLP from Echis multisquamatus was the first example of a 
different class of venom proteins showing an antagonistic effect on integrins (Marcinkiewicz et al., 2000). In 
addition, BJcuL, from the snake Bothrops jararacussu inhibits tumor and endothelial cell growth (de Carvalho et 
al., 2001) and rhodocetin from Calloselasma rhodostoma antagonises tumor invasion (Eble et al., 2002). 
We recently reported that lebectin and lebecetin, two C-type lectins from Macrovipera lebetina, are potent 
inhibitors of cell adhesion, migration and invasion of tumor cells (Sarray et al., 2004, 2007). 
Previously, all snake venom CLPs were known to interfere with integrin activity by inhibiting the collagen 
receptor  α2β1.  This is the case of EMS16 (Marcinkiewicz et al., 2000), bilinexin (Du et al., 2001), aggretin 
(Suzuki-Inoue et al., 2001) and rhodocetin (Eble et al., 2002). However, the α2β1 integrin is likely not involved 
in the effect of CLPs used in our studies. Indeed, none of the two peptides inhibit attachment of fibrosarcoma 
cells (HT1080) to type I collagen, the ligand of α2β1  integrin in these cells (Cardarelli et al., 1992). Moreover, 
neither migration, nor invasion is affected by the peptides when using collagen as substrata. 
Both venom lectins (lebectin and lebecetin) appear to exert their effect on cell adhesion, migration, invasion 
and proliferation by inhibiting 5β1 and v-containing integrins. Moreover, the inhibition of 5β1 and  v 
integrins is likely due to the binding of venom peptides, as both lebectin and lebecetin co-immunoprecipitate 
with these integrins. Lebectin and lebecetin are thus the first examples of venom C-type lectins inhibiting an 
integrin other than the collagen receptor α2β1 (Sarray et al., 2007). Furthermore, lebectin acts as a very potent 
inhibitor (IC50 ~ 0.5 nM) of human brain microvascular endothelial cells (HBMEC) adhesion and migration on 
fibronectin by blocking the adhesive functions of both the 1 and v integrins. In addition, lebectin strongly 
inhibits both HBMEC in vitro tubulogenesis on MatrigelTM (IC50 ~ 0.4 nM) and proliferation. Finally, using both a 
chicken CAM assay and a MatrigelTM plug assay in nude mice (Figure 1), we showed that lebectin displays 
potent anti-angiogenic activity in vivo. 
 
Figure 1. Lebectin blocks in vivo angiogenesis. Control: CD-1-nuBR mice were injected subcutaneously with 0.5 ml of 
MatrigelTM alone or with MatrigelTM containing FGF-2 (125 ng) with or without lebectin (5 µg). After 7 days, the mice 
were euthanized and the MatrigelTM plugs excised. Representative MatrigelTM plugs from each of the different conditions 
were photographed (left panels). Neovessel formation was quantified by measurement of hemoglobin in the MatrigelTM 
(right). Two mice were used per group and the experiment was repeated twice. Statistically s ignificant differences, as 
compared to control FGF-2 conditions (as well as between the two control conditions), are indicated by* for P < 0.05 
and ** for P < 0.001. 
Figure 1. La lebectine bloque l’angiogenèse in vivo. Contrôle: les souris (CD-1-nuBR) ont été injectées par voie sous 
cutanée avec 0,5 ml de MatrigelTM seul ou avec du MatrigelTM contenant le FGF-2 (125 ng) avec ou sans lebectine (5 
µg). Après 7 jours, les souris sont euthanasiées et le MatrigelTM de chacune des différentes conditions a été 
photographié (panneaux de gauche). La formation de néovaisseaux a été quantifiée par mesure de l'hémoglobine 
(droite). Deux souris ont été utilisées par groupe et l’expérience a été répétée deux fois. Les différences statistiquement 
significatives, comparées aux conditions contrôle, sont indiquées par * pour P < 0,05 et ** pour P < 0,001. 
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Lebectin thus represents a new C-type lectin with anti-angiogenic properties, having thus great potential for 
the treatment of angiogenesis-related diseases (Pilogret et al., 2007). Recently, we demonstrated that lebectin 
induces a strengthening of intercellular adhesion by promoting N-cadherin/catenin complex reorganisation at 
cell-cell contact (Sarray et al., 2009). 
Phospholipases A2 
Phospholipases A2 (PLA2s; EC 3.1.1.4) are among the best-characterized components of snake venom. Based 
on their source, amino acid sequences and disulfide bond patterns, snake venom PLA2s (svPLA2s) are classified 
into group I and group II PLA2 (Six and Dennis, 2000). They are interesting proteins, containing 120-130 
amino acids that are cross-linked by seven disulfide bonds. In addition to their enzymatic activity for the 
cleavage of ester bonds at the sn-2 position of 1,2-diacyl-3-sn-phosphoglycerides, svPLA2s display several 
pharmacological effects, including pre- or post-synaptic neurotoxicity, cardiotoxicity, myotoxicity and platelet 
aggregation modulation (for a review see Kini, 2003). 
We have isolated three PLA2 from Tunisian vipers venoms: MVL-PLA2 (Macrovipera lebetina; Bazaa et al., 
2009), CC-PLA2-1 and CC-PLA2-2 (Cerastes cerastes; Zouari-Kessentini et al., 2009). They inhibited, in a dose-
dependent manner, adhesion of IGR39 melanoma and HT1080 fibrosarcoma cells to fibrinogen and fibronectin. 
Furthermore, MVL-PLA2, CC-PLA2-1 and CC-PLA2-2 abolished HT1080 cell migration towards fibrinogen and 
fibronectin. Hence, we showed for the first time that svPLA2s inhibit adhesion and migration of tumor cells. We 
also demonstrated that these effects were not mediated by the phospholipase catalytic activity but through the 
inhibition of 5β1 and v integrins. Given the key role of and vβ3 in neo-angiogenesis, we decided to 
further evaluate the capacity of svPLA2s to exert an anti-angiogenic activity. Indeed, svPLA2s efficiently 
inhibited endothelial cell adhesion and migration to fibrinogen and fibronectin in a dose-dependent manner 
(Kessentini-Zouari et al., 2010). We showed that this anti-adhesive effect was mediated by 5β1 and v-
containing integrins. Using Matrigel™ and chick chorioallantoïc membrane (CAM) assays, we demonstrated that 
the three isolated svPLA2s, significantly inhibited angiogenesis both in vitro and ex vivo (Figure 2). 
 
Figure 2. CC-PLA2s block in vitro and in vivo angiogenesis. (A) Representative tubulogenesis assay after pretreatment 
of HBMEC with 1 mM CC-PLA2-1 or CC-PLA2-2 for 30 min at room temperature. Cells (2x104) were then added to the 
Matrigel-coated wells in culture medium and allowed to form capillary like structures for 18 h at 37°C. Scale bar = 100 
µm. (B) Quantification of the capillary-like structures formed in the gel after treatment with the indicated 
concentrations of CC-PLA2-1 or CC-PLA2-2. (C) The CAM models were prepared using 8-day-old chick embryos. Filter 
disks were soaked in (a) 0.9% NaCl alone, (b) 1 µM CC-PLA2-1, (c) 1 µM CC-PLA2-2, (d) 200 ng bFGF, (e) 200 ng 
bFGF and 1 µM CC-PLA2-1, (f) 200ng bFGF and 1 µM CC-PLA2-2, (g) 200 ng VEGF, (h) 200 ng VEGF and 1 µM CC-
PLA2-1, (i) 200 ng VEGF and 1 µM CC-PLA2-2. After incubation for 72 h, CAMs were photographed with a digital 
camera. Each group contained four CAMs and the experiment was repeated three times. (D) The quantitative 
measurement of total vessel length was performed on 50% of the total CAM surface treated in the absence (black 
columns) or in the presence of CC-PLA2-1 (white columns) or CC-PLA2-2 (grey columns). 
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Figure 2. CC-PLA2 bloque l’angiogenèse in vitro et in vivo. (A) Processus de tubulogenèse après prétraitement des cellules 
HBMEC avec 1 mM de CC-PLA2-1 ou CC-PLA2-2 pendant 30 min à température ambiante. Les cellules (2x104) ont ensuite 
été ajoutées dans des puits cotés avec du Matrigel et mises en culture pendant 18 h à 37°C pour former des structures en 
forme de capillaire. Barre d'échelle = 100 µm. (B) Quantification des structures capillaires formées dans le Matrigel après 
traitement avec les concentrations indiquées de CC-PLA2-1 ou CC-PLA2-2. (C) Les modèles CAM ont été préparés en 
utilisant des embryons de poulet de 8 jours. Les disques ont été trempés dans (a) 0,9% de NaCl, (b) 1 µM de CC-PLA2-1, 
(c) 1 µM de CC-PLA2-2, (d) 200 ng de bFGF, (e) 200 ng de bFGF et 1 µM de CC-PLA2-1, (f) 200 ng de bFGF et 1 µM CC-
PLA2-2, (g) 200 ng de VEGF, (h) 200 ng de VEGF et 1 µM de CC-PLA2-1, (i) 200 ng de VEGF et 1 µM de CC-PLA2-2. Après 
une incubation de 72 h, les CAM ont été photographiées avec un appareil photo numérique. (D) La mesure quantitative de 
la longueur totale des vaisseaux a été réalisée sur 50% de la surface totale traitée en l'absence (colonnes noires) ou en 
présence de CC-PLA2-1 (colonnes blanches) ou CC-PLA2-2 (colonnes grises). 
We have also found that the actin cytoskeleton and the distribution of vβ3 integrin, a critical regulator of 
angiogenesis and a major component of focal adhesions, were disturbed after MVL-PLA2 treatment. In order to 
further investigate the mechanism of action of this protein on endothelial cells, we analyzed the dynamic 
instability behavior of microtubules in living endothelial cells. Interestingly, we showed that MVL-PLA2 
significantly increased microtubule dynamicity in endothelial cells by 40% (Figure 3). We propose that the 
enhancement of microtubule dynamics may explain the alterations in the formation of focal adhesions, leading 
to inhibition of cell adhesion and migration (Bazaa et al., 2010). 
 
Figure 3. MVL-PLA2 increases microtubule (MT) dynamics in Human Microvascular Endothelial Cells (HMEC-1). (A) 
Time-lapse sequence of video frames of the plus ends of several MT in a control cell (top panels) or in a cell treated 
with 100 nM MVL-PLA2 (bottom panels). Arrowheads indicate one MT end for which the position did not change over a 
period of 24 s in the control cell and one MT that underwent a shortening event in the treated cell. Time is indicated in 
seconds. Scale bar: 10 µm. (B) Life history plots of the length changes of 3 representative MTs in living HMEC-1 cells  
treated or not (control) with 100 nM MVL-PLA2. In the presence of 100 nM MVL-PLA2, MTs are characterized by more 
extensive growth and shortening events compared to control cells. 
Figure 3. La MVL-PLA2 augmente la dynamique des microtubules (MT) dans les cellules endothéliales microvasculaires 
humaines (HMEC-1). (A) Séquence d'images vidéo des terminaisons (+) dans une cellule contrôle (panneaux 
supérieurs) ou dans une cellule traitée avec 100 nM de MVL-PLA2 (panneaux inférieurs). Les flèches indiquent une 
extrémité MT pour laquelle la position n'a pas changé sur une période de 24 s dans la cellule de contrôle et un MT qui a 
subi un raccourcissement dans la cellule traitée. Le temps est indiqué en secondes. Barre d'échelle: 10 µm. (B) Suivi 
des changements de longueur de 3 MT dans une cellule HMEC-1 traitée avec 100 nM de MVL-PLA2 ou non (contrôle). 
En présence de 100 nM de MVL-PLA2, les MT sont caractérisés par des phases de croissance plus importante et de 
raccourcissement plus nombreuses que dans la cellule contrôle. 
Disintegrins 
Disintegrins are a family of low molecular weight proteins present in many Viperidae venoms. They are divided 
into five different subgroups according to their polypeptide length and number of disulfide bonds. The long 
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subgroup (83 amino acids) with seven disulfide bonds includes bitistatin. The medium subgroup (68-73 amino 
acids) with six disulfide bonds contains kistrin, flavoridin and barbourin. The third subgroup includes the short 
disintegrins, single polypeptide chains of 49-51 amino acids with four disulfide bonds. Echistatin and eristostatin 
belong to this group. The disintegrin domains of PIII snake-venom metalloproteinases, containing 
approximately hundred amino acids with 16 cysteine residues involved in the formation of eight disulfide bonds, 
constitute the fourth subgroup of the disintegrin family. Unlike short-, medium- and long-sized disintegrins, 
which are single-chain molecules, the fifth subgroup is composed of homo- and heterodimers (Calvete et al., 
2005). Snake disintegrins are potent and specific antagonists of several integrins. 
Lebestatin, a new member of the lysine-threonine-serine (KTS)-disintegrin family, was purified to 
homogeneity from Tunisian snake (Macrovipera lebetina) venom. It is a single-chain polypeptide composed of 
41 amino acids. The amino-acid sequence of lebestatin shows that it displays a pattern of cysteines similar to 
other short disintegrins, but contains the sequence KTS rather than RGD in its integrin-binding loop. Lebestatin 
presents a high homology with obtustatin and viperistatin. It interacts specifically with the  integrin. It was 
thus able to inhibit both adhesion and migration of PC12 and  integrin-expressing CHO cells (CHO-1) to 
type I and IV collagens. This disintegrin also affected adhesion and migration of endothelial cells and exhibited 
an anti-angiogenic effect in vivo when using the 8-day-old embryo chick chorioallantoic membrane model 
(Kallech-Ziri et al., 2005). 
Leberagin-C, a new member of the disintegrin-like/cysteine-rich (D/C) family, was purified to homogeneity 
from the venom of Tunisian snake Macrovipera lebetina. It is a monomeric protein with a molecular mass of 
25,787 Da. Its complete sequence of 205 amino acid residues was established by cDNA cloning. Leberagin-C 
shows many conserved sequences with other known D/C proteins, like the SECD binding sites and a pattern of 
28 cysteines. It is the first purified protein from Macrovipera lebetina venom with only two disintegrin-
like/cysteine-rich domains. It was able to inhibit the adhesion of melanoma tumor cells on fibrinogen and 
fibronectin, by interfering with the function of v3 and, to a lesser extent, with v6 and 5β1 integrins. To 
our knowledge, leberagin-C is the sole described D/C protein that does not specifically interact with the 21 
integrin. Structure-activity relationship study of leberagin-C suggested that there are some important amino 
acid differences with jararhagin, the most studied PIII metalloproteinase from Bothrops jararaca, notably 
around the SECD motif in its disintegrin-like domain. Other regions implicated in leberagin-C specificity could 
not be excluded (Limam et al., 2010). 
Conclusion 
Several proteins and peptides were purified from Macrovipera lebetina and Cerastes cerastes venoms. These 
proteins are characterized as efficient modulators of integrin functions. They exhibit in vitro and ex vivo anti-
tumor and anti-angiogenic activity. Thus, it is conceivable that these proteins could be used as models for 
designing new compounds with therapeutic value and open new potent and selective drugs for the treatment of 
many types of cancer. 
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Abstract 
Natural toxins, derived from plants, animals or other organisms, have shown an important role in 
the development of pharmacological tools. Dinoponera and Paraponera, two common ant genera 
in Brazil, are among the groups that show potential medical interest. In this work, we 
investigated the effect of Dinoponera quadriceps venom (DQv) on chemical-induced seizures 
models in mice. DQv presented effect only in models of seizures induced by pentylenetetrazole. 
Pretreatment with this venom increased significantly the time to first seizure and proved a 
tendency to delay the death time of mice. Analyzing thiobarbituric acid reactive substances 
revealed that DQv reduces the malondialdehyde amount only in prefrontal cortex. These results 
strongly suggest a possible neuroprotective effect of the venom. 
Effet du venin de Dinoponera quadriceps sur des modèles de 
convulsion chimiquement induits chez la souris 
Des toxines naturelles, dérivées de plantes, d’animaux ou d’autres organismes, ont démontré leur 
rôle important dans le développement d’outils pharmacologiques. Dinoponera et Paraponera, 
deux genres de fourmis communs au Brésil, figurent parmi les groupes d’intérêt médical 
potentiel. Nous avons étudié l’effet du venin de Dinoponera quadriceps (DQv) sur des modèles de 
convulsion chimiquement induits chez la souris. DQv présentait un effet uniquement sur des 
modèles de convulsion chimiquement induits par le pentylènetétrazole. Un prétraitement avec ce 
venin augmentait de façon significative le temps de la première convulsion et a démontré une 
tendance à retarder le temps de la mort des souris. L’analyse des substances réagissant avec 
l’acide thiobarbiturique a révélé que DQv réduit la quantité de malondialdéhyde seulement dans 
le cortex préfrontal. Ces résultats suggèrent fortement un effet neuroprotecteur possible du 
venin. 
Keywords : Dinoponera quadriceps venom, pentylenetetrazole, pilocarpine, seizures, strychnine. 
 
Introduction 
Natural toxins, derived from plants, animals or other organisms, have shown an important role in the 
development of therapeutic values with substances. Thus, Brazil has an extensive biological diversity and 
appears as a rich environment for studying natural products. Venoms of arthropods, such as scorpions, spiders 
and wasps, appear as potential sources of neuroactive substances, providing new tools for rational drug design. 
Ants are among the most biologically diverse organisms on Earth (Hoffman, 2010). The subfamily Ponerinae 
includes ants with large size, which even measure up to 3.0 cm in diameter, and is represented by various 
genus such as Dinoponera, Paraponera and Diacamma. This subfamily is distributed mainly along the South 
America, and some species can be found in the Cerrado, Caatinga and Atlantic Forest (Schoeters and Billen, 
1995; Siquieroli et al., 2007). Ants of medical interest belong to the genus Dinoponera and Paraponera 
(Haddad Junior et al., 2005). Previous studies demonstrated that the venom Ponerinae subfamily is composed 
of complex mixtures of proteins and neurotoxins (Lima and Brochetto-Braga, 2003). 
Some animal models have been developed to analyze the pro- or anticonvulsant activity of various 
substances, such as models of seizures induced by pentylenetetrazole (PTZ), pilocarpine (PILO) and strychnine 
(STRC). 
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Materials and methods 
Venom, chemicals and drugs 
The ants were collected in Maranguape, Ceará, Brazil. The Dinoponera quadriceps venom (DQv) was extracted 
in the Laboratory of Entomology (State University of Ceará, UECE, Fortaleza, Brazil). PTZ, PILO and STRC were 
purchased from Sigma Chemical Co., USA. 
Models of chemical-induced seizures and behavioral assessment 
Male Swiss mice (28-33g) were pretreated with DQv (0.5 or 2.0 mg/kg, i.p., n=8). After 30 minutes, seizures 
were induced with PTZ (80 mg/kg, i.p.), PILO (400 mg/kg, i.p.) or STRC (3.0 mg/kg, i.p.) (Yilmaz et al., 2007; 
Turski et al., 1983; Aprison et al., 1987). Then, the animals were placed in individual cages and observed over 
time. For the behavioral assessment, latency time to the first seizure and latency of death within the first 30 
minutes were recorded. Control group of each model was treated only with the inductor agents. 
Measurement of oxidative stress parameters by lipid peroxidation degree 
Three brain areas of mice (prefrontal cortex, hippocampus and striatum) were dissected, after behavioral 
assessment, to determine the lipid peroxidation degree. According to Huong et al. (1998), lipid peroxide 
formation was analyzed by measuring the thiobarbituric acid reactive substances (TBARS), i.e. malondialdehyde 
(MDA) levels. The brain areas were homogenized in sodium phosphate buffer. The homogenates were mixed 
with 35% perchloric acid and centrifuged. Then, thiobarbituric acid (1.2%) was added to the supernatants 
which were heated in a boiling water bath for 30 min. Finally, the MDA levels were determined by absorbance 
at 535 nm. 
Committee of Ethics 
The protocols were accepted by the Ethics Committee on Animal Research of the Federal University of Ceará 
(protocol nº 43/2011). 
Statistical analysis 
Results are presented as the mean ± standard error of the mean (S.E.M.) of eight experiments for each group. 
Differences between groups were compared using analysis of variance (ANOVA) and Student-Newman-Keuls as 
post hoc test with significance set at 5%. 
Results and Discussion 
Effects of DQv on chemical-induced seizures models 
Behavioral observation revealed that DQv (0.5 mg/kg), in PTZ-induced seizures mice, increased significantly 
the time to the first seizure (155.40 ± 27.70 sec versus 79.75 ± 3.90 sec for the control group; Figure 1A) and 
presented tendency to increase survival and the time to death (444.30 ± 82.47 sec, i.e. 12.5% survival, versus 
307.40 ± 36.52 sec, i.e. 0% survival for the control group; Figure 2A). No significant alteration in both PILO- 
and STRC-induced models was observed (Figures 1B, C and 2B, C). 
 
Figure 1. Effects of DQv on latency of the first seizure in the models of PTZ (A), PILO (B) and STRC (C). Results 
are expressed as means ± S.E.M (n=8). * P < 0.05 compared to the control group. 
Figure 1. Effets du DQv sur la latence de la première convulsion dans les modèles du PTZ (A), de la PILO (B) et de 
la STRC (C). Les résultats représentent les moyennes ± les erreurs standards de la moyenne (E.S.M.) de 8 
expériences. * P < 0,05 comparé au groupe contrôle. 
PTZ, PILO and STRC have different mechanisms of action. The convulsant mechanism of action of PTZ is 
poorly understood but it was reported that PTZ is able to inhibit chloride channels associated with γ-
aminobutyric acid type A (GABAA) receptors, reducing the inhibitory neurotransmission mediated by GABA 
(Silva et al., 1998). Other studies showed that PILO induces the development of seizures, status epileptics and 
brain damage in rodents (Turski et al., 1989; Marinho et al., 1997) but the blockade of glutamatergic receptors 
prevents the propagation of seizures induced by PILO and brain damage (Jope et al., 1986; Marinho et al., 
1997; Morrisett et al., 1987). STRC, a competitive antagonist of glycine, exerts its inhibitory effects on the 
central nervous system, causing a severe seizure that usually leads the animals to death (Mazzambani, 2005). 
According this, our results demonstrate that DQv effects are probably not related to the cholinergic and 
glycinergic pathways but could be involved with the modulation of chloride channels. 
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Figure 2. Effects of DQv on latency of death in models of PTZ (A), PILO (B) and STRC (C). Results are expressed 
as means ± S.E.M. (n=8).  
Figure 2. Effets du DQv sur la latence de la mort dans les modèles du PTZ (A), de la PILO (B) et de la STRC (C). 
Les résultats représentent les moyennes ± E.S.M. (n=8). 
Ants, as well as bees and wasps, belong to the order of Hymenoptera. It was reported recently that the 
venom of the ant Dinoponera australis contains more than 75 proteins and peptides, including modifiers of ion 
channels (Hoffman, 2010; Johnson et al., 2010). Cunha et al. (2005) observed that the denatured venom of 
the wasp Polybia ignobilis presents anticonvulsant activity in some animal models. In addition, the neurotoxin 
AvTx7, isolated from Agelaia vicina wasp venom, has been reported to inhibit glutamate uptake in a dose-
dependent and non-competitive manner (Pizzo et al., 2004). 
Effects of DQv on oxidative stress parameter 
We observed that pretreatment with DQv (2.0 mg/kg) decreased MDA amount only in the cortex of PTZ model 
mice (38.86 ± 3.43 μg of MDA/g of tissue versus 58.74 ± 3.76 μg of MDA/g of tissue for the control group) 
(Figure 3A). Modifications of this parameter were not found within another cerebral area of PTZ model animals, 
as well as in PILO- and STRC-induced models whatever the cerebral area was studied. 
Oxidative stress in the central nervous system has been shown in various models of experimental epilepsy, 
such as the PTZ model (Gupta et al., 2003; Patsoukis et al., 2004) and is characterized by an imbalance 
between oxidant and antioxidant substances. According to Patel (2004), epileptic seizures can result from free 
radical production and oxidative damage in cell structures such as lipids, protein and DNA. Bashkatova et al. 
(2003) demonstrated that TBARS formation is increased in the brain cortex of rats during PTZ-induced seizures. 
However, the rise of lipid peroxidation in brain tissues after convulsions is decreased by substances with 
antioxidant properties (Yamamoto and Tang, 1996; Gupta et al., 2001). We observed that previous 
administration of DQv is able to cause a reduction of MDA levels in cortex. Thus, it is likely that this venom 
contains a component with antioxidant property that has affinity for some specific structure(s) present in the 
prefrontal cortex. This activity may be involved, at least in part, in a neuroprotective action since the increase 
in levels of free radicals and decrease of antioxidant defense mechanisms in seizure processes are well 
documented. Thus, a substance able to reduce the oxidative stress levels may ameliorate the damaging effects 
caused by convulsions. 
 
Figure 3. Effects of DQv in the lipid peroxidation degree, by measurement of MDA levels in three brain areas, in 
models of PTZ (A), PILO (B) and STRC (C). Results are expressed as means ± S.E.M (n=8). * P < 0.05 compared 
to the control group. 
Figure 3. Effets du DQv sur le degré de péroxydation des lipides, par la mesure des niveaux de MDA dans trois 
aires du cerveau, dans les modèles du PTZ (A), de la PILO (B) et de la STRC (C). Les résultats représentent les 
moyennes ± E.S.M. de 8 expériences. * P < 0,05 comparé au groupe contrôle. 
Conclusion 
In the present work, we show that pretreatment with DQv is able to cause some neuroprotective effects on 
PTZ-induced seizures. In behavioral assessment, the venom increased the time to the first seizure and showed 
a tendency to enhance the time of death. We observed that DQv reduces MDA (as an oxidative parameter) 
levels in prefrontal cortex. Further investigations are needed to elucidate the involved molecular mechanisms of 
action, as well as to identify the venom component(s) responsible for DQv effects. 
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Abstract 
L-amino acid oxidases from snakes’ venom have bactericidal, leishmanicidal and trypanocidal 
activity. Epimastigote forms of Trypanosoma cruzi were treated with different doses (100-3.125 
µg/mL) of L-amino acid oxidase isolated from Bothrops marajoensis venom (LAAOBM) in the 
absence or presence of catalase. We observed that LAAOBM demonstrated dose-dependent 
trypanocidal activity after 48 h and 72 h incubation. In the presence of catalase, this activity was 
completely abolished after 48 h incubation and was markedly reduced after 72 h incubation. 
These results show that L-amino acid oxidase from B. marajoensis venom exerts a trypanocidal 
activity and that the removal of hydrogen peroxide (H2O2) by addition of catalase is able to 
abolish or decrease the cell death induced by this oxidase. 
Effet de la L-amino-acide oxydase isolée du venin du serpent 
Bothrops marajoensis sur les formes épimastigotes de Trypanosoma 
cruzi 
Les L-amino-acide oxydases isolées du venin de serpents ont une activité bactéricide, 
leishmanicide et trypanocide. Les formes épimastigotes de Trypanosoma cruzi ont été traitées 
avec différentes doses (100–3,125 µg/mL) de L-amino-acide oxydase isolée du venin du serpent 
Bothrops marajoensis (LAAOBM) en l’absence ou la présence de catalase. Nous avons observé 
que la LAAOBM montrait une activité trypanocide, dépendante de la dose, après 48 h et 72 h 
d’incubation. En présence de catalase, cette activité était complètement supprimée après 48 h 
d’incubation et largement réduite après 72 h d’incubation. Ces résultats montrent que la L-amino-
acide oxydase du venin de B. marajoensis a une activité trypanocide et que la suppression de 
péroxyde d’hydrogène (H2O2), par l’addition de catalase, est capable d’abolir ou de réduire la 
mort cellulaire produite par cette oxydase. 
Keywords : Bothrops marajoensis, epimastigote forms, L-amino acid oxidase, snake venom, 
Trypanosoma cruzi. 
 
Introduction 
Snake venoms comprise a complex mixture of proteins, peptides, lipids and other substances, such as 
phospholipases A2, metalloproteases and L-amino acid oxidases, that vary in proportions and characteristics 
among the different species (Queiroz et al., 2008; Alves et al., 2008). 
L-amino acid oxidases are a family of flavoenzymes that catalyze oxidative deamination of L-amino acids to 
produce the corresponding -ketoacids, hydrogen peroxide (H2O2) and ammonia (Ehara et al., 2002; Du and 
Clemetson, 2002). These flavoenzymes are largely studied due their biological effects including bactericidal, 
leishmanicidal and trypanocidal activity (Stábeli et al., 2004; Izidoro et al., 2006; Deolindo et al., 2010; De 
Melo Alves Paiva et al., 2011). 
Chagas disease is a parasitosis caused by the protozoan Trypanosoma cruzi which continues to represent a 
health problem for an estimated 28 million people, living mostly in Latin America (Maya et al., 2010). It is 
recognized by the World Health Organization (WHO) as one of the world’s 13 most neglected tropical diseases 
(Hotez et al., 2007). The drugs available to treat Chagas disease are nifurtimox and benznidazole (BZN). 
However, due to toxicity and prolonged therapy, these treatments are not effective. It is worth noting that side 
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effects are observed in up to 40% of patients. They include nausea, vomiting, abdominal pain and several 
neurological effects (Marin-Neto et al., 2009). 
Within this context, the toxins may represent a rich therapeutic potential and/or provide data for 
development of pharmacology tools. The present study demonstrates the cytotoxic effect of L-amino acid 
oxidase isolated from Bothrops marajoensis venom on epimastigote forms of T. cruzi. 
Materials and methods 
Venom and reagents 
The L-amino acid oxidase isolated from B. marajoensis venom (LAAOBM) was kindly donated by Dr. Marcos H. 
Toyama (Paulista State University, UNESP, São Paulo, Brazil). Benzonidazole was donated by LAFEPE 
(Phamaceutical Laboratory of Pernambuco State), and catalase was purchased from Sigma. 
Trypanocidal activity 
Epimastigote forms of T. cruzi were grown at 28°C in Liver Infusion Tryptose (LIT) medium supplemented with 
10% fetal bovine serum. The epimastigotes used for all experiments were those from the log-growth phase (6th 
day). The experiments were performed in 96-well plates at a density of 1x106 parasites/mL treated with 
different doses (100–3.125 µg/mL) of LAAOBM in the absence or presence of catalase (90 µg/mL). BZN was 
used as the reference drug. The plates were incubated for 48 or 72 h, and the cell viability was determined by 
quantification in a Neubauer Chamber. Cultures of the parasite without treatment were considered as 100% 
growth. 
Statistical analyses 
Results are presented as the mean ± standard error of the mean (S.E.M.) of three experiments in triplicate. 
The statistical significance of data was determined by ANOVA, Dunett, post-test. 
Results and Discussion 
The cellular viability of epimastigote forms of T. cruzi was investigated after treatment with LAAOBM. LAAOBM 
demonstrated a dose-dependent cytotoxic effect on epimastigote forms with 50% inhibition doses (ID50) of 
16.58 µg/mL and 13.52 µg/mL after 48 h and 72 h incubation, respectively (Figure 1A and B). Recent studies 
have reported trypanocidal activity for L-amino acid oxidases isolated from B. atrox (Alves Paiva, 2011), B. 
jararaca (Deolindo, 2010) and B. marajoensis (Torres, 2010). 
 
Figure 1. Effects of different doses of LAAOBM on epimastigote forms of T. cruzi treated for 48 h (A) and 72 h (B). The 
graph represents means ± S.E.M. of data (n=3). The statistical significance of data was determined by ANOVA, Dunett, 
post-test. * P < 0.05 compared to the corresponding control group. 
Figure 1. Effets de différentes doses de LAAOBM sur les formes épimastigotes de T. Cruzi traitées pendant 48 h (A) et 
72 h (B). Les graphiques représentent les moyennes ± l’erreur standard de la moyenne (E.S.M.) des résultats (n=3). 
La signification statistique des résultats a été determinée par ANOVA, Dunett, post-test. * P < 0,05 comparé au groupe 
contrôle. 
The toxicity of L-amino acid oxidases is thought to be due to the production of H2O2 (Zhang et al., 2004a). 
This production might be the underlying mechanism for trypanocidal activity (Du and Clemetson, 2002). In 
order to test this hypothesis, we studied the trypanocidal activity of various doses of LAAOBM in the presence 
of a given dose of catalase (i.e. 90 µg/mL), an enzyme known to suppress the production of H2O2. Our results 
show that in the group treated with both LAAOBM and catalase for 48 h, only an about 40% cell death was 
observed at the highest dose (100 μg/mL) of LAAOBM whereas at lower doses, no significant effect of LAAOBM 
occurred (Figure 2A). These results indicate that the inhibition of cytotoxic effect of LAAOBM by catalase is 
probably due to the breakdown of H2O2 production (Stabéli et al., 2007; Deolindo et al., 2010; Naumann et al., 
2011). However, in the group treated with both LAAOBM and catalase for 72h, an about 40-50% cell death 
reduction was observed whatever the LAAOBM doses were (Figure 2B). These results indicate that the cell 
death induced by 3.125-6.25 and 25-100 µg/mL LAAOBM for 72 h was increased and decreased, respectively 
by catalase. Indeed, it has been reported in the literature that the biological actions of ophidian L-amino acid 
oxidases are only partly dependent on H2O2, suggesting that there are specific receptors or targets on the cells 
(Li et al., 2008; Zhang et al., 2004b). 
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Figure 2. Effects of different doses of LAAOBM on epimastigote forms of T. cruzi treated for 48 h (A) and 72 h (B) in 
the presence of 90 µg/mL catalase. The graph represents means ± S.E.M. of data (n=3). The statistical significance of 
data was determined by ANOVA, Dunett, post-test. * P < 0.05 compared to the corresponding control group. 
Figure 2. Effets de différentes doses de LAAOBM sur les formes épimastigotes de T. cruzi traitées pendant 48 h (A) et 
72 h (B) en présence de 90 µg/mL de catalase. Les graphiques représentent les moyennes ± E.S.M. des résultats 
(n=3). La signification statistique des résultatsa été determinée par ANOVA, Dunett, post-test. * P < 0,05 comparé au 
groupe contrôle. 
The Figure 3 demonstrates the cytotoxic effect of BZN on epimastigote forms treated for 48 h and 72 h. 
 
Figure 3. Effects of different doses of BZN on epimastigote forms of T. cruzi treated for 48 h (A) and 72 h (B). The 
graph represents means ± S.E.M. of data (n=3). The statistical significance of data was determined by ANOVA, Dunett, 
post-test. # P < 0.05 compared to the corresponding control group. 
Figure 3. Effets de différentes doses du benznidazole sur les formes épimastigotes de T. cruzi traitées pendant 48 h 
(A) et 72 h (B). Les graphiques représentent les moyennes ± E.S.M. (n=3). La signification statistique des résultats a 
été determinée par ANOVA, Dunett, post-test. * P < 0,05 comparé au groupe contrôle. 
Conclusion 
L-amino acid oxidase, an enzyme widely distributed among different snake species, has been reported to have 
several biological effects. Our results show that L-amino acid oxidase from B. marajoensis venom exerts a 
trypanocidal activity on epimastigote forms of T. cruzi and that the removal of H2O2 by addition of catalase 
abolishes or markedly reduces the cell death induced by this oxidase. 
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Abstract 
Infectious diseases due to Staphylococcus aureus include painful symptoms suggesting 
involvement of the nervous system. This led us to evaluate the potential neurotoxicity of bi-
component leucotoxins released by this bacterium. In rat granular neuronal cells, low 
concentration of leucotoxins causes the release of significant amounts of glutamate due to an 
increase in [Ca2+]i. By monitoring the [Ca2+]i changes with the fluorescent indicator Fura-2, we 
found that the [Ca2+]i imbalance is due to the interaction of leucotoxins with the store operated 
Ca2+ entry complex. Indeed, drugs targeting the refilling of intracellular Ca2+ stores [Sarco-
Endoplasmic Reticulum Ca2+-ATPase (SERCA), H+-ATPase] and antagonists of the store 
operated Ca2+ entry complex blunted, or reduced considerably, the leucotoxin induced [Ca2+]i 
elevation. Simultaneously, signal transduction pathways that include the phosphatidylinositol 
3-kinase and the ADPribosyl cyclase CD38 were activated. Moreover, confocal analysis of 
immunolabelled neurons shows that, shortly after binding, the leucotoxin was localised with the 
Ca2+ sensor stromal interacting molecule Stim1 in the same endosomal compartment. 
Furthermore, the mobilisation of free internal Ca2+ is antagonized by specific anti-Stim1 
antibodies. Our results suggest that, following toxin internalisation, Ca2+ stored in the 
endosomal compartment leaks out, probably inducing the Stim1 aggregation to the membrane 
protein ORAI1, which leads to a subsequent increase in [Ca2+]i. 
Neurotoxicité des leucotoxines de Staphylococcus aureus : interaction 
avec le complexe impliqué dans l’influx de calcium dépendant de la 
libération des réserves calciques intracellulaires dans des neurones 
centraux et sensoriels 
Les infections à Staphylococcus aureus comportent souvent des syndromes douloureux qui 
peuvent suggérer une atteinte du système nerveux. Partant de cette idée, nous avons cherché 
à évaluer le potentiel neurotoxique des leucotoxines à deux composants libérées par la 
bactérie. Sous l’effet des leucotoxines, les neurones granulaires de rat en culture libèrent du 
glutamate suite à une augmentation de [Ca2+]i. Nous avons suivi les variations de [Ca2+]i à 
l’aide de l’indicateur fluorescent Fura-2 et nous observons que les changements en [Ca2+]i sont 
dus à l’interactions de leucotoxines avec le complexe impliqué dans l’influx de calcium 
dépendant de la libération des réserves calciques intracellulaires (SOCE pour « Store Operated 
Calcium Entry »). Les drogues qui bloquent le remplissage des réserves de Ca2+ intracellulaires 
[SERCA pour « Sarco-Endoplasmic Reticulum Ca2+-ATPase », H+-ATPase] et des antagonistes 
du complexe SOCE, bloquent, ou réduisent considérablement, les élévations de [Ca2+]i 
provoquées par la leucotoxine. Aussi, le blocage des activités phosphatidylinositol 3-kinase et 
de l’ADPribosyl cyclase CD38 inhibe l’effet de la leucotoxine sur la [Ca2+]i. A l’aide d’un dérivé 
fluorescent de la sous-unité HlgB nous avons suivi la localisation de la toxine après fixation; les 
analyses en microscopie confocale situent la leucotoxine dans le même compartiment que la 
protéine senseur de Ca2+ Stim1 (pour « Stromal interacting molecule 1 »). La mobilisation du 
Ca2+ intracellulaire est aussi bloquée par des anticorps dirigés contre Stim1. Nos résultats 
suggèrent qu’après internalisation, la leucotoxine favorise la sortie du Ca2+ de l’endosome, ce 
qui pourrait faciliter l’agrégation de Stim1 à la protéine ORAI1 et entrainerait l’augmentation 
du [Ca2+]i. 
Keywords : Neurotoxicity, staphylococcal leucotoxins, stromal interacting molecule 1, store 
operated calcium entry. 
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Introduction 
Staphylococcus aureus strains causing human pathologies produce several toxins, including a pore-forming 
protein family formed by the single-component -hemolysin and the bicomponent leucotoxins. The last 
comprise two protein elements, S and F, which co-operatively form the active toxin. -Hemolysin is always 
expressed by S. aureus strains, whereas bicomponent leucotoxins are more specifically involved in a few 
diseases. The pore-forming toxins (PFTs) are expressed as water soluble monomeric proteins that assemble on 
the membranes of the target cells to form bilayer-spanning pores (Menestrina et al., 2003). Even before protein 
extension in the bilayer is completed, the formation of an oligomeric pre-pore can trigger Ca2+-mediated 
activation of some white cells, initiating an inflammatory response. Major advances have been made over the 
last decade in the understanding of the structure and mechanism of pore formation by PFTs from S. aureus 
(Kaneko and Kamio 2004; Gonzalez et al., 2008; Yamashita et al., 2011). In contrast, much less is known 
about all the cell targets of S. aureus PFTs and the responses of cells confronted with the presence of 
leucotoxins. 
Our work focused on neurons sensitivity to S. aureus PFTs. We used rat cerebellar granular to study 
intracellular [Ca2+] variations. The leucotoxin HlgC/HlgB evoked rises of free [Ca2+]i that were blocked or 
strongly reduced by antagonists of the store operated Ca2+ entry (SOCE) system. Antagonists of 
phosphatidylinositol 3-kinase and ADPribosyl cyclase CD38 blocked the intracellular [Ca2+] variations activated 
by the leucotoxin. The toxin was internalised and was found in a compartment where it partially colocalized 
with the Stromal interacting molecule Stim-1. 
Intracellular Ca2+ mobilization by Staphylococcus aureus leucotoxins 
We used the Fura-2 calcium fluorescent indicator to observe intracellular [Ca2+] variations. As shown in Figure 
1, the cerebellar granular neurons reacted to the presence of the leucotoxin HlgC/HlgB through a transient peak 
of [Ca2+]i that was followed by the return to a new resting value of [Ca2+]i higher than the initial (Figure 1A). 
The latency between toxin application and the rise of [Ca2+]i was asynchronous between cells. Depending on 
the concentrations of leucotoxin, a second rise of [Ca2+]i often followed with a variable delay. To be able to 
compare sets of cells incubated with different toxin concentrations and pharmacological drugs, three 
parameters were measured from individual cell responses: (i) the amplitude of [Ca2+]i at the peak, (ii) the time 
latency to reach the peak of [Ca2+]i and (iii) the proportion of cells displaying a second [Ca2+]i rise. The point 
plots presented in Figure 1B (peak amplitude) and 1C (latency of the response) report the responses variability 
at different toxin concentrations. However, the pooling of the data from a large number of independent 
experiments showed a significant concentration dependent effect on median and mean values of the peak 
amplitude and the time latency of the response (Table 1). Therefore, the peak [Ca2+]i amplitude and the time 
latency will be presented in Figures as box plots with median and percentiles. 
 
Figure 1. The leucotoxin HlgC/HlgB induced intracellular [Ca2+] variations in granular neurons in a concentration dependent 
manner. The results are from three independent records obtained at different leucotoxin concentrations. (A) Examples from 
individual cell at three concentrations, illustrating that increasing concentrations of toxin tend to reduce the latency of the 
response, to increase the amplitude of the peak and to produce an secondary [Ca2+]i rise. However, as shown by the point 
plots in (B) for the peak amplitude or in (C) for the latency of the response, in a group of cells (same dish) the variability of 
the responses is high. Nevertheless, pooling a large numbers of independent experiments, confirms the concentration 
dependence of the effect. This is illustrated in Table 1. 
Figure 1. Les variations de [Ca2+] intracellulaire provoquées par la leucotoxine HlgC/HlgB dépendent de la concentration. 
Les résultats présentés ici ont été obtenus avec trois boites de cellules enregistrées à des concentrations différentes. (A) 
Exemples de trois cellules enregistrées à des concentrations de toxine différentes qui illustrent que lorsque la concentration 
augmente le temps de réponse diminue, l’amplitude du pic de Ca2+ augmente et il peut apparaitre une deuxième 
augmentation de [Ca2+]i. Mais, comme le montrent les nuages de points en (B) pour le pic de [Ca2+] et en (C) pour la 
latence, les réponses sont très variables d’une cellule à l’autre. Cependant, la réunion des valeurs issues d’un grand nombre 
d’expériences confirme la relation ente la concentration de toxine et l’amplitude moyenne des réponses. Ceci est illustré à 
l’aide du Tableau 1. 
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Table 1. Values for the [Ca2+]i peak amplitude (A) and the time latency (B) from a large number of experiments 
(three different concentrations) were pooled together in order to compare the mean, the median and the 
percentiles and to evaluate the statistical significance. The differences between the three groups are statistically 
significant (P < 0.001) according the one way ANOVA analysis of variance. 
Tableau 1. Les valeurs de l’amplitude de la [Ca2+]i (A) et du délai de réponse (B) pour un nombre élevé 
d’enregistrements (trois concentrations de toxine) sont réunies afin de comparer les moyennes, les médianes et les 
percentiles et de vérifier si les trois groupes sont statistiquement différents. Le test ANOVA d’analyse de variances 
considère les différences significatives (P < 0.001). 
 
The activity of different leucotoxins was then compared. Starting at 2 nM toxin, near 100% of granular 
neurons were sensitive to the leucotoxin HlgC/HlgB. However, under similar conditions, 20 nM leucotoxin 
HlgA/HlgB was necessary to activate 40% of granular neurons and 2 nM leucocidin LukS-PV/LukF-PV modified 
[Ca2+]i in less than 20% of neurons. 
Intracellular stores Ca2+ mobilization 
To determine the contribution of intracellular Ca2+ stores to the leucotoxin HlgC/HlgB, neurons were incubated 
in the presence of 1 µM thapsigargin or 0.2 µM bafilomycin to prevent loading of reticular Ca2+ stores by SERCA 
or acidic Ca2+ stores by H-ATPase, respectively. In both cases, the activity of leucotoxin (4 nM) was strongly 
reduced (Figure 2A). 
 
Figure 2. Contribution of intracellular Ca2+ stores to the leucotoxin HlgC/HlgB activity and antagonist effect of drugs 
active on the store operated calcium entry. (A) Incubation of neurons with 1 µM thapsigargin before addition of 
leucotoxin strongly inhibits the [Ca2+]i changes. Results are presented by a single trace, mean of all records from a 
same dish, and as box plots that present the median, the percentile and the mean as a red line. The box plots gather 
results from three experiments. (B) Blocking effect of Gd3+ and econazole and (C) of 2-APB; all drugs known to 
antagonize store operated calcium entry (SOCE). The same representation as in A is shown, except for SOCE 
antagonists where no [Ca2+]i changes were observed or they were extremely reduced. 
Figure 2. Contribution des réserves calciques intracellulaires à l’activité de la leucotoxine HlgC/HlgB et effet 
antagoniste des drogues qui agissent sur l’entrée de calcium activée à partir des réserves. (A) Les neurones pré-
incubés avec 1 µM de thapsigargine donnent des réponses très réduites et dispersées à l’application de leucotoxine. Les 
résultats sont présentés sous la forme d’un seul tracé qui est la moyenne de ceux des toutes les cellules d’un même 
enregistrement. Les boites longeant les axes représentent les médianes, les percentiles et les moyennes (trait rouge) 
des valeurs de trois expériences. (B) Effet bloquant du Gd3+ et de l’éconazole et (C) du 2-APB; trois drogues connues 
pour leurs effets antagonistes de SOCE. Mêmes représentations qu’en A, à l’exception des antagonistes SOCE pour 
lesquels pas ou peu de changements de [Ca2+]i étaient observés. 
A 
Toxin concentration 
Mean of Peak 
amplitude 
Median of Peak 
amplitude 
25% 75% Cells (exp) 
2 nM 178 ± 89 nM 159.2 nM 110.4 nM 227.8 nM 396 (14) 
4 nM 355 ± 223 nM 297.8 nM 197.8 nM 469.7 nM 862 (24) 
8 nM 416 ± 228  nM 389.9 nM 234.5 nM 542.6 nM 178 (6) 
      
B 
Toxin concentration 
Mean of time 
latency 
Median of time 
latency 
25% 75% Cells (exp) 
2 nM 687 ± 413 s 701 s 300 s 1026 s 396 (14) 
4 nM 551 ± 445 s 423 s 144 s 868 s 862 (24) 
8 nM 221 ± 237 s 125 s 88 s 232 s 178 (6) 
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In 7 independent experiments, 56% of the cells incubated with thapsigargin (154 out of 277 cells) showed a 
leucotoxin induced transient peak of low amplitude. Blockade of the vesicular H-ATPase by 0.2 µM bafilomycin 
strongly reduced the leucotoxin HlgC/HlgB induced [Ca2+]i changes. Leucotoxin induced delayed transient 
increases of [Ca2+]i, that hardly ever reached twice the amplitude of the resting value, in 60% of treated cells. 
Interestingly, granular neurons are known to keep an active Ca2+ entry pathway, independent of VOCCs, which is 
antagonized by molecules known to operate in SOCE and TRP channels (Pinilla et al., 2005). We, therefore, tested 
whether the leucotoxin effect may be altered by drugs modifying SOCE activity (Bird et al., 2008). When 100 µM 
Gd3+ (Figure 2B) or 100 µM La3+ (not shown) were present in the bath a few minutes before the leucotoxin, its 
effect was totally blunted. The antagonist econazole (5 µM) completely prevented the toxin-induced rise in [Ca2+]i 
(Figure 2B). Application before the toxin of 100 µM 2-APB, a cell permeable modulator of Inositol (1,4,5)-P3-
induced Ca2+ release that targets SOCE, decreased by 40% the average of the peak amplitude (203 ± 56 nM 
versus 335 ± 126 nM) and increased more than 10 times  the average of the time latency (1140 ± 159 s versus 
latency 99 ± 8 sec) (Figure 2C). Furthermore, cells incubated for 15 min in the presence of 90 µM dantrolene, 
which blocks ryanodine receptors at 10 µM and Ins(1,4,5)-P3 receptors at 50 µM, showed a reduced amplitude 
(144 ± 27 nM) and a delayed toxin response (latency 593 ± 176 s) compared to control cells. 
When the contribution of extracellular Ca2+ to the leucotoxin effect was evaluated, a resting activity of the 
toxin (i.e. [Ca2+]i rise) could still be observed in neurons incubated in 3 µM and in 30 µM [Ca2+]e buffer. But 
cells bathing in a free Ca2+ buffer (0 mM Ca2+ - 5 mM EGTA) kept constant the resting [Ca2+]i for the whole 
recording period in presence of the toxin. These results suggest that extracellular Ca2+ also contributes to the 
accumulation of cytosolic free Ca2+, which reinforces the SORE hypothesis. 
Leucotoxin internalization and interaction with Stim-1 
The SOCE complex works through the interaction between the reticular Ca2+ sensor stromal interacting 
molecule (Stim) and the plasma membrane Ca2+ channel Orai (Parekh and Putney 2005; Varnai et al., 2009; 
Collins and Meyer 2011). We used specific antibodies targeting Stim-1 to disrupt the equilibrium of SOCE 
system before challenging the neurons with the leucotoxin. Both the average of the peak amplitude and the 
response latency were modified when antibodies were added 20 min before the toxin (Figures 3A and B). The 
goat polyclonal N-19 antibody was less effective than the mouse monoclonal A-8 antibody, which recognizes 
the C-terminal region of the molecule. 
Simultaneously, we checked for the subcellular location of the leucotoxin HlgC/HlgB tagged with Alexa-488 
in HlgB, and the Stim-1 protein using the same antibodies to immune-label the cells. Figure 4 shows that the 
toxin localizes in an internal compartment which is also labeled by the anti-Stim antibodies. In this example, 
the co-localization ratio was of 85% (Pearson’s correlation: 0.69). Internalization of the leucotoxin HlgC/HlgB 
was verified by the labeling of the external leaflet of the plasma membrane with the B subunit of the cholera 
toxin. An example is given in Figure 5, where the co-localization ratio between the two molecules was of 46% 
(Pearson’s correlation: 0.4). 
  
Figure 3. Effect of incubating granular neurons with specific 
antibodies against the Stim1 molecule prior to the [Ca2+]i 
measurements. (A) Peak amplitude; (B) time latency. The 
plots, indicating the mean (red line), the median (black line) 
and the percentiles, present values from three independent 
experiments. Control, 190 cells; N-19 antibody, 188 cells; A-8 
antibody, 85 cells. The results were statistically significant 
according to the Kruskal-Wallis test (P < 0.001). 
Figure 3. Effet de l’incubation des neurones avec des anticorps 
anti-Stim1 sur l’augmentation de [Ca2+]i. (A) Valeur maximale 
au pic, (B) délai de réponse. Sont représentées les moyennes 
(ligne rouge), les médianes (ligne noire) et les percentiles des 
trois expériences. Contrôle, 190 cellules; anticorps N-19, 188 
cellules; anticorps A-8, 85 cellules. Le test de Kruskal-Wallis 
considère les résultats statistiquement différents (P < 0.001). 
Figure 4. Neurons labelled with leucotoxin HlgC/HlgB-Alexa-
488 (green) and the anti-Stim1 H-19 antibody (red). Images 
show a 0.3 µm optical section captured with a Leica SP5-II 
microscope equipped with quantitative co-localization 
software. Images correspond to pixels labelled with both 
markers; (A) toxin, (B) H-19 and (C) merge. (D) 
Superimposition of the fluorescence to the Nomarski view of 
the observed area (nuclei are labelled with Hoechst 33258). 
Figure 4. Neurones marqués avec la leucotoxine HlgC/HlgB-
Alexa-488 (vert) et l’anticorps anti-Stim1 (rouge). Les 
images montrent une coupe optique de 0.3 µm obtenue à 
l’aide d’un microscope Leica SP5-II équipé d’un programme 
pour la quantification des colocalisations. (A) Pixels marqués 
par la toxine, (B) par H-19, (C) colocalisation. (D) 
Superpositions des vues de fluorescence et Nomarski (les 
noyaux sont marqués avec du Hoechst 33258). 
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Figure 5. Neurons labelled with leucotoxin HlgC/HlgB-Alexa-488 (green), the cholera toxin B 
subunit-Alexa-594 (red) and Hoechst 33258 (blue). Images show the merge of the three markers 
signal acquired independently; an optical section of 0.3 µm is presented. Bars size = 5 µm. 
Figure 5. Neurones marqués avec la leucotoxine HlgC/HlgB-Alexa-488 (vert), la sous-unité B de la 
toxine cholérique couplée à l’Alexa-594 (rouge) et du Hoechst 33258 (bleu). Les images 
correspondent à la superposition du signal des trois marqueurs saisis indépendamment; section 
optique de 0.3 µm. Barres de calibration = 5 µm. 
Conclusion 
The results presented here form a first step to evaluate the potential risk that a local or systemic infection of S. 
aureus can be for the nervous system. Leucotoxins mobilize [Ca2+]i in cerebellar granular neurons while 
preserving the cellular integrity, independently of the toxin concentration. This Ca2+ mobilization was prevented 
by incubation with drugs targeting the refilling of intracellular Ca2+ stores. Moreover, known SOCE inhibitors as 
2-APB or dantrolene were effective at high concentrations for blocking the leucotoxin effect. On the other hand, 
the use of antibodies directed against the proteins involved in SOCE, particularly against the endoplasmic 
reticulum sensor of Ca2+ levels Stim1 (Liou et al., 2005; Roos et al., 2005), inhibited leucotoxin-induced [Ca2+]i 
variations and were found in the same internal compartment. 
Overall, our results qualify leucotoxins as disruptive agents for the SOCE complex. However, the 
experimental data presented here are not sufficient to infer that the leucotoxin, after binding to the membrane, 
activates a signalling pathway that impinges in SOCE. Similarly, we cannot infer that the toxin binds to, or 
directly acts through Stim1 or ORAI1. A working hypothesis would be that the internalised leucotoxin, by its 
presence in endosomes carrying Stim1, starts a process which includes the Ca2+ release from the endosome 
and that may be followed by the formation of the Stim1/ORAI1 complex. More work is needed to determine the 
basis of the initial Ca2+ mobilisation. 
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Abstract 
Currently, there are at least 28 known paralytic shellfish toxin derivatives classified into four 
groups based on their chemical structure. Since 2006, many samples collected from the Gulf of 
Gabes (Southern Tunisia) were tested positive using the mouse bioassay (MBA) despite the 
absence of gymnodimines, the only family of marine biotoxins detected in Tunisian shellfish. This 
paper reports the analyses of toxic clams (Ruditapes decussatus) collected along the Gulf of 
Gabes coasts (Southern Tunisia) during the period 2006-2009. Toxic compounds were detected 
by liquid chromatography-mass spectrometry (LC–MS) in all clams extracts known to be 
contaminated according to the MBA. Three molecular ions were identified (M+H+): 431.14 m/z, 
453.12 m/z and 469.10 m/z. Toxicity events coincided with the presence of the dinoflagellate 
Gymnodinium catenatum, species associated worldwide with the production of paralytic shellfish 
poisoning (PSP) toxins. The presence of toxic species, i.e. G. catenatum, and detection of PSP-
like toxins in clams warn of potential PSP problems in the Gulf of Gabes. 
Détection d’une toxicité atypique chez les palourdes du golfe de Gabes 
La famille des toxines paralysantes renferme actuellement plus de 28 dérivés qui sont classés en 
quatre groupes en fonction de leur structure chimique. En 2006, plusieurs échantillons de 
palourdes (Ruditapes decussatus) collectées dans le golfe de Gabès ont été testés positifs par le 
test biologique sur souris, malgré l’absence de gymnodimines qui sont depuis longtemps connues 
pour être responsables de la contamination des palourdes du golfe de Gabès. L’analyse par 
chromatographie liquide–spectrométrie de masse (LC-MS) des fractions toxiques a permis 
d’identifier trois composés de masse moléculaire (M+H+): 431.14 m/z, 453.12 m/z et 469.10 
m/z. Les épisodes de toxicité coïncidaient avec la présence du dinoflagellé Gymnodinium 
catenatum, espèce connue pour produire des phycotoxines ayant un effet paralysant. En 
conclusion, la détection de composés toxiques (toxines ayant un effet paralysant) ayant des 
masses moléculaires non habituelles et l’apparition du dinoflagellé G. catenatum dans le milieu 
constituent des indices pour des problèmes potentiels de contamination des palourdes du golfe de 
Gabès par des phycotoxines paralysantes. 
Keywords : Gymnodinium catenatum, liquid chromatography-mass spectrometry, mouse 
bioassay, paralytic shellfish toxins. 
 
Introduction 
Toxins associated with Paralytic Shellfish Poisoning (PSP) are among the most acutely toxic substances known 
(Asp et al., 2004). Currently, there are at least 28 known PSP toxin derivatives (Llewellyn, 2006). They can be 
classified into four groups based on their chemical structure as follows: saxitoxins (saxixotoxin: STX, 
decarbamoyl saxitoxin: dcSTX, neosaxitoxin: neoSTX, decarbamoyl neosaxitoxin: dcneoSTX, and nonsulfated 
STX), gonyautoxins (GTX1 to 6, dcGTX1 to 4, and single-sulfated GTX), C-toxins (C1 to 4, doubly sulfated C-
toxins), and other variants identified in Lyngbya wollei (LWTX1 to 6) (Clemente et al., 2010). 
PSP toxins are synthesized by several Alexandrium species (Schantz et al., 1966), Gymnodinium catenatum 
(Oshima et al., 1987), Pyrodinium bahamense (Harada et al., 1982) and freshwater cyanobacteria (Garcia et 
al., 2010; Araoz et al., 2010). 
STX, a carbamate toxin, is generally considered the most potent. Other highly potent carbamate toxins 
include neoSTX and GTX1 to 4 while the N-sulphocarbamoyl (C) toxins are generally considered to be less 
potent (Turrell et al., 2007). STX and derivatives are potent marine neurotoxins which block voltage-dependent 
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sodium channels in excitable cells (Long et al., 1990). Consumption of shellfish contaminated by PSP toxins 
causes paresthesia, astenia, distonia, ataxia, dyspnea, hypotension, tachycardia, vomiting, skeletal muscle 
paralysis (Garcia et al., 2010) and death, which can occur in severe cases when respiratory assistance is 
delayed or absent. 
Officially, the traditional mouse bioassay (MBA; AOAC, 1990) has been the only method adapted for the 
detection of PSP toxins in bivalves. Recently, pre-column oxidation high-performance liquid chromatography 
(HPLC) technique was approved and has been validated for monitoring STX, neoSTX, GTX2 and GTX3 together, 
GTX1 and GTX4 together, dcSTX, GTX5, C1 and C2 together, and C3 and C4 together, in mussels, clams, 
oysters and scallops (Etheridge, 2010). 
In 1994, clams collected from Boughrara lagoon (Gulf of Gabes, Southern Tunisia) were tested positive 
using the MBA. Further investigations revealed that gymnodimine-A was responsible for the toxicity of Tunisian 
clams (Biré et al., 2002). The causative dinoflagellate was later identified as Karenia cf. selliformis (Drira et al., 
2008). Bivalve mollusks are monitored for PSP toxins regularly since 1998, covering the entire coast. Currently, 
the official regulatory method for monitoring PSP toxins in shellfish remains the AOAC International MBA 
(AOAC, 1990). 
In 2006, many samples collected from the same area were tested positive despite the absence of 
gymnodimines. This paper reports on the analyses of toxic clams (Ruditapes decussatus) collected along the 
Gulf of Gabes coasts (Southern Tunisia) during the period 2006-2009 in which there was a bloom of G. 
catenatum. 
Materials and methods 
Materials 
Samples of clams (Ruditapes decussatus) were collected weekly from the Gulf of Gabes between September 2006 
and December 2009. Sampling was carried out and controlled by the “Commissariat Régional au Développement 
Agricole de Médnine” (CRDA, Southern Tunisia). Samples were kept at +4°C until analyzed. Acetonitrile, diethyl 
ether and dichloromethane (DCM) were purchased from Panreac Quimica SA (Spain), acetone from Carlo Erba 
reagents (France), trifluoroacetic acid (TFA) and Tween 60 from Sigma-Aldrich (Ireland). 
Toxicity assays 
Toxicity analyses were carried out using the MBA according to the AOAC method (1990) for PSP toxin 
monitoring. Briefly, 100 g of homogenized tissues were mixed with 100 ml of 0.1M HCl and the extract was 
boiled for 5 min. After cooling, the pH was adjusted to 2-3 by 5 M HCl or 0.1 M NaOH. Then, the mixture was 
transferred to a graduated cylinder, diluted to 200 ml by distilled water and centrifuged at 3000 g for 15 min. 
The supernatant (1 ml) was injected intraperitoneally (i.p.) into three 20 g male adult Swiss-Webster mice. The 
mice were observed for 24 h, and signs of illness and death times were recorded. The values are expressed in 
µg STX eq/100 g meat. 
The MBA based on the protocol of Yasumoto et al. (1978) was used to detect Diarrhoeic Shellfish Poisoning 
(DSP) toxins. Briefly, 20 g of digestive glands were extracted three times with acetone. Each extract was 
evaporated to dryness, suspended in 4 ml of 1% Tween-60 saline and injected i.p. into male adult Swiss-Webster 
mice (20 g, three mice). The mice were observed for 24 h, and signs of illness and death times were recorded. 
Control mice were injected i.p. with only 4 ml of 1% Tween-60 saline (three mice receiving 1 ml/mice). 
Samples extraction and solvent partition 
Samples shown to be positive according to the MBA were further studied. Extraction was performed using 
methods previously published (Kharrat et al., 2008; Marrouchi et al., 2009). Briefly, 20 g of meat were minced 
and extracted three times, with 50 ml acetone each time, using a screw mixer. The combined acetone extract 
was filtered and evaporated in a rotary evaporator with a temperature-controlled bath. The residual aqueous 
layer was defatted with diethyl ether (1:1) and extracted with dichloromethane (1:1) three times. Aqueous, 
diethyl ether and dichloromethane layers were evaporated to dryness and suspended in 1 ml of MilliQ water to 
be used for toxicity assays and chromatographic analysis. 
Chromatographic analysis 
Following liquid/liquid extraction, the water-soluble extract, which possessed the entire toxic activity, was 
analyzed by a reversed-phase HPLC C18 symmetry column (4.6 x 250 mm, 5 µm, Waters). Elution was done with 
a mobile phase composed of a gradient of solvent A (aqueous phase: Milli-Q water + 0.1% TFA) and solvent B 
(organic phase: acetonitrile + 0.1% TFA), whose proportions were controlled by a programmable pump system. A 
linear gradient from 10-90% B was run between 2 and 35 min. Temperature was fixed to 25°C, and the run lasted 
for 35 min. Series of fractions were hand-collected, lyophilized, and tested for activity. The active fraction was 
further purified using analytical reversed-phase HPLC C18 symmetry column, under the same conditions as 
reported above. Individual fractions were collected, lyophilized, and stored at -20°C until use. 
HPLC-ESI-LC analysis 
The HPLC equipment was formed by a binary system U3000 Dionex. Samples were carried out with manual 
injector with a 25 µl sample loop .The column used was a Zorbax SB-C18 (1 mm, 15 mm, 3 µm). The products 
were eluted using a linear gradient between 5 and 50% of acetonitrile in 40 min, and then with an increase 
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gradient to 100% on 5 min. This system was coupled to a mass spectrometer (MS) LTQ-ORBITRAP instrument 
from THERMO Fisher (Bremen, Germany) equipped with an electrospray (ESI) source. The injection volume was 
25 μl. The mobile phase for analysis was solvent A (water + 0.1% formic acid) and solvent B (acetonitrile + 
0.09% formic acid). 
Mass measurement was done in positive mode using the ORBITRAP set to a resolution of 6000 at m/z 400 
Da. The automatic gain control was fixed to a target of 5.106. The scan was set between m/z 200 and 1700. 
Data were analyzed using the Xcalibur software from Thermo Instrument Systems Inc. 
Results and Discussion 
No mortality was recorded on mice injected with clams extracts using the AOAC (1990) MBA method. However, 
toxicity was observed in all the mice injected with extracts using MBA based on the protocol of Yasumoto et al. 
(1978). Mice injected with diethyl ether or dichloromethane layers, as well as those injected with only Tween-
60 saline, showed neither mortality nor signs of toxicity up to 24 h, whereas an acute toxicity was observed in 
all mice injected (i.p. or intracerebroventricularly) with the crude water soluble extract for all samples tested 
positive for DSP toxins. Common mouse toxic symptoms included paralysis of hind legs followed by rapid death 
(i.e. within 5 min after injection of high amounts of water soluble toxic extract). 
The bio-guided chromatographic fractionation of the water soluble toxic extract was used to identify the 
peak corresponding to the elution of toxic compounds. As shown in Figure 1, toxicity was concentrated 
exclusively in a peak eluated at 8.18 min. Toxic peaks were traced by MS (Figure 2), and three molecular ion 
were detected (M+H+): 431.14 m/z, 453.12 m/z and 469.10 m/z. Toxic compounds were detected by LC–MS in 
all clams extracts shown to be contaminated using the MBA. 
 
Figure 1. Chromatogram of toxic fraction eluated at 8.18 min and purified from water soluble toxic extract. 
Figure 1. Chromatogramme de la fraction toxique éluée à 8,18 min et purifiée à partir de l’extrait aqueux toxique. 
 
Figure 2. Base peak LC–MS chromatogram (m/z 200–1700) extracted from LC–MS analyses of the fraction eluated at 8.18 min. 
Figure 2. Chromatogramme LC-MS du pic de base (m/z 200–1700) extrait des analyses LC-MS de la fraction éluée à 8,18 min. 
It should be noted that episodes of toxicity coincided with the presence of G. catenatum, species associated 
worldwide with the production of PSP toxins (Oshima et al., 1987; Vale, 2010) on Tunisian coasts of the Gulf of 
Gabes (Dammak-Zouari et al., 2009). This species proliferates episodically in summer and autumn and resides 
in the central zone of the Gulf of Gabes (Dammak-Zouari et al., 2009). 
Recently, several hydrophobic hydroxybenzoate analogues have been found. Apparently, their production is 
related to G. catenatum (Negri et al., 2003; Vale, 2008) although this species is known to produce hydrophilic 
analogues (Negri et al., 2007). 
In the Mediterranean coasts, episodes of contamination by PSP toxins were recorded in Morocco, and the 
toxicity in shellfish has been associated with G. catenatum (Taleb et al., 2001). The same phenomenon was 
observed after blooms of Alexandrium minitum in Italy (Honsell et al., 1996) and A. catenella in Spain (Vila et 
al., 2001). 
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The presence of toxic species, G. catenatum, and detection of PSP-like toxins in clams warn of potential PSP 
problems in the Gulf of Gabes. We have to be vigilant of the population of the toxic species on the coasts and 
the levels of these toxins in shellfish. We must remember that clams harvesting [production reaches 500 tones 
during the last five years (FAO, 2011)] have considerable importance for the national economy since this sector 
generates 6000 jobs and provides considerable revenue currency (7 million Euros per year; Hamza, 2003). 
Conclusion 
In this paper, we report that clams collected in coastal water of the Gulf of Gabes contain some PSP toxins-like, 
although in very small amounts. To our knowledge, this is the first report of PSP toxins in shellfish from the 
Gulf of Gabes where DSP occurs more frequently. More investigations are needed to elucidate the structure of 
these new toxic compounds and to adapt appropriate tests for their monitoring. 
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Résumé 
Les toxines des venins de scorpions sont responsables de la quasi-totalité des symptômes et des 
désordres biologiques observées après envenimation scorpionique accidentelle ou expérimentale. 
L’immunothérapie reste la seule thérapie efficace contre ce fléau. Pour améliorer les conditions 
d’utilisation de l’anti-venin, une première envenimation expérimentale par le venin de scorpion 
Androctonus mauretanicus (Am) a été réalisée chez des lapins pour évaluer les paramètres 
toxico-cinétiques de ce venin : volumes totaux de distribution (Vdss et Vdβ), clairance totale (ClT) 
et demi-vie terminale (t1/2β). Une deuxième envenimation expérimentale par ce venin a été faite 
chez des lapins pour étudier les variations des marqueurs biochimiques : glucose, urée, 
créatinine, transaminases (AST et ALT), CPK et LDH au niveau sanguin. Après administration du 
venin (24 h), les animaux témoins et envenimés ont été sacrifiés et leurs organes ont été 
prélevés pour réaliser une étude histologique sur les parenchymes cardio-pulmonaires, 
hépatiques et rénaux. L’étude toxico-cinétique du venin Am a montré que ce dernier se distribue 
rapidement du compartiment vers les tissus. Les résultats de l’étude physiopathologique ont 
montré une augmentation significative des paramètres biochimiques étudiés. Cette augmentation 
s’explique par l’observation d’importantes lésions tissulaires (œdèmes, foyers hémorragiques, 
infiltration des cellules inflammatoires, …). 
Biological and toxicokinetics study of Androctonus mauretanicus 
scorpion venom in rabbit 
The toxins of scorpion venom are responsible for the majority of the symptoms and biological 
disorders observed after accidental or experimental scorpion envenomation. Immunotherapy is 
the only specific and effective treatment against scorpion’s stings. To improve the use of anti-
venom, a first experimental study with Androctonus mauretanicus (Am) scorpion venom was 
conducted in rabbits. We have evaluated the venom toxicokinetics parameters: total volume of 
distribution (Vdss and Vdβ), total clearance (ClT) and terminal half-life (t1/2β). A second 
experimental envenomation with this venom was made in rabbits to study changes in biochemical 
markers: glucose, urea, transaminases (AST and ALT), CPK and LDH in blood. After 
administration of venom (24 hr), control and envenomed animals were sacrificed and their organs 
were taken to study the effect of Am venom on histological structures on heart, lungs, liver and 
kidneys. The results revealed that the venom was rapidly distributed from blood to tissues. 
Biochemical analysis showed a significant increase in all parameters translating a serious damage 
tissue. The histological study of organs showed disruption and tissue alterations caused by Am 
venom, expressed especially by foci hemorrhagic, edema, infiltration of inflammatory cells, …. 
Keywords : Androctonus mauretanicus scorpion venom, pathophysiology, toxicokinetics. 
 
Introduction 
Au Maroc, comme dans de nombreux pays tropicaux et sub-tropicaux, les envenimations par piqûres de 
scorpions constituent un réel problème de santé publique rencontré surtout durant la saison estivale. Le 
scorpion Androctonus mauretanicus est le plus incriminé dans de nombreux cas d’envenimations graves et 
souvent mortelles surtout chez les enfants (Ghalim et al., 2000, El Hafny et Ghalim, 2002). Selon les données 
épidémiologiques, les envenimations scorpioniques représentent 30 à 50% de l’ensemble des intoxications 
reçues dans les structures sanitaires avec un taux d’incidence pouvant atteindre 8,2 ‰ de la population à 
risque (Soulaymani-Bencheikh et al., 2004). Les venins de scorpions sont riches en toxines létales douées 
d’actions physiopathologiques importantes induisant des dysfonctionnements multifactoriels touchant la quasi-
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totalité des systèmes vitaux chez l’homme dont le pronostic vital peut être engagé (Adi-bessalem et al., 2008, 
Oukkache et al, 2009). La sévérité de l’envenimation scorpionique nécessite des traitements spécifiques et 
symptomatiques associés et précoces (Ismail., 1995). L’amélioration de la prise en charge des patients 
envenimés nécessite une meilleure connaissance du mécanisme d’action du venin sur les différentes fonctions 
vitales pour pouvoir établir un schéma thérapeutique plus spécifique et plus efficace. 
Première étude : Etude toxico-cinétique du venin de scorpion Am 
Deux groupes de lapins albinos (2,8 - 3 kg) ont été utilisés dans cette étude. Le premier groupe constitué de 
quatre lapins, a reçu une dose sub-létale du venin (100 µg/kg) par voie sous cutanée (s.c.). Le deuxième 
groupe, constitué aussi de quatre lapins, a reçu une dose sub-létale du venin (100 µg/kg) par voie 
intraveineuse (i.v.). Des prélèvements sanguins sur les huit lapins ont été effectués sur tubes secs avant 
envenimation et 5, 15, 30, 60, 120, 180, 240, 300, 360 min après administration du venin. Les concentrations 
sériques du venin circulant ont été déterminées par ELISA. Les paramètres toxico-cinétiques [volumes totaux 
de distribution (Vdss et Vdβ), clairance totale (ClT) et demi-vie terminale (t1/2β)] ont été évalués en utilisant le 
logiciel Kinetica (InnaPhase, France). 
Deuxième étude : Etude biochimique et histologique après envenimation par le 
venin Am 
Deux autres lots de lapins albinos (2,8 - 3 kg) ont été soumis à une envenimation expérimentale par une une 
autre dose sub-létale (617,5 µg/kg) d’un autre lot de venin de scorpion Am. Les prélèvements sanguins ont été 
réalisés entre 0 min et 1440 min. Le dosage sérique des paramètres biochimiques (glycémie, urée, créatinine, 
transaminases, LDH et CPK) a été effectué selon les recommandations de l’automate KODAK VITROS 
Chemistry (Ortho Clinical Diagnostics, USA). Après envenimation (24 h), les organes des animaux (témoins et 
envenimés) ont été prélevés pour la réalisation des coupes histologiques (7 µm), colorés à l’hématéine-éosine 
pour l’examen microscopique. 
Expression des résultats 
Les résultats des paramètres biochimiques ont été traités statistiquement par le test ANOVA, ils sont présentés 
sous la forme de moyenne de 4 essais ± écart-type. Les valeurs de p inférieures à 0,05 sont considérées 
significatives. 
L’étude toxico-cinétique a montré que le venin de scorpion Am se distribue rapidement du compartiment 
sanguin vers les tissus (Figures 1 et 2). La concentration maximale du venin a été détectée 5 min après 
injection du venin par voie s.c. (Tmax = 0,5 h). La demi-vie terminale est de 2,8 h, valeur proche de celle 
obtenue après injection i.v. (3,2 h). Les volumes de distribution sont compris entre 317 et 380 ml/kg. La 
clairance corporelle est de l’ordre de 82 ml/kg/h (Tableau 1). 
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Figure 1. Cinétique du venin de scorpion Androctonus 
mauretanicus par voie intraveineuse (au temps zéro) 
chez le lapin. Concentration du venin exprimée en ng/ml, 
échelle semi-logarithme. 
Figure 1. Kinetics of Androctonus mauretanicus venom 
intravenously (at time zero) in rabbit. Concentration of 
venom expressed in ng/ml, semi-logarithmic scale. 
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Figure 2. Cinétique du venin de scorpion Androctonus 
mauretanicus par voie sous cutanée (au temps zéro) chez 
le lapin. Concentration du venin exprimée en ng/ml, échelle 
semi-logarithme. 
Figure 2. Kinetics of Androctonus mauretanicus venom 
subcutaneously (at time zero) in rabbit. Concentration of 
venom expressed in ng/ml, semi-logarithmic scale. 
Tableau 1. Paramètres toxico-cinétiques du venin de scorpion Androctonus mauretanicus. 
Table 1. Toxico-kinetics parameters of Androctonus mauretanicus scorpion venom. 
Voie 
d’administration 
Cmax (µg/ml) Tmax (h) t1/2β (h) Vdβ (ml/kg) Vdss (ml/kg) ClT 
(ml/kg/h) 
Intraveineuse - - 3,2 ± 0,2 379,88 ± 32,87 316,77 ± 39,79 82,32 ± 1,54 
Sous-cutanée 0,240 ± 0,037 0,5 ± 0,0 2,8 ± 1,1 562,74 ± 162,97 688,20 ± 98,58 143,42 ± 16,50 
 
Les résultats de l’analyse biochimique ont montré une augmentation significative des marqueurs 
biochimiques étudiés (glucose, urée, créatinine, transaminases, LDH et CPK). Nous avons noté le taux maximal 
de glucose sanguin 90 min après injection du venin (Figure 3). Les concentrations sanguines maximales de 
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l’urée et de la créatinine sanguines ont été observées 15 min après envenimation (Figures 4 et 5). Les 
concentrations sériques optimales en transaminases AST et ALT ont été enregistrées respectivement en 90 min 
et 120 min (Figure 6). Les concentrations sanguines maximales en LDH et CPK ont été détectées 90 min après 
l’administration du venin Am (Figure 7). 
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Figure 3. Variation de la glycémie après envenimation 
expérimentale (au temps zéro) chez le lapin. 
Figure 3. Variation in glycemia after experimental scorpion 
envenomation (at time zero) in rabbit. 
Figure 4. Variation de l’urée après envenimation 
expérimentale (au temps zéro) chez le lapin. 
Figure 4. Variation in uremia after experimental scorpion 
envenomation (at time zero) in rabbit. 
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Figure 5. Variation de la créatinine sanguine après 
envenimation scorpionique expérimentale (au temps zéro) 
chez le lapin. 
Figure 5. Variation in serum creatinine after experimental 
scorpion envenomation (at time zero) in rabbit. 
Figure 6. Variation des AST et ALT sériques après 
envenimation scorpionique expérimentale (au temps 
zéro) chez le lapin. 
Figure 6. Variation in serum AST and ALT after 
experimental scorpion envenomation (at time zero) in 
rabbit. 
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Figure 7. Variation des LDH et CPK sériques après 
envenimation scorpionique expérimentale (au temps 
zéro) chez le lapin. 
Figure 7. Variation in serum LDH and CPK after 
experimental scorpion envenomation (at time zero) in 
rabbit. 
Des altérations sévères au niveau de la structure du parenchyme des différents tissus examinés 24 heures 
après envenimation des lapins par le venin d’Am ont été observées sur des coupes histologiques (Tableau 2). 
Au niveau du myocarde, le venin a provoqué des dégénérescences des myofibrilles, des hémorragies avec une 
infiltration des cellules inflammatoires. Au niveau du parenchyme pulmonaire, on a noté une rupture des 
cloisons inter-alvéolaires, un élargissement des parois alvéolaires, une importante infiltration de cellules 
inflammatoires et la présence d’œdème avec des foyers de congestion et de suffusion hémorragiques. Au 
niveau hépatique, des hémorragies interstitielles, des dilatations des sinusoïdes et une infiltration des cellules 
inflammatoires ont été observées. Les lésions élémentaires des hépatocytes sont prédominantes avec 
turgescence et nécrose hépatocytaire. Les noyaux de certaines cellules sont pycnotiques, d’autres sont en état 
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de caryolyse ou nécrose. Au niveau rénal, les effets du venin Am ont provoqué des hémorragies, une 
dégénérescence ou lésion de l’épithélium tubulaire au niveau de la médullaire. An niveau de la zone corticale, 
une dilatation de la lumière des tubules et une désorganisation de glomérules avec destruction de la capsule de 
Bowman. 
Tableau 2. Lésions tissulaires engendrées 24 h après envenimation scorpionique expérimentale chez le lapin (grossissement x40). 
Table 2. Tissue damage 24 hr after experimental scorpion envenomation in rabbit (magnification x40). 
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Fms : Fibres musculaires striées (Striated muscle fibers), Dfm : Dégénérescence des myofibrilles (Degeneration of myofibrils), 
Hr : Hémorragie (Hemorrhage). Av : Alvéole (Alveolus), Dcia : Dilatation des cloisons interalvéolaires (Expansion 
of interalveolar walls), Eea : Elargissement des espaces alvéolaires (Extension of alveolar spaces), Oe : Œdème (Edema). Hp : 
Hépatocyte (Hepatocyte), Vcl : Veine centrolobulaire (Central vein), Leh : Lésion élémentaire hépatocytaire (Elementary 
lesion hepatocyte), Ds : Dilatation des sinusoides (Dilatation of sinusoids). Gm : Glomérule (Glomerulus), CB : Capsule de 
Bowman (Bowman's capsule), Dg : destruction glomérulaire (Glomerular destruction).  
Conclusion 
Le venin de scorpion Am est caractérisé par une diffusion rapide dans l’organisme. Il est doué d’un pouvoir 
toxique élevé qui est responsable de nombreuses perturbations métaboliques accompagnées d’importantes 
désorganisations tissulaires. 
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Abstract 
The aim of this study is to investigate the ion balance importance in the regulation of various 
biological processes by using kaliotoxin (specific inhibitor of potassium channels) injected to mice 
by intracerebroventricular route. Obtained results indicate that the electrolyte dysfunction 
induced by kaliotoxin is the principal cause of toxic effects. It is responsible for massive 
neurotransmitter release which could be, in turn, involved in the induced pathologic effects. 
These effects are characterized by an inflammatory response associated to leukocyte infiltration 
and an increase of two biomarkers’ enzymatic activities (EPO and MPO). Tissue damage 
correlated with metabolic changes was also observed. 
Déséquilibre ionique, altérations tissulaires et réponse inflammatoire 
induits par la kaliotoxine 
L’objectif de cette étude est de montrer l’importance de l’équilibre ionique dans la régulation de 
différents processus physiologiques en utilisant la kaliotoxine (bloquant spécifique des canaux 
potassium) injectée à des souris par voie intracérébroventriculaire. Les résultats obtenus 
montrent que le déséquilibre ionique provoqué par la kaliotoxine est la principale cause des effets 
toxiques. Il est responsable de la libération massive des neurotransmetteurs qui, a leur tour, sont 
impliqués dans les effets pathologiques induits. Ces derniers se traduisent par une réponse 
inflammatoire associée à une infiltration leucocytaire et à une augmentation des activités 
enzymatiques de deux biomarqueurs (EPO et MPO). Des altérations tissulaires corrélées avec des 
déséquilibres métaboliques sont également observées. 
Keywords : Kaliotoxin, ionic balance, inflammation. 
 
Introduction 
Excitable cells express voltage-gated potassium (KV) channels. Due to their high ion selectivity and distribution in 
many tissues, KV channels play an important role in a variety of physiological processes including the regulation of 
neuronal and cardiac electrical pattern, muscle contractility, neurotransmitter release, hormone secretion, 
regulation of cell secretion and activation of lymphocytes. This diversity of function is reflected in their sensitivities 
to various blockers (Mourre et al., 1999). Potent tools are used to identify and characterize these membrane 
proteins. Among these tools, kaliotoxin, a neurotoxin purified from Androctonus australis hector venom and 
exhibiting a high affinity for KV channels (KV1.1) of the mammalian nervous system, has been used to study the 
functional role of KV channels (Laraba-Djebari et al., 1994). Binding of kaliotoxin to their targets induces an ion 
transfer dysfunction which could be responsible for the induced specific pharmacological properties. 
Ionic imbalance induced by kaliotoxin 
Injection of kaliotoxin to mice induced an electrolyte dysfunction accompanied by modification of seric levels of 
Ca++, Na+ and K+ (Figure 1). These electrolyte changes (hypercalcemia, hyponatremia and hypokalimia, 
respectively) may be associated with kaliotoxin binding to its targets. This could be responsible for the 
hyperexcitability-induced massive release of cathecholomines and acetylcholine which are the cause of the 
toxin-induced pathophysiological effects (Ismail, 1995; Possani et al., 1999). 
Tissue damage and biochemical modification induced by kaliotoxin 
Inoculation of the purified kaliotoxin by intracerebroventricular route induced severe disturbance of nervous 
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and cardiopulmonary functions. This tissue damage was observed in the cerebral cortex (oedema, hemorrhage, 
necrosis and neuronal darkness), myocardium (interstitial oedema, hemorrhage and hypertrophy) and 
pulmonary parenchyma (interstitial oedema and thickening of interalveolar septa). It was also accompanied by 
an important increase in some biomarker levels of the vital organes [creatine phosphokinase (CPK) and lactate 
dehydrogenase (LDH)]. 
 
Figure 1. Seric levels of Ca++ (A), Na+ (B) and K+ (C) of intoxined mice with kaliotoxin (electrolyte disturbance). 
Figure 1. Taux des électrolytes Ca++ (A), Na+ (B) et K+ (C) au niveau du sérum des souris intoxinées avec la kaliotoxine 
(déséquilibre électrolytique). 
Tissue alterations of organs can be explained by the release of cholinergic and adrenergic neuromediators from 
sympathetic and parasympathetic nerve terminals induced by the binding of scorpion toxins to their targets 
(Ismail, 1995; De Davila et al., 2002). The presence of metabolic enzymes in the blood serum is usually used as a 
marker for the in vivo diagnosis of tissue injuries. High seric levels of the enzymes CPK and LDH are most likely a 
consequence of cerebral, myocardial and pulmonary damage. Hence, after extensive tissue destruction, these 
enzymes are known to be released into the serum (Daisley et al., 1999; Adi-Bessalem et al., 2008). 
Inflammatory response 
The inflammatory response was analyzed by evaluation of the recruitment of cell population in the vascular 
compartment and cell infiltration in tissue. The obtained results showed that kaliotoxin injection induced an 
inflammatory response marked by the presence of neutrophils followed by lymphocytes, monocytes, 
eosinophiles and basophiles in sera. A significant increase in eosinophil peroxidase activity (EPO) and 
myloperoxydase (MPO) was observed in the brain and lungs, indicating an infiltration of eosinophiles and 
neutrophiles in these organs. 
Leukocyte recruitment at the site of injury is involved in the host defense against offending agent and is a 
key mediator in the inflammatory response. Neutrophiles are usually the cell type that reaches the site of injury 
and predominates in an immediate inflammatory reaction (Smith, 1994). 
Conclusion 
The present results show that the fixation of kaliotoxin to its targets induces an ion transfer’s dysfunction which 
could be responsible for the induced complex pathophysiological effects such as tissue damage, metabolic 
alterations and inflammatory response. These results strongly suggest the involvement of ionic balance in 
various regulations (nervous and cardio-respiratory systems, inflammatory reaction). 
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Abstract 
Scorpion venom components act as a toxic agent that influence immune response including 
leukocyte, cytokine and reactive oxygen species release. Tissue damage and acute lung injury 
following envenomation by Androctonus australis hector (Aah) is in part due to the activation of 
this response. However, the cellular and molecular mechanisms remain unclear. The present 
study was undertaken to analyze the toxic effects of Aah venom on cell lines. Biochemical 
analyses were also conducted to evaluate oxidative/antioxidative balance disorders induced after 
cellular stimulation. The results showed that Aah venom induced cytotoxic effects on splenocytes 
isolated from BALB/c mice and Vero cells in a time- and dose-dependent manner. Hydrogen 
peroxide production increase was observed at 24 h in the supernatant of cell culture compared to 
the control. In addition, lipid peroxidation was also induced in the same manner, as measured by 
malonaldehyde (MDA) production, with mobilization of glutathione. Lactate deshydrogenase 
(LDH) release into extracellular medium and in the supernatants of spleen cultures indicated a 
decrease of cell viability, probably due to cell membrane damage. This release in supernatants 
and the fragmentation of cellular DNA could be the consequence of oxidative stress responsible 
for cell membrane alterations leading to the inhibition of some enzymatic activities. 
Cytotoxicité et activités antioxydantes du venin de scorpion sur des 
lignées cellulaires 
Les venins de scorpions agissent comme des agents toxiques sur la réaction immunitaire 
induisant l’activation des leucocytes, des cytokines et des espèces réactives d'oxygène. Des 
altérations tissulaires et la formation d’un œdème aigu, suite à l’envenimation par le scorpion 
Androctonus australis hector (Aah) sont la conséquence de cette activation. Cependant, les 
mécanismes cellulaires et moléculaires induits par le venin d’Aah demeurent méconnus. Cette 
étude a été entreprise pour analyser les effets toxiques du venin sur des lignées cellulaires. Une 
analyse biochimique a été également menée afin d’évaluer les perturbations au niveau de la 
balance oxydative/antioxydative induites après stimulation cellulaire. Les résultats obtenus 
montrent que le venin présente des effets cytotoxiques, qui dépendent de la dose et du temps, 
sur les splénocytes isolés à partir de souris BALB/c et des cellules Vero. L'augmentation de la 
production d’H2O2 a été observée après 24 h dans les surnageants de culture cellulaire comparés 
au témoin. Par ailleurs, le venin induit une peroxydation lipidique évaluée par une production du 
malonaldéhyde (MDA) et une mobilisation de glutathion. La libération de lactate déshydrogénase 
(LDH) dans le milieu extracellulaire et dans les surnageants de culture cellulaires serait due aux 
altérations de la membrane cellulaire. La fragmentation de l’ADN cellulaire pourrait être 
également la conséquence d’un stress oxydatif responsable des changements cellulaires et de 
l'inhibition de quelques activités enzymatiques. 
Keywords : Cell lines, cytotoxicity, oxidative stress, venom. 
 
Introduction 
The pathogenesis caused by scorpion envenomation could be a model to understand the complex immune 
response. In this model, inflammatory response is essential for structural and functional repair of injured tissue 
observed in scorpion pathology (Adi-Bessalem et al., 2008; Petricevich, 2010). 
Tissues damage during inflammation by two separate oxidative pathways involves the synthesis of 
superoxide anion and the production of various cytokines, active substances and enzyme activities. Spleen cells 
refer to cells that line hollow organs and glands and those that make up the outer surface of the body and 
constitute another inevitable target. Kidney tissues also constitute an inevitable target for action of different 
components. Therefore, these cell lines are an appropriate in vitro model system to evaluate the toxicity and 
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the events involved in the cell death caused by Androctonus australis hector (Aah) venom. The aim of this 
study was to assess the direct action of venom on cultured cells. Cytotoxicity of Aah venom was determined on 
splenocytes and renal cell lines. 
Effects of Aah scorpion venom on cell viability 
Cytotoxicity was studied for the two types of cells. The studies were performed under similar conditions to 
enable a direct comparison of the results in order to evaluate the effects of Aah venom on viability of monkey 
(Vero) and mice spleen cell lines. Growing cultures of cells were exposed to venom at doses ranging from 0 to 
100 µg/ml for 24, 48 and 72 h. As shown in Figure 1, a dose-dependent decrease of cell viability was clearly 
observed with increasing venom doses. Interestingly, when exposed to various venom doses, spleen cells were 
more strongly affected than the Vero cell lines (Figure 1). The Aah venom doses producing 50% of cytotoxicity 
(ID50) were 17 µg/ml for spleen cells and 85 µg/ml for Vero cells. It is well known from the literature that crude 
or purified components of venom are likely to contain bioactive compounds which may be responsible for, or 
contribute to, the observed toxicity since cells exposed to these several components showed decreased cell 
viability. Hence, morphological defects inhibit functional activities, the metabolism of cells, or lead to a 
particular activation stage of these cells that exhibits oxidative stress (Kumar et al., 2003). 
 
Figure 1. Effect of Aah venom dose on spleen and Vero cells. Cells were incubated for 48 h in 
RMPI-1640 medium containing various doses of Aah venom. Cells were isolated from BALB/c 
mice (1 × 106 cells/ml), and cultured in 96-well flat-bottomed microtiter. Each value represents 
the mean ± standard deviation (n = 3). * P ≤ 0.05 and ** P ≤ 0.001, versus control. 
Figure 1. Effet de la dose de venin Aah sur les splénocytes et les cellules Vero. Les cellules ont 
été incubées pendant 48 h dans un milieu RMPI-1640 contenant des doses croissantes de venin 
Aah. Les cellules ont été isolées à partir de souris BALB/c (1 × 106 cellules/ml) et mises en 
culture dans des microplaques de 96 puits à fond plat. Chaque valeur représente la moyenne 
± la déviation standard (n = 3). * P ≤ 0,05 et ** P ≤ 0,001, versus contrôle. 
Assessment of antioxidant activity 
Malonaldehyde (MDA) level, an index of lipid peroxidation, and glutathione were analyzed 
spectrophotometrically. The rate of MDA and glutathione increased according to the venom doses (10, 17, 34, 
51, 68 and 85 µg/ml), 48 h after cell culture. However, the increase in the MDA rate was significantly more 
important for Vero lines (Table 1). The onset of lipid peroxidation persisted for several hours, suggesting an 
important role from oxidative stress in the cell cytotoxicity induced by Aah venom. Aah venom induced also an 
increase in superoxide anion (H2O2) in spleen cells. The production of superoxide anion might be due to 
receptor competition, superoxide dismutase and/or catalase activities. Cell death was investigated by 
measuring the release of lactate dehydrogenase (LDH) in the culture medium. The intracellular LDH was found 
to be released when cell membrane damage occurred and/or when the cells were visibly dead. Cell membrane 
integrity can be assessed by monitoring the passage to the outside of substances that are normally sequestered 
into cells. LDH has been identified and allowed to measure relative numbers of live and dead cells within the 
same cell population (Decker et al., 1988). 
Lipid peroxidation and H2O2 products are known to be highly reactive or even toxic compounds associated 
with oxidative stress induction. These substances, when produced in high amounts, may cause disturbances in 
cell functions and subsequent pathophysiological action. 
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Table 1. Effects of Aah venom (10 µg/ml) on oxidative/antioxidative balance, 48 h after cell stimulation.  
Tableau 1. Les effets du venin d’Aah (10 µg/ml) sur la balance oxydative/antioxydative, 48 h après stimulation cellulaire. 
Samples H2O2 
(µmoles) 
MDA 
(nM) 
Glutathione 
(nmole/min) 
LDH 
(U/l) 
Control 25.00±1.03 90.00± 5.56 2.25±1.30 100.0±8.8 
Spleen cells 125.0±11.5 150.0±10.7* 3.25±1.40 190.0±11.9 
Vero cells ND 225.0±10.7** 3.5±1.5 ND 
Each value represents the mean ± standard deviation (n = 3). * P ≤ 0.05 and ** P ≤ 0.001, versus control. 
Chaque valeur représente la moyenne ± la déviation standard (n = 3). * P ≤ 0,05 et ** P ≤ 0,001, versus contrôle. 
Conclusion 
The present results, regarding the Aah venom cell toxicity, could be the way through which oxidative stress is 
mediated. This may help to determine whether oxidative stress or proteases are involved in the 
cardiopulmonary damages caused by the venom. However, understanding the molecular cell cytotoxicity 
mechanisms following envenomation, as well as characterization of the venom compounds responsible for the 
observed effects, have yet to be determined. 
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Abstract 
Cerastes cerastes snake venom contains diverse proteins with a variety of biological and 
physiological activities. Most of them are proteases which are the largest group of proteins in 
Viperidae venoms. In this study, we describe the requirement of zinc in the metalloproteinase 
activity of CCSV-MPase. CCSV-MPase hydrolyzes natural substrates such as casein, haemoglobin 
and fibrinogen. It also hydrolyzes benzoyl-L-arginine-ethyl-ester (BAEE) as a synthetic substrate. 
The proteolytic and esterasic activities of CCSV-MPase were inhibited by ethylene diamine 
tetraacetic acid (EDTA) and 1.10 O-phenantroline, chelators of bivalent cation metals and Zn2+, 
respectively. CCSV-MPase is therefore a zinc-metalloproteinase with fibrinogenase activity. 
Hence, CCSV-MPase hydrolyzes the Bβ chain of human fibrinogen in vitro, releasing fibrinopeptide 
B only. This fibrinolytic activity was also found to be inhibited by 1.10 O-phenantroline. Proteomic 
analysis of CCSV-MPase, using LCMS/MS, revealed some sequence similarities between CCSV-
MPase and five Zn2+-metalloproteinases from other venoms. 
Zn2+ : un ion nécessaire aux activités biologiques et enzymatiques de 
la métalloprotéinase procoagulante (CCSV-MPase) isolée à partir du 
venin de Cerastes cerastes 
Le venin du serpent Cerastes cerastes contient une variété de protéines ayant des activités 
biologiques et physiologiques diverses. La plupart d'entre elles sont des protéinases constituant le 
plus grand groupe de protéines dans les venins de Viperidae. Dans cette étude, nous décrivons la 
nécessité de l'ion zinc pour les activités enzymatiques et biologiques d'une métalloprotéinase 
appelée CCSV-MPase. CCSV-MPase hydrolyse des substrats naturels tels que la caséine, 
l'hémoglobine et le fibrinogène, ainsi que le benzoyl-L-arginine-éthyl-ester (BAEE) comme 
substrat synthétique. Les activités protéolytiques et estérasiques de la CCSV-MPase sont inhibées 
par l'acide éthylène diamine tétraacétique (EDTA) et le 1,10 O-phénantroline. CCSV-MPase est 
donc une Zn2+-métalloprotéinase ayant une activité enzymatique sur le fibrinogène. Ainsi, CCSV-
MPase hydrolyse la chaîne Bβ du fibrinogène humain in vitro, libérant seulement le fibrinopeptide 
B. Cette activité fibrinolytique est aussi inhibée par le 1,10 O-phénantroline. L’analyse 
protéomique de CCSV-MPase par LCMS/MS a révélé quelques similitudes de séquence entre 
CCSV-MPase et cinq autres Zn2+-métalloprotéinases isolées à partir d’autres venins. 
Keywords : 1.10 O-Phenantroline, β-fibrinogenase, proteomic analysis, zinc-metalloproteinase. 
 
Introduction 
Viperidae and Crotalidae venoms are rich sources of hydrolytic enzymes which produce a complex pattern of 
clinical and toxic effects such as haemorrhage and blood-clotting disorders because they act at various steps of 
blood coagulation (Rivière and Bon, 1999; Braud et al., 2000; Castro et al., 2004; Castro and Rodriguez, 2006; 
Kornalik, 1990; Liu et al., 2006). These components have antagonist functions, while some of them act 
synergistically (Laraba-Djebari et al., 1995). Among these components, metalloproteinases are widely found in 
Viperidae venoms. They may cause local haemorrhage following accidental or experimental envenoming 
(Kamiguti, 2005; Chérifi et al., 2010). Some of these metalloproteinases are known to display fibrino(gen)lytic 
activity. 
Cerastes cerastes venom is a mixture of bioactive molecules. Some molecules isolated from this venom act on 
blood coagulation, i.e. three phospholipases A2 (Laraba-Djebari and Martin-Eauclaire, 1990; Zouari-Kessentini et 
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al., 2009) and thrombin-like enzymes, coagulant fraction V (El-Asmar et al., 1986), proteinase RP34 (Laraba-
Djebari et al., 1992), afaâcytin (Laraba-Djebari et al., 1995), cerastotin (Marrakchi et al., 1997a), cerastocytin 
(Marrakchi et al., 1997b), anticoagulant protease fraction (Chérifi and Laraba-Djebari, 2007), and aggregant 
serine protease (Chérifi and Laraba-Djebari, 2008). Only two metalloproteinases have been recently purified from 
Cerastes cerastes venom: haemorrhagic metalloproteinase CcH1 (Boukhalfa-Abib et al., 2009) and non-
haemorrhagic metalloproteinase CCSV-MPase (Chérifi et al., 2010). Proteomic analysis of Cerastes cerastes 
venom has shown the presence of at least 37 Zn2+-metalloproteinases (Bazaa et al., 2005). CCSV-MPase was 
identified by proteomic study (Chérifi et al., 2010). Here, we report requirement of Zn2+ for its activities. 
MALDI MS/MS analysis and identification of CCSV-MPase 
For mass spectrometry (MS) analysis of CCSV-MPase, 4800 MALDI TOF/TOF Analyzer was operated in positive 
reflector ionization mode (m/z range: 800 to 4000). 3000 laser shots/spot were used to ensure S/N quality for 
precursor selection. Internal calibration of the MS spectra using the Glu-1 fibrino peptide B ([M+H]+ = 
1570.670) was performed automatically. For the MS/MS experiment, 2 kV positive CID ON methods were 
chosen. Non-redundant ions with a S/N> 30 were selected as precursors and submitted to CID fragmentation 
(4000 laser shots/precursor, up to 15 precursors/spot). MS/MS queries were carried out using a local copy of 
MASCOT search engine 2.1 embedded into GPS-Explorer Software 3.5 on the NCBInr database. MASCOT files of 
the identified proteins were re-tested with Scaffold software which used two independent search engines 
(MASCOT and X! Tandem) and a workflow including PeptideProphet (peptide filtering) and ProteinProphet 
(protein identification filtering). The results obtained with two search engines were then automatically 
combined, and only proteins with a minimum of two distinct peptides (peptide confidence index ≥ 95) and a 
protein confidence index ≥ 95% were taken into consideration. 
Proteomic analysis led to 312 collected fractions after off-line nano liquid chromatography of digested CCSV-
MPase. Overall; 1207 MS/MS spectra were acquired. Analysis LC/MS/MS of tryptic fragments of CCSV-MPase 
showed some sequence similarity with other metalloproteinases isolated from other venoms (Table 1). 
Table 1. Some identified proteins by LC-MALDI-MS/MS with sequence similarit ies to CCSV-MPase. 
Tableau 1. Quelques protéines identifiées par LC-MALDI-MS/MS ayant une homologie de séquence avec la CCSV-MPase.  
Protein  Accession 
number 
Species Molecular 
mass (kDa) 
Peptide 
number 
Scaffold protein 
confidence index 
Group III snake 
venom 
metalloproteinase 
gi| 83523642 Echis oecllatus 69714 3 100 
Zinc 
metalloproteinase- 
brevilysin-H6 
gi|190358877 Gloydius blomhoffi 
brevicaudus 
68199 2 998 
Zinc metalloproteinase 
berythractivase  
gi| 82216043 Bothops 
erythmelas 
68513 3 100 
Disintegrin CV-11beta gi|123913579 Cerastes vipera 7000 3 100 
Effect of inhibitors on the enzymatic activities of purified CCSV-MPase 
Various inhibitors were used to determine the metal ion effect on the CCSV-MPase activities. Enzymes were 
pre-incubated with 5 mM ethylene diamine tetraacetic acid (EDTA), ethylene glycol tetraacetic acid (EGTA), 
phenylmethylsulfonyl fluoride (PMSF), heparin, 1.10 phenanthroline, antithrombin III and aprotinin (Figures 1 
and 2). Activities were measured using casein and benzoyl-L-arginine-ethyl-ester (BAEE) as natural and 
synthetic substrates, respectively. 
 
Figure 1. Inhibitor effect of CCSV-MPase proteolytic activity. 
Figure 1. Effet des inhibiteurs sur l’activité protéolytique de CCSV-MPase. 
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Figure 2. Inhibitor effect on arginine ester hydrolase activity of CCSV-MPase. 
Figure 2. Effet des inhibiteurs sur l’activité arginine ester hydrolase de CCSV-MPase. 
The use of inhibitors indicated that only EDTA and 1,10 phenanthroline inhibit completely the proteolytic 
activity of CCSV-MPase while PMSF, heparin, aprotinin and EGTA have no significant effect on this activity. 
These results strongly suggest that CCSV-MPase could be a zinc-dependant metalloproteinase with no 
requirement of Ca2+ for its catalytic activity. 
Conclusion 
CCSV-MPase is a metalloproteinase displaying a proteolytic activity on natural and synthetic substrates. This 
proteolytic activity is sensitive to EDTA as a chelator of all bivalent ions as well as to 1.10 O-phenantroline, a 
unique specific chelator of zinc. However, both enzymatic and biological activities of CCSV-MPase are non-
affected by the presence of EGTA, a specific chelator of calcium. Regarding the chelator action and the 
sequence analogies between CCSV-MPase and other previously isolated Zn2+-metalloproteinases, it seems that 
Zn2+ is required for biological and enzymatic activities of CCSV-MPase. 
The partial amino acid sequence of CCSV-MPase was identified by MALDI-TOF MS/MS analysis. CCSV-MPase 
has 15 amino acids in common with group III snake venom metalloproteinase isolated from Echis ocellus and 
39 amino acids with zinc-metalloproteinase-disintegrin berythractivase purified from Bothrops erythromelas. 
Proteomic approach of CCSV-MPase leads to classify this metalloproteinase into the P-III class of snake venom 
metalloproteinases containing a proteinase domain and two other domains: disintegrin-like metalloproteinase 
and cystein-rich domain. 
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Abstract 
Ophidian envenomation is a serious public health problem in many countries in the world. Over 5 
million of the accident cases occur each year causing more than 100,000 deaths. In Africa, more 
than 20,000 deaths per year are registered and 400,000 victims of envenomation keep severe and 
permanent functional sequels. In Morocco, the snake bites are frequent and of greater severity in 
children. They occur mostly in rural areas. The incidence of these bites remains poorly understood 
and largely underestimated. The epidemiological data are not well known due to the absence of a 
national registry, as well as non-medical intensive care of a significant proportion of envenomed 
that use only traditional treating methods. Better characterization of the biological activities of 
Morocco snake venoms is of great importance, not only to elucidate the molecular mechanisms of 
the venom action, but also to seek new approaches for the patient treatment. In this study, we 
report a preliminary venom characterization of Cerastes cerastes (Cc) and Vipera lebetina (Vl) and 
the cross-reactivity that may exist between their venoms and Bitis arietans (Ba). These venoms are 
known to be very toxic and contain several proteins that differ by molecular weights. Interestingly, 
both Cc and Vl venoms are characterized by a high hemorrhagic and phospholipase A2 activities and 
their ability to degrade the  and γ chains of fibrinogen. They display a very low proteolytic activity 
with the casein test. After injection in mice, Cc and Vl venoms induce myonecrosis in skeletal and 
cardiac muscles that is most likely the consequence of a direct action of myotoxins and an indirect 
action of hemorrhagic molecules present in the venoms. In mice, this myonecrosis produces a 
decrease of creatine phosphokinase concentration in the muscle and its increase in the serum. As 
expected, Cc venom is a good immunogen and induces high protective antivenom against Vl and Ba 
venom antigens, higher than that of the antivenom produced against the Vl venom. 
Caractérisation préliminaire des venins des serpents les plus 
dangereux du Maroc 
Les envenimations ophidiennes constituent un sérieux problème de santé publique dans de 
nombreux pays du monde. A l’échelle mondiale, plus de 5 millions de cas d'envenimations 
surviennent chaque année provoquant plus de 100 000 décès. En Afrique, plus de 20 000 décès 
sont enregistrés et 400 000 victimes d'envenimation gardent des séquelles fonctionnelles graves et 
permanentes. Au Maroc, les morsures de serpents, principalement des vipères, restent fréquentes 
et de gravité plus importante chez l’enfant. Elles se produisent surtout en milieu rural. L’incidence 
réelle de ces morsures et leur gravité restent mal connues et largement sous-estimées. Les données 
épidémiologiques restent mal connues du fait de l’absence d’un registre national et de la non-
médicalisation d’une proportion importante des patients victimes d’envenimation et recourant à des 
procédés traditionnels. Ainsi, une meilleure caractérisation de l'activité biologique des venins de 
serpents est très importante, non seulement pour élucider certains mécanismes moléculaires, mais 
aussi afin de rechercher de nouvelles approches pour le traitement des patients. Ce travail porte sur 
une caractérisation préliminaire des venins de Cerastes cerastes (Cc) et de Vipera lebetina (Vl) et 
l’étude des immunoréactivitées croisées entre les venins de ces deux vipères et celui d’une autre 
vipère Bitis arietans (Ba). Nous avons montré que les venins Cc et Vl sont très toxiques et 
contiennent plusieurs protéines qui diffèrent par leur poids moléculaire. Ces deux venins possèdent 
une faible activité protéolytique sur les tests standards et une très forte activité hémorragique et 
phospholipasique. Ils ont aussi la capacité de dégrader les sous-unités  et γ du fibrinogène. Suite à 
une injection, les venins Cc et Vl induisent une nécrose des muscles squelettique et cardiaque qui 
serait la conséquence d’une action directe des myotoxines et indirecte des hémorragines des 
venins. Cette myonécrose produit une diminution de la concentration en créatine phosphokinase au 
niveau musculaire et son augmentation au niveau sérique. Soulignons que le venin Cc est un très 
bon immunogène capable d’induire la production d’un antivenin possédant un pouvoir protecteur 
contre les antigènes des venins Vl et Ba. Cette capacité protectrice est plus élevée que celle 
engendrée par l’antivenin produit spécifiquement contre le venin Vl. 
Keywords : Biological activities, cross reaction, snake venom. 
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Introduction 
In North Africa, there are many species of front fanged snakes but only a few are known to be dangerous. The 
foremost medically important species belong to Viperidae [i.e. Cerastes Cerastes, Cc (horned viper); Bitis 
arietans, Ba; Vipera mauritanica (Vipera lebetina, Vl] which were reported as dramatically responsible for 
hemorrhagic effects (Chippaux and Goyffon, 1998) and Elapidae family of snakes (i.e. Naja haje, Nh) mostly 
incriminate in neurotoxic effects (Chippaux and Goyffon, 2006). The majority of bites (53% of venomous 
animal bites and 5.6% of registered lethality) occur in rural areas during the summer season. They are inflicted 
on the feet or ankles, most of the time during the evening when people tread on snake, sometimes at night 
while sleeping or moving. In Morocco, most snake bite envenomings are inflicted by snakes belonging to 
Viperidae and Elapidae families (Chani et al., 2008). 
Venom glands are very specialized tissues that possess a high capacity of protein secretion, and are a rich 
source of active proteins. Snake venoms are known to contain a complex mixture of pharmacologically active 
molecules, including organic and mineral components, small peptides and proteins. According to their major 
toxic effect, snake venoms may be conveniently classified as neurotoxic (Elapidae) or hemorrhagic (Viperidae). 
For instance, envenomings by Vipera lebetina and Cerastes cerastes are characterized by hemorrhage and 
abnormalities in the blood coagulation system, while the venom of the cobra Naja haje is mainly neurotoxic and 
affects the nervous system (Chippaux et al., 1999). 
Viperidae snake venoms contain a number of different proteins (i.e. proteases, fibrinolytic enzymes) that 
induce alterations in the blood coagulation cascade and interfere with the normal haemostatic system and tissue 
repair, resulting usually in an observed persistent bleeding. Studies on patients envenomed by some species of 
the Viperidæ family revealed a fascinating variation in clinical manifestations, ranging from neurological 
perturbations to increased capillary permeability and edema. These pathological outcomes may be due to the 
additive or synergistic effects of various enzymes and toxins present in the venom (Teixeira et al., 2005). 
Fighting measurement against envenoming and concomitantly to the symptomatic handling, specific 
treatment consisting of immunotherapy, using polyvalent antivenom, is still of great importance. When 
administered at due time, antivenom is considered as the only efficient treatment of snake envenomed 
patients. Experimental data and clinical observations confirmed the rapid venom neutralizing effect of potent 
antivenom (Chippaux and Goyffon, 1998; Quesada et al., 2006). However, to produce effective and safe 
antivenom, more precise biological and biochemical characterizations of the venom composition and analysis of 
the neutralization capacity of antivenom are essential. This prompted us to look for the venom biochemical 
contains and to investigate the enzymatic and biological properties of the most endemic snake venoms in 
Morocco: Cerastes cerastes and Vipera lebetina. In this paper, we studied the immune cross reactivity between 
Cc and Vl venoms and compared to Ba venom (one of the most dangerous viper in Morocco) with the main 
objective to identify the best candidates (venom or a mixture of venoms) to address the best way to produce 
the most efficient and protecting antivenom. 
Material and methods 
Venoms 
Cc, Vl, Ba and Nh venoms were extracted by manual stimulation, centrifuged, lyophilized and kept at -20°C at 
the experimental Center of Pasteur Institute of Morocco. 
Protein content 
The protein content of venoms samples was determined by the colorimetric method of Markewell et al. (1978). 
Bovine serum albumin (BSA, Sigma) was used for standard assay. 
SDS-polyacrylamide gel electrophoresis 
Sodium dodecyl sulfate - polyacrylamide gel electrophoresis (SDS-PAGE) was carried out as previously 
described (Laemmli, 1970). Samples were pretreated under reducing conditions (using β-mercaptoethanol). 
Determination of median lethal dose 
Swiss strain male mice of 2 months aged, weighing 18-20 g, were used. All the procedures involving animals 
were in accordance with the ethical principles in animal research adopted by the World Health Organization 
(WHO, 1981). 
Lethal potency of venom (in µg per mice) was assessed by intravenously routes as recommended by the 
World Health Organization (WHO, 1981). Increasing amounts were injected into mice (groups of five mice) in 
final volumes of 500 µl. Percent of mortality was recorded 24 h after injections. The median lethal dose (LD50) 
was determined according to the method described by the Software package (Prism 4 5GraphPad, Inc.). 
Proteolytic activity 
Proteolytic activity was estimated using casein as substrate, according to previously described method 
(Lomonte and Gutiérrez, 1983). Venoms were used at 50, 100 and 200 μg doses. Blank was made without 
venom sample. The caseinolytic activity was expressed in U/mg, i.e. as following: AU/mg = (ΔA280/mg of 
venom) × 100. 
Procoagulant activity 
Coagulant activity was determined in human plasma (Theakston and Reid, 1983). Citrated blood samples 
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(1 volume of 129 mM trisodium citrate and 9 parts of blood) were centrifuged at 1,700 g for 15 min at 4°C and 
plasma was recovered. The coagulation activity was estimated after addition of venom serial dilutions. The 
minimum coagulant dose (MCD) was defined as the least amount of venom resulting in clot formation of human 
plasma through 60 s at 37°C. 
Phospholipase A2 activity 
The phospholipase A2 activity was determined as described by Holzer and Mackessy (1996). Specific activity 
was expressed as following: produced substrate nM/min/mg of venom. 
Hemorrhagic activity 
Hemorrhagic activity was assessed as described by Kondo et al. (1960) and modified by Theakston and Reid 
(1983). Increasing venom doses (15 to 31 µg in 50 µl of saline solution) were injected by intradermal route 
(i.d.) in mice. Hemorrhagic measurements were recorded after 2 h, according to the kinetics assay (after this 
time interval, the hemorrhagic areas are reabsorbed; Furtado et al., 1991). Diameters were measured and the 
minimum hemorrhagic dose (MHD) was defined as the venom dose that induced a lesion of 10 mm diameter. 
All procedures involving the use of animals were approved by the Ethical Committee for the Use of Animals 
(WHO, 1981). 
Histological study 
To analyze the histopathological effects of venom, two groups of six mice were used. Each mouse received a 
sublethal dose of venom by intraperitoneal route (i.p.). The animal was sacrificed 60 min after venom injection, 
and organ tissues of 5 µm thickness were investigated through microscopic examination.  
Assay of creatine phosphokinase in the blood  
Assay of creatine phosphokinase (CPK) concentration in blood were performed after 3 h of venom injection. 
Serum was recovered from blood by centrifugation. CPK measurement was performed according to the 
recommendations of the sheets of the Chemistry Kodak VITROS System (USA).  
Fibrinogenolytic activity 
Proteolytic activity upon fibrinogen was measured as described by Rodrigues et al., (2000) with some 
modifications. Fibrinogen solution (2mg/ml) in 20 µl phosphate buffered saline (PBS) was incubated with 
venom dilution at 37°C for 2 h. Fibrinogenic activity was stopped using 20 µl of a solution containing 10% (v/v) 
glycerol, 10% (v/v) β-mercaptoethanol, 2% (v/v) SDS and 0.05% (w/v) bromophenol blue. Fibrinogen 
hydrolysis was demonstrated using SDS-PAGE. 
Antivenom production 
Monospecific antivenom was produced as follows. Horses were hyper-immunized subcutaneously with 
increasing doses of Cc or Vl venom, at multiple sites near the lymphatic system. Complete Freund Adjuvant 
(CFA) was used for primary immunization and incomplete Freund Adjuvant (IFA) for secondary immunization. 
Boosts were made using a saline solution (0.85% NaCl). Hyper-immunization program was assessed by 
injection of same dose, at two weeks intervals, until the antibody titer reaches a high level. At the end of the 
immunization program, horses were bled, plasma proteins fractionated by precipitation with ammonium sulfate 
and immunoglobulins enzymatically digested to produce F(ab’)2 fragments. The fractions containing F(ab’)2 
fragments were extensively dialyzed against saline solution (Raw, 1991). 
Double immunodiffusion for the control of the specificity of the antivenom 
Double immunodiffusion assay was performed using slides containing 5 ml of 1% Agarose (Sigma) in PBS (pH 
7.4). Wells were punched and filled with 20 µl of 20 mg/ml venom proteins or with 100 µl of antivenom 
solution. After 48 h incubation at 37°C, the slides were washed with 0.15 M NaCl for 72 h, the solution being 
changed each 12 h, before dried at 37oC and stained with Coomasie Brilliant Blue R (Bio-Rad). 
Determination of effective doses (ED50) 
A fixed amount (3 LD50) of venom was incubated with increasing (0 to 300 µl) volumes of antivenom, for 30 
min at 37°C. Each mixture (0.5 ml) was injected by i.p. and intravenous (i.v.) routes into five mice. Death was 
recorded up to 48 h. As control, mice received 3 LD50 of venom without antiserum treatment. Data were 
analyzed using the method of the Software package (Prism 4 5GraphPad, Inc.), and effective neutralization was 
expressed as effective dose 50% (ED50). ED50 was defined as the volume (µl) needed to prevent death in 50% 
of the injected mice with 3 LD50 venom dose. 
Results 
Protein content and lethal dose 50% (LD50) of snake venoms 
Mice were used throughout to evaluate the toxicity of tested venoms. First, we estimated the protein 
concentrations, using BSA as standard. Our results showed that 1 mg of lyophilized venom contains 1,000 µg of 
Vl proteins and about 987 µg of Cc proteins. Thus, we considered 1 mg of venom has an average of 1 mg of 
proteins. Herein, protein is corresponding to the total dry weight venom used to study biological effects. 
Toxicity was assessed by i.v. injection of increasing amount of venom. The toxicity assessment was repeated 
three times. The Cc venom is the most toxic with an LD50 of 5.75 µg/mouse; Vl venom displays an LD50 that 
average 5.97 µg/mouse. However, Ba venom is approximately 10 fold less toxic (LD50 of 52.54 µg/mouse). 
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Biochemical characterization of Cerastes cerastes and Vipera lebetina venoms 
The SDS-PAGE protein profiles were analyzed following coomassie blue staining. Figure 1 shows that all venoms 
differ in composition, number and intensity of peptide bands. According to the molecular weight makers, both 
Cc and Vl venoms contain three major classes of proteins with relative molecular weights (MW) of 
approximately 14, 30 and 67 kDa. However, Nh venom profile reveals protein bands of lower molecular weights 
with ranging values from 21 kDa to less than 10 kDa. Interestingly, Cc venom presents richer number of 
protein bands. 
In comparison, a number of protein bands showing singular molecular masses and present in Cc venom 
were absent in Vl venom profiles. Moreover, intensity of the protein bands is variable suggesting disparity in 
quality and quantity of the venoms’ protein composition. 
 
Figure 1. SDS-PAGE profiles of venoms. Electrophoretic separation of venom was performed on a 
vertical slab of 15% acrylamide under reducing condition. Lane 1: molecular mass markers (kDa); 
Lane 2: Cc venom sample; Lane 3: Vl venom sample; Lane 4: Nh venom sample. The markers 
indicated in the left are expressed as kDa. Gel was stained using Coomassie blue. 
Figure 1. Profil de SDS-PAGE des venins. La séparation électrophorétique des venins a été réalisée 
sur une un gel vertical de 15% d'acrylamide dans des conditions réductrices. Piste 1: marqueur de 
poids moléculaire (kDa); Piste 2: venin de Cc; Piste 3: venin de Vl; Piste 4: venin de Nh. 
Proteolytic, coagulant and phospholipase A2 activities 
Casein substrate was used to determine the proteolytic activity displayed by snake venoms. According to the 
results, proteolytic activity is estimated of 31 ± 1.5 U/mg and 20.2 ± 6.0 U/mg for of Vl and Cc venoms, 
respectively. 
A procoagulant activity in human plasma was detected for both Cc and Vl venoms. Compared to value 
recorded for the positive control (8.00 ± 2.67 nM/min/mg, Crotalus durissus terrificus venom), Cc venom 
showed higher phospholipase activity (25.0 ± 3.0 nM/min/mg) when compared to Vl (7.0 ± 5.0 nM/min/mg) 
and Nh (6,7 ± 4.0 nM/min/mg) venom activities. Among all recorded phospholipase activity, we conclude that 
Cc venom present the most intensive one. 
Hemorrhagic activity 
Intradermal injection was used to estimate hemorrhagic potency of the venoms. Our results show that Cc and 
Vl venoms are endowed with a hemorrhagic feature. This activity is dose dependent and proportional to the 
injected dose (Figure 2). 
 
 
 
Figure 2. Recording of hemorrhagic activity of 
Cc (A, B, C, D) and Vl venoms (A’, B’, C’, D’) 
of the "Skin-Test". This activity is dose 
dependent. A: control, B: 5 μg, C: 10 μg, D: 
20 μg of injected venom. 
Figure 2. Détermination de l’activité 
hémorragique du venin de Cc (A, B, C, D) et Vl 
(A’, B’, C’, D’) par le "Skin-Test". L’activité est 
dépendante de la dose. A: contrôle, B: 5 μg, C: 
10 μg, D: 20 μg de venin injecté. 
The minimal hemorrhagic dose (MHD) was used to evaluate the hemorrhagic power. Our results 
demonstrated that an i.d. inoculation induces a strong hemorrhage with MHD of 0.128 and 0.630 µg/mouse for 
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Cc and Vl venoms, respectively. Nh venom has no hemorrhagic effect, even if we clearly observed the presence 
of edema and myotoxicity symptoms (Figure 3). 
 
Figure 3. Minimum hemorrhagic dose (MHD) of Vl (1), Cc (2) and Nh (3) venoms. 
Figure 3. Détermination de la dose minimale d’hémorragie des venins de Vl (1); Cc (2) et Nh (3). 
Effects of the venoms on muscle metabolism 
Evaluation of enzyme activity of creatine phosphokinase (CPK) in blood is the method used for estimating 
pathological effects such as myonecrosis. The serum CPK concentration was recorded 3 h after induced 
envenomation. For both Cc and Vl venoms, we observed a 3 fold increase of CPK serum concentration and this 
variation was depending on the dose of venoms. 
Change in muscle tissue of mice 
The intramuscular injection of the venom causes tissue changes such as intense hemorrhages, edema, 
myonecrosis and inflammatory infiltrates. The alterations are more severe in the case of Cc venom effect 
analysis (Figure 4). 
 
Figure 4. Effect of sublethal dose of Cc and Vl (7 μg/20g mice) venoms on the intestinal tissue. 
Figure 4. Effet de la dose sublétale (7 μg/20g souris) des venins de Cc et Vl sur les tissus intestinaux. 
Fibrinogenolytic activity 
Vl and Cc venoms have a fibrinolysis activity on two subunits of fibrinogen ( and ). This activity is not 
detected for Nh venom. 
Indeed, the ability of Vl and Cc venoms to degrade  and γ chains of fibrinogen is evident. However, 
degradation of β chain was not detectable (Figure 5). 
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Figure 5. Fibrinogen degradation profile. Lane 1: Nh; Lane 2: Cc; Lane 3: Vl 
venoms; Lane 4: fibrinogen. 
Figure 5. Profil de dégradation du fibrinogène. Piste 1: venin de Nh; Piste 2: 
venin de Cc; Piste 3: venin de Vl et Piste 5: fibrinogène. 
Purity of the plasma fraction containing F(ab’)2 
Purity of plasma and serum fractions containing F(ab’)2 fragments was checked by electrophoresis assay. 
According to our results, the absence of contaminating bands shows the purity of the purified F(ab’)2 
fragments. The concentration of the protein of the antivenom solution was determined and estimated ranging 
about 70 mg/ml (Figure 6). 
 
Figure 6. Electrophoresis profile of serum (A) and purified plasma containing 
F(ab’)2 (B). Analysis of results was made by Software (SDS CELM 60 - Software 
for densitometry scanner). 
Figure 6. Profil d’électrophorèse du sérum (A) et du plasma purifié contenant 
F(ab’)2 (B). 
Control of the specificity of the antivenom 
Qualitative immunodiffusion assay was used to check antivenom specificity against particular venom. Strong 
specific immunoprecipitation was observed among Cc venom and monospecific Cc antivenom. Similar result was 
obtained with Vl venom and its antivenom (Figure 7). For both monospecific antivenoms, the immunoprecipitation 
bands demonstrate the existence of specific antibodies against different venom proteins. 
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Figure 7. Double immunodiffusion of the Cc venom (V) against Cc antivenom (Av) with 
different dilutions (1, 1/2, 1/4 and 1/8) (A) and purified Vl venom against Vl antivenom with 
different dilutions (1, 1/2, 1/4 and 1/8) (B). 
Figure 7. Contrôle de la spécificité des antivenins produits par la technique de double 
immunodiffusion des venins (V) Cc (A) et Vl (B) et de leurs antivenins (Av) respectifs. 
Determination of effective doses (ED50) 
In order to analyze the ability of monovalent Cc and Vl antivenoms in neutralizing the lethal effect of Cc, Vl and 
Ba venoms, in vivo experiments were performed. Table 1 show that both monovalent antivenoms (i.e. Cc and 
Vl antivenoms) were able to neutralize the toxicity of venom molecules responsible for the lethality. Indeed, Cc 
antivenom was more effective in neutralizing Ba venom, with an ED50 of 84.3 µl/mouse, when compared to Vl 
antivenom capacity (ED50 of 117.3 µl/mouse). 
Table.1. Determination of neutralizing effective doses (ED50) in mouse. 
Tableau 1. Détermination de la dose effective de neutralisation, chez la souris. 
ED50 in µl/mouse (95% c.i.) 
Venom Cc antivenom Vl antivenom 
Cerastes cerastes (Cc) 18.7 78.0 
Vipera libetina (Vl) 62.4 48.3 
Bitis arietans (Ba) 84.3 117.3 
Cc antivenom was more effective in neutralizing Vl venom with an ED50 of 62.4 ul/animal than Ba venom 
(ED50 of 84.3 µl/mouse). In the same way, Vl antivenom neutralizing capacity was higher against Cc venom 
than Ba venom (ED50 of 78.0 and 117.3 µl/mouse, respectively). However, the best protective effect is obtained 
with a given antivenom and venom used in the program of immunization (i.e. 18.7 and 48.3 µl/mouse for Cc 
and Vl, respectively). 
Discussion and Conclusion 
The snake bites are common causes of injury and death in several regions of the world where they are 
considered as an important public health problem. Their epidemiology is known only in a fragmentary way and 
is under estimated to 5 million cases of poisoning per year with a mortality rate of 2.5%. 
In Morocco, the vipers are responsible for large number of accidents which may reflect the general 
abundance of this species and the increased level of marked contact. The accidents occurring by these snakes 
are mainly characterized by hemorrhage damage (Chani et al., 2008). 
 The aim of the present study was to evaluate the biochemical characteristics, as well as the enzymatic and 
biological properties, of venoms from Cc and Vl, two vipers endemic in Morocco. To study the cross-reactivity 
that may exist between the venoms, horse specific antivenoms were produced with the aim to identify the best 
candidate or mixture for producing highly protecting antivenom to fight snake envenomation in North Africa. 
 First, dried venoms were biochemical investigated. Gel electrophoresis analysis demonstrated several 
protein bands certainly responsible for most of the observed biological effects (Teixeira et al., 2006; Warrel, 
2010). Proteolytic activity following casein test was low compared to other venom reported in the literature (i.e. 
Philodryas venom). Interestingly, we noticed a total absence of coagulant activity, on the contrary to 
Colubridae family venoms. Phospholipase A2 activity was an important characteristic observed with Cc and Vl 
venoms. We estimated this activity four times higher in Cc venom than in Vl venom, when compared to the 
positive control. Our results are in accordance with recently reported studies (Teixeira et al., 2006; Warrel, 
2010; Hamza et al., 2010). It is worth noting that phospholipase A2 from Cc venom was well studied, 
sequenced and characterized by Laraba-Djebari et al. (1990). 
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 Cc and Vl venoms were characterized by their ability to degrade fibrinogen subunits (i.e.  and γ chains). 
However, Nh (belonging to Elapidae family) venom did not display any detectable hemorrhagic activity. 
Nevertheless, we highlighted the presence of edema with symptoms of myotoxicity, very lower proteolytic and 
phospholipase activities, and an absence of fibrinogenolytic activity with this venom. 
 Hemorrhage is one of the most significant pathophysiological effects induced by viper snakes. In this study, 
we have shown that Cc and Vl venom injections induce myonecrosis in skeletal and heart muscles, which likely 
resulted from myotoxin direct action and hemorragin indirect action. The myonecrosis produced a reduction of 
CPK concentration in muscle and its increase in serum (Boukhalfa et al., 2009). 
 Cc and Vl venoms were immunogenic and able to induce high level of specific antibody titers when 
inoculated in horses. Indeed, monovalent Cc and Vl antivenoms cross-recognized several protein bands within 
Cc and Vl venoms, and were able to cross-reactively recognize Ba venom. The data obtained from in vivo 
neutralization clearly indicate that both monovalent Cc and Vl antivenoms contain a high ratio of specific 
antibodies capable to recognize, and without doubt neutralize, Cc, Vl and Ba venom components. The best 
cross-reactivity was observed with Cc antivenom. 
In conclusion, our results are in accordance with recently published data (André et al., 2010; Furtado, 
2005). Moreover, our investigation clearly demonstrate that viper venoms of Morrocco contain homologous 
proteins displaying hemorrhagic (39, 67 and 100 kDa), caseinolytic (72 to 74 kDa), phospholipasis (13 kDa), 
anticoagulant, myonecrotic (75 and 100 kDa) and edematous (29 to 39 kDa) activities. Our results point out 
the high immunogenicity of Cc venom, leading to induce a horse antivenom able to highly protect against Cc, Vl 
and Ba whole venoms. Indeed, this protecting capacity is high when compared to the Vl specific antivenom 
product. 
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Abstract 
Xenopus laevis oocytes provide a successful electrophysiological model for heterologous de-novo 
expression of channels and receptors as well as for the incorporation of exogenous membrane 
preparations rich in receptors/channels for pharmaco-toxinological studies. The method of choice 
for oocyte harvesting is repetitive surgical laparotomy of female adult Xenopus. The lack of 
policies regulating oocyte surgery in France prompted us to design a follow-up study to assess 
the effect of repetitive laparotomy on Xenopus. To this end, we used a batch of 24 female 
Xenopus which were tagged with an electronic chip. The amphibians were housed by colonies of 
eight in 20-L plastic containers. Groups of six amphibians were operated every two, three, four 
and six months. The weight of each female amphibian was recorded before and after the 
operation. The recovery from anesthesia, the incision healing, the Xenopus behavior and the skin 
health were also monitored. The impact of repetitive surgery on the oocytes survival following 
nanoinjection with cDNA, mRNA or Torpedo membranes was systematically assessed. Here, we 
show that repetitive surgery every two months does affect animal weight. In addition, a four-
months-recovery period should be allowed between each laparotomy. However, repetitive surgery 
does reduce the number of Xenopus used for electrophysiological/pharmaco-toxinological 
characterization of receptors and channels. 
Suivie des effets de l’extraction chirurgicale répétitive d’ovocytes 
chez Xenopus laevis 
Les ovocytes de Xenopus laevis constituent un modèle d’électrophysiologie réussi pour 
l’expression de-novo des canaux et récepteurs, l’incorporation de membranes exogènes riches en 
récepteurs et canaux et leur caractérisation pharmaco-toxinologique. La méthode acceptée pour 
l’extraction d’ovocytes est la laparotomie répétitive de xénopes adultes. L’absence de régulations 
concernant l’extraction d’ovocytes de xénopes femelles en France nous a incités à suivre et à 
évaluer l'effet de laparotomies répétitives sur les xénopes. Dans ce but, nous avons utilisé un lot 
de 24 xénopes femelles, marquées avec une puce électronique. Les amphibiens ont été placés 
par colonies de huit dans des bacs en plastique de 20 litres. Des groupes de six xénopes ont été 
opérés tous les deux, trois, quatre et six mois. Le poids de chaque xénope a été déterminé avant 
et après l’intervention. Leur récupération de l'anesthésie, leur guérison de l’incision pratiquée, 
leur comportement ainsi que l’état de leur peau ont également été surveillés. L’impact des 
laparotomies répétitives sur la survie des ovocytes après nano-injection avec de l’ADN, l’ARN ou 
des préparations de membranes de torpille a été systématiquement évalué. Nous montrons ici 
que la chirurgie répétée tous les deux mois affecte le poids de l'animal. De plus, une période de 
récupération de quatre mois est nécessaire entre chaque laparotomie. Cependant, la chirurgie 
répétitive réduit effectivement le nombre de xénopes utilisées pour la caractérisation 
électrophysiologique/pharmaco-toxinologique des récepteurs et des canaux. 
Keywords : Heterologous expression, voltage-clamp electrophysiology, Xenopus laevis. 
 
Introduction 
The African Clawed Frog Xenopus laevis is an amphibian of the order Anura and the family Pipidae. X. laevis is 
an aerobic amphibian but behaves as an entirely aquatic animal. It needs to breath air but it does not need 
land-based existence. X. laevis is very susceptible to desiccation, and can die from being out of the water for a 
few hours (Goldin, 1992). 
Gurdon et al. (1971) originally demonstrated that Xenopus oocytes can be used to express exogenous 
messenger RNA (mRNA) when microinjected into the cytoplasm. The contribution of Xenopus oocyte 
microinjection methods to the rapid progress seen in molecular and cellular biology since their introduction as 
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an heterologous expression model is remarkable (Soreq and Seidman, 1992; Brown, 2005). The nicotinic 
acetylcholine receptor (nAChR) was the first functional receptor to be expressed in Xenopus oocytes following 
microinjection of exogenous messenger RNA coding for Torpedo nAChRs subunits that allowed the 
electrophysiological and molecular characterization of the cholinergic receptor (Barnard et al., 1982; Sakmann 
et al., 1982). Rapidly, Xenopus oocytes became one of the most widely used systems for heterologous 
expression and functional characterization of ion channels, receptors and transport proteins after microinjection 
of mRNA or cDNA (for reviews, see Lester, 1988; Soreq and Seidman, 1992). Xenopus oocytes were also 
shown to be able to incorporate purified Torpedo electroplaque membranes into their plasma membrane 
(Marsal et al., 1995). Later, human functional receptors issued from surgically resected and from post-mortem 
brain tissues were microtransplanted into the plasma membrane of Xenopus oocytes (Miledi et al., 2002; 
Bernareggi et al., 2007). The advantage of the transplantation of biological membranes into Xenopus oocytes is 
that native receptors/channels can be reconstituted together with their associated lipids and proteins. 
Female Xenopus produce thousands of oocytes over their lifetime period. The oocytes were morphologically 
classified into six stages according to their development (Dumont, 1972). Stage V-VI oocytes are used for 
electrophysiological studies. These oocytes of ~1.2 mm diameter show a clearly defined vegetative pole and an 
animal pole where the nucleus is located. Repetitive surgery on a single female Xenopus is a commonly 
worldwide accepted practice for oocyte extraction since it reduces the number of laboratory amphibians to be 
used. However, there is no consensus on the number and frequency of laparotomies that could be performed 
on one female Xenopus. As example, the Guidelines for egg and oocyte harvesting in Xenopus laevis limit the 
number of surgical oocyte harvesting procedures to six (the sixth being a terminal surgery), and fix a recovery 
time of at least 4 weeks for the female Xenopus between each surgery (ARAC, 2005). The Boston University, 
which is committed to observe Federal Guidelines and AAALAC International Guidelines for humane care and 
use of animals, recommend 4 repetitive surgeries per female Xenopus (the fourth being terminal) and a 
minimum of one month recovery period between surgical oocyte extractions (Boston University, 2009). In 
contrast, in Switzerland, only one terminal operation is consented (Bertrand et al., 2008). The lack of guidelines 
regulating X. laevis surgery for oocyte extraction in France prompted us to undertake a monitoring study to 
assess the effect of repetitive surgery on X. laevis tagged with an electronic chip. 
Materials and methods 
Xenopus laevis culturing 
Xenopus laevis tagged with an electronic chip were purchased from the Xenopus Biological Resources Center 
(University of Rennes 1, France; Figure 1A). The cylindrical chip FDX B of 12 mm long and 2.12 mm diameter 
made of transparent bio-glass (Real Trace, Villebon sur Yvette, France) was inserted subcutaneously in the 
ventral side of the left leg of the amphibians using an injector (Real Trace; Figure 1B and C). The Xenopus were 
housed at the animal facilities conditioned at 21°C with a light/dark cycle of 12 h and fed with trout pellets 
twice a week and with living bloodworms (Aquarélite, France) once a week. The water was dechlorinated by 
passage through a charcoal activated filter (Cuno, 3M Purification Inc., St. Paul, MN, USA) and was thermo-
regulated to a temperature of 20°C. Water quality was controlled twice a week using a potassium iodide starch 
paper indicator to avoid any chlorine traces that can harm the skin of the amphibians. At the beginning of this 
study, the Xenopus were disposed in groups of 12 amphibians in 20 liters plastic containers (Figure 1A). We 
have observed that the number of female Xenopus per tank could affect oocyte quality and therefore, in the 
third year of this follow-up study, the number of Xenopus per tank was reduced to 8. 
 
Figure 1. Xenopus laevis tagged with an electronic chip were purchased from the Xenopus Biological Resource Center 
(University of Rennes 1, France). (A) Female Xenopus were housed in colonies of 12 amphibians at the beginning of 
this trial. (B) Dorsal view of a “chip”-tagged left leg of a female Xenopus. (C) Ventral view of the left leg of a female 
Xenopus tagged with an electronic chip. The FDX B chip of 12 mm long and 2.12 mm diameter is clearly seen. The 
electronic chips were fully tolerated, without secondary effects, through the whole study (3 years for the first batch of 
12 animals). 
Figure 1. Les Xenopus laevis marquées avec une puce électronique ont été achetées au Centre de Ressources 
Biologiques de Xénopes (Université de Rennes 1, France). (A) Les Xenopus femelles ont été logées par colonies de 12 
amphibiens au début de cet essai. (B) Vue dorsale d'une Xenopus femelle marquée à la patte gauche avec une "puce". 
(C) Vue ventrale de la patte gauche d'une Xenopus femelle marquée avec une puce électronique. La puce FDX B de 12 
mm de long et 2,12 mm de diamètre est clairement visible. Les puces électroniques ont été parfaitement tolérées, sans 
effets secondaires, au cours de l'ensemble de l'étude (3 ans pour le premier lot de 12 animaux). 
A B C 
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Oocyte defollicularization 
The ovarian lobes were pulled apart into small pieces using a pair of forceps and placed in a 10-mL OR2 
solution (88 mM NaCl, 1 mM MgCl2, 5 mM HEPES; pH 7.6) containing 1 mg/mL collagenase type I (Sigma). The 
whole was incubated for 10 min under gentle shaking. The small pieces of partially digested ovarian lobes were 
washed three times with 50 mL OR2 solution and once with 50 mL Barth’s solution (88 mM NaCl, 1 mM KCl, 
0.41 mM CaCl2, 0.82 mM MgSO4, 2.5 mM NaHCO3, 0.33 mM CaNO3, 7.5 mM Hepes; pH 7.6). Finally, the 
treated ovarian lobes were transferred into a plastic Petri dish (56 mm diameter) containing 10 mL Barth’s 
solution supplied with 2 mg/mL kanamycin (Sigma). The connective tissue and the follicular cell layer of stage 
V-VI oocytes, were removed under a stereoscopic microscope using a pair of forceps. The defolliculated oocytes 
were transferred into a 56 mm Petri dish containing 10 mL Barth’s solution. The quality of the oocytes was 
controlled and groups of 50 oocytes were dropped into 35 mm plastic Petri dishes containing 5 mL Barth’s 
solution supplied with 2 mg/mL kanamycin. The oocytes treated in this manner stick to the clean surface of 
plastic Petri dishes facilitating the microinjection. 
Surgical extraction of ovarian lobes from X. laevis 
The amphibian to be operated was identified by positioning the petSCAN RT 100V5 scanner (Real Trace) 5 - 10 
cm over the tagged leg. The amphibian was isolated in a 3-L plastic container for 1 h to reduce handling stress. 
The Xenopus was anaesthetized by immersion for 20 min in a water bath containing 1 g/L ethyl-3-amino 
benzoate methanesulfonate salt (Sigma, St. Louis, MO, U.S.A.). The laparotomy was performed using 
autoclaved material. An incision of 1 cm through the skin and muscle was performed in the inferior ventral side 
of the Xenopus. Several ovarian lobes were extracted with sterile forceps and immediately immersed in 10 mL 
OR2 solution. The muscle plane was sutured using undyed braided absorbable suture (Ethicon, Johnson & 
Johnson, New Brunswick, NJ, U.S.A.), and the epidermal layer was sutured using a blue non-absorbable suture 
(Ethicon). Afterwards, the Xenopus was placed in a water bath taking care not cover the dorsal side of the 
amphibian to allow respiration through the skin. Once the Xenopus was recovered from anesthesia, the 
recipient was filled with water and the amphibian was observed for 1 day before being replaced into the main 
tank. 
Microinjection of purified membranes, cDNA and mRNA into Xenopus oocytes 
Torpedo electrocyte membranes, rich in muscle type (12) nicotinic acetylcholine receptors (nAChRs), were 
purified as previously described (Krieger, 2007). Aliquots of 20 µL of Torpedo membranes (2.7 mg/mL total 
proteins) in 5 mM glycine were conserved at -80°C until use. For microtransplantation, a volume of 50 nL of 
Torpedo electrocyte membrane solution was injected into the vegetative pole of Xenopus oocytes using a 
micro-syringe pump controller, Micro4TM (World Precision Instruments, Sarasota, FL, U.S.A.), mounted on a 
stereoscopic microscope. Glass micropipets for microinjection (3.5 nL, World Precision Instruments) were 
prepared using the micropipet puller PP-830 (Narishige Scientific Instruments, Tokio, Japan). Following 
microinjection, Xenopus oocytes were incubated at 18°C. Incorporation of Torpedo electrocyte membranes into 
the plasma membrane of the oocyte took place 1 day after microinjection. 
To express 42 nAChR, 50 nL of an aqueous mixture of pRcCMV cDNA vectors encoding for human 4 and 
2 nAChR subunits (kindly provided by Dr P. J. Corringer, Pasteur Institute, Paris, France), were injected into 
the animal pole of Xenopus oocytes. A 12 ng amount of each plasmid was injected. Plasmids were purified 
using an endotoxin-free plasmid maxiprep kit (GenEluteTM, Sigma). The injected oocytes were incubated for 3 
days at 18°C prior to electrophysiological experiments. 
The expression of human 7 nAChR was obtained following injection of 50 nL aqueous mRNA (5 ng) in the 
vegetative pole of Xenopus oocytes. Messenger RNA was prepared using a mMESSAGE mMACHINE® SP6 kit 
from Ambion (Austin, TX, U.S.A.) and, as template, pcDNA3.1 cDNA vector encoding human 7 nAChR subunit 
(kindly provided by Prof. I. Bermudez, Oxford Brookes University, Oxford, U.K.). Translation of mRNA into 
functional 7 nAChRs took place after 48 h incubation at 18°C. 
Experimental design 
A group of 12 female Xenopus was divided into four groups: Group 1, amphibians operated every two months; 
Group 2, amphibians operated every three months; Group 3, amphibians operated every four months; and 
Group 4, amphibians operated every six months. The number of repetitive interventions prior to euthanasia 
was five with the exception of Group 1. The parameters measured for each individual were: (i) the weight prior 
and following chirurgical intervention, in a weekly basis, (ii) the recovery from anesthesia, (iii) the behavior of 
female Xenope following laparotomy, (iv) the incision healing and the skin health of the amphibians and (v), 
the quality of Xenopus oocytes for the expression and incorporation of nAChRs into their membranes. 
Results and Discussion 
Xenopus eggs and oocytes continue to play a central role in many biological disciplines including developmental 
studies, structural biology, cell biology, physiology, pharmacology, toxinology, biochemistry to mention some of 
them (Brown, 2004). For the purpose of electrophysiological characterization of excitable membrane proteins, 
Xenopus oocytes not only efficiently translate exogenous mRNA or cDNA but, in addition, they are able to 
process post-translational modifications necessary for the correct folding and positioning of a synthesized 
protein at the plasma membrane of the oocyte (Barnard and Miledi, 1982; Soreq and Seidman, 1992). Finally, 
the microtransplantation into Xenopus oocytes of human brain membranes from frozen tissues containing 
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functional receptors and channels opens new avenues for pharmacology of receptor-associated brain disorders 
(Miledi et al., 2002). 
Xenopus could be easily stressed. When this happens, they can lose their skin and regurgitate their food. The 
protocol we apply for surgical extraction of Xenopus oocytes is in accordance to the existing international 
guidelines (ARAC, 2005; Boston University, 2009; IACUC Guidelines, 2001, 2007) to minimize animal distress 
(Figure 2). Following laparotomy, the amphibians were placed in a separate room at 20°C for observation. Their 
initial behavior when they were replaced into their colonies was to slide down the other amphibians and to stay 
quiet for a prolonged period back the black siphon corner of their tank (see Figure 1A). The members of the colony 
have never shown signs of aggression towards the operated amphibians. There is no need for us to take out the 
skin sutures since they disappear in a week, and there was no Xenopus mortality associated with the laparotomy. 
 
Figure 2. Summarized protocol for surgical extraction of Xenopus oocytes for 
electrophysiological/pharmaco-toxinological studies. 
Figure 2. Résumé du protocole pour l'extraction chirurgicale d'ovocytes de 
xénopes pour les études électrophysiologiques/pharmaco-toxinologiques. 
To assess the effect of multiple surgeries of oocyte extraction on female Xenopus, we have surveyed the 
weight of the amphibians in a weekly-basis, before and after laparotomy. The survey of female Xenopus from 
Group 1 that were operated every 2 months showed that their weight was stable although they had a tendency 
to decrease with negative slopes varying from -0.025 to -0.006 (Figure 3A). Then, the female Xenopus of 
Group 1 have lost 5.6  2.6 g (n = 3) in a period of 200 days. In addition, the scar under the incision zone was 
hypertrophied, which rendered oocyte extraction difficult. These observations led us to stop performing the 
surgery every two months for the female Xenopus of Group 1. 
Figure 3B shows the evolution of the weight of Group 2, i.e. female Xenopus that were operated every 3 
months for five times. The weight of these females was stable although a tendency to increase with positive 
slopes varying from 0.005 to 0.018 was observed. Xenopus of Group 2 have gained 4.1  2.3 g (n = 3) in the 
whole period of the study. 
Figure 3C illustrates the evolution of the weight of female Xenopus of Group 3 that were operated every 4 
months. There was a clear increase tendency of their weight, with a positive slope ranging from 0.005 to 0.25. 
Group 4, i.e. amphibians that were operated every 6 months for oocyte extraction, showed a weight profile 
similar to that of Group 3 (data not shown). 
These results indicate that laparotomy performed every two months affects the weight of the amphibians 
(~10% after three operations). In several cases, the scars under the skin of female Xenopus of Group 1 were 
hypertrophied and difficulties for suturing the muscle and epidermal layers were experienced. It was the raison 
why this group was operated only three times. However, repetitive laparotomies did not seriously affect the 
weight of the amphibians whenever an adequate recovery time is allowed to female Xenopus subject to surgery 
for oocyte harvest. A recovery time of three months for female Xenopus subject to laparotomy for oocytes 
harvest is thus here proposed. 
Figure 3D illustrates a batch of twelve amphibians operated every ~3 months. It is worth noting that the 
operated female Xenopus lost in average 4.53 ± 1.14 g after each laparotomy (n = 12; 45 laparotomies). Yet, 
the amphibians recovered back to their average weight in two weeks. Repetitive surgery for oocyte extraction is 
an accepted procedure that promotes the reduction of the total number of amphibians used over long term. 
The quality of the oocytes also reflects the amphibian health. Therefore, we have also surveyed the quality 
of the oocytes for heterologous expression of nAChRs and electrophysiological studies. Repetitive laparotomies 
did not affect the size of stage V – VI oocytes. Oocyte survival after nanoinjection was also not affected by 
repetitive laparotomies. Finally, repetitive laparotomies neither affect heterologous expression of receptor 
proteins nor Torpedo membrane incorporation into the plasma membrane of Xenopus oocytes for 
electrophysiological/pharmaco-toxinological studies. 
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Figure 3. Evolution of the weight of female Xenopus subject to repetitive laparotomy. A. Group 1: 
female Xenopus operated every 2 months. B. Group 2: female Xenopus operated every 3 months. C. 
Group 3: female Xenopus operated every 4 months. D. Batch of female Xenopus of year 2009 which 
were operated every 3 months: 6094 (), 6456 (○), 5338 (►), 4685 (▲), 6588 (♦), 6645 (), 6836 
(), 1998 (□), 5334 (■), 6953 (♦), 4273 () and 6156 (). The “zero” in the abscise axe indicate the 
first operation practiced to the female Xenopus. 
Figure 3. Evolution du poids de xénopes femelles sujettes aux laparotomies répétitives. (A) Groupe 1: 
xénopes femelles opérées tous les 2 mois. (B) Groupe 2: xénopes femelles opérées tous les 3 mois. (C) 
Groupe 3: xénopes femelles opérées tous les 4 mois. (D) Lot de xénopes femelles de l'année 2009 qui 
ont été opérées tous les 3 mois: 6094 (), 6456 (○), 5338 (►), 4685 (▲), 6588 (♦), 6645 (), 6836 
(), 1998 (□), 5334 (■), 6953 (♦), 4273 () and 6156 (). Le “zéro” dans l'axe des abscisses indique la 
première opération pratiquée à la xénope femelle. 
Conclusion 
Repetitive surgery for oocyte extraction is a usual practice worldwide accepted which may be justified 
considering the REDUCTION in the total number of animals used over a long term period, without affecting the 
quality of the obtained results. The aim of this paper was to assess the effects of multiple surgeries on female 
Xenopus by using chip-tagged amphibians to individualize each animal. An electronic chip is a REFINEMENT 
alternative to minimize pain, as well as to distress and enhance Xenopus well-being, as it is promoted by the 3 
R's in animal research (REDUCTION, REFINEMENT, and REPLACEMENT; Russell and Burch, 1959). 
Electronic chips are low-cost devices representing ~1% of the cost of a living female Xenopus, and its use 
should be encouraged to individualize the amphibians for surveying the weight of the animal, which is a 
measurable indicator of Xenopus health. 
In conclusion, a minimum of three months recovery between each laparotomy should be allowed to female 
Xenopus subject to repetitive laparotomies for oocyte extraction. 
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Ce livre électronique est le quatrième volume de la nouvelle série de livres électroniques directement 
édités par la SFET, après sept ouvrages imprimés et distribués par Elsevier puis la Librairie Lavoisier 
depuis 2001. Il rassemble 30 articles organisés en quatre chapitres : Toxines et canaux ioniques, Toxines 
formant des pores, Toxines en tant qu’outils d’études ou agents thérapeutiques et Toxines diverses. La 
majorité de ces articles illustre parfaitement le thème « Toxines et Transfert ioniques » retenu cette 
année par le Conseil Scientifique de la SFET pour les 19èmes Rencontres en Toxinologie (RT19, 2011). 
Qu’ils soient écrits par des chercheurs de renommée internationale ou par de plus jeunes chercheurs, ces 
articles mettent en évidence le dynamisme de la communauté toxinologiste dans l’identification et  la 
compréhension du mode de fonctionnement de ces toxines d’origines animales et bactériennes qui 
perturbent, par leur impact sur les flux ioniques, des processus physiologiques vitaux. De plus, 
l’exploitation des ces toxines en tant qu’outils d’études de leur récepteurs et canaux cibles ainsi que de 
leur potentialité thérapeutique est mise en évidence dans différents articles. Enfin, un certain nombre 
d’articles illustre des résultats récents et originaux, en dehors du thème central des RT19, démontrant la 
diversité des recherches actuellement mises en œuvre en toxinologie. Ces 19èmes Rencontres en 
Toxinologie réuniront dans le centre de conférence de l’Institut Pasteur de Paris plus d’une centaine de 
participants, français comme étrangers, témoignant de la volonté de notre Société de continuer à 
développer et promouvoir la recherche en Toxinologie. 
 
 
 
Toxins and Ion transfers 
 
This ebook is the fourth issue of the new series of e-books directly edited by the SFET, after seven books 
printed and distributed by Elsevier and then Librairie Lavoisier publishers since 2001. It gathers 30 
articles organized in four sections: Toxins and ion channels, Pore-forming toxins, Toxins as tools and 
therapeutics and Miscellanous. The major part of these articles closely reflects the theme retained by the 
Scientific Board of the SFET for the 19th Meeting on Toxinology (RT19, 2011): “Toxins and Ion transfers”. 
Written either by well-known or young researchers, these articles highlight the dynamism of the 
toxinologist community in the identification and study of the mode of action of these animal and bacterial 
toxins affecting ion transfers and finally vital physiological processes. Furthermore, the use of these 
toxins as tools for studies of their receptors and ion channels targets and their therapeutic potential is 
highlighted in various articles. Finally, a number of articles illustrates recent and original results, outside 
the central theme of the RT19, showing the diversity of research currently being implemented in 
toxinology. This 19th Meeting in Toxinology will be held in the Conference Center of the Pasteur Institute 
in Paris and meet over a hundred French and foreign participants, reflecting the willingness of our Society 
to keep developing and promoting research in Toxinology. 
 
Denis Servent, 
President of the SFET 
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